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CHAPTER I 
 
INTRODUCTION TO VOLTAGE-GATED SODUM CHANNELS 
 
Overview 
 Electrical signaling events are required for every human thought, feeling, and perception, 
the movement of our limbs, and each beat of our hearts.  Not surprisingly, the fundamental 
contribution of electrical signals to so many defining human qualities has lured several 
generations of accomplished scientists to study the basis of membrane excitability.  In this 
chapter, a brief history of the milestones that culminated in an ion theory for membrane 
excitability is presented.  Although unknown until relatively recently in this history, the remarkable 
ion channel proteins that mediate electrical signals in response to changes in membrane potential 
are introduced.  As the initiators of action potentials in excitable tissues, voltage-gated sodium 
channels play significant roles in both normal and pathological signaling events.  In the heart, the 
opening of sodium channels initiates the cardiac cycle and culminates in contraction.  Not 
surprisingly, mutations in the gene encoding the cardiac sodium channel have been linked to 
multiple distinct disorders of heart rhythm.  Although it is increasingly well-appreciated that 
sodium channels exist in the membrane as macromolecular complexes, the functions of channel-
associated proteins are not well understood.  In Chapter 1, I propose that zebrafish, a tractable 
vertebrate model amenable to reverse genetics and with numerous additional experimental 
advantages, could serve as a valuable in vivo platform to test hypotheses regarding the role of 
sodium channel subunits and associated proteins in the regulation of heart rhythm.  In chapters 2 
and 4, I discuss the identification, cloning, and evolution of zebrafish cardiac-type α and β subunit 
genes.  In chapter 3, I describe the unexpected discovery of a role for sodium channels in early 
heart development, prior to their role in modulating heart rhythm. 
 2
Voltage-gated sodium channels 
Coordinated electrical signals in the metazoan nervous system, heart, and skeletal 
muscle depend on the generation of action potentials, rapid changes in membrane potential 
mediated by the passage of ions through voltage-gated ion channels (1). The initial upstroke or 
phase 0 of the action potential in most excitable cells is determined by sodium channels (Figure 
1.1), membrane proteins characterized by rapid activation and inactivation and high ionic 
conductance (1-3). Unlike evolutionarily-ancient, tetrameric potassium channel complexes, 
sodium channels consist of four homologous domains with 6 membrane-spanning segments each, 
which are encoded by a single polypeptide (1-3). Sodium channels are suspected to have 
evolved from structurally-similar calcium channels, which in turn likely arose following 
reduplication of potassium channel genes (1-3). The use of sodium as a conducting ion rather 
than calcium is thought to have permitted rapid conduction and high-frequency electrical signaling 
in the rudimentary nervous systems of early multicellular animals, without the numerous 
additional intracellular effects mediated by calcium’s role as a second messenger (1;4). 
In mammals, members of the Nav1 family of voltage-gated sodium channels are multi-
protein complexes that include a pore-forming α subunit and 1 or more modulatory β subunits (5-
9). Whereas sodium channel α subunits are ~260kDa proteins with 24 membrane-spanning 
domains, β subunits are smaller 30-40kDa proteins with a single transmembrane domain and an 
extracellular V-type immunoglobulin-like domain (10-14).  Ten distinct α subunit genes (SCNxA) 
and 4 β subunit genes (SCN1B-4B) have been cloned from mammals, and their protein products 
have been functionally expressed with the exception of SCN7A (2;3;15). Using tetrodotoxin (TTX), 
a pufferfish toxin that blocks the external vestibule of the sodium channel pore, all functionally-
expressed mammalian sodium channels have historically been classified as “TTX-sensitive” 
(Nav1.1/SCN1A, Nav1.2/SCN2A, Nav1.3/SCN3A, Nav1.4/SCN4A, Nav1.6/SCN8A, Nav1.7/SCN9A) 
or “TTX-resistant” (Nav1.5/SCN5A, Nav1.8/SCN10A, Nav1.9/SCN11A) based on whether they 
exhibit sensitivity to nanomolar or micromolar concentrations of this potent toxin (15).  While 
heterologous expression of α subunit genes alone can reconstitute key properties of voltage-
gated sodium channels observed in native tissues, including sensitivity to TTX, co-expression 
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with β subunit genes modifies channel gating and increases channel cell surface expression (10-
13;16). Studies of mice with targeted ablation of either scn1b or scn2b genes corroborated these 
roles for β subunits in vivo and revealed an additional function for β subunits in α subunit 
localization (17;18). Moreover, the unique expression profiles of each β subunit gene and their 
variable effects on α subunit function, expression, and localization suggest that different subunit 
combinations in heart, brain, and muscle may contribute to diversity and specialization in 
electrical signaling (19;20). 
 
The ion theory for membrane excitation 
Although it is now well-appreciated that action potentials are self-propagating electrical 
signals generated by transient, selective changes in the permeability of various ions through 
protein channels in the membrane (Figure 1.1), this basic understanding has resulted from nearly 
two centuries of investigation into the basis of membrane excitability (1).  One of the first reported 
observations of an electrical potential in resting muscle was the injury current observed by 
Matteuchi in 1840, when dissection of a frog leg muscle was found to produce a measurable 
outward current flow from the interior of the tissue to the undamaged surface (21;22).  Upon 
stimulating a frog nerve, du Bois-Reymond noted a transient decrease in the outward, injury 
current, which he named negative variation (21;22).  In 1868, Julius Bernstein developed the first 
device (“differential rheotome”) that enabled accurate measurement of this negative variation and 
demonstrated that when induced by strong stimuli, its amplitude exceeded that of the “injury 
current” (21-23).  For his device and his measurements, Bernstein is widely credited for the first 
quantitative description of the action potential in nerve and muscle.   
 In the late nineteenth century, it became increasingly well-appreciated that ions in 
solutions surrounding excitable tissues were essential for electrical signaling and function.  In a 
series of studies of frogs, Sidney Ringer and colleagues made a number of salient observations 
regarding the basis of function of excitable tissues:  1. potassium salts induced sensory loss and 
motor paralysis when locally applied to the leg (24;25); 2. systemic injection of potassium and 
sodium salts produced markedly different effects on motor and nerve function (26); 3. application
 4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Currents contributing to the cardiac action potential.  Cardiac action potentials 
exhibit four phases.  Phase 4 is the resting membrane potential, typically between -85 and -90mV, 
which is primarily determined by the equilibrium potential for potassium.  Nodal cells exhibit 
pacemaker currents (Ih/If) that result in spontaneous depolarization of the membrane.  Phase 0 is 
the upstroke, a rapid membrane depolarization mediated by sodium influx (INa) through voltage-
gated sodium channels.  Phase 1 is the notch and results from the inactivation of sodium 
channels and the activation of transient outward potassium currents (ITO).  Phase 2 is the plateau 
and represents the balancing of inward currents primarily through L-type calcium channels and 
outward currents through delayed rectifier potassium channels.  Phase 3 is characterized by the 
closing of calcium channels, continued activation of delayed rectifier potassium channels, and the 
activation of inward rectifier potassium channels that return the membrane potential to baseline.   
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of potassium salts directly to the heart arrested its function (27); and 4. normal, continuous 
function of the beating heart required perfusion with solutions containing small quantities of 
sodium, potassium, and calcium, whereas absence of any of these ions from the perfusate 
perturbed heart function (28-30).  The experimental findings of Ringer demonstrated that 
perturbation of the normal ionic gradients required for establishing the resting potential and 
generating action potentials adversely affected the function of excitable tissues. 
Building on the ideas of Nernst and Ostwalt, who earlier had developed theories to 
describe the basis of electrical potentials resulting from the movement of ions through semi-
permeable barriers in solution, Bernstein formulated his famous membrane theory for electrical 
signaling in cells of living organisms (1;21;23;31;32).  His theory represented a conceptual 
milestone in ion channel biology and inspired the efforts of a number of biophysicists in the 
twentieth century, including the Nobel laureates Hodgkin and Huxley (33;34).  Bernstein posited 
that all excitable cells were surrounded by membranes with selective permeability towards certain 
ions, particularly K+, and with limited permeability to other larger, negatively-charged ions within 
the cell such as phosphates.  In his view, the measurable, negative resting potential of a nerve 
cell thus resulted from the “leak” of potassium ions from the inside of a cell to the outside, 
following the concentration gradient for potassium.  Electrical signals, Bernstein argued, were 
then generated by a breakdown of the membrane that temporarily eliminated this selective 
permeability for potassium and made it permeable to other ions.  His theory predicted that 
electrical signals traveling through nerve fibers represented the transient elimination of the 
negative resting potential.  Although later studies revealed that Bernstein had accurately 
conceptualized the basis of membrane resting potential, however, he did not account for the 
action potential overshoot which he had measured in his own recordings.  The overshoot made 
action potentials greater in amplitude than the resting potential of excitable cells, and could not be 
explained by a breakdown of the membrane that transiently eliminated the resting membrane 
potential.  It was in fact Charles Overton who first predicted than an exchange of Na+ and K+ ions 
were required for the signals measured by Bernstein (35). 
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Studies into the molecular basis of electrical signaling were accelerated in the 1930s by 
the discovery that axonal processes of squid neurons were of large enough size to permit direct 
electrical recording (1;36;37).  The squid giant axon thus facilitated the first intracellular 
recordings of the neuronal resting membrane potential and action potential.  Working with this 
system, Alan Hodgkin and Bernard Katz directly tested Bernstein’s membrane theory.  Among 
their earliest contributions was confirmation of significant differences between the magnitudes of 
the resting potential and the action potential (38), and the recognition that Bernstein’s theory 
could not adequately explain for the transient reversal of membrane potentials they routinely 
observed in squid giant axons.  Hypothesizing that action potentials resulted from a transient 
increase in the permeability of an ion other than potassium (39), Hodgkin and Katz conclusively 
demonstrated that the rate of rise and the amplitude of neuronal action potentials depended on 
the concentration of extracellular sodium ions (40).  By modifying methods developed by Cole 
and Marmont to clamp voltage across the giant axon membrane (41;42), Hodgkin and Huxley 
analyzed the changes in current through the nerve membrane at different potentials and were 
thus able to model the time- and voltage-dependence of Na+ and K+ components of the action 
potential (43).  These experiments led them to theorize the existence of membrane channels that 
mediated the selective permeability of sodium and potassium ions in response to changes in 
membrane potential.  Although they had no means of observing the function of single ion 
channels, the studies of Hodgkin and Huxley remarkably led them to predict many of the 
fundamental properties of voltage-gated ion channels that have since been observed and earned 
them the Nobel Prize in 1963.  Many experimentalists have contributed further results that have 
gained wide acceptance for the ion channel hypothesis for membrane excitability, most notably 
the Nobel laureates Neher and Sakmann, who developed electrophysiological methods for 
resolving the behavior of single channels in patches of excitable membranes (1;44-46). 
 
Physiology of voltage-gated sodium channels 
Voltage-gated sodium channel proteins undergo conformational changes in response to 
changes in membrane potential (1).  Once triggered to open, sodium channels act similarly to 
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other ion channels in that they are passive conduits for the flow of ions.  The number of ions that 
flow through a single open channel is dependent upon an intrinsic property of the channel protein 
referred to as conductance, which is expressed as charge per second per volt (1;36;47).  
Mathematically, conductance is the reciprocal of resistance, and is represented as:   
 
 G = i/V 
 
where i represents the current through the channel and V represents the voltage that acts as a 
driving force for the flow of ions (1;36;47).  Sodium channels have extremely high conductance 
for sodium, permitting a large influx of these ions to enter the cell during a very brief period of 
opening during depolarization (approximately 10ms) (1;36).     
Although intrinsic properties of a channel determine the number of ions that can travel 
across the membrane, the direction of ion movement is determined by extrinsic properties of the 
membranous environment including the concentration gradient of ion on each side of the 
membrane and the prevailing electrical potential established by the permeability of all other ions 
across the membrane (1).  Excitable cells bear large energetic costs (up to 30% of total energy 
expenditure) to fuel the Na+-K+ ATPase transporters that concentrate sodium ions extracellularly 
and potassium ions intracellularly (47).  The potential energy stored within these gradients drives 
the depolarizing influx of Na+ ions that follows the opening of sodium channels and the 
repolarizing efflux of K+ ions that follows the opening of potassium channels.  Without gradients of 
ions across the membrane, the driving force behind their movement would be lost.    
In excitable membranes, electrical forces normally act to balance the driving force 
established by a concentration gradient for any particular ion.  For example, as any particular ion 
moves through its channel across the membrane driven by its concentration gradient, the 
accumulation of charge on the other side of the membrane alters the prevailing membrane 
potential in a manner that acts to oppose the further movement of ion. Without considering the 
intrinsic time-dependent properties of ion channel closing here (for simplicity), the flow of charged 
particles would be self-limiting as chemical and electrical forces come into balance.  The 
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equilibrium potential for any ion across an excitable membrane describes the voltage at which 
electrical and chemical forces across the membrane are equal and there is no net movement of 
charge.  For any single ion species, this value can be predicted by the Nernst equation (1;36): 
 
Ex = (RT/zF) * ln[X2]/[X1] 
     
where Ex = equilibrium potential for any ion “X”; R = gas constant; T = temperature in Kelvin; z = 
valence of the permeant ion; F = Faraday constant (amount of charge of 1 mole of a monovalent 
ion); X = ion concentration on each side of a membrane.  In mammalian skeletal muscle, for 
example, where the extracellular sodium concentration is typically 145mM and the intracellular 
sodium concentration is 12mM, the equilibrium potential for sodium is +67mV (1).  Therefore, a 
membrane potential of +67mV would be required to oppose the driving force for sodium influx 
that is established by the concentration gradient of sodium across the myocyte membrane.  If 
sodium channels exclusively open under such conditions, sodium ions will move into the cell until 
the membrane potential nears the equilibrium potential or this ion.  If multiple permeant ions are 
unequally distributed across an excitable membrane, consideration must be given to the 
permeability of each respective ion.  As predicted by Bernstein over 100 years ago, the resting 
potential of a cell (approximately -70mV) thus most closely resembles the equilibrium potential of 
the ion with the greatest resting permeability (potassium, approximately -98mV).  In summary, the 
movement of any ion across the membrane at a particular point in time through an open channel 
is thus largely determined by the three key factors: 1. the conductance of an ion through its 
channel; 2. the ion concentration on each side of the membrane; 3. the prevailing membrane 
potential.  The forces that determine when a channel opens and closes are briefly described 
below. 
 
Sodium channel “gating” 
In their seminal work, Hodgkin and Huxley made the important observation that kinetic 
processes termed activation and inactivation also controlled the permeability of specific ions such 
as sodium across the membrane, because depolarization induced a rapid rise in current that was 
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inevitably followed by a slower decay (43;48).  In fact, ion channels in excitable tissues have 
intrinsic gates that represent conducting and non-conducting conformational states of the protein.  
Voltage-gated sodium channels, for example, are dynamic proteins that move between open, 
closed, and inactivated states that are co-dependent on the prevailing membrane potential and 
on time.  As whole-cell and single-channel electrophysiological approaches have directly revealed 
for sodium channels, for example, a prolonged depolarizing pulse does not lead to individual 
sodium channels staying open throughout the pulse.  Rather, channels open for a brief period of 
time before inactivating.  Once inactive, they have entered into a state from which the channel 
opening cannot be achieved with further depolarization.  Sodium channel inactivation is a time- 
and voltage-dependent process, and only recovery from this state will permit the channel to 
subsequently reopen.   
 
Sodium channel structure-function relationships 
Similar to voltage-gated calcium channels, the secondary structure of a typical Nav1 
family member includes 4 homologous domains (DI-DIV) that are each comprised of 6 
membrane-spanning segments (S1-S6) (Figure 1.2) (49-51).  The pore of the channel is 
comprised predominantly of residues in the S5-S6 linkers or pore loops and S6 segments in each 
of four domains.  Deep within the extracellular pore, the residues “D” (DI), “E” (DII), “K” (DIII), and 
“A” (DIV) come together to form the channel’s selectivity filter.  The intracellular linker connecting 
domains III and IV acts as the fast inactivation gate, which plugs the ion permeation pathway 
during repolarization.  The opening of the channel in response to depolarization is suspected to 
be mediated by the outward movement of the S4 transmembrane segments of each domain, 
which have charged residues (arginine or lysine) at every third position. 
 
Sodium channel subunits in human disease 
As integral components of action potential generation, voltage-gated sodium channels 
have been implicated in a number of heritable disorders of membrane excitability including 
arrhythmia, epilepsy, and myotonia (50;52).  The cloning and functional expression of sodium 
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channel genes harboring mutations identified in human patients have revealed that a number of 
distinct biophysical abnormalities of sodium channel function may result in disease (50).  
Moreover, these studies have contributed to our appreciation that even subtle changes in sodium 
channel function can act a substrate for severe, paroxysmal phenotypes. To date, mutations in 6 
α subunit genes (SCN1A, SCN2A, SCN4A, SCN5A, SCN8A, SCN9A) have been linked to human 
disease (53-59). Mutations in SCN1A (encoding the neuronal sodium channel Nav1.1) were first 
linked to an autosomal dominant epilepsy syndrome termed generalized epilepsy with febrile 
seizures plus type 2 (GEFS+2) and have more recently been associated with severe myoclonic 
epilepsy of infancy (SMEI), intractable childhood epilepsy with generalized tonic-clonic seizures 
(ICEGTC), familial hemiplegic migraine-3, and familial febrile convulsions-3 (53;60-65). Mutations 
in SCN2A (encoding the neuronal sodium channel Nav1.2) are most commonly associated with 
another autosomal dominant seizure disorder, benign familial neonatal-infantile seizures 
(BFNISs), and in one case, have been linked to febrile seizures associated with afebrile seizures 
(54;66;67).  SCN1A and SCN2A mutations may also be associated with familial autism (55).  
Mutations in SCN4A (encoding Nav1.4) have been associated with multiple disorders of skeletal 
muscle, including paramyotonia congenita, hyperkalemic periodic paralysis, hypokalemic periodic 
paralysis, and potassium-aggravated myotonia (56;68-73).  In a single case, a mutation in 
SCN8A (encoding Nav1.6) was associated with mental retardation, pan-cerebellar atrophy, and 
ataxia (58). Mutations in SCN9A (encoding Nav1.7) underlie primary erythermalgia, paroxysmal 
extreme pain disorder (PEPD), and a recently-identified, autosomal recessive condition known as 
channeolopathy-associated insensitivity to pain (59;74;75). There is an extensive literature 
associating variants in SCN5A (encoding Nav1.5) with cardiac disease, notably the type 3 variant 
of the long QT syndrome (LQT3) and Brugada syndrome, as will be discussed further. 
Given their important modulatory effects on the expression and function of sodium 
channel α subunits, β subunits are also important candidate genes for human diseases related to 
sodium channel dysfunction. β1 subunit gene mutations are a cause of generalized epilepsy with 
febrile seizures plus (GEFS+), and variants in sodium channel α subunits that disrupt their
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Figure 1.2: Secondary structure of a typical voltage-gated sodium channel.  Voltage-gated 
sodium channels are comprised of 4 homologous domains, each with 6 membrane-spanning 
segments.  Among the functionally-important regions of the channel are the S4 voltage sensors 
(red), which have basic residues at every third position and act to transduce changes in 
membrane potential into movement of the channel; the pore loops (blue), comprised of the 
linkers connecting the S5 and S6 transmembrane segments within each domain and which 
contain the channel’s selectivity filter (D-E-K-A) and TTX binding site; the fast inactivation gate 
(orange), which is the intracellular linker connecting domains III and IV that acts to plug the ion 
permeation pathway after depolarization; and the C-terminus (green), which has calcium-binding 
EF hand structures and motifs for interaction with diverse proteins including calmodulin, FHF1b, 
syntrophin, and Nedd4-2 ubiquitinase.  
N
C
DI DII DIII DIV
 12
interaction with β subunits may be pathological in the heart (76-80).  A recent report has 
implicated a mutation in the β4 subunit gene as a cause of the long QT syndrome (81). 
 
Murine models of sodium channel loss-of-function 
Although not yet available for every mammalian sodium channel gene, loss-of-function 
mouse models have further enhanced our understanding of the consequences of reduced sodium 
channel expression in excitable tissues.  In the mammalian central nervous system, the 
expression of multiple sodium channel genes (SCN1A, SCN2A, SCN3A, and SCN8A) suggests 
either functional redundancy or specialization of neuronal sodium channel proteins.  To begin to 
explore these possibilities, Planells-cases et al. targeted exon 1 of the scn2a locus on mouse 
chromosome 2 (82).  Scn2a-/- mice displayed significantly reduced levels of scn2a transcripts in 
the brainstem, cortex, and hippocampus and died within two days of birth from severe hypoxia, 
suggesting a specific, non-redundant role for scn2a in brainstem neurons (82).  These findings 
were consistent with the results of 3H-saxitoxin binding assays, which demonstrated a significant 
reduction of activity in the brainstem of scn2a-/- mice compared to wild-type mice (82).  Despite 
the absence of gross anatomical or histological abnormalities in the brains of scn2a-/- mice, 
assays for cell death revealed significantly increased neuronal apoptosis in the brainstem and 
neocortex (82).  Although the authors could not rule out that apoptosis was secondary to hypoxia, 
they hypothesized that decreased neuronal electrical activity in these regions may have directly 
initiated programmed cell death (82). 
 Murine scn6a (SCN7A in humans) encodes the atypical sodium channel Nax.  Although 
phylogenetically classified as a member of the Nav1 sodium channel family, neither scn6a nor 
SCN7A have ever been shown to encode a functional voltage-gated sodium channel by 
heterologous expression.  To better understand the function of this gene, Watanabe and 
colleagues targeted the scn6a locus in mice (83).  Scn6a-/- mice were born healthy and were 
fertile but displayed abnormalities of salt consumption (83).  As lacZ knocked into the scn6a locus 
revealed expression of this gene in regions of the brain that are normally involved in body-fluid 
homeostasis, these data suggested that scn6a may have evolved a role in regulating salt intake 
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behavior (83).  Since scn6a was also found to be expressed in the lung and the heart, future 
studies of these mice may seek to investigate the role of scn6a in these tissues. 
 Although the gene scn8a has not been directly targeted by homologous recombination, 
several mutant alleles have provided insight into the function of Nav1.6 in mice.  The motor 
endplate disease (med) mutant mouse resulted from the random insertion of a transgene that 
produced a 5-10kb deletion within the scn8a locus, eliminating expression of this gene and 
resulting in hindlimb paralysis, perturbed development of the neuromuscular junction, muscular 
atrophy, and degeneration of Purkinje cells in the cerebellum (84).  Moreover, med mutant mice 
died as juveniles.  Four additional mutant alleles of scn8a induced by ENU or by spontaneous 
mutation resulted in similar spectrum of defects including sustained dystonic postures, hindlimb 
paralysis, cerebellar ataxia and juvenile lethality (85). 
The gene scn9a, which was found to be highly expressed in dorsal root ganglia and the 
adrenal and thyroid glands, was deleted from mice both globally as well as specifically in 
nociceptor neurons using Cre-loxP technology (86).  Global scn9a-/- mice died shortly after birth 
because of a failure to feed (86).  Deletion of scn9a specifically in nociceptive neurons, however, 
resulted in mice that displayed increased pain thresholds in response to mechanical, thermal, or 
inflammatory stimuli (86).  The gene scn10a also appears to have evolved non-redundant 
functions in nociception.  Mice lacking scn10a were healthy and viable, but displayed profound 
resistance to pain induced by mechanical stimuli, and attenuated responses to pain induced by 
both thermal and inflammatory stimuli (87).  A recent study also revealed that scn10a has evolved 
a specific role in pain transmission at cold temperatures (88). 
Finally, the gene scn5a has also been targeted in mice, resulting in phenotypes that will 
be discussed below. 
 
Cardiac sodium channels 
In the mature mammalian heart, the opening of sodium channels initiates the cardiac 
cycle (Figure 1.1) (89).  Inward, depolarizing sodium current underlies the upstroke or phase 0 of 
the cardiac action potential in all areas of the heart except for the sinoatrial (SA) and 
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atrioventricular (AV) nodes, where inward calcium currents underlie depolarization (90). The wave 
of depolarization mediated by sodium channels results in the activation of myocardial L-type 
calcium channels at the myocyte plasma membrane (“sarcolemma”), which then act to provide 
the calcium spark that triggers the opening of large, calcium-release channels on the 
sarcoplasmic reticulum (SR) known as ryanodine receptors (91;92).  During systole, the opening 
of ryanodine receptors permits the release of calcium stores from the SR, resulting in the 
elevation of cytosolic calcium levels nearly 100-fold (from approximately 10-7 to 10-5M) (91;92). 
Elevated cytosolic calcium regulates the activity of troponin-C, which then permits the interaction 
of actin and myosin filaments, cross-bridge formation and contraction. To initiate diastole, 
cytosolic calcium levels are normalized by the re-sequestration of calcium into the SR by the 
intracellular SR membrane pump SERCA, and by calcium extrusion extracellularly via the 
Na+/Ca2+ ATPase transporter.  Meanwhile, at the depolarized sarcolemma, a number of voltage-
dependent potassium channels open to permit the efflux of K+ ions and repolarization of the 
membrane to values near the myocyte resting potential (-70mV) (Figure 1.1). Every heartbeat is 
thus the result of two distinct biophysical processes: excitability, which is localized at the 
sarcolemma and results in the activation of L-type calcium channels; and contraction, which 
occurs intracellularly and results from transient elevations in cytosolic calcium that permit 
functional interactions between cardiac actin and myosin.  For these reasons, the term 
“excitation-contraction coupling” is commonly used to describe the physiology whereby electrical 
activity generates and regulates contractile function of the heart (93;94). 
 
SCN5A: the cardiac isoform of the voltage-gated sodium channel 
In humans and other mammals, SCN5A is most highly expressed sodium channel gene 
in the mature myocardium and the function of Nav1.5, the protein encoded by this gene, is 
required for imitating cardiac excitation-contraction coupling (89).  At the genomic level, SCN5A is 
comprised of 28 exons that span approximately 80kb (95).  Prior to the sequencing of the human 
genome, SCN5A was mapped to 3p21 by fluorescence in situ hybridization (96).  SCN5A resides 
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alongside the genes SCN10A and SCN11A, supporting the idea that these three genes arose 
following the tandem duplication of a common ancestral sodium channel gene (97;98). 
 
Roles for other Nav1 sodium channel isoforms in the heart 
Although SCN5A is the most highly expressed sodium channel in mammalian cardiac 
tissue, emerging evidence suggests that additional sodium channel isoforms are also expressed 
in the heart (albeit at lower levels) where they may act to perform more specialized roles.  By 
immunohistochemistry, Maier and colleagues detected expression of the TTX-sensitive “brain-
type” channels Nav1.1 (scn1a), Nav1.3 (scn3a), and Nav1.6 (scn8a) in murine ventricular 
myocytes (99-101).  While Nav1.5 appeared to localize at the intercalated disks, other Nav1 
sodium channel isoforms were expressed in the transverse tubules, specialized invaginations of 
myocyte sarcolemma where L-type calcium channels are closely apposed to ryanodine receptors 
(99).  This expression pattern and functional studies demonstrating reduced cardiac contractility 
in the presence of nanomolar concentrations of TTX suggested that brain-type sodium channels 
play a specialized role in transmitting excitation on the sarcolemma to the cell’s interior, in order 
to permit the more efficient EC coupling (99).  Similarly, isoform-specific antibodies detected 
expression of Nav1.1 and Nav1.3, but not Nav1.5, in the mouse SA node (102).  Exposure of the 
mouse heart to nanomolar quantities of TTX elicited bradycardia and heart rate variability in a 
Langendorff preparation (102).  A subsequent study, however, detected expression of both 
Nav1.1 and Nav1.5 in the SA node and demonstrated that both channels are likely to be important 
for pacemaking (101).  Some evidence suggests that SCN4A (Nav1.4) is also expressed in the 
heart, but the importance of Nav1.4 to cardiac function has not been thoroughly investigated 
(103;104).  Similarly, the gene SCN7A is also expressed in cardiac tissue, but with unknown 
functions (105;106).   
 
Sodium channels in human heart disease 
Sudden cardiac death (SCD) due to ventricular fibrillation is a leading cause of mortality 
in the United States, contributing to over 300,000 deaths in 1998 (107).  The risk for this fatal 
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cardiac arrhythmia is heightened by rare mutations, including those in SCN5A found to cause the 
Brugada and long QT syndromes (90;108), by drugs that either intentionally or inappropriately 
bind to ion channels (antiarrhythmic agents, IKr blockers) (89) (109), and more commonly, by 
pathological cardiovascular states such as myocardial ischemia, cardiomyopathy, and heart 
failure (107;110).  The pharmacological management of abnormalities of cardiac rhythm is 
suboptimal and patient outcomes are highly variable (107;111).  Existing antiarrhythmic agents – 
which primarily target and block cardiac ion channels – are often inefficacious, unsafe, and may 
even contribute to patient mortality (111-114).  As a result, implantable devices such as 
pacemakers and defibrillators constitute the current standard of care for the prevention of many 
arrhythmias (111;115). 
Although rare, mutations in SCN5A have been associated with a number of distinct 
disorders of cardiac rhythm including the long QT syndrome (type 3), Brugada syndrome, 
progressive cardiac conduction system (Lenègre’s) disease, congenital sick sinus syndrome, 
atrial standstill, and sudden infant death syndrome (SIDS) (50;52).  As demonstrated by SCN5A 
mutations that cause the Brugada and long QT syndromes, the human heart is highly sensitive to 
even slight perturbations of sodium channel expression or function (116;117).  The Brugada 
syndrome is characterized by right bundle branch block, persistent ST segment elevation in ECG 
leads V1-V3, and predisposition to ventricular fibrillation in patients with structurally normal hearts 
(118).  SCN5A mutations associated with this condition appear to result in a loss of channel 
function through one of multiple mechanisms, including perturbations of gating that reduce 
sodium channel availability and reduced trafficking of mutant channels to the cell membrane 
(119-122).  The long QT syndrome (LQTS) is characterized by QT interval prolongation, recurrent 
syncope, and sudden death due to a polymorphic tachycardia called torsades de pointes (123), is 
linked to inherited defects in multiple cardiac ion channel subunits in addition to SCN5A  
(57;124;125), as well as occasionally in other genes thought to regulate ion channel function 
(126;127).  When studied in heterologous expression systems, sodium channels with LQTS 
mutations do not appear to normally inactivate, leading to sustained inward depolarizing current 
during the plateau phase of the action potential (128-130).  Although mutations in SCN5A have 
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contributed to our understanding of the molecular determinants of arrhythmia susceptibility, nearly 
80% of patients with the Brugada syndrome do not appear to have variants in the coding regions 
of this gene (116;131).  Likewise, the etiology of disease in approximately 35% of patients with 
the LQT syndrome remains unknown (124). 
Mouse models of Nav1.5 dysfunction/loss-of-function have further solidified our 
mechanistic understanding of the relationship between sodium channel dysfunction and 
arrhythmia.  Mice heterozygous for a knock-in long QT syndrome mutation (∆KPQ) developed 
both spontaneous and triggered polymorphic ventricular arrhythmias (132).  Similarly, mice 
heterozygous for scn5a by targeted deletion displayed slow conduction, increased refractoriness, 
sinus node dysfunction and pacing-induced ventricular tachycardia (133;134).  Notably, both 
scn5a∆/∆ and scn5a-/- mice were reported to be embryo-lethal, suggesting an important role for 
sodium current in the embryonic heart (132;133).  
Finally, the importance of sodium channels in the heart has been supported by data from 
patients demonstrating that Nav1.5-blocking antiarrhythmic agents paradoxically induce lethal 
arrhythmias, a phenomenon referred to as proarrhythmia.  The Cardiac Arrhythmia Suppression 
Trial (CAST) reported that suppression of ventricular ectopic beats with the sodium-channel 
blocking agents flecainide and encainide led to a 3-fold increase in mortality in patients 
convalescing from myocardial infarction (135).  Although the use of many sodium channel 
blocking agents to suppress arrhythmias has since fallen out of favor, the phenomenon of sodium 
channel blocker-induced proarrhythmia has been extensively studied.  Existing evidence 
suggests that conditions that reduce sodium current such as SCN5A mutations or acute ischemia 
may in turn increase the risk of sodium channel blocker-related proarrhythmia (136-140). 
 
The sodium channel “complex” 
It has become increasingly well-appreciated that voltage-gated sodium channel pore-
forming α subunits do not exist alone at the membrane but form macromolecular complexes with 
a number of ancillary proteins.  Despite clear evidence implicating the perturbed function or 
expression of Nav1.5 in multiple disorders of heart rhythm, however, little is known about the 
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potential role of altered protein-protein interactions as a substrate for arrhythmia.  Literature 
demonstrating the functional importance of sodium channel-interacting proteins is expanding 
rapidly (141), and presents the intriguing possibility that the study of Nav1.5 protein partners may 
help to further clarify the molecular determinants of the risk for arrhythmia. 
 
Sodium channel β subunits: modulators of Nav1.5 expression and function 
Ancillary sodium channel β subunits are small, single membrane-spanning proteins with 
extracellular immunoglobulin-like domains and short intracellular C-terminal tails.  These proteins 
were first identified over 2 decades ago during the biochemical purification of much larger pore-
forming α subunit proteins from rat brain and skeletal muscle (5-7;142-145).  Since that time, 
numerous studies have demonstrated that mammalian sodium channel β subunits proteins are 
integral components of the channel complex in excitable tissues, modulators of the expression 
and function of the larger pore-forming α subunits, and genes that underlie clinical disorders 
linked to perturbed membrane excitability such as epilepsy and arrhythmia (19;76;146-150).  In 
mammals, four sodium channel ancillary β subunits (β1-4) have been identified, encoded by the 
genes SCN1B-4B.  Primarily through evidence derived from heterologous systems, sodium 
channel β subunits have been shown to influence the expression and function of Nav1.5 as well 
as its affinity for antiarrhythmic medications (19;151).   
 
Sodium channel β subunits in the heart 
Although β1 was originally cloned from the human brain, mRNA transcripts for this 
subunit have since been identified in the rat heart by northern blotting and in the human heart by 
RT-PCR (152-154).  The functional importance of β1 in the heart is not well-understood.  While 
two studies reported that co-expression of SCN1B and SCN5A resulted in enhanced channel 
expression with no effect on channel function (154;155), two additional studies reported that β1 
affected both sodium current density and channel gating (156;157).  The β1 subunit has also 
been implicated as a modifier of SCN5A mutations that cause the Brugada syndrome and 
idiopathic ventricular fibrillation (IVF) (158).  Moreover, it was suggested that the long QT 
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syndrome may be caused by mutations in SCN5A that specifically affect α-β subunit interactions 
(78).  Finally, some evidence suggests that β1 modulates the sensitivity of Nav1.5 to 
antiarrhythmic drugs such as lidocaine, reducing the rest affinity for the drug (159;160).  Taken 
together, the available data strongly suggest that β1 increases the amplitude and may influence 
the gating of sodium currents conveyed by Nav1.5.  
Although scn1b has been targeted in mice, analysis of the resulting phenotype has 
heretofore been limited to the nervous system (17;18).  However, the deficits seen in this model 
may provide clues to the types of functions this gene may have in the heart.  Loss of β1 resulted 
in mice with an ataxic gait and spontaneous seizure activity (17).  At the cellular level, these 
scn1b-/- mice displayed slow conduction (as measured in optic nerve fibers), defects in the 
architecture of nodes of Ranvier, and changes in the expression of Nav1.1 and Nav1.3 in a subset 
of hippocampal neurons (17).  Despite the evidence that β1 affects sodium channel expression 
and localization in vivo, analysis of the cardiac phenotype of these mice has not yet been 
reported.   
 Less is known about the roles of β2 (SCN2B), β3 (SCN3B), and β4 (SCN4B) subunits in 
cardiac tissue.  Unlike β1, β2 is suspected to form covalent linkages pore-forming α subunits via 
disulfide bonds (11).  Since co-expression of SCN2B and SCN5A was not demonstrated to 
modulate the function of Nav1.5 in vitro, it has been hypothesized that β2 may be more important 
for cell-adhesion, a property that has been attributed to all 4 subunits because of their 
extracellular IG domains (161;162).  SCN3B expression has been detected in the rat and human 
heart by RT-PCR (12;163).  Northern and Western blots of sheep heart extracts also 
demonstrated that SCN3B is highly expressed in both the endocardium and epicardium of the 
ventricles as well as in the Purkinje fibers, but is absent from the atrium (164).  Co-expression of 
SCN3B and SCN5A resulted in a threefold increase in peak sodium current amplitude, faster 
recovery from inactivation, and a significant depolarizing shift in the half-voltage (V1/2) of steady-
state inactivation (164).  SCN4B encodes the more recently-discovered fourth β subunit of 
voltage-gated sodium channels (13).  Although SCN4B expression in the rat heart was detected 
by RT-PCR, co-expression of SCN4B and SCN5A in tsA-201 cells did not appear to alter channel 
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function (13).  However, a mutation in SCN4B was recently described in a single patient with the 
congenital long QT syndrome (165).  Although no significant differences were observed in the 
amplitude and time course of whole cell sodium currents when either wild type or mutant β4 was 
expressed in a line of HEK 293 cells that stably expressed Nav1.5, the mutant subunit affected 
the voltage-dependence of inactivation of the channel resulting in a significant increase in late 
sodium current (166). 
 
Immunohistochemistry of β subunits in the heart 
To resolve discrepancies regarding the expression and subunit composition of sodium 
channels in the heart, detailed immunohistochemical analyses of α and β subunits have been 
recently been performed.  Using subunit-specific antibodies, Malhotra et al. demonstrated 
expression of both β1 and β2 proteins in mouse and rat ventricular myocytes, where they 
appeared to co-localize with Nav1.1 and Nav1.5 in the transverse tubules (161).  Maier et al. 
subsequently analyzed the expression of all four β subunit proteins in murine ventricular 
myocytes (100).  In this report, Nav1.5 was found exclusively at the intercalated disks, the 
junctional complex connecting adjacent cardiomyocytes (100).  Moreover, Nav1.5 was found to 
co-localize with the β2 and β4 subunits in all cells analyzed, and with the β1 subunit in a fraction 
of cells (100).  Interestingly, β1 and β3 were found to primarily co-localize with the “brain-type” 
sodium channels Nav1.1, Nav1.3, and Nav1.6 in the transverse tubules (100).  These studies 
revealed that all 4 sodium channel β subunits are expressed in the heart and suggested that the 
stoichiometry of subunits in cardiac sodium channel complexes is likely to be similar to that of 
channels found in the central nervous system (1:1:1, α:βx:βy). 
 
Limits of traditional approaches to studying subunit-subunit interactions 
Although β subunits are logical candidate genes for human disease, the functional 
importance of this gene family in vivo is still not well understood.  Although in vitro studies have 
clearly advanced our understanding of the role of β subunits in modulating membrane excitability, 
heterologous expression systems may not accurately recapitulate complex in vivo mechanisms.  
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The observed effects of α-β subunit interactions in cells are variable, for example, and may 
depend on the cell-type in which these genes are co-expressed (154;155;157;167).  This implies 
that the intracellular milieu and its specific complement of endogenously-expressed proteins 
influence the functional interactions that occur between transfected α and β subunits.  Numerous 
studies have demonstrated that the functional properties of a sodium channel complex in vitro 
may be modulated by a diverse array of proteins including cell-adhesion molecules, calcium 
binding proteins, and components of the extracellular matrix and cytoskeleton that are capable of 
functionally interacting with either α or β subunits (19;168).  The expression of any of these 
modulatory factors may differ among the cell lines currently employed for in vitro biophysical 
studies.  Moreover, both the purification of neuronal sodium channel subunits and the 
immunohistochemical analyses of these proteins in native cardiac tissues described above 
suggested that sodium channel complexes are likely to exist as heterotrimeric structures 
comprised of one α subunit and two different β subunits (9;169).  For these reasons, it may be 
difficult to accurately model in vivo interactions by the transient transfection of single α and β 
subunits in heterologous cell systems.  Additional studies using the intact hearts of animal models 
are clearly needed to both confirm and expand upon the results of in vitro experiments. 
 
Zebrafish: a genetically-tractable vertebrate model system 
 Large-scale forward genetic screens conducted in the mid-1990s demonstrated that 
zebrafish could facilitate the identification of novel genes that regulate the development and 
function of the vertebrate cardiovascular system (170;171).  From these initial efforts, a number of 
mutant fish lines were recovered that displayed arrhythmias including fibrillation, AV block, and 
bradycardia, demonstrating that the simple two-chambered heart of a young fish embryo could 
manifest physiologically-meaningful rhythm phenotypes and be useful as a model to study the 
molecular determinants of cardiac impulse propagation (172;173).  Moreover, initial 
electrophysiological studies of cultured embryonic zebrafish cardiomyocytes revealed currents 
typical of the multiple families of cardiac ion channels found in the mammalian heart (174).  For 
these reasons, we surmised that zebrafish could serve as a valuable experimental platform for 
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clarifying the role of sodium channel-associated proteins such as ancillary β subunits in the 
regulation of heart rhythm.  
 Compared to mammals such as mice and dogs, zebrafish appeared to be an attractive 
model system for a number of key experimental advantages.  First, zebrafish embryos are 
amenable to efficient reverse genetic manipulation using morpholino-modified antisense 
oligonucleotides, facilitating the rapid knockdown of genes individually or in combination (e.g. 
genes encoding two different β subunits).  Second, the zebrafish cardiovascular system develops 
quickly, permitting one study the rhythm of the embryonic heart as early as 1-2 days following the 
formation of the beating heart tube and basic circulatory loop at approximately 24 hours post 
fertilization.  Third, large clutch sizes facilitate the simultaneous study of dozens of embryos, 
improving the validity of experimental findings.  Fourth, zebrafish embryos are optically 
transparent and develop externally, allowing one to study cardiovascular physiology at any stage 
of development without surgical or other manipulation.  Fifth, zebrafish embryos do not require 
circulation for survival during the first several days of development, enabling one to study defects 
in cardiovascular function (induced by gene knockdown or mutagenesis) that would be embryo 
lethal in other model organisms.  Sixth, zebrafish embryos are permeable to most 
pharmacological compounds placed in their surrounding medium, an important tool for confirming 
the effects of gene knockdown and for studying phenotypes elicited by drug challenge.  Seventh, 
gene overexpression phenotypes can be readily characterized following the injection of sense 
RNA into early embryos.  Finally, a draft zebrafish genome sequence was available to help 
identify and clone genes of interest. 
 
Experimental objective(s) 
 Because of the exquisite sensitivity of the heart to perturbations of sodium current, we 
hypothesized that sodium channel-interacting proteins including ancillary β subunits would be 
important regulators of heart rhythm in vivo.  The specific aim of our studies was thus to 
create and characterize a loss of function model for the cardiac sodium channel Nav1.5 in 
zebrafish embryos.  This model would be a useful benchmark for parallel studies of sodium 
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channel-interacting proteins, or serve as the background in which gain- or loss-of-function studies 
of such ancillary molecules could be performed.  Our larger goal was to establish a new in vivo 
platform for investigating the function of various components of the cardiac voltage-gated sodium 
channel complex, with the aim of being able to rapidly test hypotheses regarding novel candidate 
genes as they emerged from studies in our laboratory or from the literature.  In chapters 2 and 4 
of this dissertation, I discuss the identification, cloning, and evolution of zebrafish cardiac-type α 
and β subunit genes.  In chapter 3, I describe the unexpected discovery of a role for sodium 
channels in early heart development, prior to their role in modulating heart rhythm. 
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CHAPTER II 
 
EVOLUTION AND FUNCTION OF CARDIAC SODIUM CHANNELS 
 
Overview 
Mammals (class Mammalia) and ray-finned fish (class Actinopterygii) are distantly-related 
vertebrate lineages whose nearest common ancestor is suspected to have lived over 400 million 
years ago (Figure 2.1).  Although humans and zebrafish share enough similarity to make the fish 
a popular model system for genetic studies, many gene families have undergone significant 
evolutionary change and diversification across vertebrate lineages.  The extension of our studies 
of cardiac sodium channels in humans and mice to a non-mammalian vertebrate model system 
thus warranted special consideration of the evolutionary history of the Nav1 family of sodium 
channel genes in vertebrates.  To identify cardiac sodium channels in zebrafish, we used both in 
silico and in vitro approaches.  While mammals have 10 Nav1 channel genes, we identified 8 
conserved sodium channel genes in zebrafish.  Although 2 of these 8 genes were putative 
homologs to scn5a by sequence, expression of only 1 gene was detected in the adult atrium and 
ventricle.  The cloning, sequence analysis, assembly, and functional expression of this gene 
revealed a probable functional ortholog to mammalian scn5a.  As a recent study revealed 
expression of the second scn5a homolog in the embryonic heart, we have pursued studies of 
both putative zebrafish scn5a genes in parallel.  To be consistent with recent literature, we have 
adopted the nomenclature scn5Laa and scn5Lab (SCN5A-like gene isoforms A and B) and 
zNav1.5a and zNav1.5b to describe the genes and the channels they encode, respectively.  The 
significance of duplicate zebrafish scn5a-like genes is discussed.  Functional studies of both 
genes are described in Chapter 3. 
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Figure 2.1: Teleosts and tetrapods diverged 400-450 million years ago.  Fish and mammals 
share a common vertebrate ancestor that is suspected to have lived 400-450 million years ago. 
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Abstract 
 Although gene duplication is widely suspected to underlie the evolution of novel protein 
function, the mechanisms that determine the fate of genes following duplication events are not 
well understood.  Nav1 voltage-gated sodium channels are highly conserved proteins that act to 
initiate action potentials in excitable tissues.  Mammalian sodium channels are encoded by 10 
distinct but homologous genes, suggesting that the duplication of ancestral sodium channel 
genes played an important role in the expansion of this gene family.  Since successful 
heterologous expression of 9 of 10 Nav1 channels has revealed conserved function among these 
proteins, however, it is unclear why many Nav1 genes have been retained in mammalian 
genomes.  To address this question, we investigated the evolution of cardiac-type sodium 
channel genes in two divergent vertebrate clades, mammals and teleosts.  In mammals, the 
genes scn5a, scn10a, and scn11a are phylogenetically related and occupy adjacent positions in 
the genome but have evolved divergent roles in cardiac excitation (scn5a) and peripheral 
nociception (scn10a, scn11a).  In zebrafish, we also observed divergence of the expression of 
scn5a-like genes.  In silico and in vitro approaches first identified 8 distinct zebrafish Nav1 sodium 
channel genes.  Phylogenetic analysis implicated two putative homologs to scn5a (scn5Laa, 
scn5Lab), one of which was found to be expressed in both the adult and developing heart, as well 
as in the central nervous system (scn5Lab).  Like scn10a and scn11a, however, the expression of 
scn5Laa was not detected in the adult heart but only in nervous tissue.  Despite its absence from 
mature heart tissue, scn5Laa transcripts were amplified from the developing myocardium.  
Cloning, assembly, and functional expression of scn5Lab in CHO cells demonstrated typical 
sodium current with gating kinetics that are similar to mammalian Nav1.5.  Our results 
demonstrate the independent duplication of an ancestral vertebrate scn5a-like gene in mammals 
(3 genes) and fish (2 genes).  The expression of both zebrafish scn5a-like genes in cardiac tissue 
suggests that Nav1.5-like sodium channels have played a conserved role in cardiac excitation at 
least since the split of tetrapods and teleosts over 400 million years ago.  The expression of 
scn5a, scn10a, scn11a, scn5Laa and scn5Lab in nervous tissue indicates, however, that the 
ancestral vertebrate scn5a-like gene may have also played an important role in neuronal 
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excitability.  We thus propose that the divergence of vertebrate scn5a-like genes following 
duplication reflects a partitioning of the role of the ancestral vertebrate gene (subfunctionalization), 
rather than the evolution of completely novel function (neofunctionalization). 
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Introduction 
The Nav1 family of sodium channel genes in mammals is comprised of 9 highly-
homologous isoforms and a 10th member that has diverged in sequence (2;15).  The unique 
expression patterns and physiological roles of sodium channels suggest that the expansion of this 
gene family may have been an adaptation that permitted their diversification and specialization in 
excitable tissues (1;175;176).  Although the cloning and heterologous expression of mammalian 
sodium channel genes have revealed many functional similarities among Nav1 isoforms in vitro, 
loss-of-function studies in vertebrate animal models suggest that extant sodium channel isoforms 
are not likely to be functionally redundant in vivo (82-84;133).   
 
Origin of mammalian sodium channel gene isoforms 
The relatively large number of distinct mammalian sodium channel α subunit isoforms 
has generated interest in the evolution of this gene family, particularly because invertebrate 
genomes often contain only 1-2 conserved Nav1 sodium channel genes (98;177-179).  The 
physical linkage of voltage-gated sodium channel genes to the 4 homeobox (HOX) gene clusters 
(HOXA-D) strongly suggests that as for HOX genes, a large-scale expansion of the vertebrate 
genome through polyploidization may have contributed to the emergence of 4 ancestral Nav1 
sodium channel genes in early vertebrates (97;98).  Phylogenetic analyses of cloned human, 
mouse, and rat sodium channel gene sequences in turn support the informal classification of 
extant Nav1 sodium channel genes into 1 of 4 groups:  group 1 includes the genes SCN1A, 
SCN2A, SCN3A, SCN7A, and SCN9A; group 2 includes the genes SCN5A, SCN10A, and 
SCN11A; group 3 includes the gene SCN8A; and group 4 includes the gene SCN4A (3;15;97;98).  
The classification of Nav1 channels in this manner is further supported by the physical proximity 
of closely-related sodium channel genes in mammalian genomes.  For example, SCN1A, SCN2A, 
SCN3A, SCN7A, and SCN9A all occupy adjacent positions on chromosome 2, whereas SCN5A, 
SCN10A, and SCN11A all localize to the same region of chromosome 3.  Taken together, these 
findings are consistent with an evolutionary model where 4 ancestral vertebrate sodium channel 
genes first arose by polyploidization from 1-2 invertebrate precursors, followed by the tandem 
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duplication of a subset of these ancestral genes to produce the 10 Nav1 sodium channel genes 
that exist today (97;98). 
An explicit test of this proposed model required the cloning and phylogenetic analysis of 
all Nav1 sodium channel genes from an appropriate non-mammalian vertebrate outgroup.  
Lopreato and colleagues investigated the Nav1 family of genes in the weakly electric fish 
Sternopygus macrurus and found evidence for 6 distinct Nav1 sodium channel genes (180).  The 
cloning of partial sequences (domains II and III) of all of these genes permitted phylogenetic 
analysis with the equivalent regions of previously cloned mammalian sodium channel genes.  As 
the prevailing evolutionary model for vertebrate Nav1 sodium channels predicted, all 6 of 
Sternopygus sodium channel genes occupied positions on 1 of 4 phylogenetic branches with their 
mammalian counterparts (180).  These findings strongly support the concept that extant 
vertebrate sodium channel genes have arisen from 4 ancestral Nav1 genes.   
One unanticipated finding of Lopreato et al. was that fish and mammals possess different 
numbers of sodium channel isoforms.   The duplication of ancestral vertebrate sodium channel 
genes thus appears to have proceeded independently in teleost and tetrapod lineages, and the 
expansion of the Nav1 sodium channel gene family in mammals (from 4 to 10 genes) is likely to 
have occurred after the divergence of teleosts and tetrapods over 400 million years ago (180).  
Additional information about the timing of these duplications cannot be gleaned from available 
sodium channel sequences.  It is thus unknown whether all tetrapod lineages including mammals, 
reptiles, birds, and amphibians share the same complement of sodium channel genes (e.g. gene 
duplications occurred prior to the split of these lineages) or whether sodium channel genes 
independently duplicated in some or all of these vertebrate classes.  This particular question may 
be resolved by cloning and analyzing the full complement of Nav1 sodium channel genes in a 
non-mammalian tetrapod. 
 
The fate of duplicate genes 
Gene duplication is suspected to be an important evolutionary mechanism underlying the 
emergence of proteins with new functions (176;181-183).  As evolutionary forces may act both on 
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coding and regulatory sequences of gene duplicates simultaneously (184-186), a number of 
models that account for both types of changes have addressed the mechanisms that promote the 
retention and evolution of genes following duplication.  
 The classical neofunctionalization or mutation during non-functionality (MDN) model 
posits that duplicate genes freed of the functional role of their parent gene are no longer subject 
to purifying selection and begin to acquire random mutations (176;181;187;188).  While most 
mutations lead to a degeneration of function and the emergence of pseudogenes, a duplicate 
gene may on rare occasions evolve useful functions that lead to the retention of its expression.  
Since the sequencing of genomes of many organisms has revealed the preservation of many 
more genes for longer periods of evolutionary time than this model would predict (189;190), other 
models for the retention and evolution of duplicate genes have been proposed.   
The model of subfunctionalization or the duplication-degeneration-complementation 
(DDC) suggests that the functional redundancy resulting from gene duplication is resolved by 
degenerative mutations that change the spatial or temporal expression of the duplicate, such that 
the function of the original gene is subdivided among its progeny (189;190).  This has also been 
referred to as gene sharing, which implies that the parent gene already plays two distinct roles, 
facilitating the functional specialization of each duplicate gene for one of those roles (176;182).  In 
these models, the complementary role of each duplicate thus leads to their preservation in the 
genome.  While evidence suggests that DDC robustly explains the origin of certain multi-gene 
families, recent studies of the homeobox (HOX) gene clusters have demonstrated that adaptive 
modification through positive selection appeared to be operative rather than the passive process 
of degeneration (191;192).  Some have referred to this as an immediate model, where positive 
Darwinian selection acts immediately on a gene after duplication (181).   
Other models for the retention and subsequent evolution of duplicate genes include 
epigenetic complementation, where the position of the duplicate in the genome may affect its 
temporal or spatial expression due to epigenetic changes (193).  Dosage compensation refers to 
the idea that increased protein levels may intrinsically be adaptive, leading the preservation of 
duplication genes (185).  In other cases, such as been observed in C. elegans, the evolution of 
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novel protein function may arise when the duplication events do not result in two exact copies of a 
gene but include genomic DNA from adjacent loci (194).  The theory of protein subcellular 
relocalization suggests that duplicate genes can evolve new functions with changes in their 
subcellular localization within cells that result in a new metabolic environment (188).  Finally, 
there are numerous instances where duplicate genes have been retained in genomes for 
functional redundancy (186). 
In the absence of data addressing the expression and function of sodium channel genes 
in multiple vertebrates, it is difficult to predict which model best explains the evolution of Nav1 
channel genes in mammals.  The distinct and often complex patterns of expression among 
closely-related mammalian Nav1 sodium channel genes strongly suggest, however, that both 
changes in the regulatory and coding sequences of sodium channel duplicate genes may have 
been an important factor contributing to the retention of 10 distinct gene isoforms.  Although the 
clusters of sodium channel genes on chromosomes 2 and 3 are each suspected to have arisen 
from common ancestors, for example, the expression patterns of these genes have significantly 
diverged.  While SCN1A-3A display temporally and spatially distinct expression domains primarily 
within the central nervous system, for example, SCN9A is expressed in the peripheral nervous 
system, adrenal glands, and thyroid tissue (195-204).  Moreover, the atypical sodium channel 
gene SCN7A is expressed in a number of tissues including the heart, uterus, lung, and fetal 
skeletal muscle, as well as in restricted areas of both the central and peripheral nervous systems 
(205;206).  Of genes belonging to the group on chromosome 3, SCN5A is expressed primarily in 
cardiac tissue whereas SCN10A is expressed selectively in sensory and nociceptive neurons of 
the peripheral nervous system (87;207-212).  Expression of the third member of this group, 
SCN11A, is also detected in peripheral nervous system but can additionally be found throughout 
the central nervous system and in diverse tissues such as the spleen and placenta (213;214).  
For the remaining channels, SCN8A and SCN4A, there has been no evidence of gene duplication 
in mammals.  SCN8A is highly expressed in the brain, spinal cord, peripheral nervous system, 
and neuromuscular junction (201;202;215-217). SCN4A is the primary sodium channel isoform of 
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skeletal muscle (218-220).  The expression patterns of SCN8A and SCN4A may be similar to 
those of the ancestral genes from which they have descended. 
 
Adaptive functions of duplicate sodium channel genes 
The evolutionary significance of an expansion in the number of Nav1 genes has been 
well-delineated by studies characterizing the expression and function of mammalian sodium 
channels.  In humans, rats, and mice, extra sodium channel genes appear to have provided the 
genetic building blocks for increasingly complex and specialized electrical signaling mechanisms 
in the central and peripheral nervous systems, heart, and other excitable tissues.  In mammals, 
for example, the expression of no less than 5 distinct sodium channel genes in neurons (including 
SCN5A) supports the idea that duplicate Nav1 channels may have facilitated the emergence of 
increasingly complex central nervous systems in early vertebrates (1).  Although SCN5A is the 
most highly expressed isoform in the mammalian heart, SCN1A, SCN3A, and SCN8A are also 
expressed to varying degrees in cardiac tissue where they may contribute to pacemaking and 
excitation-contraction coupling, among other functions (99;100;102;221).  The atypical sodium 
channel Nax, encoded by the gene SCN7A, may have evolved specialized functions essential to 
regulating salt homeostasis (83).  SCN9A is highly expressed in sensory neurons of the dorsal 
route ganglia where the channel it encodes (Nav1.7) plays a non-redundant role in nociception: in 
humans, loss of function of this gene resulted in a congenital loss of pain experience without 
other detectable neurological deficits (74;222;223).  Similarly, Nav1.8 (SCN10A) is selectively 
expressed in nociceptive neurons where it has evolved functions essential to the transmission of 
pain at cold temperatures (88).  Given the energetic costs associated with retaining or expressing 
non-functional genes, multiple Nav1 channel genes are likely to have been retained in mammals 
because they have evolved specialized and adaptive roles that contribute to genetic fitness. 
 
Zebrafish sodium channel genes 
Despite the popularity of zebrafish embryo as a model system, the family of zebrafish 
Nav1 sodium channel genes has only recently attracted attention in this model system.  The few 
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reports available at the outset of this work suggested that zebrafish Nav1 sodium channel genes 
are likely to be conserved in sequence, expression and function (174;224-226).  However, the 
complex evolutionary history of Nav1 genes in vertebrates, as well as strong evidence for lineage-
specific whole-genome expansion in teleosts via polyploidization, suggested that the zebrafish 
genome may not possess easily identifiable, single orthologs for each of the 10 mammalian 
sodium channel genes (227;228).  Moreover, even in mammalian models, the expression of Nav1 
sodium channel genes during embryogenesis has not been well documented.  A single report 
describing the sequence and embryonic expression pattern of a conserved zebrafish homolog of 
the mammalian gene scn8a, however, supported the idea that this model may prove useful for in 
vivo studies of Nav1 sodium channel function (225).   
To use the zebrafish embryo as a model system to study the function of sodium channel 
subunits in the heart, we first attempted to understand the evolution of this gene family, 
particularly of the phylogenetic group that includes scn5a, scn10a, and scn11a.  In zebrafish, our 
in silico and in vitro strategies produced evidence for 8 conserved Nav1 channel genes, 2 of 
which appeared to be putative sequence homologs of the mammalian gene scn5a.  The 
expression of only one of these genes in the adult zebrafish atrium and ventricle (“scn5Lab”), 
however, suggested the presence of a single functional ortholog of mammalian scn5a in fish.  
Despite only 63% identity to human Nav1.5 in amino acid sequence and significant phylogenetic 
distance, this zebrafish Nav1.5 channel conserves many of the important structural features found 
in its human counterpart.  Moreover, heterologous expression of this zebrafish channel in CHO 
cells revealed typical sodium currents with biophysical properties that are similar to mammalian 
sodium channels.  Expression of this gene was also detected in the developing heart, suggesting 
that the sodium channel it encodes may contribute to cardiac excitation and function from the 
early stages through adulthood. 
Another laboratory recently reported expression of the second zebrafish scn5a gene 
homolog (“scn5Laa”) in the embryonic myocardium (229).  Accordingly, we confirmed this 
expression and initiated studies of scn5Laa including the independent cloning and assembly of a 
full-length expression vector (see Chapter 5, Future Directions).  To distinguish between the 2 
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zebrafish scn5a homologs, we have adopted names suggested by the literature (scn5Laa and 
scn5Lab for SCN5A-like gene isoforms A and B) that indicate the phylogenetic relationship of 
these genes to the group of HOXA-linked, mammalian Nav1 channel genes that include SCN5A, 
SCN10A, and SCN11A (230). 
Our results demonstrate the independent duplication of an ancestral vertebrate scn5a-
like gene in mammals (3 genes) and fish (2 genes).  The expression of both zebrafish scn5a-like 
genes in cardiac tissue suggests that Nav1.5-like sodium channels have played a conserved role 
in cardiac excitation at least since the split of tetrapods and teleosts over 400 million years ago.  
The expression of scn5a, scn10a, scn11a, scn5Laa and scn5Lab in nervous tissue indicates, 
however, that the ancestral vertebrate scn5a-like gene may have also played an important role in 
neuronal excitability.  We thus propose that the divergence of vertebrate scn5a-like genes 
following duplication reflects a partitioning of the role of the ancestral vertebrate gene 
(subfunctionalization), rather than the evolution of completely novel function (neofunctionalization).  
The functional characterization of both scn5Laa and scn5Lab in vivo will be described in Chapter 
3. 
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Methods 
 
Identification and cloning of a putative zebrafish scn5a (“scn5Lab”) gene homolog 
BLAST searches of the draft zebrafish genome cDNA database (ensembl Zv2, Zv3) were 
performed using full-length cDNA sequences and individual exons of the genes encoding the 
mammalian voltage-gated sodium channels Nav1.1-1.9.  Manual searches of unmapped contig 
hits and alignments of protein sequences predicted by the top 60 hits subsequently identified 15 
highly-conserved, predicted zebrafish sodium channel cDNAs of varying lengths whose 
sequences were used to generate PCR primers.  Primers directed against two of the 15 predicted 
cDNAs consistently produced single amplicons of the anticipated size from an adult zebrafish 
heart cDNA library (Stratagene) which were gel purified, subcloned, and sequenced in their 
entirety to confirm their specificity.  The larger RT-PCR amplicon, whose deduced translation 
product corresponded to the terminal exon and 3’UTR of a sodium channel, was used to generate 
reverse primers that were used in conjunction with forward primers directed against vector-
specific promoter sites (T7, SP6) to isolate 3 additional, overlapping sections of the zscn5a cDNA 
from the adult zebrafish heart library.  5’ and 3’ RLM-RACE (Ambion) was used to complete the 
preliminary full-length cDNA sequence and extend sequences corresponding to 5’ and 3’ 
untranslated regions (UTRs).  All amplicons were subcloned directly into the pGEM-Teasy vector 
(Invitrogen), transformed into DH5α competent cells, and sequenced in their entirety.  In the 
process of cloning zscn5a, it was determined that both partial cDNAs expressed in the zebrafish 
heart library represented upstream and downstream regions of a single cDNA.  The preliminary, 
full-length zscn5a cDNA sequence was confirmed by using new primer pairs to amplify the entire 
channel in 6 overlapping sections (A>F) from total D2 embryonic RNA using one-step Titan RT-
PCR (Roche).  The PCR primers used to amplify these sections are reported in Table 1.  These 6 
sections also provided the template for assembling a full-length cDNA construct for heterologous 
expression (see “Assembly of full-length zNav1.5 expression construct,” below).  The final zscn5a 
cDNA consensus sequence was determined after aligning the forward and reverse sequences of 
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8-10 clones of each of the 6 overlapping channel sections and was deposited in GenBank 
(DQ837300). 
 
Zebrafish Nav1 gene expression screen 
Using in silico and in vitro approaches, the entire complement of zebrafish Nav1 channel 
genes was identified and assayed for expression in different excitable tissues.  This was achieved 
by using sequences of the distinctive, conserved terminal two-most exons of mammalian voltage-
gated sodium channel genes in BLAST searches of updated versions of the draft zebrafish 
genome (ensembl Zv4, Zv5) to identify in silico predicted “sequence tags” of all non-redundant 
Nav1 genes.  Eight unique zebrafish sodium channel genes were identified using this strategy.  
These in silico Nav1 sequence tags were then used to design primers that spanned the 
intervening intron, and RT-PCR was performed to both validate these sequences and determine 
their pattern of expression in RNA extracted from various zebrafish tissues.  Primer pairs used for 
this experiment are listed in Table 2.  Tissues were freshly dissected from wild type adult 
zebrafish (strain TuAB, 12-16 months old) and flash frozen on dry ice in ethanol.  Tissue-specific 
total RNA was isolated RNA using Trizol (GIBCO), digested with RQ1 DNase (Promega), and 
purified with the RNeasy Mini Kit (Qiagen).  First strand cDNA synthesis was performed using 
1µg of RNA from each tissue, random hexamer primers, and Transcriptor reverse transcriptase 
enzyme (Roche).  2µl of first strand cDNA was used in 25µl PCR reactions with Expand High 
Fidelity DNA polymerase (Roche).  Amplicons were analyzed on a 1-2% agarose gel made with 
1x Tris-Acetate-EDTA (TAE) buffer.  All amplicons were subcloned directly into the pGEM-TEasy 
vector (Promega) and sequenced in their entirety in both sense and antisense directions.  
 
Identification of additional Nav1 gene sequences      
 The entry for a putative zebrafish homolog to mammalian scn8a was the only sodium 
channel sequence available in GenBank (NM_131628) at the outset of this work (225).  Therefore, 
to facilitate reconstruction of the phylogeny of sodium channel genes in zebrafish, we additionally 
determined the complete full-length sequence of a zebrafish brain-type Nav1 sodium channel 
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gene.  Predicted exons spanning 90% of the coding region for a putative zscn2a homolog were 
identified in the draft zebrafish genome sequence (ensembl Zv4) during the expression screen 
described above.  These predictions were used to design primers that successfully amplified 
overlapping sections of a near-complete, full-length cDNA from D2 total embryonic RNA by Titan 
one-step RT-PCR (Roche).  5’/3’ RLM-RACE PCR (Ambion) was used to complete the ends of 
this cDNA.  The final putative zscn2a cDNA consensus sequence was determined after aligning 
forward and reverse sequences of 6-8 clones of each overlapping section.  During our efforts to 
clone additional full-length zebrafish sodium channel genes for phylogenetic analysis, two new 
zebrafish Nav1 sequences appeared in public databases encoding putative zebrafish homologs of 
the skeletal-muscle type mammalian sodium channel scn4a (DQ221253, DQ221254) (231).  The 
collection of our zebrafish clones (zscn5a, zscn2a) and publicly available sequences (zscn8a, 
zscn4aa, zscn4ab) spanned the 4 phylogenetic groups of related sodium channel genes 
proposed in the evolutionary literature (97;98;180): (1. scn5a/10a/11a – heart/DRG – HOXA; 2. 
brain – scn8a – HOXB; 3. skeletal muscle – scn4a – HOXC; 4. brain – scn1a/2a/3a/7a/9a – 
HOXD).  We reasoned that these five sequences would thus be sufficient to reconstruct the 
phylogeny of zebrafish sodium channels (and confirm the identity of our clone), even without 
access to the remaining 3 (and possibly other) full-length sodium channel gene sequences. 
 
Phylogenetic analysis of zebrafish Nav1 Sequences 
To estimate phylogeny, nucleotide and amino acid sequences of human voltage-gated 
sodium channels (SCN1A-11A) were each aligned with cloned zebrafish sequences using 
CLUSTALX (v1.83).  Phylogenetic trees were reconstructed using the neighbor-joining method of 
Saitou and Nei (232) and viewed with NJplot software.  Alignment gaps were excluded in the 
analysis, and the Kimura correction was made for multiple substitutions.  The robustness of each 
node in the phylogenetic tree was tested with bootstrap analysis (n=1000).  Trees were rooted 
with sodium channel sequences from invertebrate species (98). 
 
 
 38
Assembly of full-length zNav1.5 expression construct 
Overlapping sections (A-F) of the putative zscn5a gene spanning the entire coding region 
and a small portion of the 5’ and 3’ UTR were amplified from Day 2 total zebrafish embryonic 
RNA using one-step Titan RT-PCR (Roche), using the primers listed in Table 1.  PCR amplicons 
for sections B and C and sections E and F were then used as templates in a second PCR 
reaction to produce the fusion products BC and EF.  PCR products for A, BC, D, and EF were 
subcloned directly into the pGEM-Teasy vector (Invitrogen) and transformed into DH5α 
competent cells.  Multiple clones of each segment were fully sequenced and aligned to identify 
single clones that matched the consensus the sequence (A*, BC*, D*, and EF*).  All 4 sections 
were designed to overlap at unique restriction enzyme sites and the full-length channel clone was 
assembled in pGEM-Teasy by a series of digests and ligations as summarized in figure 2.9.  The 
entire 5.9kb zscn5a insert was then removed from the pGEM-Teasy cloning vector using NheI 
and KpnI restriction sites that had been initially appended to the primers used to amplify sections 
A and F, and subcloned into a pBK-CMV mammalian expression vector to produce pBK-CMV-
zscn5a.  The full-length channel construct was propagated in DH5α cells under standard 
conditions. 
 
Transient transfection and electrophysiology  
Cultured Chinese Hamster Ovary (CHO) cells were transiently transfected with the pBK-
CMV-zscn5a construct using FuGENE6 (Roche).  Cells were grown for 48 hours after 
transfection prior to electrophysiology.  Whole-cell voltage clamp was performed at room 
temperature with 2MΩ patch microelectrodes and an Axopatch 200A amplifier. To minimize the 
capacitive transients, we compensated for approximately 70% to 80% of the cell capacitance and 
series resistance (233). Cells exhibiting very large currents (>6 nA) were also excluded from 
further analysis.  Cells were also excluded if voltage control was compromised.  The extracellular 
bath solution contained (in mmol/L) NaCl 145, KCl 4.0, MgCl2 1.0, CaCl2 1.8, glucose 10, and 
HEPES 10; the pH was 7.4, adjusted with NaOH.  The pipette (intracellular) solution contained (in 
mmol/L) NaF 10, CsF 110, CsCl 20, EGTA 10, and HEPES 10; the pH was 7.4, adjusted with 
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CsOH.  Cells were held at -120 mV, and activating currents were elicited with depolarizing pulses 
from -100 to +50 mV in 10 mV increments.  Specific clamp protocols are indicated with the data.  
Data were acquired by pClamp8.0 (Axon Instruments Inc), sampled at 50 kHz, and low-pass 
filtered at 5 kHz.  All currents were normalized to the cell capacitance calculated by Membrane 
Test (OUT O) in pClamp8.0. 
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Results 
 
Identification and cloning of a putative zebrafish scn5a gene homolog 
 In humans, SCN5A is a large gene comprised of 28 exons spanning nearly 80kb of 
genomic DNA.  Initial BLAST searches of the draft zebrafish genome (Zv2) using the full-length 
human SCN5A cDNA sequence (approximately 6kb) and smaller regions of the gene that are 
highly conserved among mammalian species (human, mouse, rat, and cow) but which distinguish 
SCN5A from other sodium channel isoforms (cytoplasmic interdomain linkers) yielded hundreds 
of unique, partial hits of varying size with e-values ranging form 10-05 to 10-276.  These sequences 
represented genes encoding sodium channels, calcium channels, and an array of non-ion 
channel genes.  Zebrafish contigs containing the top 30 hits were individually analyzed with MIT 
Genscan software to predict exons, and the resulting partial cDNAs and their translated protein 
products were aligned against the known sequences of all 10 human voltage-gated sodium 
channels.  However, this approach did not identify any convincing zebrafish homologs to 
mammalian scn5a. 
Given the extensive number of non-specific hits in our initial screen, subsequent in silico 
strategies focused on first identifying all conserved zebrafish Nav1 genes.  BLAST searches of 
updated versions of the draft zebrafish genome cDNA database (ensemble Zv3) were performed 
using both full-length cDNA sequences and individual exons of the genes encoding the 
mammalian voltage-gated sodium channels Nav1.1-1.9.  As before, this approach yielded >100 
hits of putative sodium channel and calcium channel genes of various lengths, scattered across 
unmapped contigs of zebrafish genomic DNA.  Manual searches, exon prediction, and alignments 
of cDNA and protein sequences predicted by the top 60 hits subsequently identified 16 highly-
conserved, predicted zebrafish Nav1 cDNAs of varying lengths (Figure 2.2).  As one of these 
genes represented a previously-cloned putative zebrafish homolog to scn8a, we tentatively 
named the remaining sequences zscn1-zscn15.  
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Figure 2.2:  Top candidates for conserved zebrafish Nav1 sodium channel genes.  
Sequences encoding both full-length cDNAs and individual exons of the mammalian voltage-
gated sodium channel genes scn1A, scn4A, scn5A, scn8A, and scn10A were used in BLAST 
searches of the draft zebrafish genome (Zv3, 2003) to identify conserved zebrafish Nav1 voltage-
gated sodium channel loci.  The results above represent the top 15 candidates of over 60 gene 
sequences manually searched and analyzed by alignment with mammalian homologs.  These 
putative Nav1 genes were named zscn1-zscn15.  Zv3 contig numbers are provided in 
parentheses.  Additional details for these these predicted genes are displayed in Figure 2-3. 
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Figure 2.3:  Details of predicted Nav1 sodium channel genes identified in an early version 
of the draft zebrafish genome (Zv3, 2003). 
Gene Contig Chromosome
# predicted 
exons
length of 
translated 
product (aa) corresponding channel domain
closest human 
homolog       
(by alignment)
% identity 
(aa)
predicted 
TTX 
sensitivity
zscn1 cloned 11 26 (actual) 1949 whole channel (cloned) SCN8A 81.7% sensitive
zscn2 ctg15651 6 30 1999 whole channel SCN2A 72.5% sensitive
zscn3 ctg13029 6 24 1456 N terminus >> DIV, S3 SCN8A 71.5% sensitive
zscn4 ctg89 11 31 1856 whole channel SCN4A 61.8% sensitive
zscn5 ctg11994 7 21 1590 D1 (S5-6 linker) >> C-terminus SCN2A 62.2% n/a
zscn6 ctg10034 3 25 1242 N terminus >> DIII (S5-6 linker) SCN4A 49.2% sensitive
zscn7 NA1136 unmapped 6 724 DIII (S3) >> C-terminus SCN5A 70.5% n/a
zscn8 ctg20892 unmapped 6 324 N terminus >> DI (S5-6 linker) SCN2A 60.0% n/a
zscn9 ctg13499 8 9 381 N terminus >> DI (S5-6 linker) SCN3A 59.9% sensitive
zscn10 NA54481 unmapped 5 265 D1(S6) >> D1-2 linker SCN5A 33.8% n/a
zscn11 ctg12427 11 5 307 N terminus >> D1 (S5-6 linker) SCN8A 53.7% n/a
zscn12 ctg19461 unmapped 4 272 DI-II linker >> DII-III linker SCN3A 40.9% n/a
zscn13 ctg30300 unmapped 6 698 DIII (S4-5 linker) >> C terminus SCN5A 71.5% n/a
zscn14 ctg14793 10 1 384 DIV (S3-4 linker) >> C terminus SCN8A 85.4% n/a
zscn15 ctg14416 3 1 411 DIV (S3-4 linker) >> C terminus SCN4A 68.0% n/a
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As several of these gene fragments displayed homology to mammalian scn5a (Figure 
2.3), all predicted sequences were used to generate primers for RT-PCR.  Primers directed 
against 2 of the 15 predicted Nav1 cDNAs (zscn7, zscn10) consistently produced single 
amplicons of the anticipated size from an adult zebrafish heart cDNA library (data not shown).  
After sequencing, it was determined that the deduced translation product of the larger RT-PCR 
amplicon (zscn7) product aligned with homology to amino acids 1445-2002 of SCN5A (74.7% 
identity, 84.0% similarity).  As the remainder of the genomic DNA sequence was missing from the 
draft zebrafish genome database (Zv3), this partial clone used as a starting point to identify 
additional overlapping clones of the putative zscn5a cDNA from the zebrafish heart library (Figure 
2.4).  5’/3’ RNA ligase-mediated rapid amplification of cDNA ends (RLM-RACE) was used to 
complete the preliminary full-length coding zscn5a cDNA sequence and extend it into regions 
corresponding to 5’ and 3’ untranslated regions (UTRs) (Figure 2.4).  In the process of cloning 
zscn5a, it was determined that both partial cDNAs initially detected in the zebrafish heart library 
(zscn7 and zscn10) represented upstream and downstream regions of a single cDNA.  The 
preliminary, full-length zscn5a cDNA sequence was confirmed by using new primer pairs (Table 1) 
to amplify the entire channel in 6 overlapping sections from total day 2 embryonic RNA.  The final 
zscn5a cDNA consensus sequence was determined after aligning the forward and reverse 
sequences of 8-10 clones of each of the 6 overlapping channel sections and was subsequently 
deposited in GenBank (DQ837300). 
 
Conserved features of zebrafish and human Nav1.5 
 The full-length cloned zscn5a cDNA sequence spans 6,541 nucleotides, with an open 
reading frame of 5,865 nucleotides that encodes a sodium channel protein of 1954 amino acids 
(Figure 2.5).  The reduced predicted protein size compared to human Nav1.5 (2016 amino acids) 
was accounted for primarily by the loss of a single 162 nucleotide exon in the zebrafish cDNA that 
encodes for a portion of the cytoplasmic linker connecting domains II and III, a region known to 
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Figure 2.4: Identification and cloning of the predicted sodium channel gene zscn7 
(putative zscn5a) from an adult zebrafish heart cDNA library.  (A) Mining of the draft 
zebrafish genome (ensembl Zv3) using human and mouse Nav1 cDNA sequences identified 
numerous partial predicted Nav1 cDNAs on unmapped contigs that were distinct from the 
previously cloned sequence of zscn8a (Tsai et al., 2001).  These included a cDNA fragment 
encoding the 4 terminal-most exons of a predicted zebrafish sodium channel gene (zscn7, 
NA1136).  The translated product of this partial cDNA (negative strand) aligned with high 
homology to amino acids 1445-2002 of the human SCN5A protein (75% identity, 84% similarity).  
Purple bar = EST.  Black, green, orange, and red bars indicate exons predicted by computer 
algorithms and/or homology (ensembl, MIT Genscan; Unigene, etc.).  (B) zscn7 transcripts were 
detected in an adult zebrafish heart cDNA library (Stratagene) using two distinct primer pairs 
(zscn7-a, zscn7-b) directed against predicted exons.  Positive controls include cardiac myosin 
light chain 2 (cmlc2), atrial myosin heavy chain (amhc), and ventricular myosin heavy chain 
(vmhc).  Although zscn7 amplicons were of the expected product size, the bands were gel 
purified, subcloned, and sequenced to ensure specificity.  (C) Identification of the full-length 
zscn7 cDNA sequence required isolation of 3 overlapping pieces from two different adult 
zebrafish cDNA libraries (heart cDNA, total cDNA).  5’ and 3’ RNA ligase-mediated rapid 
amplification of cDNA ends (RLM-RACE) were used to complete the full-length putative zscn5a 
cDNA sequence at 5’ and 3’ ends, respectively. 
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Figure 2.5: Annotated alignment of the putative zNav1.5 (zscn5a) with human Nav1.5 
(SCN5A).  Top = schematic of Nav1.5 with important functional domains highlighted in color. 
Bottom = annotated amino acid alignment (top = human, bottom = zebrafish). Color coding: Pore 
loops = S5-6 linkers, domains I-IV); * = D-E-K-A residues that constitute the ion selectivity filter; # 
= single cysteine residue in Nav1.5 that confers TTX resistance. Voltage “sensors” = S4 
membrane-spanning segments. Inactivation gate = intracellular DIII-IV linker. Sites of 
predicted protein-protein interaction/Ca2+ regulation: P* = PKA phosphorylation site; ER = 
endoplasmic reticulum retention motif; ANK-G = ankyrin-G interaction motif; EF hand = Ca+ 
binding motif; FHF1b = fibroblast growth factor homologous factor 1b interacting domain; IQ = 
calmodulin binding domain; PY = interaction motif for Nedd4-like E3 ubiquitin-protein ligases. 
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vary among sodium channel isoforms in humans (Figure 2.6). Analysis of the genomic structure 
otherwise revealed homology to SCN5A, including a first exon that is entirely non-coding (Figure 
2.6).  Alignment of the deduced protein sequence of zNav1.5 with its human counterpart 
demonstrated 63.4% identity and 71.9% similarity between the two proteins.  Unexpectedly, these 
initial assessments revealed significantly greater sequence divergence between the two Nav1.5 
homologs than was previously demonstrated for human and zebrafish homologs of Nav1.6 
(scn8a), which share 82% identity in amino acid sequence (225).  As indicated by a full-protein 
alignment, most of the divergence between human and zebrafish Nav1.5 is found in the 
cytoplasmic linker regions connecting domains I-II and domains II-III, as well as at distal N- and 
C-termini (Figure 2.5).  Nonetheless, annotation of the aligned Nav1.5 protein sequences 
revealed conservation of important functional domains in both proteins. These regions included 
the S5-6 linkers or pore loops of domains I-IV, which contribute to the external pore of the 
channel and display the highly conserved D-E-K-A residues that constitute the Nav1 ion selectivity 
filter (calcium channels have E-E-E-E residues); the S4 membrane-spanning segments in each 
domain that act as the channel’s voltage sensors and display the expected basic amino acid 
residues (arginine, lysine) at every third position within the 4 amphipathic alpha helices; the 
intracellular DIII-IV linker, which functions as the channel’s fast inactivation gate and plugs the ion 
permeation pathway after depolarization; and finally, sites of demonstrated, functional protein-
protein interactions including an ankyrin-G interaction motif (234;235); a fibroblast growth factor 
homologous factor 1b (FHF1b) interacting domain (236); an IQ domain associated with 
calmodulin binding (237-240), and a PY motif that permits interaction with Nedd4-like E3 
ubiquitin-protein ligases (141;241). Moreover, putative Ca+ binding EF hand structures also 
appear to be conserved in the C-terminus of zebrafish Nav1.5 (240;242).  We did not, however, 
observe conservation of a PDZ binding domain at the distal tip of the channel (“SIV”) (243).  In 
other regions of the channel, we noted conservation of an endoplasmic reticulum (ER) retention 
motif and putative PKA phosphorylation sites (122;244;245). 
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Figure 2.6: The genomic structure of human (Hs) SCN5A and zebrafish (Dr) zscn5a differ 
by a single exon.  The genomic structure of the zebrafish scn5a gene was solved by comparing 
our cloned cDNA sequence to recently-released contigs of genomic DNA in updated versions of 
the zebrafish genome (ensembl Zv5-Zv6).  The genomic structure of zscn5a is completely 
conserved with human SCN5A with the exception of a single exon in the II-III linker. 
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Cardiac expression of zscn5a 
 Cloning of the full-length cDNA of zscn5a permitted a preliminary assessment of the 
gene’s 5’ regulatory regions in silico (Figure 2.7).  Both human and zebrafish scn5a genes have 
untranslated initial exons and large intervening introns between exons 1 and 2.  Alignment of 
2000 nucleotides flanking the transcriptional start site (TSS) of SCN5A and zscn5a revealed 
moderate levels of conservation between putative regulatory elements for the two genes (Y-axis 
= 0-90%; each peak represents a window size of 10 nucleotides).  Using the program 
MatInspector, binding sites for cardiac transcription factors including MEF2, SRF, and Nkx2.5 
were predicted in this putative regulatory region of zscn5a.  To examine the cardiac expression of 
zscn5a in vitro, three independent primer pairs (a, b, c) corresponding to different regions of the 
cloned zscn5a cDNA were designed.  By RT-PCR, zscn5a transcripts were detected in total RNA 
isolated from the adult atrium and ventricle (panel A) and the embryonic heart (panel B) (Figure 
2.8).  These findings reinforced the putative identity of this cloned channel as an ortholog to 
mammalian scn5a. 
 
Functional expression of zscn5a (zNav1.5) 
 To study the biophysical properties of zNav1.5 in vitro, a full-length, 10.5kb expression 
construct was assembled as detailed in Methods and Figure 2.9.   Successful heterologous 
expression of zscn5a in CHO cells demonstrated that zNav1.5 functions as a typical voltage-
gated sodium channel (Figure 2.10A), with biophysical properties comparable to those observed 
for mammalian sodium channels expressed in heterologous systems (Table 3).  Current-voltage 
(I-V) analysis, for example, indicated peak inward sodium current density at membrane potentials 
between -40 and -30mV (Figure 2.10B).  Analysis of steady state activation and inactivation 
properties revealed V1/2 values of -42.2±1.1 and -85.3±0.8, respectively.  Finally, analysis of the 
time-dependence of recovery from inactivation, which can be resolved into two components T1 
and T2) indicated values of 9.1±1.4ms and 144.8±15.1ms, respectively.  
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Figure 2.7: In silico analysis of putative 5’ regulatory regions of human SCN5A and 
zebrafish scn5a.  (A) Comparison of putative 5’ regulatory regions of the human SCN5A and 
zebrafish scn5a genomic loci.  Both genes have untranslated initial exons and large intervening 
introns between exons 1 and 2.  Alignment of 2000 nucleotides flanking the transcriptional start 
site (TSS) of SCN5A and zscn5a revealed moderate levels of conservation between putative 
regulatory elements for the two genes (Y-axis = 0-90%; each peak represents a window size of 
10 nucleotides).  Position 1 is 1327bp upstream of the TSS for SCN5A and 1187bp upstream of 
the TSS for zscn5a, as indicated.  (B)  Using the program MatInspector, predicted binding sites 
for cardiac transcription factors including MEF2, SRF, and Nkx2.5 were identified in this region of 
zscn5a.   
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Figure 2.8: RT-PCR was used to assay for expression of zscn5a in the adult atrium and 
ventricle and in the day 3 embryo heart.  Three primer pairs (a, b, c) corresponding to different 
regions of the cloned zscn5a cDNA were used to assay for expression in total RNA isolated from 
the adult atrium and ventricle (A) and the embryonic heart (B).  To avoid amplification of genomic 
DNA, RNA templates were DNAse treated and primers were located in different exons with large 
intervening introns.  cmlc2 is a positive control for cardiac RNA.  vmhc is a positive control for 
ventricular RNA and a negative control for atrial RNA.  β-Actin transcripts were amplified as an 
additional positive control.  Negative control reaction included primers for cmlc2 and DNA 
polymerase but no reverse transcriptase.  (n)* indicates a nested PCR reaction that used 1µl of 
amplicon from the initial RT-PCR reaction as a template for the second reaction.  In (B), 
cmlc2:eGFP5 transgenic zebrafish embryos were used to facilitate the microdissection of day 3 
hearts.  
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Figure 2.9: Assembly of a full-length mammalian expression vector for zscn5a (zNav1.5).  
See methods for details of amplification, ligation, and assembly. 
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Figure 2.10: Heterologous expression of zscn5a (zNav1.5) in CHO cells.  zscn5a encodes a 
typical voltage-gated sodium channel.  (A) Whole cell sodium current trace.  (B) Current-voltage 
(I-V) relationship. (C) Voltage-dependent activation and inactivation properties. (D) Time-
dependent recovery from inactivation.  See methods for details on electrophysiology protocols. 
A B
C D
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 Key differences between zNav1.5 (zscn5a) and mammalian Nav1.5 (scn5a) 
 Despite preliminary evidence supporting the identity of zebrafish scn7 as an ortholog to 
mammalian scn5a, the large number of homologous Nav1 sodium channel genes in other species 
and the moderate level of amino acid identity with human Nav1.5 (63%) prompted us to further 
scrutinize the putative zNav1.5 sequence by direct, domain-by-domain comparison to all other 
mammalian sodium channel amino acid sequences (Figure 2.11).  In this analysis, each domain 
of the putative zebrafish Nav1.5 (zscn7) protein was aligned with equivalent regions of human 
Nav1 channels to determine percent identity and similarity.  Domains were identified based on the 
secondary structure predicted by the amino acid sequence of each channel.  Similar comparisons 
were performed for the pore loop sequences (S5-6 linkers) which represent subdomains of 
domains I, II, III, and IV that contribute to the sodium channel pore (Figure 2.11).  Despite 
conserved features of the amino acid sequence identified by direct alignment (Figure 2.5) and 
significant similarity to mammalian Nav1.5 in domains III and IV and the C-terminus (Figure 2.3), 
this follow-up analysis unexpectedly revealed homology of the putative zNav1.5 to several 
different mammalian Nav1 channels across multiple domains.  The DI-II and DII-III linker regions 
displayed the lowest overall levels of similarity.  Notably, these are known to be regions of 
divergence among sodium channels both with and between species. 
 As another means of investigating the identity of our cloned channel, we examined its 
sequence for the specific determinants of toxin sensitivity.  Historically, sodium channels have 
been classified by their sensitivity to the pufferfish toxin TTX, which blocks sodium permeation 
through Nav1 channels by binding to residues in the outer vestibule of the pore (1;15).  While 
most cloned sodium channels are sensitive to nanomolar concentrations of TTX, all mammalian 
Nav1.5 channels are blocked by micromolar concentrations of toxin and are thus considered 
prototypical TTX-resistant channels.  The basis of this resistance to TTX, which is also displayed 
by other members of the HOXA-linked Nav1 channel group in mammals including Nav1.8 
(SCN10A) and Nav1.9 (SCN11A), was determined to result from the loss of an aromatic amino 
acid in the domain I pore loop (Y>C in Nav1.5 and Y>S in both Nav1.8 and Nav1.9) (246).  To 
predict whether zNav1.5 (like mammalian Nav1.5) is likely to be resistant to TTX, we aligned the 
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Figure 2.11: Amino acid sequence homology between zebrafish Nav1.5 (zscn5a) and 
human Nav1 sodium channels.  Each domain of the putative zebrafish Nav1.5 (zscn5a) protein 
was aligned with the equivalent regions of all human Nav1 channels to determine % identity and 
% similarity (amino acids).  The pore loop sequences (S5-6 linkers) are subdomains of Domains 
I, II, III, and IV that contribute to the sodium channel pore.  Red = highest match.  Grey = other 
matches within top 5%. 
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pore-loop sequences of this zebrafish channel with several different mammalian Nav1.5 channels, 
with human Nav1.8 and Nav1.9, and with several TTX-sensitive human Nav1 channels (Figure 
2.12).  This analysis revealed that unlike mammalian Nav1.5, zebrafish Nav1.5 possesses the 
canonical aromatic residue (Y) required for high-affinity TTX binding.  The putative zebrafish 
Nav1.5 channel is thus predicted to be sensitive to nanomolar TTX because it lacks a key 
structural determinant of toxin binding that is considered to be a distinguishing feature of 
mammalian Nav1.5 channels.  Electrophysiological analysis subsequently confirmed these 
predictions, demonstrating that zNav1.5 is sensitive to nanomolar quantities of toxin (Chapter 3). 
 
Consideration of additional Nav1 channels 
In the mammalian Nav1 sodium channel literature, emerging evidence suggests that both 
TTX-resistant (scn5a) and TTX-sensitive (scn1a, scn3a, scn8a) isoforms are expressed to 
varying degrees in the mammalian heart where they may play diverse functional roles 
(9;99;101;102).  Because of the key differences between our cloned channel and mammalian 
Nav1.5 channels, we considered the possibility that we had cloned a gene other than the true 
functional ortholog of mammalian scn5a.  We also contemplated whether our initial efforts in 
mining early versions of the draft zebrafish genome had resulted in the identification of all 
functionally-important cardiac sodium channels.  Therefore, in parallel with the initiation of 
functional studies of the putative zNav1.5 in vivo (Chapter 3), we formulated a plan for: 1. 
continued evaluation of new and/or more complete Nav1 gene sequences appearing in 
subsequent versions of the draft zebrafish genome; and 2. reconstruction of the phylogeny of 
zebrafish Nav1 sodium channel genes by the cloning and mapping of each full-length isoform in 
the genome (long-term, facilitated by improved zebrafish genome resources).  Phylogenetic 
modeling of full-length sodium channel sequences in combination with the analysis of synteny 
between these genes and various HOX clusters appealed to us as the most direct means of 
revealing the identity of each sodium channel isoform in the zebrafish genome, particularly in the 
context of emerging empirical support for a model of the evolution of Nav1 channels in vertebrates 
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Figure 2.12:  Unlike human Nav1.5, zebrafish Nav1.5 is predicted to be sensitive to 
nanomolar concentrations of the pufferfish toxin TTX.  Mammalian sodium channels have 
evolved resistance to the pufferfish toxin TTX via single amino acid substitutions in the domain I 
pore (Y > C or S).  A cysteine residue in the outer vestibule of the DI pore confers > 100 fold 
increased resistance to TTX in human Nav1.5 (position marked by red asterisk).  Alignment of 
the relevant amino acid sequence of zebrafish Nav1.5 (zscn5a) revealed the aromatic residue (Y) 
required for high-affinity binding in TTX-sensitive channels.  Unlike mammalian Nav1.5, zebrafish 
Nav1.5 (zscn5a) is thus predicted to be a TTX sensitive channel.  Red arrow marks zebrafish 
Nav1.5. 
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(97;180).  To begin to address these objectives, we devised a simple expression screen to 
identify the entire complement of zebrafish Nav1 sodium channels. 
 
Expression screen reveals 8 genes encoding zebrafish Nav1 channels 
We combined in silico and in vitro approaches to identify all non-redundant Nav1 sodium 
channel genes in the zebrafish genome, ascertain their putative phylogenetic identities (based on 
partial cloned sequences), and subsequently survey their patterns of expression in various 
excitable tissues from adult zebrafish (Figures 2.13-17).  This effort was supported by updated 
public genome resources (Zv4, Zv5) and by our identification of particular characteristics of the 
genomic structure of Nav1 sodium channel genes that would distinguish between them.  As 
illustrated in Figure 2.13, the genes encoding human Nav1 channels all possess large terminal 
exons (“TE”) that encode nearly all of domain IV and the C-terminus of the protein and preceding 
exons that encode part of the highly-conserved inactivation gate (“TE-1”).  Despite distinct 
evolutionary origins, we observed that the size of the second to last exon (TE-1) is identical in 
every human channel (271 nucleotides).  Importantly, we determined that the nucleotide 
sequence of the terminal exon clearly distinguished SCN5A from among other isoforms belonging 
to the three other phylogenetic sodium channel groups (Figure 2.14).  Moreover, the large size 
and sequence of Nav1 sodium channel terminal exons also differentiated these genes from other 
related genes in the ion channel superfamily such as those encoding L- and T-type voltage-gated 
calcium channels (Figure 2.14). 
By searching specifically for 3’ exons (TE, TE-1) of Nav1 sodium channels in the draft 
zebrafish genome (Zv4, Zv5), we identified a total of 8 conserved and non-redundant zebrafish 
Nav1 genes.  These partial clones most resembled the mammalian genes scn1a, scn2a, scn4a (2 
genes), scn5a (2 genes), and scn8a (2 genes), indicating that zebrafish possess 2 genes for each 
of the four phylogenetic groups and are thus likely to display a different pattern of Nav1 gene 
duplication than has occurred in mammals (Figure 2.15).  These gene identities were putatively 
assigned based on phylogenetic relationships (Figure 2.16) and alignment with the nucleotide 
and amino acid sequences of human sodium channel genes.  The identified sequences 
 58
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.13:  Genomic structure of human Nav1 sodium channel genes.  Nav1 voltage-gated 
sodium channel genes are distinguished by large, terminal exons that encode nearly all of domain 
IV of the protein (TE) and preceding exons that encode part of the highly-conserved inactivation 
gate (TE-1).  Shown above are the genomic structures of human sodium channel genes, adapted 
from the National Cener for Biotechnology Information (NCBI) gene database.  Blue underline 
demarcates TE and TE-1.  Note that despite distinct evolutionary origins, the size of the second 
to last exon (TE-1) is identical in every human channel (271 nucleotides). n = nucleotide number; 
aa = amino acid number. 
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Figure 2.14:  Utility of 3’ sequences (TE, TE-1) in differentiating sodium channel isoforms 
from each other and from more distantly-related calcium channel genes.  For human Nav1 
sodium channels, the nucleotide sequence of the terminal exon clearly distinguishes individual 
genes from other homologous isoforms.  (A) Alignments of the 3’ region of SCN5A versus 
analgous regions of channels belonging to the three other phylogenetic sodium channel groups.  
(B) The large size and/or sequence of Nav1 sodium channel terminal exons also differentiate 
these genes from other related genes in the ion channel superfamily such as those encoding L- 
and T-type voltage-gated calcium channels.  A red asterisk marks the gene CACNA1G, which 
also has a large terminal exon.  However, the terminal exon of this gene shares little homology 
with that of SCN5A.  For all alignments above, Y-axis = identity (0-1) where the alignment window 
is 1 nucleotide. 
SCN5A vs SCN1A
SCN5A vs SCN8A
SCN5A vs SCN4A
+1 
1 400 800 12
64.1% ID
+1 
1 400 800 12
68.0% ID
+1 
1 400 800 12
72.2% ID
1 400 800 120
SCN5A vs. CACNA1G (TE)
gene channel exon size
CACNA1A L-type 741
CACNA1B L-type 531
CACNA1C L-type 300
CACNA1D L-type 294
CACNA1E L-type 543
CACNA1F L-type 231
CACNA1S L-type 735
CACNA1G T-type 1014
CACNA1H T-type 645
CACNA1I T-type 252
Terminal Exon - VGCCs
*
42.0% ID
A 
B 
 60
constituted in silico predicted “sequence tags” for the genes encoding each zebrafish Nav1 
isoform.  Chromosome assignment within the zebrafish genome was based on the reported map 
positions of contigs that encoded these sequence tags (ensembl).  
To validate these Nav1 sequence tags and determine their pattern of expression in 
various excitable organs, primers were designed in flanking exons (TE and TE-1) for RT-PCR.  
As displayed in figure 2.17, primers directed against all 8 predicted Nav1 sodium channel genes 
successfully and specifically amplified their targets, as confirmed by direct sequencing of PCR 
amplicons.  Despite two putative scn5a-like genes in the zebrafish genome (zscn6, zscn7), only 
one Nav1 gene appeared to be highly-expressed in the adult zebrafish atrium and ventricle (zscn7, 
our cloned Nav1 gene).  Expression of zscn5 was also detected in the atrium, but at very low 
levels.  These results confirmed that we had cloned the primary sodium channel gene expressed 
in adult zebrafish heart muscle. 
 
Phylogeny of full-length zebrafish Nav1 gene sequences 
An accurate assessment of the phylogeny and identity of zebrafish Nav1 channel genes 
optimally required full-length sequences for each gene.  Unfortunately, a putative zebrafish 
homolog to mammalian scn8a was the only sodium channel sequence available in GenBank 
(NM_131628) at the outset of this work (225).  Therefore we sought to ascertain the complete 
sequences of additional zebrafish sodium channel genes. Initially, we cloned a brain-type Nav1 
sodium channel gene that appeared to be a putative homolog to zscn2a (see Methods). During 
our efforts to clone additional genes, 2 new zebrafish Nav1 sequences appeared in public 
databases.  These genes encoded putative homologs of the skeletal muscle-type mammalian 
sodium channel gene scn4a (231).  The collection of our zebrafish clones (zscn5a, zscn2a) and 
publicly available sequences (zscn8a, zscn4aa, zscn4ab) thus spanned the 4 phylogenetic 
groups of related genes proposed in the sodium channel evolutionary literature (97;98;180): 
(group 1: scn5a/10a/11a – heart/DRG – HOXA; group 2: brain – scn8a – HOXB; group 3: skeletal 
muscle – scn4a – HOXC; group 4: brain – scn1a/2a/3a/7a/9a – HOXD).  We therefore reasoned 
that these five sequences would be sufficient to reconstruct the phylogeny of zebrafish sodium 
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Figure 2.15: In silico zebrafish Nav1 “sequence tags.”  A bioinformatics strategy using 3’ 
exons (TE, TE-1) of mammalian sodium channel genes that encode all of domain IV identified 8 
conserved and non-redundant zebrafish Nav1 genes in updated versions of the zebrafish genome 
(Zv4, Zv5).  Putative gene identities were assigned based on phylogenetic relationships (Figure 
2-16) and alignment with the nucleotide and amino acid sequences of human sodium channel 
genes.  The identified sequences constituted putative in silico sodium channel “sequence tags.”  
Chromosome assignment was based on the reported map positions of the relevant contigs within 
the draft zebrafish genome sequence.  Updated map positions are displayed in Figure 2-17.  For 
simplicity, zscn7 above = the previous zscn7. 
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Figure 2.16: Evolutionary relationships of zebrafish Nav1 sequence tags (TE, TE-1) with 
human Nav1 genes.  Neighbor-joining phylogenetic tree based on the alignment of zebrafish 
sequence tags (TE, TE-1) with relevant regions of mammalian sodium channel genes.  The Para 
sodium channel gene sequence from Drosophila was included as an outgroup.  Interestingly, the 
3’ sequence of the human sodium channel SCN11A also aligns as an outgroup, indicating 
significant divergence from other human sodium channels in regions encoding DIV.  Zebrafish 
Nav1 channel sequences are marked in red. 
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Figure 2.17: Primers directed against in silico predicted Nav1 sequence tags amplify actual 
sodium channel genes from total RNA.  Putative in silico sodium channel sequence tags were 
used to design forward and reverse primers in flanking exons (TE and TE-1) for RT-PCR.  
Primers directed against all 8 putative Nav1 sodium channel genes successfully and specifically 
amplified their targets, as confirmed by direct sequencing. Total RNA was isolated from the 
following adult zebrafish tissues: A = atrium; V = ventricle; SM = skeletal muscle; B = brain; E = 
eye and optic nerve; L = liver; G = gill; SC = spinal cord.  Despite two putative scn5a-like genes in 
the zebrafish genome, only one Nav1 gene is highly-expressed in the adult zebrafish atrium and 
ventricle (zscn7). Expression of zscn5 was also detected in the atrium, but at very low levels.   
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channels, even without full-length sequences for the remaining 3 (and possibly other) sodium 
channel genes. 
Incorporation of multiple full-length zebrafish sodium channel amino acid sequences in 
neighbor-joining (distance matrix) phylogenetic model clarified relationships between zebrafish 
and mammalian channels (Figure 2.18).  Moreover, our results supported the model proposed by 
Lopreato et al., which was based on the analysis of partial sodium channel sequences (encoding 
domains II and III) from the teleost Sternopygus macrurus (180).  With the exception of zscn5a, 
all cloned zebrafish channels clearly aligned with mammalian channels on one of 4 branches 
representing the ancestral vertebrate phylogenetic groups.  Although the precise position of 
zNav1.5 (arrow) was somewhat unresolved in our model (suggesting greater evolutionary 
divergence for the gene encoding this channel than for other isoforms), our analysis provided an 
initial basis for understanding the evolution of Nav1 sodium channels in zebrafish.  For clarity, 
human sodium channel sequences were color coded in figure 2.18 both according to their linkage 
to a particular HOX gene cluster and by their location in the genome. 
 
A comprehensive evolutionary model for vertebrate Nav1 genes 
Many of our preliminary assessments regarding the total number and putative identities 
of zebrafish Nav1 channel genes (including 2 scn5a-like genes) were confirmed by a recent 
publication from another laboratory (230).  The use of parsimony and likehood methods to 
reconstruct the phylogeny of cloned vertebrate Nav1 channel genes, the mapping of each 
zebrafish sodium channel gene isoform on radiation hybrid panels, and the detailed analysis of 
synteny of zebrafish Nav1 channel genes with HOX gene clusters together revealed that different 
evolutionary mechanisms are likely to have contributed to the evolution of voltage-gated sodium 
channel genes in mammals and in fish (230).  Figure 2.19 displays the location of Nav1 sodium 
channel genes relative to HOX gene clusters in human and zebrafish genomes (a second HOXD 
cluster has been lost in zebrafish), as determined by BLAST searches of mapped contigs and 
information obtained from published reports (180;227;228;230).  As illustrated in figure 2.20, 
current evidence suggests that the duplication of Nav1 genes in fish and mammals occurred 
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Figure 2.18: Evolutionary relationships of full-length human and zebrafish Nav1 channel 
amino acid sequences.  Incorporation of multiple full-length zebrafish sodium channel amino 
acid sequences in neighbor-joining phylogenetic model clarified the evolutionary relationships of 
vertebrate channels and supports the model proposed by Lopreato et al., which used partial 
sodium channel sequences (representing Domains II and III) from Sternopygus macrurus.  The 
phylogenetic position of DrNav1.5 (arrow) is unresolved, suggesting evolutionary divergence.  Dr 
= Danio rerio; Hs = Homo sapiens; Dm = Drosophila melanogaster; Bootstrapping values 
(n=1000) for this tree have been included at key nodes; human sodium channel sequences are 
color coded by their linkage to one of four HOX gene clusters and by their location in the genome; 
* = Drosophila outgroup sequence. 
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independently.  While expansion of the Nav1 gene family in mammals appears to have occurred 
by tandem duplication of 4 ancestral vertebrate sodium channel genes, the Nav1 gene family in 
fish likely resulted from a whole-genome polyploidization event specific to the teleost lineage that 
also produced additional HOX gene clusters (97;180;227;228;230). 
 
Consideration of the second scn5a-like gene in zebrafish 
To be consistent with this recent literature, we have adopted the nomenclature scn5Laa 
and scn5Lab (SCN5A-like gene isoforms A and B) and zNav1.5a and zNav1.5b to describe the 
genes zscn6 and zscn7 and the channels they encode, respectively.  Despite our inability to 
detect expression of scn5Laa in mature heart tissue, one recent study reported the amplification 
of scn5Laa transcripts from the developing myocardium (229).  We confirmed these findings by 
designing primers specifically directed against this isoform and used RT-PCR to amplify this gene 
from and day 2 and 3 embryonic heart total RNA template (data not shown).  Moreover, we have 
independently determined the sequence of scn5Laa and have recently initiated efforts to clone 
and assemble this gene in a full-length vector for heterologous expression (see Chapter 5, Future 
Directions).  Our preliminary sequence analysis suggests that scn5Laa encodes a typical voltage 
gated sodium channel of 1932 amino acids.  Zebrafish Nav1.5a displays 76.1% identity and 
82.8% similarity with its counterpart Nav1.5b, and 62.2% identity and 70.5% similarity with human 
Nav1.5.  These data suggest that both scn5a-like genes in zebrafish have similarly diverged in 
sequence from their mammalian counterparts, each displaying approximately 60% amino acid 
identity to mammalian Nav1.5.  However, the divergence between zebrafish Nav1.5a and Nav1.5b 
is far less than that observed among mammalian Nav1.5, Nav1.8, and Nav1.9, suggesting that the 
duplicate genes in zebrafish may encode channels with similar functions.  Notably, zebrafish 
Nav1.5a and Nav1.5b both display significant conservation of residues in important functional 
domains including the transmembrane segments, voltage-sensors, pore loops, inactivation gate, 
and C-terminus.   
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Figure 2.19: Location of Nav1 sodium channel genes in the human and zebrafish genomes, 
as determined by BLAST searches of mapped contigs.  Chromosome images adapted from 
ensembl genome browsers (www.ensembl.org).  * indicates location on an unmapped contig; 
position recently revealed by radiation hybrid mapping (AE Novak, et al., 2006). 
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Figure 2.20: Model for the evolution of Nav1 sodium channel genes in mammals and 
zebrafish.  The family of Nav1 channel genes in mammals and zebrafish has evolved by different 
mechanisms. Analyses by Plummer and Meisler (1999), Piontkivska and Hughes (2003), and 
Lopreato et al. (2001) suggested that all vertebrate sodium channels are derived from 4 ancestral 
vertebrate Nav1 genes and that expansion of this gene family in mammals to 10 genes occurred 
by tandem duplication.  Novak et al. (2006) demonstrated that expansion of the Nav1 family in 
teleosts to 8 genes likely occurred as part of an additional whole-genome polyploidization event.  
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Discussion 
Deciphering the evolutionary history of Nav1 sodium channel genes in vertebrates may 
provide important clues to the function of these proteins in excitable tissues.  Tetrapod and 
teleost genomes both contain multiple, homologous Nav1 sodium channel genes, with 10 
isoforms in mammals and 8 isoforms in fish (230).  Despite the similarity in sodium channel 
function observed among different isoforms, the retention of multiple sodium channel genes in 
both vertebrate lineages supports the concept that having multiple sodium channel isoforms is an 
evolutionary advantage.  In the context of vertebrate evolution, which has been characterized by 
increasing structural and functional complexity in the nervous system and other excitable tissues, 
the availability of multiple sodium channel genes may have provided an important template for the 
specialization of proteins that regulate membrane excitability (4).  Although it has been suggested 
that the retention of multiple sodium channel isoforms may simply have resulted from the 
partitioning of these genes into various excitable tissues, the simultaneous expression of different 
sodium channel genes in single cells may be evidence that even homologous sodium channel 
proteins play distinct and non-redundant roles that are important for cellular function 
(4;100;161;247).  Moreover, one sodium channel gene in (SCN7A in humans, scn6a in mice) 
appears to encode a channel (Nax) that has evolved entirely new functions in regulating salt 
homeostasis (83).  The gene encoding this channel displays significant divergence in key regions 
of sodium channel function and has never been shown to act as a voltage-gated sodium channel 
in vitro (206). 
The zebrafish genome contains two genes, zscn5Laa and zscn5Lab, that are 
evolutionarily related to the HOXA cluster of genes on human chromosome 3 that includes 
SCN5A, SCN10A, and SCN11A (230).  At the protein level, they are approximately 75% identical 
in sequence.  We detected mRNA expression of both scn5a-like genes in the central nervous 
system, one of these genes in the adult atrium and ventricle (zscn5Lab), and both genes in the 
day 3 embryonic heart by RT-PCR (figures 2.8, 2.17, and data not shown).  By in situ 
hybridization, both genes are only weakly expressed in the developing zebrafish embryo (229).  
While expression of zscn5Laa was detected diffusely in the brain, zscn5Lab expression was 
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detected in somites, spinal cord and lateral line (229).  Expression of neither gene was detected 
in the embryonic heart by in situ hybridization; however, both transcripts were detected in the 
developing heart by RT-PCR (229).   
Our findings regarding the sequence and expression of zebrafish scn5a-like genes are 
consistent with what is known about HOXA-linked Nav1 channel genes mammals.  Although 
suspected to be derived from a single ancestral vertebrate sodium channel gene, scn5a, scn10a 
and scn11a display significant differences in sequence and in expression.  By direct sequence 
alignment, for example, we determined that human Nav1.5 shares only 60% identity with Nav1.8 
and 47% identity with Nav1.9, whereas Nav1.8 and Nav1.9 share only 48% identity with each 
other.  As in zebrafish, mammalian scn5a-like genes are expressed in primarily in the heart and in 
neurons.  While scn5a is the primary sodium channel isoform of cardiac muscle, expression of 
this gene has also been detected in neurons of the peripheral and central nervous systems and in 
intestinal smooth muscle (248-253).  Scn10a is selectively expressed in sensory fibers of the 
peripheral nervous system, particularly in dorsal route ganglia (DRG) (87;211;212).  While the 
gene scn11a shares a similar expression pattern with scn10a in rats, transcripts of this gene are 
detectable across the central nervous system in humans (213;214;254). 
The expression of both zebrafish scn5a-like genes in cardiac tissue suggests that Nav1.5-
like sodium channels have played a conserved role in cardiac excitation at least since the split of 
tetrapods and teleosts over 400 million years ago.  The expression of scn5a, scn10a, scn11a, 
scn5Laa and scn5Lab in the nervous system indicates, however, that the ancestral vertebrate 
scn5a-like gene may have also played an important role in neuronal excitability.  We thus 
propose that the divergence of vertebrate scn5a-like genes following duplication reflects a 
partitioning of the role of the ancestral vertebrate gene (subfunctionalization), rather than the 
evolution of completely novel function (neofunctionalization).  However, these processes are not 
likely to be mutually exclusive, particularly over long periods of evolutionary time.  Nav1.8, for 
example, was recently found to have evolved certain unique biophysical properties that allow it 
signal during cold temperatures (88).  While homology and expression are thus reasonable 
starting points to estimate the potential functions of Nav1.5a (zscn5Laa) and Nav1.5b (zscn5Lab) 
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in zebrafish, loss of function studies are required to accurately delineate their roles in vivo.  These 
studies are described in Chapter 3. 
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Table 2.1: Primer sets used to amplify zscn5a (scn5Lab) in 6 overlapping sections. 
 
Section Nest* Forward (5’-3’) Reverse (5’-3’) Length (bp) 
A Outer CGAAGTTTCACATCTGTGAA GATGAAAGTGCTGTTGTTGT 950 
A Inner TCGGACAGAGGCTCAGGATG TGTCGGTAAGGTGGTGTTGA 901 
B Outer AGTACACTTTCACTGGCATT AGAAGAACTGTGAGCTGTGG 1269 
B Inner TACACGTTCGAGTCGCTGAT TCTGAGCACTGGTGCGTCTG 1219 
C Outer AGACAAACCGGCCAAACTGG ATCACGCCGGCTGTCCCATT 1557 
C Inner ACCCCATAGAGGGCATTAAGCAA CGCTTCAGTTTCAGCATGGC 1486 
D Outer CATGTGGGATTGTATGGAAG ATAGATGAAACCCGTCCGGT 1264 
D Inner ACAGCCGCTCTGCATCCTGGTGTT CGGCCGAACTTTCCAGCGAA 1209 
E Outer CTTCATTCTGGAGATGAGCT ATCATCAATGCAAACAGGAG 1200 
E Inner AAGTGGATCGCCTACGGTTT CGGATCACGCGGAAGAGAGT 1100 
F Outer AGAGCAGAAGAAATATTACAACGC AACACGTTTCCTCAAGAGAA 1469 
F Inner CATGAAGAAACTGGGCTCCA CGTCACAGAAAAGTTTCGCT 1377 
 
*Although nesting was not frequently necessary, primers were initially designed for this purpose. 
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Table 2.2: Primer sets* used to identify all non-redundant zebrafish Nav1 sodium channel 
genes. 
 
Gene Set Forward (5’-3’) Reverse (5’-3’) Length (bp) 
zscn1 1 GAGACAGAGAACATCTTGTATTGG AGTTTGTTGTTGGCAGGCCT 1133 
zscn1 2 TCAGACGAGACAGAGAACAT TTAACTGTGGTTCCTGGGTT 560 
zscn1 3, nest† AAACTTCGTATTCATCGTGGCC GTTTGCAGATGAAGCCCCTG 1085 
zscn2 1 GACAGAGGATATGGACAATA CCTTCTTAACTGTTTGTCTT 1118 
zscn2 2 GACAGAGGATATGGACAATA AATCTGGATCTTGCTTGTTC 527 
zscn3 1 AGTGCTGAGAAAGAATATGTC TTGAGAAGATGCCTACGGTA 1100 
zscn3 2 AGTGCTGAGAAAGAATATGTC GAGGGCCACTGTTTAGAATA 520 
zscn4 1 CAATCACAGGAGACGGAAAA ATGAAGCCTTTCCGAATCAG 1112 
zscn4 2 ATCACAGGAGACGGAAAACA GGATTTTCTTTAGTTGGCTC 546 
zscn5 1 TGCTGAGATAGAGGAAATATTG CTTCTCCGGTTGGTTTCTTT 1163 
zscn5 2 AAGTGCTGAGATAGAGGAAA GTAGTTGAACCTGGGTTATC 558 
zscn6 1 AATCTGCTCGCATGGAGACC CCAGGGCGTCTCTTGGTTAA 1160 
zscn6 2 ATCCTCAATAACATCAACTTGG CCACAGTTGCCCTTAGTATT 505 
zscn7 1 CGCCCTCCATCAAACACATC TTTATCAGCGTCCGGCATGG 1160 
zscn7 2 GCCCTCCATCAAACACATCC GCCAGTGTGGGGAATTTCGG 550 
zscn8 1 ATTGAAATGACCCGTGCGCT CCCATTCTGATGCTTGTTTT 1152 
zscn8 2 GATTGAAATGACCCGTGCGC GCCTACGACCGAACTTCCAG 565 
zscn8 3, nest† GTACTGGATCAATGTCATTTTC TGCGAACTTTCTTCATGCTA 1100 
 
* To control for amplification of contaminating genomic DNA, all forward and reverse primers are 
located in different exons (terminal exon and terminal exon -1). 
 
† As indicated for zscn1 and zscn8, additional nested primers were designed to facilitate 
subcloning because of low gene expression levels and/or low PCR amplification efficiency.  For 
other genes, the following nested primer combinations were used as necessary: zscn2 
(1F/1R>2F/2R); zscn3 (1F/1R>2F/2R); zscn4 (1F/1R>2F/2R); zscn5 (1F/1R>2F/1R); zscn6 
(1F/1R>2F/2R); zscn7 (1F/1R>2F/2R). 
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Table 2.3: Biophysical properties of zNav1.5b in CHO cells. 
 Steady-state activation  
Steady-state 
inactivation  Recovery from inactivation 
 V 1/2, mV N  V 1/2, mV N τ1, ms (%)  τ2, ms (%) N
zNav1.5b -42.2±1.1 18  -85.3±0.8 10 9.1±1.4 (96.2±1.2) 144.8±15.1 (3.8±1.1) 8
Values are shown as mean ± s.e.m. 
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CHAPTER III 
 
VOLTAGE-GATED SODIUM CHANNELS REGULATE CARDIAC CELL FATE 
SPECIFICATION VIA A NOVEL, NON-ELECTROGENIC MECHANISM IN ZEBRAFISH 
 
Overview 
In prior work, we identified two scn5a-like genes in zebrafish, scn5Laa and scn5Lab, 
encoding the putative sodium channels zNav1.5a and zNav1.5b.  Transcripts of both genes were 
detected in the embryonic zebrafish heart.  To determine the roles of scn5Laa and scn5Lab in 
regulating embryonic zebrafish heart rhythm, we knocked-down their expression using 
morpholino antisense oligonucleotides.  Unexpectedly, reduced expression of either of these 
genes resulted not only in defects of cardiac function but of cardiac morphogenesis.  By confocal 
imaging of transgenic zebrafish expressing fluorescent proteins in the embryonic heart, we 
developed methods for quantifying total embryonic heart cell number and discovered a significant 
reduction in the number of nascent cardiomyocytes in morphant versus wild type embryos.  In 
studying the mechanisms underlying these defects, we found that reduced sodium channel 
expression disrupted early signaling events in pre-cardiac mesoderm that are required for 
production of normal numbers of cardiac progenitor cells.  Although sodium channels have not 
previously been implicated to function in undifferentiated tissues, one obvious possibility raised by 
these findings was that membrane depolarization is required in the gastrulating zebrafish embryo 
to establish the cardiac cell fate.  However, a series of additional studies led us to conclude that 
channel-mediated electrical activity plays no role in the observed developmental defects.  The 
results of our studies in zebrafish embryos thus suggest that cardiac-type sodium channels have 
evolved two mechanistically-distinct roles in vertebrates: 1. in differentiated cardiomyocytes, 
sodium channels depolarize the membrane to initiate action potentials; 2. during development, 
sodium channels act via a novel, non-electrogenic mechanism to regulate cardiogenesis.   
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Abstract 
Voltage-gated sodium channels initiate action potentials and are required for impulse 
propagation in excitable tissues.  While sodium channel-mediated electrical signaling is critical to 
the normal development of the nervous system, the role of these channels in the genesis and 
early function of other excitable tissues is not well understood.  Here we report that sodium 
channels are also required for heart development, but via mechanisms that are independent of 
electrical signaling.  Knockdown of cardiac sodium channel expression in embryonic zebrafish 
resulted in a failure of chamber morphogenesis and looping, prior to any requirement for these 
channels in myocardial excitation.  These abnormalities were associated with a significant deficit 
in the production of cardiac progenitor cells and a selective loss of expression of the 
homeodomain transcription factor nkx2.5 in early bilateral cardiac primordia.  Analysis of mosaic 
embryos demonstrated that sodium channels are required cell-autonomously in mesoderm for 
cardiac cell fate determination.  However, potent modulators of Na+ influx failed to perturb 
cardiac lineage specification.  Our results indicate that voltage-gated sodium channels have 
evolved two distinct roles in the vertebrate heart: in addition to acting as the principal 
orchestrators of heart rhythm, they perform a previously-unappreciated, non-electrogenic function 
in early cardiogenesis.  These findings suggest that other vertebrate sodium channel isoforms 
may also have important roles in development, via mechanisms that are independent of their role 
in initiating action potentials. 
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Introduction 
In the adult heart, the voltage-gated sodium channel Nav1.5 initiates the cardiac cycle by 
permitting a rapid influx of Na+ ions across the sarcolemma in response to changes in membrane 
potential (89). Mutations in the gene encoding Nav1.5 (SCN5A) are associated with the long QT 
Syndrome (255;256) and a range of other heritable arrhythmia syndromes (257).  Moreover, 
drugs that block the cardiac sodium channel have been demonstrated to be arrhythmogenic in 
human patients (258).  The arrhythmogenic substrate associated with Nav1.5 dysfunction has 
been recapitulated in mouse models as mice heterozygous for scn5a deletion (+/-) displayed 
increases susceptibility to arrhythmias (133).  Similarly, mice heterozygous for a gain-of-function 
mutation that underlies the long QT Syndrome displayed prolonged action potentials and 
spontaneous polymorphic ventricular tachycardia (132).   
Although coordinated electrical activity is apparent soon after the fusion of cardiac 
primoridia at the midline in the beating heart tube, evidence from mice, birds, and fish suggest 
that important electrophysiological changes accompany the dramatic morphological 
transformation of this tube-like structure to a multi-chambered, looped organ.  The genetic and 
molecular mechanisms that govern excitability during heart development, and the contribution of 
heart beating itself to normal development, however, are not well understood.  We hypothesized 
that voltage-gated sodium channels, the initiator of action potentials in the mature myocardium, 
would also have critical roles in regulating the rhythm of developing heart.  We first determined 
whether scn5a is expressed in the developing mouse heart.  For the ease of access to the 
embryonic heart at early stages of development, we then used zebrafish embryos to create loss 
of function models for cardiac sodium channels.   
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Methods 
 
Zebrafish strains 
The zebrafish strains used in this study were raised according to standard procedures.  
The cmlc2:eGFP and cmlc2:dsRed-nuclear transgenic lines have been described (259;260). 
 
In situ hybridization 
 In situ hybridization was performed on mouse embryos sectioned at 5µm using P33-
labeled antisense and sense probes directed against regions of scn5a that have diverged from 
other sodium channel isoforms.  Slides were processed with silver grain emulsion and visualized 
with dark-field microscopy.  For zebrafish, whole embryos at various stages were fixed in 4% 
paraformaldehyde in PBS overnight at 4ºC.  As for mouse scn5a, antisense and sense probes 
were designed against divergent regions of scn5Laa and scn5Lab transcripts to prevent cross 
hybridization with other expressed sodium channel genes.  In situ hybridization was performed 
under standard conditions using digoxigenin-labeled probes.  Antisense probes against the 
following zebrafish genes were used: nkx2.5 (NM_131421), nkx2.7 (NM_131419), gata4 
(NM_131236), gata5 (NM_131235), dHand (NM_131626), cmlc2 (NM_131692), vmhc 
(AF114427), amhc (NM_198823). 
 
Immunohistochemistry 
Immunohistochemistry was performed on whole mount zebrafish embryos using the 
following primary antibodies: S46, MF20 (Developmental Studies Hybridoma Bank, University of 
Iowa), and monoclonal pan anti-sodium channel, K58/35 clone (Sigma).  For S46/MF20 staining, 
embryos were first fixed for 60 minutes in 1% EM grade formaldehyde in PBS.  Embryos were 
blocked in PBS with 10% (v/v) sheep serum, 2 mg/ml BSA, and 0.2% (w/v) saponin.  Primary 
antibodies were diluted 1:10, and visualized with the appropriate FITC and TRITC-conjugated 
secondary antibodies (Southern Biotech, 1:100).  For sodium channel staining, larve were fixed at 
room temperature for 30 minutes in freshly-made 4% paraformaldehyde in PBS.  Embryos at day 
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3 and day 6 were permeabilized by washing for 1 hour in PBS with 0.8% Triton X-100 (“PBST”), 
followed immersion in deionized water for five minutes, immersion in acetone for 7 minutes at -
20ºC, and re-immersion in deionized water for an additional five minutes.  Embryos were then 
blocked for at least one hour in 10% goat serum in PBST.  Anti-sodium channel primary 
antibodies were diluted 1:500, and Alexa secondary antibodies (Molecular Probes) were diluted 
1:1000.  Stained embryos were analyzed with confocal microscopy. 
 
Design and use of antisense-morpholino oligonucleotides     
 Morpholinos were designed to inhibit translation of mRNAs or perturb splicing of pre-
mRNAs.  To ensure specificity against specific sodium channel isoforms, all translation blockers 
were designed using alignments of the identical target regions of all available zebrafish sodium 
channel sequences.  Target specificity was also tested by using putative morpholino sequences 
in BLAST queries of the zebrafish genome.  To identify additional putative target sites for 
translation inhibiting morpholinos, RNA ligase-mediated rapid amplification of cDNA ends (RLM-
RACE) PCR was used to extend 5’ untranslated sequence of both scn5Laa and scn5Lab.  For 
scn5Laa, morpholinos with the following sequences targeting the ATG translation initiation site 
and 5’UTR were used to block translation: ATG1: 5’-CCGCTGGTAAGAGCATGGTCGCCAT-3’ 
and UTR1: – 5’- CTTTTCATCCTGATCGGCCTGTACT-3.’  For ATG1, the following 5-mismatch 
control oligonucleotide was used, where lower case letters represent the substituted nucleotides: 
5’-CCcCTGcTAAGAcCATGcTCGCgAT-3’.  For scn5Lab, the following morpholino was directed 
against the translation initiation site: ATG1: 5’-TGGCTGCCATCTTCTCATCCTGAGC-3’.  Optimal 
splice site targets were identified by examining the pre-mRNA sequence of both scn5Laa and 
scn5Lab for exons/introns that were predicted to lead to frameshifts and premature termination of 
translation if skipped or retained respectively, after splicing.  All putative splice-blocking 
morpholinos were designed by comparing identical intron-exon junction sites between scn5Laa 
and scn5Lab to ensure target specificity, when possible.  For scn5Laa, the following splice site-
directed morpholino was used (exon/intron): E3/I3 – 5’-AGGCTGTGGAAGGATATGAATGGAC-3’.  
A 5-mismatch control morpholino with following sequence was also used: 5’-
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AGcCTGTcGAAcGATATcAATGcAC-3’.  Splicing of scn5Lab was disrupted with the following 
morpholino oligonucleotide: E24/I24 - 5’-AATTTGTGCTGACCGGTGGTCTGGG -3’; E6/I6- 5’-
AGCGGCCTCTCACCTGGGATGACTG-3’.  For E6/I6, the following 5-mismatch morpholino was 
used: 5’-AGCcGCCTgTCAgCTGGcATGAgTG-3’.  In all instances where a specific 5-mismatch 
control morpholino was not mentioned, we used the “standard control” morpholino from Gene 
Tools.  Identical stock and working concentrations of both active and control morpholinos were 
prepared in Danieu’s buffer (58mM NaCl, 0.7mM KCl, 0.4mM MgSO4, 0.6mM Ca(NO3)2, 5mM 
HEPES) or water.  Solutions were injected into 1-2 cell stage wild type zebrafish embryos at a 
consistent volume, calculated from the direct measurement of the injectate diameter under a 
stereomicroscope.  To analyze disruptions of splicing, total RNA from morphant, control MO 
injected, and WT embryos was extracted following phenotyping using the Trizol reagent. 4µg of 
total RNA was used for first strand cDNA synthesis with the Transcriptor reverse transcriptase 
enzyme (Roche), and 2µl of cDNA was subsequently used as template for PCR (25µl reaction 
volume) using Expand Hi-Fidelity polymerase (Roche).  
 
Phenotyping of zebrafish embryos      
 Morphant embryos were phenotyped at various timepoints after injection as indicated.  
Heart rate, morphology, and circulation were assessed using a simple dissecting microscope.  
 
Drug and toxin studies 
Lidocaine, flecainide, mexiletine, TTX, ATX II, and veratridine were all obtained from 
Sigma-Aldrich.  Nisoldipine was obtained from Bayer.  Antiarrhythmic/anesthetic compounds 
were obtained as salts and were thus directly mixed into embryo medium.  To facilitate absorption, 
the pH of each drug solution was adjusted to values that were above pKA of each compound with 
1N NaOH. Control solutions contained no drug but were of the equivalent pH as drug solution.  
Stock concentrations of toxins were either prepared in water (TTX, ATX II) or ethanol (veratridine) 
prior to dilution in physiological buffer (Tyrode’s).  Toxins were pressure injected directly into the 
yoke sack of early embryos or the trunk circulation or pericardial sack at later stages.   
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Cell death and proliferation assays 
TUNEL staining was performed with the In Situ Cell Death Detection KIT, TMR red 
(Roche), according to the manufacturer’s instructions. TUNEL assays were first performed by 
fixing embryos in 4% paraformaldehyde at 4°C, followed by dehydration in a graded 
methanol:PBS series (25%:75%, 50%:50%, 75%:25%, 100%:0%) at room temperature. Following 
dehydration, embryos were incubated in 100% acetone for 10 minutes at -20°C and then washed 
with PBS. Embryos were then treated with permeabilization solution (0.1% Triton X-100 in 0.1% 
sodium citrate in 1xPBS) for 15 minutes and washed in PBS. To permit access of the terminal 
deoxynucleotidyl transferase enzyme (TdT) to the heart, embryos were further treated with 0.25% 
trypsin-EDTA (Gibco) for 20 minutes before 3 final washes in PBS (5 minutes each).  As a 
negative control, TUNEL staining was performed with all reaction components except for the TdT 
enzyme.  As a positive control, embryos were treated for 15 minutes with 100U/mL DNase I 
(Promega) in 50mM Tris-HCl, pH7.5, and 1mg/ml BSA, prior to the TUNEL reaction to induce 
DNA strand breaks. TUNEL-stained embryos were visualized with fluorescence microscopy.  
Acridine orange staining was used to visualize cell death in live embryos.  Embryos at the desired 
stage were incubated for 30 minutes in 10µg/mL acridine orange (Sigma) made from a 100-fold 
dilution of 1mg/mL stock solution in E3 embryo medium. Acridine orange-labeled embryos were 
visualized with fluorescence microscopy.  Cellular proliferation was assessed by incubating 
embryos in 10mM BrdU in 15% DMSO/embryo medium on ice for 20 minutes, followed by 
incubation in BrDU solution at 28.5ºC until the desired age.  BrDU labeling was visualized with 
anti-BrDU antibody (Roche). 
 
Real-time PCR 
Transcript levels of nkx2.5 (NM_131421), gata4 (NM_131236), gata5 (NM_131235), and 
dHand (NM_131626) were measured using SYBR green dye (Applied Biosystems).  Data were 
collected on an ABI 7900HT real-time PCR instrument, quantified by the standard curve method, 
and normalized to zebrafish β-actin levels.  No RT and water templates (performed in duplicate) 
did not yield signal.  When possible, real-time PCR primers spanned introns, amplified single 
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bands by standard RT-PCR, and did not form primer dimers as analyzed by the first derivative of 
the product melting curve.  Standard curves were generated from dilutions of plasmids containing 
each of the respective targets.   
 
Quantification of cardiomyocyte size and number 
For measurement of cell size, cmlc2:GFP transgenic embryos were gently flat-mounted 
between two coverslips.  Z-stack images captured for ascertainment of cell number used the 
same sample preparation.  Total embryonic heart cell number was subsequently determined 
using cmlc2:dsRED-nuclear transgenic embryos that were positioned ventral side in a special 
viewing chamber, stabilized with 1% low melt agarose.  Confocal images were captured using a 
Zeiss LSM 510 Confocal Microscope System equipped with either 40x or 20x objective lenses.  
Three dimensional projections were constructed using the LSM Browser software (Zeiss), and 
image analysis was performed using Image J.  Cell size was measured as the surface area 
surrounded by visible cell boundaries.  Total embryonic cell number was quantitated using the 
Pointpicker function of Image J, which permits a single user-defined mark to appear through 
multiple images in a z-stack.  This allowed the tracking of a single cell in subsequent z sections 
without double counting.   
 
Transplantation 
Uninjected or morpholino-injected donor cmlc2:GFP embryos were labeled by co-
injection of 5% tetramethyl rhodamine dextran (MW 10,000, Molecular Probes) in 0.2M KCl and 
transplanted into uninjected cmlc2:GFP embryos.  Transplantation was performed on blastula 
stage embryos (oblong) at approximately 4hpf.  Mosaic embryos were created by removing a 
total of 50-75 cells from the margin of each donor embryo and transplanting them to the margin of 
a wild type host embryo of the equivalent stage.  Host embryos were reared in darkness at 28.5º 
in Danieu buffer supplemented with penicillin/streptomycin.  Surviving embryos were examined 
for rhodamine-labeled beating cells within the green transgenic hearts at days 2 and 3 using both 
fluorescence and confocal microscopy.  
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Action potential recordings 
The intact, beating heart was exposed in 1 year old TuAB strain zebrafish anesthetized 
on ice and fixed into a tissue chamber perfused with 95% O2/5% CO2 and Tyrode’s solution 
(120mM NaCl, 4mM KCl, 1.8mM CaCl2, 1mM MgCl2, 20mM NaHCO3, 1.2mM NaH2PO4, 10mM 
glucose, 5mM sucrose, pH 7.35 with NaOH) warmed to 37 degrees C.  Action potentials were 
recorded from ventricular muscle using a conventional 3M KCl-filling microelectrode technique.  
Data were acquired using AcqKnowledge 3.7.3 software (Biopac System, Santa Barbara, CA).  
Ventricular action potentials were recorded prior to and after perfusion with 50nM TTX prepared 
in Tyrode’s solution. 
 
Transient transfection and electrophysiology 
Cultured Chinese Hamster Ovary (CHO) cells were transiently transfected with the pBK-
CMV-zscn5a construct using FuGENE6 (Roche).  Cells were grown for 48 hours after 
transfection prior to electrophysiology.  Whole-cell voltage clamp was performed at room 
temperature with 2MΩ patch microelectrodes and an Axopatch 200A amplifier. To minimize the 
capacitive transients, we compensated for approximately 70% to 80% of the cell capacitance and 
series resistance (233). Cells exhibiting very large currents (>6 nA) were also excluded from 
further analysis.  Cells were also excluded if voltage control was compromised.  The extracellular 
bath solution contained (in mmol/L) NaCl 145, KCl 4.0, MgCl2 1.0, CaCl2 1.8, glucose 10, and 
HEPES 10; the pH was 7.4, adjusted with NaOH.  The pipette (intracellular) solution contained (in 
mmol/L) NaF 10, CsF 110, CsCl 20, EGTA 10, and HEPES 10; the pH was 7.4, adjusted with 
CsOH.  Cells were held at -120 mV, and activating currents were elicited with depolarizing pulses 
from -100 to +50 mV in 10 mV increments.  Specific clamp protocols are indicated with the data.  
Data were acquired by pClamp8.0 (Axon Instruments Inc), sampled at 50 kHz, and low-pass 
filtered at 5 kHz.  All currents were normalized to the cell capacitance calculated by Membrane 
Test (OUT O) in pClamp8.0. 
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Data Analysis         
 Continuous variables are expressed as means ± SEM and categorical variables are 
expressed as numbers and percentages. The Student’s unpaired t-test was used for statistical 
analysis, when appropriate. P<0.05 was considered statistically significant. 
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Results 
 
Developmental expression of murine scn5a  
In mice, differentiating cardiac progenitors from the cardiac crescent fuse at the midline to 
form a beating heart tube on E8, followed by looping and chamber morphogenesis on E9.  To 
determine whether scn5a is expressed during these early stages of development in mammals, we 
isolated total RNA from mouse embryos starting at E7.5 and embryonic hearts starting at E9.5 to 
assay for expression of scn5a transcripts.  Using isoform-specific primers, scn5a expression was 
detected starting at E8.5 in total embryo template and at E9.5 in heart template, suggesting a 
potential role in the developing heart (Figure 3.1).  To resolve the early expression pattern of 
scn5a spatially, we raised two different P33-labeled antisense and sense (control) probes directed 
against divergent regions of the murine scn5a mRNA for section in situ hybridization (Figure 3.2).  
At E9.5 and E10.5, both antisense probes detected expression of scn5a transcripts primarily in 
the developing heart and somites, with weaker expression detected in the forebrain and 
developing olfactory apparatus (Figure 3.3).  In the heart, scn5a expression was observed in both 
the developing myocardium of the common atrial and ventricular chambers, but was absent from 
the endocardium and the endocardial cushions (Figure 3.3).  Sense control probes did not result 
in specific signals from any of these tissues.  These data demonstrate that scn5a is expressed 
during early development of the mammalian heart. 
 
Developmental expression of zebrafish scn5Laa and scn5Lab 
We applied similar strategies to assess the expression of scn5Laa and scn5Lab in 
zebrafish embryos.  In zebrafish, the elongating heart tube commences beating between 22 and 
24 hours post fertilization (hpf), and begins to elaborate morphologically distinct atrial and 
ventricular chambers between 32 and 36hpf coincident with the initiation of looping.  During this 
time period, the initial peristaltic-like activity of the heart tube develops into a more mature pattern 
of activation with different regions of the heart displaying distinctive patterns of impulse 
propagation:  between 36 and 48hpf, impulses begin to conduct rapidly through the atrial 
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Figure 3.1: Temporal assessment of scn5a expression in the developing mouse embryo.  
Total RNA was isolated from the entire embryo (top) or the embryonic heart (bottom) at different 
stages of development.  The amount of template used for the RT reaction is indicated below each 
stage.  Scn5a expression begins between E7.5 and E8.5 where E = embryonic day. 
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Figure 3.2: Description of probes used for isotopic in situ hybridization in mice.  (Top) 
Similarity plot based on alignment of cDNAs of murine voltage-gated sodium channel isoforms 
(scn5a vs. 7 other murine sodium channels).  Areas of lowest inter-isoform homology occur at the 
domain I-II and domain II-III linkers, as indicated by red asterisks on the diagram of the predicted 
channel secondary structure (bottom). 
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Figure 3.3: Murine section in situ hybridization at E9.5 and E10.5.  Representative brightfield 
(top) and darkfield (bottom) images are presented.  (A, A’): E9.5 heart.  (B, B’): E10.5 embryo.  
(C, C’): E10.5 heart at higher magnification, as indicated by dotted box in B, B’.  In these 
sections, specific staining is visible in the heart and somites. A = atrium; V = ventricle; OT = 
outflow tract; SC = superior endocardial cushion; IC = inferior endocardial cushion. 
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myocardium, move more slowly in the region constituting the developing atrial-ventricular (AV) 
node, and then conduct rapidly through the ventricular myocardium (261).  During this time period, 
we detected expression of transcripts of both zscn5Laa and zscn5Lab in total RNA templates 
isolated from whole embryos (Figure 3.4).  To determine whether zscn5Laa and zscn5Lab are 
expressed in the developing myocardium, we microdissected hearts from transgenic zebrafish 
expressing GFP under the control of the cardiac myosin light chain 2 promoter (Tg[cmlc2:gfp]), 
which specifically drives GFP expression in the developing heart, and assayed expression using 
gene-specific primers and RT-PCR.  As illustrated in figure 3.4, expression of both zscn5Laa and 
zscn5Lab was detected in the developing myocardium.  To determine the localization of 
zscn5Laa and zscn5Lab expression in whole-mount embryos, we generated antisense and sense 
(control) probes against each gene in selected regions of divergence determined by alignment of 
the full-length, cloned zebrafish Nav1 cDNA sequences (Figure 3.5).  Although antisense probes 
against zscn5Lab initially detected expression of this gene in the embryo heart at 54hpf, we were 
unable to consistently reproduce these results by standard methods for in situ hybridization. 
Similar difficulties were encountered using probes directed against different regions of the 
zscn5Lab mRNA sequence that because of high-homology with other Nav1 sequences, may 
possibly have detected other isoforms.  No in situ expression pattern was detected at any stage 
between day 1 and day 4 using probes directed against zscn5Laa mRNA, using standard 
methods.  A survey of the expression of all 8 zebrafish sodium channel genes was recently 
reported in the literature (229).  Antisense probes were directed at similar locations of zscn5Laa 
and zscn5Lab mRNA transcripts (229).  By in situ hybridization, expression of zscn5Laa was 
nearly undetectable at 24 hours post-fertilization (hpf) (229).  Between 48hpf and 60hpf, 
zscn5Laa appeared to be weakly and diffusely expressed in the head region, possibly in head 
muscle or in the central nervous system (229).  Expression of the second scn5a-like gene, 
zscn5Lab, was detected most clearly in somites at 19hpf using a fluorescent chromogen (229).  
This expression in somites disappeared and was followed by weak expression in the ventral 
spinal cord at 30hpf (229).  At 60hpf, the expression of zscn5Lab was again nearly below the 
level of detection, but may be expressed in developing lateral line structures (229).  Unexpectedly, 
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Figure 3.4: Expression of cardiac sodium channels in the zebrafish embryo.  (A) Use of 
cmlc2:GFP transgenic zebrafish embryos facilitated microdissection of the developing heart.  (B) 
Primers were designed to amplify transcripts of scn5Laa or scn5Lab from the embryonic 
zebrafish heart (HT) or total embryo at different stages of development.  cmlc2 = cardiac myosin 
light chain 2. 
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Figure 3.5: Probe design for in situ hybridization in zebrafish.  (A) Similarity plot of the 
alignment of all 8 zebrafish Nav1 channel genes.  Probes 1 and 2 targeted areas of high 
divergence.  (B) Percent homology of in situ probes to each full-length Nav1 sequence. 
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expression of 0/8 zebrafish sodium channel genes were detected in the developing heart at any 
stage by in situ hybridization (229).  The difficulty in detecting sodium channel transcripts in the 
zebrafish heart by standard in situ hybridization may reflect the low abundance of sodium channel 
transcripts, detectable by only methods that greatly amplify these transcripts such as PCR or 
isotopic in situ hybridization with long exposure times. 
 
Function of sodium channels in the developing heart 
 The external fertilization of zebrafish embryos, the ease of observing aberrant heart 
rhythms, and their permeability to small molecules enabled us to survey the putative function of 
cardiac sodium channels from the earliest stages of heart function using chemicals that target 
these channels.  For their solubility, low cost, and ease of delivery, we tested the effects of the 
sodium channel blockers lidocaine, mexiletine, and flecainide, as well as the pufferfish toxin TTX, 
in two strains of wild type zebrafish (EK and TU) at day 2 and day 3.  As shown in Figure 3.6, 
application of lidocaine to the embryo medium resulted in significant, dose-dependent 
bradycardia in wild-type embryos.  Application of mexiletine also resulted in bradycardia, whereas 
treatment with the more potent drug flecainide elicited 2:1 and 3:1 atrioventricular block.  
Unexpectedly, TTX in the bath solution did not produce any effects on cardiac rhythm at these 
stages of development.  As embryos immersed in between 10 and 100µM concentrations of TTX 
continued to display normal muscle and nerve function (e.g. swimming, touch sensitivity), we 
considered the possibility that the charge and the size of TTX prevented this molecule from freely 
crossing biological membranes.  Similarly, we earlier noted the effects of local anesthetics (which 
are weak bases) were potentiated by altering the pH of the solution above of the pKa of the drug 
(e.g. lidocaine pKa ~ 8.2).  This suggested that despite the relatively small size of local 
anesthetics, the charge on these drugs in neutral or acidic solutions was likely to prevent these 
molecules from freely crossing lipid membranes. Taken together, the results of our chemical 
studies suggested that sodium channels are likely to be important regulators of beating in the 
embryonic heart.  However, the bradycardia and heart block elicited by sodium channel blockers 
are not specific for sodium channel perturbation, as similar rhythm abnormalities occur with 
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Figure 3.6: Sodium channel blockers such as lidocaine induced bradycardia in the 
zebrafish heart on day 2 of development.  Lidocaine was placed in the bath solution of 
zebrafish embryos at 48 hours post fertilization and heart rate was assessed.  N = number of 
embryos tested at each drug concentration. 
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disruption of cardiac potassium channel zERG potassium channel (262).  Furthermore, none of 
the sodium channel blockers used display exquisite specificity for sodium channels, particularly at 
the doses used to elicit rhythm phenotypes from bath solutions (263-268).   
 
Initial analysis of the function of zNav1.5Lb (zscn5Lab) 
To determine which sodium channel gene(s) were likely to underlie the observed cardiac 
drug-response phenotypes in the zebrafish embryo heart, we designed experiments to 
knockdown channel expression using morpholino antisense oligonucleotides.  As zNav1.5Lb was 
the first cardiac sodium channel we identified, and because of its expression in the embryonic 
heart and both chambers of the adult heart (Figure 2.8), we first directed morpholino 
oligonucleotides against transcripts of the gene zscn5Lab.  Traditionally, antisense morpholino 
oligonucleotides were designed to recognize the translation start site of processed mRNAs, 
where they reduced protein expression by acting as steric inhibitors of the ribosome complex.  
Since morpholinos could penetrate the nucleus, however, it was recognized that they could be 
directed against intron-exon junctions of pre-mRNAs to perturb splicing, which would in turn 
knockdown protein expression (269). The latter approach presented certain advantages: in the 
absence of antibodies against the zebrafish protein target, one could easily track the action of the 
morpholino oligonucleotide by RT-PCR with priming sites on either side of the splice junction.   
As the cloning of zscn5Lab proceeded from the 3’ end (Figure 2.4), we first analyzed this 
region of the gene for optimal morpholino target sites and identified the E24/I24 splice junction as 
a reasonable candidate (see Methods for morpholino design criteria).  Injection of low quantities 
(1-2ng) of E24/I24 morpholino oligonucleotides into 1 cell stage embryos resulted in retention of 
intron 24 as assayed by RT-PCR across this splice junction (Figure 3.7).  This retained intron was 
predicted to result in a frameshift and likely premature termination of the translation of zscn5Lab 
transcripts prior to domain IV, predicting a loss of approximately 25% of the mature protein 
(Figure 3-7).  As voltage-gated sodium channels are formed from a single polypeptide, we 
predicted this perturbation would result in complete loss of functional zNav1.5Lb channels at the 
membrane.  Injection of similar (and greater quantities) of a standard control morpholino that was 
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not directed against any particular gene did not result in any abnormalities of splicing of zscn5Lab 
transcripts (Figure 3-7).   
To determine whether knockdown of zNav1.5Lb resulted in abnormalities of heart rhythm, 
we examined injected embryos at 2 and 3 days post fertilization.  As predicted by the drug-
response phenotype, knockdown of zNav1.5Lb resulted in bradycardia whose severity depended 
on the amount of morpholino injected (Figure 3.8).  At later stages (day 4), a small but significant 
percentage of morphant embryos also developed more complex arrhythmias such as sinus 
pauses and AV-block (Figure 3.8).  As a simple assay of overall cardiac function, we determined 
whether morphant hearts could adequately maintain circulation in the embryo.  Both by direct 
observation of circulation through the transparent trunk, as well as by the injection of fluorescent 
beads into the sinus venosus in a smaller number of embryos, it was revealed that the weakly 
contractile morphant heart could not sustain circulation (Figure 3.9).  Moreover, as revealed by 
knockdown of zNav1.5b in the flk:GFP transgenic background, morphant circulation was impaired 
in the absence of defects of development of primary vascular structures (Figure 3.9).  Our results 
indicated that reduced expression of zNav1.5Lb significantly compromised heart function in the 
zebrafish embryo.  Most embryos injected with 1.5ng of morpholino died by 5 days post 
fertilization.    
In addition to these functional deficits, however, morphant embryos unexpectedly 
displayed developmental abnormalities that included reduced body and head size, a slight body 
curl, and most strikingly, a significant defect in cardiac morphogenesis (Figures 3.10-11).  These 
findings are consistent with the observation that mice homozygous null (-/-) for scn5a (but not 
heterozygote mice) were reported to be embryo-lethal on E10 with significant defects in cardiac 
morphogenesis, primarily of the developing ventricular myocardium (see Discussion) (133).  
Zebrafish embryos mutant for the cardiac L-type calcium channel gene CACNA1C also displayed 
significant defects in ventricular morphogenesis at 3 days post-fertilization (270).  Moreover, in 
mouse models and human patients, an array of unexpected myocardial phenotypes have been 
linked to SCN5A mutations and reduced sodium channel expression including dilated 
cardiomyopathy, left ventricular non-compaction, and age-related cardiac fibrosis (271-276).  
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Figure 3.7: E24/I24 antisense oligos (“MO1”) effectively reduced wild-type zscn5Lab mRNA 
transcripts.  (A) Target sites of antisense oligos displayed in reference to scn5Lab pre-mRNA.  
Exon nomenclature above (E26) was based incomplete information while scn5Lab was being 
cloned from its 3’ end.  (B) As determined by RT-PCR across the splice junction and direct 
sequencing of aberrant splice products (C), the E24/I24 MO induced retention of intron 24, 
predicting a termination of translation after 4 codons of intronic sequence (VSTN*).  Amino acid 
sequences are listed above the nucleotide sequences in (C).  (D) The truncated protein is 
predicted to be 1458 amino acids long and lacks all of domain IV.    
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Figure 3.8: Heart rhythm defects at days 2 and 4 following knockdown of Nav1.5b 
(scn5Lab).  (A) Morphant embryos display dose-dependent bradycardia at 48-52 hours post-
fertilization.  (B) Morphant embryos display more complex arrhythmias at later stages (96-100 
hours post-fertilization). 
B 
A 
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Figure 3.9: zNav1.5b morphants displayed severe perturbations of heart function that 
prevented normal circulation.  (A, B) Fluorescent beads were pressure-injected into the sinus 
venosus of control and morphant embryos (arrow) to determine whether the heart could 
adequately maintain systemic circulation. (C, D) As assessed by injection of the E24/I24 
morpholino into the flk:GFP transgenic line, zNav1.5b knockdown perturbed circulation without 
affecting the development of primary vascular structures.  
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Since the mechanisms linking ion channel activity to myocardial morphogenesis or maintenance 
are not well understood, we investigated the morpholino-induced zebrafish cardiac developmental 
abnormalities in greater detail.   
To more easily study cardiac morphogenesis, we used transgenic cmlc2:GFP zebrafish 
embryos, where the embryonic heart structures were clearly visible by fluorescence microscopy 
starting from early stages.  At 36 hours, E24/I24 morphant hearts displayed significantly reduced 
size and GFP intensity and a delay in the initiation of looping (Figure 3.11).  Where wild type 
hearts at 60hpf elaborated morphologically-distinct atrial and ventricular chambers which have 
looped, morphant hearts remained straight and tube-like, with no evidence of ventricular chamber 
morphogenesis and compromised atrial formation.  At 84hpf, when in wild type embryos the 
ventricle displayed evidence of concentric thickening and looping had progressed to place the 
atrium and ventricle into apposition, morphant hearts deteriorated into a stretched, string-like form 
analogous to those seen in zebrafish mutants of early cardiac transcription factors such as tbx5 
(277).  Atrial and ventricular chambers arise from two distinct groups of progenitor cells in the 
early embryo (278;279).  To determine whether the atria and ventricles were patterned properly in 
morphant hearts, we used double-immunostaining with antibodies that recognize myosin chain 
epitopes in the atrium and whole heart (S46 and MF20, respectively) (Figure 3.12).  These 
studies revealed normal A-V patterning in morphant hearts, and more clearly demonstrated that 
both chambers were significantly perturbed following knockdown of zNav1.5Lb.   
As revealed by zebrafish mutants identified in forward genetic screens, defects in 
embryonic heart morphogenesis may result from perturbations of genetic pathways that control 
the number (280), growth (281), movement (282), or patterning (283) of nascent cardiomyocytes. 
To begin to distinguish between these possibilities in sodium channel morphants, we first 
sectioned the cardiac chambers of wild type and morphant hearts at 80hpf.  Qualitatively, 
hematoxylin & eosin (H&E) staining revealed that morphant hearts had less cells than wild-type 
hearts and failed to display the normal concentric thickening of the ventricle (morphant chambers 
are a single layer) (Figure 3.13).  Despite the apparent reduction in cell number, morphant 
myocytes appeared to be comparable in size to those in wild-type embryos (Figure 3.13).   
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Figure 3.10: Whole-body phenotypes resulting from E24/I24 or control morpholino 
injections.  Embryos were photographed at the designated timepoints using brightfield 
microscopy.  Morphant embryos are shorter in length, have smaller heads, and display abnormal 
tail curvature. 
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Figure 3.11: Knockdown of zNav1.5b resulted in defects in cardiac morphogenesis, as 
assessed in cmlc2:GFP transgenic zebrafish embryos.  The sodium channel morphant 
phenotype was visualized in cmlc2:GFP embryos.  At 1.5 days post fertilization, morphant hearts 
(J) elaborated less myocardial tissue than uninjected (B) and control-injected (F) embryos.  At 2.5 
days post-fertilization, morphant chamber morphogenesis and looping were severely perturbed 
(K versus C, G).  At 3.5 days post-fertilization, the morphant heart deteriorates while wild-type 
and control-injected hearts proceed with looping and chamber development (L versus D, H).  
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To quantitate cardiomyocyte growth and number, we developed methods to image the 
hearts of cmlc2:GFP transgenic embryos with single-cell resolution using confocal microscopy 
(Figure 3.13).  By gently flat-mounting transgenic embryos, samples could be imaged within the 
narrow working distances of high magnification confocal lenses (approximately 200µM for 40x/1.3 
aperture lens), without damage to individual cardiomyocytes.  Cell boundaries were clearly visible 
at high power in unfixed, unstained embryos (Figure 3.13).  Our method of imaging cmlc2:GFP 
hearts thus enabled us to use Image J analysis software to measure the surface area (µM2) of 
embryonic cardiomyocytes at different stages in both wild-type and mutant embryos.  Moreover, 
by collecting stacks of images that spanned the entire heart in the Z dimension, we were able to 
use the Pointpicker function of Image J to count the total number of cardiomyocytes across Z 
sections without double-counting cells.  Prior methods of quantifying the total number of cells in 
the heart relied on the use of serial H&E-stained sections and may have greatly overestimated 
the true cell number. 
To determine whether and to what extent embryonic cardiomyocytes grow in size over 
the course of early stages of heart development, we first imaged the developing heart at its 
“cone” stage (22-24 somites), the earliest timepoint at which GFP is expressed in our transgenic 
embryos and shortly after the fusion of cardiac primorida at the midline, and again after chamber 
formation on day 3.  As prior studies have revealed that differentiating cardiomyocytes already 
display distinct atrial- and ventricular-specific gene expression patterns prior to heart tube 
formation, we measured cells in the presumptive ventricle (inner heart cone) at 22-24 somites 
and compared them to ventricular cells on day 3 for consistency (278;279).  Between 24 somites 
(~20hpf) and day 3 (~76-78hpf), the average size of a wild-type ventricular cardiomyocyte 
increased from 180±4.1µM2 (mean±SEM; n = 90 total cells, 4 heart cones) to 250.5±0.69µM2 
(mean±SEM; n = 68 total cells, 4 ventricles).  To determine the normal developmental change in 
cardiac cell number, we counted the number of cells in wild type heart cones (22-24 somites) and 
in day 2 hearts (54hpf).  Our analyses revealed that the total number of embryonic myocardial 
cells normally increases in number during this time period from 153±7 to 227±16 cells (n=4).  
While morphant hearts displayed normal cellular growth compared to wild type hearts, they had 
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Figure 3.12:  Double immunostaining of morphant embryo hearts revealed normal atrial-
ventricular patterning.  Despite severe defects in morphogenesis, zNav1.5b (scn5Lab) 
morphant hearts displayed normal atrial-ventricular patterning as assessed by MF20/S46 double 
immunostaining. A = atrium (green), V = ventricle (red).   
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Figure 3.13: Knockdown of zNav1.5b resulted in a reduced number of embryonic 
cardiomyocytes.  (A-C)  Hematoxalin and eosin-stained transverse sections of control and 
morphant zebrafish hearts on day 3 (80 hours post-fertilization).  (A) In wild type embryos, 
chambers were looped and the ventricle displayed concentric thickening.  (B, C) Morphant hearts 
lacked concentric thickening of the ventricular wall and displayed abnormal looping as indicated 
by the appearance of the atrium and ventricle in different sections.  The endocardium is also 
reduced in morphants but intact.  Note the massive edema.  (D) Typical confocal image of a wild 
type cmlc2:GFP embryo heart at 2 days post-fertilization, showing single cell resolution and clear 
cellular boundaries.  (E) Total cardiomyocyte number is reduced in morphants (wild type: 227±16; 
morphant: 182±13, mean±SD, p<0.001, n=4 hearts each). 
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significantly fewer cells 182±13 cells (n=4), suggesting a possible cellular mechanism for the 
observed defects in organ morphogenesis (Figure 3.13).   
 
Is function required for development? 
The vertebrate heart begins to beat well before its development is complete.  In zebrafish, 
the simple tube-like heart exhibiting peristaltic-like contractions establishes circulation within the 
embryo early on day 1.  Given the well-established role for sodium channels in initiating the 
cardiac cycle, we next tested the hypothesis that altered electrical activity resulting from 
morpholino treatment generated the defects in heart development we observed.  As a critical test 
of this hypothesis, we sought to more clearly establish that voltage-gated sodium channels 
regulate heart rhythm at early stages (day 1-2) when zNav1.5b morphants already displayed 
significant defects in cardiac morphogenesis.  The absence of any effect of micromolar 
concentrations of TTX in embryo medium suggested the possibility that sodium channels are not 
required to regulate heart beat in early zebrafish. 
To study the functional differentiation of the sodium channel complex in zebrafish, we 
took several approaches including electrophysiology, in vivo administration of channel-specific 
toxins, and immunohistochemistry of sodium channels in developing excitable tissues.  We used 
three toxins in our studies with distinct binding sites and mechanisms of action on sodium 
channels: the sodium channel “blocker” tetrodotoxin and the channel “activators” anemone toxin II 
and veratridine (284;285).  As zebrafish sodium channels cDNAs have never been previously 
functionally expressed and screened for toxin sensitivity, we performed initial experiments in vitro 
to determine the effects of different doses of TTX and ATX II on whole cell sodium currents of 
zNav1.5b.  In CHO cells, both toxins profoundly affected the function of this zebrafish channel 
(Figure 3.14).  For TTX, 100nM concentrations were sufficient to nearly completely eliminate 
inward sodium current through the channel (Figure 3.14).  Conversely, similar concentrations of 
ATX II prevented the channel from closing by nearly completely blocking channel inactivation 
(Figure 3.14).  In vivo, we successfully recorded action potentials from the adult zebrafish 
ventricle using the sharp microelectrode technique.  To determine whether zebrafish cardiac 
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Figure 3.14: Changes in zNav1.5b whole cell sodium currents in CHO cells following 
exposure to TTX and ATX II.  Inward sodium currents are downward/negative by convention.  
Tetrodoxin (TTX) is a heterocyclic guanidinum toxin that binds to “receptor site 1” on the channel 
from the extraceullar compartment.  Since site 1 contributes to the outer vestibule of the sodium 
channel pore, TTX acts to block the permeation of sodium ions.  The 47 amino acid peptide 
anenome toxin II (ATX II) binds to “receptor site 3,” which includes the extracellular linker 
connecting transmembrane segments S3 and S4 of domain IV.  By interfering with the S4 voltage 
sensor of domain IV, ATX II perturbs movements of the protein that are required for fast 
inactivation, resulting in channels that do not properly close.  The ATX II diagram above was 
found in the Orientation of Proteins in Membranes (OPM) database, University of Michigan 
College of Pharmacy: http://opm.phar.umich.edu/protein.php?pdbid=1atx 
Tetrodotoxin (TTX)
Anemone toxin (ATX II)
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Figure 3.15: Nanomolar concentrations of tetrodotoxin (TTX) suppressed adult zebrafish 
ventricular action potentials.  N = 4; representative traces shown above. (A) Action potentials 
generated by the adult zebrafish ventricular myocardium bathed in Tyrode’s solution 
(physiological control).  (B) 50nM TTX in physiological solution disrupts the generation of 
ventricular action potentials.  (C) At five minutes of TTX exposure, the frequency and amplitude of 
ventricular action potentials are markedly reduced and the heart stops beating. 
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action potentials depend on the function of voltage-gated sodium channels, we applied TTX to the 
bath solution.  As shown in Figure 3.15, as little as 50nM TTX completely inhibited the generation 
of ventricular action potentials (n = 4 hearts), with effects that were nearly completely reversible 
on washout.  As mammalian cardiac channels are blocked only by micromolar doses of TTX, 
these findings confirmed our prediction of a key difference between zebrafish and mammalian 
cardiac sodium channels predicted from sequence analysis (Figure 2.12).  More importantly, the 
exquisite sensitivity of the adult zebrafish heart to TTX provided us with a starting point for 
studying the developmental time-course of sodium channel function in the heart.  
   On day 1 of development, when the zebrafish embryo heart has just commenced beating, 
we exposed zebrafish embryos to the sodium channel toxins and examined the effects on the 
beating heart tube.  By this approach, no sodium channel modulators elicited any visible effects 
on heart beat (Figure 3.16).  As a positive control, we immersed embryos in 10-50µM 
concentrations of the L-type calcium channel blocker nisoldipine, which promptly slowed and then 
arrested the heartbeat within 20 seconds.  Veratridine (150µM) caused hyperkinetic movements 
of the entire embryo body, followed by tonic contraction of the trunk.  However, neither TTX nor 
ATX II produced any effect, raising the possibility that the compounds were not able to 
adequately penetrate into the embryo. Therefore, we pressure injected TTX and ATX II directly 
into the trunk circulation of day 1 embryos.  A few seconds after acute delivery into the circulation, 
150µM TTX completely inhibited spontaneous movement and the normal “escape response” 
elicited by stimulation at this stage of development.  Conversely, injection of 20µM ATX II by 
identical methods of delivery promptly resulted in hyperkinetic movements of the embryo for 
approximately 15-20 seconds, followed by tonic contraction and then complete relaxation.  After 
this initial response, hyperkinetic movements were readily elicited by gentle stimulation, 
presumably because sodium channels in nerve and muscle needed to be opened before these 
toxins could exert their effects.  Despite the dramatic effects seen on sodium channel-related 
physiological responses in nerve and muscle, no effect was observed on the beating of the day 1 
heart tube.  The lack of any effect of high concentrations of any toxin indicated that sodium 
channels do not play a role in mediating excitability within the early developing heart of zebrafish.  
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Figure 3.16: Effects of sodium channel modulators on early zebrafish heart function.  (A) 
Sodium channel blockers had little effect on heart beating on day 1, whether delivered by 
injection or placed in the bath solution. (B) 1mM TTX injected into the yoke of 1-2 cell stage 
embryos resulted in profound paralysis for the first 4-5 days of development, but no change in 
heart rhythm.  (C) TTX and ATX II were acutely delivered into the pericardium, as demonstrated 
by red dye.  ATX II caused arrhythmias in a few embryos between days 2 and 3 and in most 
embryos thereafter.  TTX caused arrhythmias in some embryos between days 4 and 5 and in 
most embryos thereafter.  D = days post-fertilization.  (D, E) ATX II caused tonic ventricular 
contraction on day 4 when delivered directly into the pericardial sack.  Atrial rate and rhythm were 
unaffected.  
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Notably, the reliance on sodium channels for excitation was observed to be significantly delayed 
in the heart compared to other excitable tissues, where sodium channel-mediated effects were 
readily apparent by the delivery of TTX, ATX II, and veratridine.  
To determine when sodium channels become required for function in the embryonic heart, 
we delivered micromolar doses of TTX in physiological vehicle or vehicle alone directly to the 
myocardium via microinjection over each of the first 7 days of development.  Live embryos were 
first anesthetized with low doses of tricaine that permitted stabilization of embryos on their lateral 
aspect in methylcellulose, with no detectable effects on heart rhythm or contractility.  Injections 
were performed with sharp-tipped, borosilicate micropipettes inserted directly from the caudal 
aspect into the sinus venous, the antechamber where blood collects before traveling into the 
atrium (day 2), or the pericardial space that surrounds the beating heart (days 3-7) (Figure 3.16).  
Direct exposure of the myocardium to 150µM TTX caused no adverse effects on heart rhythm 
until between days 4 and 5 of development, when a small percentage of embryos began to 
display specific arrhythmias including 2:1, 3:1, and 4:1 AV conduction block and less frequently, 
atrial and ventricular standstill.  By days 5 and 6, a greater percentage of embryos displayed 
these phenotypes and between days 6 and 7, nearly all embryos tested exhibited these 
phenotypes.  At all stages tested, the zebrafish ventricles appeared to be more adversely effected 
by application of TTX than the atria, with many atria actually appearing completely unaffected.  
Unexpectedly, these data suggested that voltage-gated sodium channels are not important 
contributors to heart rhythm until between days 4 and 5 of development, well after early chamber 
morphogenesis and looping have occurred, making in unlikely that sodium channel-mediated 
excitability contributed to the observed defects in cardiac morphogenesis.  Moreover, our data 
also suggested an alternative, yet-unidentified mechanism for depolarization in the early heart, 
perhaps by voltage-gated calcium channels.  Therefore, to directly address whether calcium entry 
is required for early cardiac development, we reared embryos from early stages in 10µM of the L-
type calcium channel blocker nisoldipine.  The hearts of embryos reared in nisoldipine were silent 
at every stage examined, demonstrating that blocking calcium entry through L-type calcium 
channels was sufficient to eliminate the cyclic cytosolic calcium transients required for contraction 
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of embryonic zebrafish cardiomyocytes.  Surprisingly, blocking calcium entry into the heart did not 
perturb morphogenesis of the heart through the end of day 2 (Figure 3.17).  The cardiac 
chambers, albeit deflated due to a lack of blood flow, formed relatively normally and initiated 
normal looping.  From these data, we deduced that excitability is not a requirement for early 
cardiac morphogenesis. 
 
Physiologically “silent” sodium channels 
The limited response of the early heart to tetrodotoxin did not preclude the existence of 
sodium channel protein in developing myocytes.  Physiologically “silent” sodium channels were 
previously identified in the chick embryo heart (286).  We therefore hypothesized that 
physiologically-silent sodium channels may play a role in cardiac development, via a previously-
unknown mechanism.  To unmask physiologically silent sodium channels in the zebrafish embryo 
heart, we used ATX II, reasoning that the application of this toxin would stabilize even a few open 
channels in the open conformation and result in an aberrant heart rhythm.  Although injection of 
ATX II into day 1 embryos resulted in no disturbance of early heart tube contractions (Figure 
3.16), a minority of embryos displayed arrhythmias between days 2 and 3 in response to ATX II 
and nearly all embryos displayed arrhythmia between days 3 and 4.  On days 3 and 4, these 
arrhythmias manifested as tonic ventricular contractions without relaxation or an intermediate 
phenotype resembling 2:1 or 3:1 AV block with compromised relaxation of the ventricle.  The 
induction of arrhythmias with ATX II primarily on day 3 revealed the presence of at least some 
competent sodium channels in the membranes of day 3 myocytes, despite the lack of any 
requirement for these channels in regulating heart rhythm until between days 4 and 5 of 
development. However, the absence of any effect of ATX II in the majority of embryos on day 2 
(54-60hpf) and in younger embryos also suggested that silent but functional sodium channels in 
the membranes of nascent cardiomyocytes were unlikely to explain the defects in cardiac 
morphogenesis induced by sodium channel knockdown.    
To directly visualize the expression of channel protein, we performed 
immunohistochemistry using anti-sodium channel antibodies that recognize an epitope in the 
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Figure 3.17: Prolonged nisoldipine treatment blocked the heart beat but did not perturb 
early heart development.  Embryos were reared in 10µM nisoldipine from early stages to block 
L-type calcium currents.  At 54 hours post-fertilization, chamber morphogenesis and looping were 
relatively unperturbed, despite the absence of blood flow, beating, and calcium transients.  B and 
C depict two different drug-treated embryos.  
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intracellular domain III-IV linker that is conserved among mammalian and zebrafish sodium 
channels.  We observed both punctuate channel clusters as well as diffuse staining in skeletal 
muscle, spinal cord, and brain of day 3 embryos (Figure 3.18).  In the heart, however, only a 
small number of channel clusters were observed at this timepoint (Figure 3.19).  At day 6, 
however, we observed an increase in the density of sodium channel clusters per field (Figure 
3.19).  These results suggested that one possible mechanism underlying the emergence of a 
physiological role for sodium channels in the heart at day 4 and day 5 might be increased 
expression of channel protein.  Moreover, the severe, early defects in cardiac morphogenesis 
observed following channel knockdown were in large part unlikely to be related to sodium channel 
function or expression in the beating embryonic heart. 
 
zNav1.5b morphants display defects in the production of cardiac progenitor cells 
Given these results, we hypothesized that zNav1.5b may adversely affect the production 
cardiac progenitor cells, thereby resulting in a reduced number of embryonic cardiomyocytes and 
perturbation of cardiac morphogenesis.  To test this hypothesis, we examined formation of the 
day 1 heart tube in live cmlc2:GFP and flk:GFP embryos, which permitted visualization of the 
myocardial and endocardial layers of the developing heart, respectively (Figure 3.20). In both 
transgenic lines, we observed a significant reduction in the size of the developing heart tube 
following knockdown of zNav1.5b.  Moreover, staining for markers of the atrial and ventricular 
myocardium (amhc, vmhc) at 30hpf by in situ hybridization indicated that both presumptive atrial 
and ventricular myocyte populations were comparably reduced (Figure 3.21).  Taken together, 
these data suggested that the differentiation of cardiac progenitor cells may be perturbed in 
morphant embryos.  To address this question, we studied the expression of cmlc2 and vmhc at 
an earlier timepoint during in the developing bilateral cardiac primordia (16 somites).  By in situ 
hybridization, both markers were reduced in expression, indicating a deficit in the production of 
adequate numbers of embryonic cardiomyocytes by differentiation in morphant embryos (Figure 
3.22).   
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Figure 3.18: Sodium channels are highly expressed in zebrafish muscle and nerve on day 
3.  Pan anti-sodium channel antibodies detected abundant protein in muscle and in the peripheral 
and central nervous systems on day 3 (78 hours post-fertilization).  Both diffuse and punctate 
staining of sodium channels are seen in skeletal muscle and in the central and peripheral nervous 
system.  (A, B, C, C’) Low power (scale = 50 microns).  (A’, B’) Magnification of boxed area in A, 
B (scale = 5 microns). Skm = skeletal muscle; sc = spinal cord; FB/MB/HB = 
forebrain/midbrain/hindbrain; ON = optic nerve. 
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Figure 3.19: Sodium channel protein is upregulated in the heart between days 3 and 6 by 
immunohistochemistry (cmlc2:GFP embryos).  Pan anti-sodium channel antibodies detected 
few sodium channel clusters per high powered field on day 3, but greater numbers on day 6.  
Representative optical sections shown above were 1 micron thick.  Arrowheads point to putative 
sodium channel clusters on the membranes of embryonic cardiomyocytes.  Scale bar = 5 
microns. 
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Figure 3.20: zNav1.5b morphant embryos displayed defects in the formation of the 
myocardial and endocardial layers of the heart tube at 30 hours post-fertilization.  
Transgenic zebrafish lines expressing GFP in the myocardium (cmlc2) or endocardium (flk) were 
used to study the effects of zNav1.5 knockdown on heart tube formation at day 1.  Both 
myocardial and endocardial components were reduced in size.  WT = wild type, MO = morphant, 
and HT = heart tube. 
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Figure 3.21: Knockdown of zNav1.5b comparably affected both presumptive atrial and 
ventricular cells of the developing heart tube at 30 somites.  In situ hybridization was 
performed for genes encoding three different markers of the sarcomere, cardiac myosin light 
chain 2 (cmlc2, whole myocardium); atiral myosin heavy chain (amhc, atrial myocardium); and 
ventricular myosin heavy chain (vmhc, ventricular myocardium). 
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Reduced expression of markers of cardiac differentiation suggested one of several 
possibilities: first, morphant embryos had defects in the specification of cardiac progenitors; 
second, cardiac progenitors could have been normally specified but then failed to properly 
differentiate; third, cardiac progenitors could have been normally specified but had defects in 
proliferation that prevented their normal expansion prior to differentiation.  To distinguish among 
these possibilities, we first stained embryos at 16 somites for expression of the homeodomain 
transcription factor nkx2.5.  Since nkx2.5 is normally expressed starting at 5-6 somites, we 
reasoned that defects in the field of cells expressing this marker at later stages would suggest 
and underlying perturbation of the specification of cardiac progenitors from mesoderm.  Indeed, 
by in situ hybridization, we found the expression of nkx2.5 to be dramatically reduced at 16 
somites (Figure 3.22).  Moreover, by incubating early embryos in the thymidine analog BrDU 
between 6 and 16 somites to label cycling cells, we found no qualitative difference in the field of 
proliferating cells with the bilateral stripes of cardiogenic mesoderm (Figure 3.24).  
Therefore, we studied whether cardiac progenitors were appropriately specified from 
mesoderm.  Early cardiogenic mesoderm is distinguished by the overlapping expression of a 
group of highly conserved regulatory genes belonging to the NK2, GATA, MEF2, T-box, and 
basic helix loop helix (bHLH) families of transcription factors (287-289).  These genes act in 
concert to establish the cardiac cell fate and control different aspects of cardiac morphogenesis, 
as has been revealed by loss-of-function studies in animal models and mutations identified in 
human patients with congenital heart disease (288-290). In zebrafish, the expression of nkx2.5 
most specifically marks the pre-cardiac mesoderm in two bilateral stripes (291).  The transcription 
factor gata4 is expressed in a larger domain of anterior lateral mesoderm, whereas early dHand 
expression marks the anterior lateral mesoderm at early stages (292-295).  By in situ 
hybridization at 6 somites, we found that zNav1.5b is required for the normal expression of both 
nkx2.5 and gata4 (Figure 3.23).  Strikingly, the expression of nkx2.5 was completely absent 
whereas gata4 was reduced.  To test whether zNav1.5b affected the viability of lateral mesoderm, 
we used the vital dye acridine orange (AO) to stain live embryos for dying cells.  At 6 somites, we 
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Figure 3.22: Cardiac gene expression domains are reduced in the differentiating cardiac 
primordia of morphant embryos at 16 somites.  Differentiating bilateral cardiac primordia were 
stained for expression of the early cardiac transcription factor nkx2.5 and for genes encoding 
components of the myocardial sarcomere.  cmlc2 = cardiac myosin light chain2; vmhc = 
ventricular myosin heavy chain.  Expression of all three genes was reduced following knockdown 
of zNav1.5b. 
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Figure 3.23: Knockdown of zNav1.5b perturbed the specification of cardiac mesoderm 
without affecting lateral mesoderm formation.  Early cardiogenic fields (6 somites) were 
stained for expression of the transcription factors nkx2.5, gata4, and dHand (Hand2).  In 
morphants, expression of nkx2.5 was absent and gata4 was reduced. dHand expression was 
unaffected.  D = dorsal, L = lateral, V = ventral; all three views are shown to highlight the 
complete expression domain of dHand in lateral mesoderm. 
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observed no qualitative difference in the number of cells labeled by AO in the lateral mesoderm of 
morphants versus controls (Figure 3.24).  Moreover, we observed no change in the expression of 
dHand, indicating that defects in the formation or migration of anterior lateral mesoderm did not 
underlie the observed changes in expression of cardiac transcription factors (Figure 3.23).  Taken 
together, these data demonstrated that cardiac-type voltage-gated sodium channels are required 
for the specification of cardiac mesoderm in the zebrafish embryo.  Moreover, the timing of the 
patterning defects induced by knockdown of zNav1.5b suggested that voltage-gated sodium 
channels may have important functions prior to the differentiation of excitable tissues.  Consistent 
with this data, we readily detected transcripts of zscn5Lab in the early blastula and during 
gastrulation (prior to the onset of nkx2.5) with expression diminishing by 10 somites (Figure 3.25).  
As transcripts of zscn5Lab were undetectable on multiple occasions by conventional in situ 
hybridization techniques, however, we do not have data addressing the spatial localization of 
zscn5Lab expression during gastrulation or in early somitogenesis. 
 
Excitability in cardiac lineage specification 
Voltage-gated sodium channels depolarize membranes by permitting the rapid influx of 
Na+ ions into the cytosol (2).  Our findings thus suggested the possibility that zNav1.5b produces 
an electrical signal during gastrulation or in early somitogenesis that is required for the expression 
of cardiogenic transcription factors in mesoderm.  To test the hypothesis that membrane 
depolarization mediated by zNav1.5b is required for early cardiogenesis, we used two approaches. 
Since sodium current requires extracellular sodium, we reasoned that rearing fertilized embryos 
in sodium-free media starting from the 1 cell stage would dramatically perturb heart development.  
However, embryos reared in sodium-free media displayed no distinguishable defects in cardiac 
morphogenesis at day 1 or day 2.  In a second approach, we reared dechorionated embryos 
starting at the 16 cell stage in solutions of modulators of sodium channel function or injected high 
concentrations of these compounds into the yoke sack of 1 cell stage embryos.  Delivery of TTX, 
ATX II, veratridine, flecainide, and lidocaine by any means did not perturb cardiogenesis, despite 
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Figure 3.24: The morphant phenotype did not appear to be caused by loss of early 
progenitor cell viability or defects in the proliferation of cells within lateral mesoderm.  Live 
embryos were stained at 6 somites with the vital dye acridine orange to label dying cells.  
Embryos were also incubated with BrDU between 6 and 15 somites to label all proliferating 
progenitors in lateral mesoderm.  No differences were appreciated in either assay upon 
qualitative inspection.  Brackets mark the anterior lateral plate mesoderm (ALPM). 
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Figure 3.25: RT-PCR detected complementary expression of both scn5Laa (zNav1.5a) and 
scn5Lab (zNav1.5b) during zebrafish gastrulation.  See methods for details. 
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clear physiological evidence at days 1 and 2 that non-cardiac sodium channels were either 
profoundly blocked or activated (total paralysis, hyperkinetic movements) (Figure 3.26).  To 
determine whether other known channels that contribute to cardiac action potential generation 
play a role in early cardiac development, we similarly reared embryos from 16 cells onwards in 
micromolar concentrations of the L-type calcium channel blocker nisoldipine, the L-type/T-type 
calcium channel blocker mibefradil, and the HERG blocker E-4031.  In every instance, embryos 
reared in solutions of these compounds displayed profound perturbations of heart beat in the 
absence of any defects in heart formation.  Moreover, we used high concentrations of an 
antisense morpholino targeting ZERG to knockdown expression of this channel (296), and 
similarly, no abnormalities of heart development were observed.  Taken together, these results 
strongly suggest that ion channel block (by toxins or by altering extracellular solution) generates 
abnormal heart beating but does not result in developmental abnormalities.  These data thus 
point to the concept that voltage-gated sodium channels play a heretofore-undescribed, non-
electrogenic role in cardiogenesis.  
 
Follow-up studies of the function of zNav1.5Lb (zscn5Lab) 
Cloning of the full-length cDNA sequence of zscn5Lab permitted the design of additional 
morpholino oligonucleotides to confirm our initial findings.  An antisense morpholino generated 
against the E6/I6 splice junction also clearly perturbed splicing of zscn5Lab but produced a milder 
heart development defect that manifested that was most obvious between days 3 and 4.  An 
E6/I6 5-mismatch control morpholino injected at the same dose did not produce any abnormal 
phenotype.  To test whether the zNav1.5b protein (and not the mRNA) is required for heart 
development, we generated a morpholino targeting the translation initiation site.  Again, 
knockdown of zNav1.5b was observed to cause defects in heart development (reduced chamber 
size, absence of looping) with subsequent embryonic lethality, the severity of which was 
comparable to the E6I6 splice-site morpholino.  In summary, all three active morpholinos used in 
this study produced a similar spectrum of defects in heart development with the following order of 
severity: E24/I24 (1-2ng/embryo) > E6/I6 (3-4ng/embryo) = ATG (5-6ng/embryo).   
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Figure 3.26: Regulation of the cardiac cell fate by zNav1.5b is independent of its activity as 
a sodium channel.  Early embryos (0-2 hours) were either injected with sodium channel 
modulators or dechorionated and immersed in drug-containing solutions.  (D-H) Specification was 
assayed by expression of nkx2.5 at 6 somites.  (I-M) Differentiation was assayed by visualizing 
heart tube formation in live cmlc2:GFP embryos.  A-C shows the effect of morpholino. 
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Function of zNav1.5La (zscn5Laa) in zebrafish embryos 
Low doses of morpholinos directed against the translation start site (4ng/embryo) and 
against the E3I3 splice junction (2ng/embryo) each produced defects of cardiac morphogenesis, 
in addition to reduced head size and body length (Figure 3.27).  Five-mismatch control 
morpholinos directed against each of these sites, however, did not produce any noticeable 
defects (Figure 3.27). Wheras wild-type and control morpholino-injected clutchmates displayed 
normal development of atrial and ventricular chambers and initiated looping by 36 hours post-
fertilization (hpf), zNav1.5La morphants retained tube-like hearts and failed to form normal cardiac 
chambers even at 60-72hpf (Figure 3.27).  These results lend further strong support to the idea 
that cardiac-type sodium channels play important roles in heart development.   
Since each morpholino directed against zNav1.5La consistently produced a severe 
phenotype, we characterized the cardiac defects in these morphants in more detail using similar 
approaches to zNav1.5Lb.  Atrial and ventricular myocytes arise from distinct populations of 
progenitor cells that exhibit genetic differences from their earliest stages of differentiation 
(297;298). At 54-60 hpf, after chamber formation, atrial and ventricular myocytes exhibited 
striking differences in cellular appearance and patterning as imaged in wild type cmlc2:GFP 
transgenic  embryos.  While atrial cells displayed less cmlc2 promoter activity and were irregular 
in shape and loosely-packed, ventricular myocytes displayed greater cmlc2 promoter activity, 
were generally more elliptical in shape, and densely-packed within the chamber wall (Figure 3.28).  
These early-appearing cellular differences, which likely reflect the future functions of the atrium as 
a receptacle of low pressure venous blood and the ventricle as a high-pressure pump that 
maintains systemic circulation, are preserved in morphant hearts and suggest normal atrial and 
ventricular patterning (Figure 3.28).  At the genetic level, this was confirmed by double 
immunostaining with S46 and MF20 antibodies.  Although morphant chambers were patterned 
normally on day 2, these hearts appeared to be dramatically reduced in cell number (Figure 3.28).  
Similar reductions were observed qualitatively by imaging both control and morphant hearts on 
day 4 of development, when the ventricular chamber has entered a phase of concentric growth.  
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Figure 3.27: Knockdown of zNav1.5a (scn5Laa) resulted in severe defects in heart 
development and function as shown on day 2.  (A, B)  Morphant embryos have reduced heart 
and head size and aberrant looping.  (C, D) Morphant embryos are also smaller in total body size 
and exhibit bradycardia compared to control embryos. 
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Confocal analysis revealed that whereas wild-type embryonic hearts added cells to the ventricular 
wall on the interior to produce a chamber that is multiple cell layers thick, morphant hearts 
maintained the single cell layer of earlier stages (Figure 3.29).  To quantify these differences in 
embryonic heart cell number, we imaged morphants in a different transgenic line, cmlc2:dsRed-
nuclear, in which the nuclear label facilitated accurate quantification of total cardiac cell number in 
embryos in their native condition (Figure 3.30).  This analysis revealed an average of 45% less 
cells in morphant hearts compared to control morpholino-injected hearts on day 3.   
 To determine whether reduced expression of zNav1.5La affected the production of 
cardiac progenitor cells, we imaged and quantified the total number of newly differentiated 
myocytes in cmlc2:GFP transgenic embryos.  As shown in Figure 3.31, knockdown of zNav1.5La 
resulted in a significant decrease in the number of progenitors.  These defects in cell number 
were correlated with the reduced expression of markers of differentiation (cmlc2, vmhc), and the 
loss of expression of nkx2.5 at 6 somites by both in situ hybridization and quantitative PCR 
(Figure 3.32).  Despite strong evidence supporting a gata5-nkx2.5 signaling axis in early 
zebrafish cardiogenesis (299;300), we found the expression of gata5 to be normal in morphant 
embryos (Figure 3.32).  These data suggested that zNav1.5La either acts downstream of gata5 in 
this signaling axis, or regulates the expression nkx2.5 by a gata5 independent mechanism, 
similar to Fgf8 (see Chapter 5). 
 
Cell-autonomous role for zNav1.5La in cardiac fate specification 
By morpholino knockdown, our data demonstrated that zNav1.5La plays a critical role in 
the patterning of pre-cardiac mesoderm.  Since earlier data suggested that sodium channels act 
via a non-electrogenic mechanisms to regulate specification of early cardiac cells, we 
transplanted late-stage blastomeres between the margins of embryos at 30% epiboly, to 
determine whether morphant cells more readily adopt the cardiac cell fate in a wild-type 
background.  As shown in Figure 3.33, labeled wild-type cells transplanted into a wild-type host 
embryo adopted cardiac cell fates in nearly 26% of embryos.  Even when placed in a wild-type 
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Figure 3.28: zNav1.5a (scn5Laa) morphants retained normal chamber-specific cellular 
morphology and differentiation as observed by confocal microscopy and double 
immunostaining.  (A, B) Morphant embryo hearts are smaller and unlooped compared to control 
embryo hearts.  A = atrium, V = ventricle, CON = control, and MO = morpholino-injected.  (C, D) 
Higher magnification of the morphant atrium and ventricle revealed normal chamber-specific 
differences in cellular morphology.  (E) Double immunostaining with MF20 and S46 antibodies 
confirm that morphant hearts have normal chamber-specific differentiation. 
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Figure 3.29: zNav1.5a (scn5Laa) morphant ventricles did not develop multiple cell layers 
through day 4.   Confocal imaging was used to optically section through the ventricular chamber 
of both wild type and scn5Laa morphant hearts.  (A)  Confocal reconstruction of wild type embryo 
heart at 104 hours post-fertilization.  (B) Optical sectioning throught the wild type ventricle 
revealed new cardiomyocytes being added to the interior of the chamber to thicken the wall.  (C) 
Wild type ventricles have two layers of cardiomyocytes at this timepoint.  (D) Higher magnification 
of red box from figure C.  (E) Confocal reconstruction of morphant embryo heart at 104 hours 
post fertilization.  (F, G) scn5Laa morphant ventricles have only one cell layer.  F and G represent 
ventricles of two different morphant embryos. 
 
A B C
Wild Type
scn5Laa MO
E F G
104hpf 
Tg(cmlc2:GFP)
D
 131
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.30: zNav1.5a (scn5Laa) morphant embryos displayed 45% less cardiomyocytes in 
the transgenic cmlc2:dsRed-nuclear background.  (A-C) Confocal reconstructions of the 
embryonic heart in Tg(cmlc2:DsRed2-nuclear) embryos at 78 hours post-fertilization.  Scn5Laa is 
required for normal embryonic heart cell number.  A and V indicate the atrium and ventricle, 
respectively. (D) At 60-62 h.p.f., scn5Laa morphant hearts (MO1, n=8) have significantly fewer 
embryonic cardiomyocytes compared to the hearts of wild type (WT, n=4) and MIS1-injected 
(MIS1, n=5) clutchmates.  Results are mean ± s.e.m; n=number of embryos analyzed.  *, 
P<0.001 versus wild-type and †, P<0.001 versus MIS1-injected, ANOVA. 
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Figure 3.31: zNav1.5a is required for the differentiation of appropriate numbers of cardiac 
progenitors.  (A-D) Confocal reconstructions of the developing heart cone in Tg(cmlc2:GFP) 
embryos at the 22 somite stage.  B-D are higher magnification images of the box shown in A.  
Scn5Laa is required for the normal number of newly differentiated embryonic cardiomyocytes.  
Scale bar = 50µm.  (E) Scn5Laa morphant heart cones (MO1, n=4) have significantly fewer 
differentiating cardiomyocytes compared to the heart cones of wild-type (WT, n=6) and MIS1-
injected (n=3) clutchmates.  Results are mean ± s.e.m; n=number of embryos analyzed.  *, 
P<0.001 versus wild-type and †, P<0.001 versus MIS1-injected, ANOVA.  
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background, however, morphant blastomeres were significantly less likely to become 
cardiomyocytes, as indicated by a lower percentage of embryos with donor cells in the heart 
(approximately 14%) (Figure 3.33).  Morphant cells, however, contributed successfully to a 
number of other mesoderm-derived lineages including blood and muscle (Figure 3.33).  These 
data suggested that cardiac sodium channels are likely to act cell-autonomously.  Reciprocal 
experiments are in progress to determine the frequency with which wild-type cells adopt cardiac 
cell fates in morphant embryo backgrounds. 
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Figure 3.32: Formation of the pre-cardiac mesoderm is perturbed in zNav1.5a (scn5Laa) 
morphants.  (A-J) Analysis of gene expression in the early heart-forming region of anterior 
lateral plate mesoderm at the 6-somite stage by in situ hybridization. Embryos injected with 
scn5Laa translation inhibitor morpholino (MO1) (B, D, F, H) had reduced expression of nkx2.5, 
gata4, and hand2 but no change in gata5 expression (J) compared to embryos injected with 5-
mismatch control morpholino (MIS1) (A, C, E, G, I).  All embryos shown are from the same 
injected clutch.  Scale bar = 200µm.  (K) Real-time quantitative RT-PCR performed using 
independent clutches of embryos also revealed significantly reduced nkx2.5 expression but no 
change in gata5 expression following injection of MO1 compared to injection of MIS1 control 
morpholino.  Results are mean ± s.e.m for three independent experiments performed in triplicate.  
P<0.05 for nkx2.5, T-test.  Overall expression levels of gata4 and hand2 were reduced by real 
time PCR, but differences were not statistically significant.  
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Figure 3.33: zNav1.5a sodium channels may act cell-autonomously in mesoderm to 
promote the cardiac cell fate.  Labeled morphant blastomeres transplanted to the margin of the 
wild type blastula displayed reduced probability of entering the cardiac lineage than wild type 
control cells.  (A, B) Multiple wild type cells were typically seen in the atrium and ventricle of 
individual host embryos.  (C) Conversely, morphant cells were infrequently observed in host 
hearts despite differentating into other mesoderm-derived lineages (D-F). 
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Discussion 
Nav1 voltage-gated sodium channels underlie the upstroke of the action potential and are 
thus the principal determinants of membrane excitability in the nervous system, skeletal muscle, 
heart, and other tissues.  Using zebrafish as a model system, we have identified a critical role for 
cardiac-type sodium channels at the earliest stages of organ formation, well in advance of their 
role in mediating excitability in the beating heart.  By use of antisense-mediated gene knockdown, 
we found that reduced expression of either Nav1.5La or Nav1.5Lb in the zebrafish embryo 
disrupted the patterning of early cardiogenic mesoderm, therein compromising the production of 
sufficient numbers of progenitor cells for cardiac morphogenesis.  By independently evaluating 
the phenotypic consequences of reduced sodium channel expression and perturbed sodium 
channel-mediated excitability, we found that cardiac-type sodium channels act via a previously-
unappreciated, non-electrogenic mechanism to regulate early cardiac development.  Moreover, 
cellular transplantation studies revealed that sodium channels are likely to be cell-autonomously 
required for specification of pre-cardiac mesoderm.  Our results thus suggest that sodium 
channels, which are among the most phylogenetically recent channels in the ion channel 
superfamily (4;301), have been recruited in vertebrates for two mechanistically-distinct roles: 1. in 
the mature heart, cardiac-type sodium channels depolarize the membrane to initiate action 
potentials; 2. during development, the same sodium channels act by a non-electrogenic 
mechanism to regulate organ formation.  Moreover, our results describe the earliest-known 
function of any vertebrate voltage-gated sodium channel during development. 
 
Limitations 
One primary limitation of this study was the use of morpholino antisense oligonucleotides, 
which in zebrafish have been demonstrated to have off-target effects (302).  Although the 
targeting of scn5Laa by both translation and splice morpholinos produced consistent 
developmental abnormalities, morpholinos directed against scn5Lab (ATG, E6/I6, and E24/I24) 
resulted in defects that were variable in severity.  Without antibodies against these proteins, we 
cannot predict whether the variability in phenotype resulted from differences in the efficiency of 
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knockdown at the protein level or from alternative mechanisms.  Notably, studies of scn5a in mice 
revealed important gene-dose effects in cardiac development: whereas mice homozygous null for 
scn5a (-/-) displayed defects in early cardiac morphogenesis, heterozygous mice (+/-) were born 
with structurally normal hearts.  Interestingly, morpholinos directed against E24/I24 of scn5Lab 
required the lowest dose but elicited the strongest effects.  Since the aberrant mRNA splice 
products induced by E24/I24 appeared to be stable (Figure 3.7), it is possible that the predicted 
truncated zNav1.5b protein (1458 amino acids) persisted and acted in a dominant negative 
fashion to repress unperturbed channels (zNav1.5a or zNav1.5b) or other proteins.  Although a 
single α subunit polypeptide is required to form the sodium channel pore, some evidence 
suggests, for example, that sodium channel proteins may interact before they reach the 
membrane (303).  Another limitation of our studies is the lack of direct evidence of sodium 
channel protein during gastrulation, the period of development when our morpholinos appear to 
be exerting their effects.  However, the combination of expression data (RT-PCR) and the use of 
morpholinos directed against the translation initiation site of zNav1.5a together suggest that the 
observed phenotypes are mediated by perturbations of sodium channel protein. 
 
Molecular basis of heart rhythm in the zebrafish embryo 
The first large-scale forward genetic screens in zebrafish uncovered a number of mutants 
displaying complex arrhythmias, demonstrating that the simple two-chambered heart of a young 
fish embryo could manifest physiologically-meaningful rhythm phenotypes and would be a useful 
model to study the molecular determinants of cardiac impulse propagation (172;173).  Moreover, 
electrophysiological studies of dissociated and cultured embryonic zebrafish cardiomyocytes 
revealed currents typical of multiple families of cardiac ion channels well-studied in other species 
(174).  The initial objective of our studies was thus to apply a reverse genetics approach to 
establish a loss of functional model for cardiac sodium channel function in zebrafish embryos, 
with the larger goal of establishing an experimental platform for clarifying the role of channel-
associated proteins in the regulation of heart rhythm.  Our identification of a relatively late 
functional requirement for sodium channels in the developing zebrafish heart (commencing 
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between days 4 and 5) was unanticipated given that multiple, well-characterized determinants of 
excitability and calcium homeostasis in the mature myocardium have also been demonstrated to 
be critical to early heart beating in this model (262;270;296;304-308).  In two independent studies, 
for example, reduced function of the repolarizing K+ channel encoded by kcnh2/zerg by mutation 
or pharmacological blockade resulted in bradycardia and AV block in the early beating heart 
(262;296).  Additional kcnh2 mutant lines displayed ventricular standstill, delayed repolarization, 
and prolonged action potentials characteristic of the hereditary long QT syndrome in humans 
(307).  In the zebrafish tremblor mutant, reduced function of the cardiac Na+/Ca2+ exchanger 
(NCX) resulted in atrial fibrillation and ventricular standstill from the very outset of cardiac function 
on day 1 (304;305).  The island beat mutant, which was found to harbor a nonsense mutation in a 
cardiac-specific L-type voltage-gated calcium channel, similarly presented with atrial fibrillation 
and a silent, non-contractile ventricle.  Finally, reduced function of the Na+-K+ ATPase by 
mutation or pharmacological blockade resulted in significant slowing of the embryonic heart rate 
(306).  As we observed for cardiac sodium channels, many of these determinants of nascent 
excitability were found to play different roles in the atrium and the ventricle.  These data 
demonstrate that the functional determinants of both excitability and calcium homeostasis, well-
appreciated to be distinct in different chambers of the mature heart, are established in chamber-
specific processes from very earliest stages of heart development.  
 
The role of sodium channels in embryonic heart rhythm 
To assay for the role of sodium channels in the embryonic heart, we employed three well-
characterized toxins that have distinct binding sites and mechanisms of action: the sodium 
channel “blocker” tetrodotoxin (TTX) and the channel “activators” anemone toxin II (ATX II) and 
veratridine (284;285).  The arrhythmias elicited by TTX were consistent with impaired ventricular 
conduction due to reduced sodium channel availability (133).  The tonic contraction and 
arrhythmias induced by ATX II on day 3 may have resulted from a loss of the sodium gradient 
across the membrane through persistently open sodium channels.  Obliteration of the sodium 
gradient likely inhibited the function of one of the primary mechanisms of calcium extrusion from 
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the cytosol of embryonic myocytes after systole, the Na+-Ca2+ exchanger (304;305), possibly 
leading to calcium overload during diastole and tonic contraction. 
Our observation of a late requirement for voltage-gated sodium channels in zebrafish 
embryonic heart function (between days 4 and 5) is consistent with the findings of previous 
studies conducted in mouse and chick embryos and murine cell lines.  Although the murine heart 
tube starts to beat at approximately E8.5, cultured myocytes isolated from E11-E13 mouse hearts 
displayed only small sodium currents with a pattern of functional expression that was suggested 
to be inconsistent with sodium channels being the primary mechanism of depolarization in the 
early mammalian heart (309).  In cardiomyocytes differentiated in vitro from murine embryonic 
stem (ES) cells, Na+ currents were absent from early beating cells and were detectable only 3-4 
days after the appearance of outwardly-rectifying K+ currents and inward Ca2+ currents (310).  
Similarly, studies of differentiating P19 embryonic carcinoma (EC) cells indicated that sodium 
currents played no role in the electrical activity of early, differentiating cardiomyocytes (311-313).  
Similar observations were made by a number of laboratories studying the molecular determinants 
of early cardiac excitability in chick embryos over two decades ago, who found that TTX produced 
limited effects on early excitability but more profoundly inhibited action potentials at later 
developmental stages (286;314-324).  These studies also revealed that the appearance of 
sodium channel-dependent action potentials coincided with a dramatic increase in the number of 
available channels and hyperpolarization of the resting membrane potential (sodium channels are 
inactivated at depolarized membrane potentials) (286;314).  Similarly, the results of our studies 
using both channel toxins and immunohistochemistry support the concept that these sodium 
channels are dramatically upregulated during the course of heart development.  Taken together, 
multiple lines of evidence from different model systems thus suggest that voltage-gated sodium 
channels are essential for cardiac excitation only after the earliest steps of cardiac 
morphogenesis have been completed.  A dynamic developmental program for electrophysiology 
characterized by changes in the expression and function of ion channel genes appears to 
accompany early morphogenesis of the vertebrate heart. 
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 Our delivery of sodium channel toxins into the systemic circulation of early embryos at 
day 1 revealed pronounced effects on movement and sensation that were consistent functional 
expression of sodium channel proteins in muscle and nerve tissue prior to heart.  On day 3, we 
similarly observed dense sodium channel staining in skeletal muscle, spinal cord, and brain but 
minimal staining in heart, using antibodies that recognize a conserved epitope present in all 
sodium channel isoforms.  In evolutionary terms, this may suggest that voltage-gated sodium 
channels, which are thought to have evolved as an adaptation that permitted high-frequency 
action potentials in the evolving nervous systems of early vertebrates, are a relatively recent 
innovation in the heart (1;325).  Since slow conduction is arrhythmogenic in the mammalian heart 
(133), we speculate that mechanisms permitting increased conduction velocity may have become 
adaptive as early vertebrate hearts grew in size and elaborated chambers with thick myocardial 
layers.  This possibility is supported by the finding that sodium channels play no functional role in 
simpler, invertebrate heart structures including the contractile dorsal vessel in Drosophila and the 
contractile pharynx in C. elegans, despite evidence of expression of an array of other ion channel 
proteins in these tissues.  Evidence to test this hypothesis could be derived from studying the 
mechanisms that underlie cardiac excitability in the simple, tubular hearts of invertebrate 
chordates such as ascidians or amphioxus (288). 
 
Role of heart function in heart development 
Given the late role for sodium channels in regulating heart rhythm in fish, mice, and chick 
embryos, our finding that reduced expression of Nav1.5-like voltage-gated sodium channels 
resulted in severe defects in cardiac chamber formation suggests that the primary function of 
sodium channels in early embryos is to support organ development, not organ function.  Notably, 
loss-of-function models of the cardiac L-type calcium channel, the Na+-Ca2+ exchanger, and the 
Na+-K+ ATPase proteins all displayed variable defects of cardiac morphogenesis in zebrafish 
(270;304;306;308).  Although these data would initially seem to support the hypothesis that early 
cardiac function is required for the development of normal cardiac form, zebrafish silent heart 
mutants which have mutations in a cardiac troponin gene that rendered their hearts completely 
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non-contractile displayed normal chamber formation, patterning, and looping through day 2 (326).  
These findings strongly suggested that early heart development is driven by an intrinsic genetic 
program that is not significantly influenced by function.  However, because silent heart mutants 
displayed normal excitability and calcium cycling, we initially hypothesized that excitation (the 
well-established function of sodium channels) might be required for cardiac morphogenesis 
independent of contraction.  In addition to being required for contraction, for example, Ca2+ is an 
integral second messenger that acts through numerous proteins including calcium-calmodulin-
dependent kinases, the calcium-activated phosphatase calcineurin, and calcium-modulated 
transcription factors such as CREB, NFAT, and Elk-1 to connect membrane excitability to 
changes in gene expression (327-331).  Moreover, the results of numerous prior studies had 
demonstrated that sodium channel-mediated action potentials are required for the normal 
development of other excitable tissues such as the nervous system (332-336).  Despite these 
previous findings, our use of the L-type calcium channel blocker nisoldipine to inhibit calcium 
entry and silence the heart from the very outset of beating did not produce any early defects in 
cardiac morphogenesis. 
Although other membrane proteins that regulate excitability and/or calcium homeostasis 
have been shown be required for normal zebrafish heart development, the mechanisms by which 
they act in cardiac morphogenesis are not well understood.  In the small heart and heart and 
mind mutants, loss of function of the zebrafish cardiac Na+/K+ ATPase resulted in diminished 
heart size because of an early defect in heart tube elongation (306;308).  However, mutation of a 
related transporter, the cardiac Na+/Ca2+ exchanger (NCX), did not affect heart tube formation 
despite being strongly expressed in this early structure (304;305).  Similarly, although blocking 
calcium entry into nascent myocytes with nisoldipine did not affect early heart development, loss 
of function of a cardiac-specific, L-type voltage-gated calcium channel (the island beat mutant) 
resulted in striking defects ventricular size attributed to perturbation of the growth and proliferation 
of embryonic myocytes (270).  The discrepancies between these findings suggests that like 
sodium channels, calcium channels may have effects in the developing heart that are 
independent of calcium entry, as was recently demonstrated in neurons (337). 
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Scn5a in the mouse heart 
In this study, we found an unexpected role for cardiac sodium channels in patterning the 
pre-cardiac mesoderm early in somitogenesis.  Because of the novelty of the findings, future 
studies should aim to verify our results in mammalian models.  Mice lacking scn5a (-/-) were 
embryo-lethal at E10 and displayed severe abnormalities of development of the ventricular 
myocardium, with a sparing of other developing heart structures including the endocardial 
cushions, the common atrial chamber, and the truncus arteriosus.  The early lethality of these 
mice and the severity of the defects were reminiscent to some degree of the phenotypes of loss-
of-function mouse models early cardiac transcription factors (289;338-340).  However, the 
timepoint at which scn5a is first required for cardiac development is unknown.  It is similarly not 
known when and where scn5a is expressed prior E9.5, when our data demonstrated its 
expression in the atrial and ventricular myocardium, and whether expression of scn5a will be 
detected in the heart tube (E8.25-8.5) or early heart fields of the cardiac crescent (E7.75).  Loss 
of function mouse models of early cardiogenic transcription factors also typically die on E10, but 
often display perturbed development at much earlier timepoints, consistent with their early 
expression patterns.  Mice null for the T-box transcription factor Tbx5, for example, died on E10 
with hypoplastic sinoatrial structures and left ventricles (341).  The expression of Tbx5, however, 
was detected in the cardiac crescent on E7.75, and then was subsequently found in a graded 
fashion in the developing heart tube before b;eing selectively expressed in the atria and left 
ventricle but not the right ventricle or outflow tract of the maturing heart (342).  Moreover, close 
examination of Tbx5-/- embryos at timepoints prior to lethality revealed developmental defects that 
first manifest at E8.5 with aberrant heart tube formation.  Analogously, the embryonic lethality of 
scn5a-/- mice on E10 is likely to reflect an early expression pattern for scn5a and an important 
functional role for Nav1.5 in cardiogenesis prior to chamber formation. 
 
A non-electrogenic role for cardiac sodium channels 
The tractability of externally-fertilized zebrafish embryos permitted us to directly test 
whether sodium channels influence cardiac development by electrogenesis or alternative 
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mechanisms.  Neither removal of sodium from the media in which early embryos were reared, nor 
prolonged exposure of embryos to modulators of sodium channel function including TTX, ATX II, 
veratridine, lidocaine, and flecainide, adversely affected cardiac development.  These data thus 
strongly suggest that sodium current is not required for cardiac specification and that cardiac-type 
sodium channels are likely to act via a previously-unappreciated, non-electrogenic mechanism in 
undifferentiated tissues to regulate cardiac cell fate specification.  Interestingly, studies of murine 
P19 EC cells and ES cells displayed clear evidence of scn5a expression in undifferentiated and 
early differentiating cells in the absence of any detectable sodium currents by patch-clamp 
electrophysiology (312;343).  Although transcripts for both zscn5Laa and zscn5Lab were readily 
detected during gastrulation, we do not yet have direct evidence that sodium channel protein is 
expressed in undifferentiated tissues of the early zebrafish embryo.  
The proposed non-electrogenic role of sodium channels in early development may 
involve one of a number of possible mechanisms.  Sodium channel complexes have previously-
described roles in cell adhesion that are mediated by their ancillary β subunits (162).  These 
small, single membrane-spanning proteins with extracellular immunoglobulin domains are integral 
members of sodium channel complexes that have been shown in multiple studies to interact with 
other cell adhesion molecules and extracellular matrix proteins (162;344-346).  Intracellularly, β 
subunits can also interact with components of the cytoskeleton through their cytoplasmic, C-
terminal tails (14;347-349).  Although the role of sodium channel β subunits in development is 
unknown, studies of the protein N-cadherin have demonstrated that cell-adhesion is an important 
requirement for normal early heart development in chicks an mice (350-352;352).  Alternatively, 
sodium channel proteins may act as scaffolds for other signaling molecules that are essential for 
early development.  It is increasingly well-appreciated, for example, that sodium channels interact 
with a diverse array of proteins through discreet domains on the channel protein (141).  We also 
cannot discount that zNav1.5La and zNav1.5Lb play important roles inside cells or on the 
membranes of subcellular organelles, as was recently shown for Nav1.5 in macrophages (353).  
Finally, we hypothesize that the pore-forming α subunit may possess an uncharacterized, non-
electrogenic signaling mechanism that is intrinsic to the channel protein.  As was recently 
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demonstrated for L-type calcium channels, for example, sodium channel proteins may have 
specific domains that are cleaved and translocate from the membrane to the nucleus to regulate 
gene expression (337).  Notably, cardiac sodium channel expression has been detected in non-
excitable tissues where they may act in any of the proposed capacities (354-357).  
In addition to informing development, further investigation into these putative 
mechanisms may also provide insight into the etiology of unanticipated disease phenotypes that 
have recently been associated with reduced function or expression of cardiac-type sodium 
channels.  Although mutations in SCN5A have most commonly been associated with heritable 
disorders of heart rhythm, for example, recent studies of human patients and mouse models have 
implicated Nav1.5 dysfunction and/or haploinsufficiency in dilated cardiomyopathy, cardiac 
fibrosis, and ventricular non-compaction, with mechanisms that are not well understood 
(272;275;276;358;359).  Although defects in excitability or ion homeostasis and subsequent 
cardiac remodeling have been hypothesized as potential mechanisms underlying these 
phenotypes, it remains to be understood why other disorders resulting from significant 
dysfunction of cardiac sodium channels do not also generate structural heart phenotypes.  Based 
on the results of our study, we hypothesize that at least some component of sodium channel-
associated structural heart disease may be attributable to non-electrogenic mechanisms (e.g. 
specific derangements of channel structure) that are required for the maintenance or integrity of 
the myocardium.  In this context, it is of interest that cardiac sodium channels have been 
demonstrated to directly interact with cytoskeletal proteins such as ankyrin as well as 
components of the dystrophin complex (360;361), and that derangements of protein components 
of the cytoskeleton or sarcomere represent the most common underlying mechanism underlying 
heritable cardiomyopathies (362). 
Although a sizeable literature has demonstrated that Nav1 channel isoforms play 
important roles in development, no prior studies have directly attributed any biological phenotype 
to the non-electrogenic functions of a sodium channel protein.  Previous studies dating back over 
a century used sensory deprivation, TTX, and other tools to demonstrate that excitability is an 
important contributor to the development of the nervous system, both in vitro and in vivo (332-
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335;363-369).  The results of our studies, however, directly implicate non-electrogenic roles for 
zNav1.5a and zNav1.5b that could only be revealed by reducing levels of sodium channel protein, 
as would be achieved in knockout models.  Interestingly, scn2a-/- mice died within two days of 
birth from severe hypoxia, suggesting a specific, non-redundant role for scn2a in the brainstem 
(82).  Despite the absence of gross anatomical or histological abnormalities in the brains of 
scn2a-/- mice, assays for cell death revealed significantly increased neuronal apoptosis in both the 
brainstem and neocortex (82).  In zebrafish, knockdown of Nav1.6a (scn8aa) resulted in 
developmental defects in selective types of motoneurons that were both cell-autonomous and 
non-cell-autonomous  (370).  It was not directly tested in either study whether the observed 
effects were mediated by excitability or by alternative mechanisms.  Because of our findings, 
future studies of zebrafish Nav1 channels will benefit from the direct comparison of phenotypes 
that result from reduced protein expression to those that result from the prolonged inhibition or 
modulation of sodium influx.  The striking early phenotype reported here is not only of 
developmental interest, but may serve as a valuable in vivo platform for future structure-function 
analysis of the non-electrogenic functions of voltage-gated sodium channels. 
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CHAPTER IV 
 
MOLECULAR CLONING AND ANALYSIS OF ZEBRAFISH VOLTAGE-GATED SODIUM 
CHANNEL BETA SUBUNIT GENES - IMPLICATIONS FOR THE EVOLUTION OF 
ELECTRICAL SIGNALING IN VERTEBRATES 
 
Overview 
In the previous chapter, we presented data that suggested critical non-electrogenic 
functions for zebrafish cardiac sodium channels in early development.  Moreover, we 
hypothesized that these functions may derive from a putative role of the sodium channel complex 
as a large scaffold for other signaling molecules that may be required for cell fate determination in 
the gastrulating embryo.  One of the most unique features of sodium channels compared to other 
ion channel complexes is their association with accessory proteins termed “β subunits,” which are 
characterized by extracellular immunoglobulin domains most commonly found in cell adhesion 
molecules and cell-surface receptors of the immunoglobulin superfamily.  Although they have 
important effects in modulating the function and cell-surface expression of pore-forming sodium 
channel α subunits, β subunits may also play non-electrogenic roles through their IG domains.  
The efforts of several laboratories have revealed that through protein-protein interactions, sodium 
channel β subunits act as transmembrane bridges linking the extracellular matrix and the 
intracellular cytoskeleton, conferring to cells the properties of adhesion and adhesion-mediated 
intracellular cell signaling. Such functions could be essential to the non-electrogenic 
developmental functions of a sodium channel complex, given the previously recognized role for 
cell adhesion molecules in cardiac development (see Chapter 5). As a critical first step towards 
investigating this putative mechanism, we have initiated studies of sodium channel-interacting 
proteins and here describe the cloning, evolution, and characterization of voltage-gated sodium 
channel β subunits in zebrafish. These efforts have been described in the context of the 
canonical role of β subunits in modulating sodium channel function and membrane excitability, 
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which are their most widely-recognized functions and for which a rich database of prior studies 
exists in the literature. 
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Abstract 
In mammals, sodium channels exist as macromolecular complexes that include a pore-
forming alpha subunit and 1 or more modulatory beta subunits. Although alpha subunit genes 
have been cloned from diverse metazoans including flies, jellyfish, and humans, beta subunits 
have not previously been identified in any non-mammalian species. To gain further insight into 
the evolution of electrical signaling in vertebrates, we investigated beta subunit genes in the 
teleost Danio rerio (zebrafish). We identified and cloned single zebrafish gene homologs for 
beta1-beta3 (zbeta1-zbeta3) and duplicate genes for beta4 (zbeta4.1, zbeta4.2). Sodium channel 
beta subunit loci are similarly organized in fish and mammalian genomes. Unlike their mammalian 
counterparts, zbeta1 and zbeta2 subunit genes display extensive alternative splicing. Zebrafish 
beta subunit genes and their splice variants are differentially-expressed in excitable tissues, 
indicating tissue-specific regulation of zbeta1-4 expression and splicing. Co-expression of the 
genes encoding zbeta1 and the zebrafish sodium channel alpha subunit Nav1.5 in Chinese 
Hamster Ovary cells increased sodium current and altered channel gating, demonstrating 
functional interactions between zebrafish alpha and beta subunits. Analysis of the synteny and 
phylogeny of mammalian, teleost, amphibian, and avian beta subunit and related genes indicated 
that all extant vertebrate beta subunits are orthologous, that beta2/beta4 and beta1/beta3 share 
common ancestry, and that beta subunits are closely related to other proteins sharing the V-type 
immunoglobulin domain structure. Vertebrate sodium channel beta subunit genes were not 
identified in the genomes of invertebrate chordates and are unrelated to known subunits of the 
para sodium channel in Drosophila. The identification of conserved orthologs to all 4 voltage-
gated sodium channel beta subunit genes in zebrafish and the lack of evidence for beta subunit 
genes in invertebrate chordates together indicate that this gene family emerged early in 
vertebrate evolution, prior to the divergence of teleosts and tetrapods. The evolutionary history of 
sodium channel beta subunits suggests that these genes may have played a key role in the 
diversification and specialization of electrical signaling in early vertebrates. 
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Introduction 
In mammals, voltage-gated sodium channels are multi-protein complexes that include a 
pore-forming α subunit and 1 or more modulatory β subunits (5-9). While sodium channel α 
subunits are large proteins with 24 membrane-spanning domains, β subunits are smaller proteins 
with a single transmembrane domain and an extracellular V-type immunoglobulin-like domain 
(10-14).  While heterologous expression of α subunit genes alone can reconstitute key properties 
of voltage-gated sodium channels observed in native tissues, co-expression with β subunit genes 
modifies channel gating and increases channel cell surface expression (10-13). Studies of mice 
with targeted ablation of either β1 or β2 genes corroborated these roles for β subunits in vivo and 
revealed an additional function for β subunits in α subunit localization (17;18). Moreover, the 
unique expression profiles of each β subunit gene and their variable effects on α subunit function, 
expression, and localization suggest that different subunit combinations in heart, brain, and 
muscle may contribute to diversity and specialization in electrical signaling (19;371). 
The physiological importance of sodium channel β subunits is reinforced by their role in 
human disease. β1 subunit gene mutations are a cause of generalized epilepsy with febrile 
seizures plus (GEFS+), and variants in sodium channel α subunits that disrupt their interaction 
with β subunits may be pathological in the heart (76-79). More recently, a mutation in the β4 
subunit gene was implicated as a cause of the long QT syndrome, a congenital arrhythmia (372). 
The unique electrophysiological properties, expression patterns, and physiological roles 
of mammalian sodium channel α subunits suggest that the duplication of these genes may have 
been an adaptation that permitted the diversification and functional specialization of electrical 
signaling in vertebrates (1;175;176). The physical interaction of α subunits with auxiliary proteins 
such as β subunits that modify their expression or function may have been similarly adaptive 
(97;98). Although sodium channel β subunits have not previously been identified in non-
mammalian species, we hypothesize that a sodium channel macromolecular complex comprised 
of α subunits and auxiliary β subunits is an evolutionarily-conserved structural entity. Evidence for 
the emergence of sodium channel β subunit genes early in vertebrate evolution would be 
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consistent with the idea that these genes may have played a role in diversifying and fine-tuning 
electrical signaling not only in mammals but in all vertebrates. 
Here we report the identification and molecular cloning of conserved orthologs of all 4 
mammalian β subunit genes in Danio rerio (zebrafish), a teleost vertebrate and a popular 
developmental and physiological model system. By direct sequence analysis and alignment, we 
assessed whether zebrafish β subunits possess the structural hallmarks of their mammalian 
counterparts. We provide evidence for extensive splicing of zebrafish beta subunit genes and 
demonstrate their expression in excitable tissues. To determine whether zebrafish sodium 
channel α and β subunits functionally interact, we studied sodium currents generated by the co-
expression of the genes encoding zNav1.5 (α subunit) and zβ1 in a heterologous cell system. 
Finally, we assessed the synteny and phylogeny of β subunits and a group of closely-related 
genes with IG domains in several vertebrate species. Our findings strongly suggest that all 4 
voltage-gated sodium channel β subunit genes emerged early in vertebrate evolution, and 
support the concept that the voltage-gated sodium channel α-β subunit macromolecular complex 
is a conserved and functionally-important vertebrate innovation. 
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Methods 
 
Identification and cloning of zSCN1B-4B genes and splice variants 
Mammalian SCN1B-4B gene sequences were used in BLASTN queries of the draft 
zebrafish genome (Ensembl Zv2-5) to identify DNA contigs containing putative zebrafish 
orthologs. Primers directed against predicted exons were then used to amplify partial β subunit 
gene sequences using the Titan RT-PCR enzyme system (Roche) and total day 2 embryonic 
zebrafish RNA as template. RNA was isolated using Trizol (GIBCO), digested with RQ1 DNase 
(Promega), and purified with the RNeasy Mini Kit (Qiagen). 5’ and 3’ ends and alternatively-
spliced forms of each gene were identified using 5’ and 3’ RNA ligase mediated rapid 
amplification of cDNA ends (RLM-RACE) PCR (Ambion). Additional splice variants were identified 
by RT-PCR while examining tissue-specific expression. All amplicons were subcloned directly 
into the pGEM-TEasy vector (Promega) and sequenced in their entirety. Consensus sequences 
for each gene were established after comparing the forward and reverse sequences of a 
minimum of 5 clones. 
 
Sequence data and annotation 
Eleven novel zebrafish gene sequences were deposited in the NCBI GenBank database: 
zβ1A [Genbank:DQ489722], zβ1B [Genbank:DQ489723], zβ1C [Genbank:DQ489724], zβ1D 
[Genbank:DQ489725], zβ2A [Genbank:DQ489726], zβ2B [Genbank:DQ489727], zβ2C 
[Genbank:DQ489728], zβ2D [Genbank:DQ489729], zβ3 [Genbank:DQ489730], zβ4 locus 1 
[Genbank:DQ489731], zβ4 locus 2 [Genbank:DQ489732]. Intron-exon boundaries for each gene 
and splice variant were determined by comparing cDNA and genomic sequences. Sequences for 
zebrafish β1-β4 were annotated by alignment with their mammalian orthologs using the AlignX 
function of Vector NTI v9.1 (Invitrogen) and by use of the following informatics resources: signal 
peptide (SMART) (373), IG-like domain (SMART (373), NCBI conserved domain database, CDD, 
v2.06 (374), and REF (14)), transmembrane (TMpred (375) and REF (376)), disulfide bridge 
(Prosite) (377), and putative N-linked glycosylation sites (NetNGlyc 1.0 server) (378). 
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Gene expression 
Tissues were dissected from wild type adult zebrafish (strain TuAB, 12-16 months old) 
and flash frozen on dry ice in ethanol. Tissue-specific total RNA was isolated and purified as 
described above. First strand cDNA synthesis was performed using 1µg of RNA from each tissue, 
random hexamer primers, and Transcriptor reverse transcriptase enzyme (Roche). 2µl of first 
strand cDNA was used in 25µl PCR reactions with Expand High Fidelity DNA polymerase 
(Roche). Amplicons were analyzed on a 1-2% agarose gel made with 1x Tris-Acetate-EDTA (TAE) 
buffer. Primer pairs used to amplify each individual gene and splice variant are listed in Table 5. 
All amplicons were subcloned directly into the pGEM-TEasy vector (Promega) and sequenced in 
their entirety in both sense and antisense directions. 
 
Identification of β subunit-like genes 
Human sodium channel β subunit nucleotide and amino acid sequences were used in 
BLAST searches of the human genome to identify β subunit-like genes. Four human genes 
sharing the greatest homology as well as similar genomic organization and/or synteny with known 
sodium channel β subunit genes were included for further analysis: myelin protein zero (MPZ) 
[Genbank:NP_000521], myelin protein zero-like gene, isoform A (MPZL1 isoform A) 
[Genbank:NP_003944], epithelial V-like antigen (EVA) [Genbank:NP_005788], and epithelial V-
like antigen-like gene (hypothetical protein LOC196264 or EVA1-like gene) 
[Genbank:NP_938016].  
 
Analysis of synteny 
Synteny between vertebrate β subunits and related genes was assessed by 
chromosomal walking and reciprocal BLAST searches of genes adjacent to β subunit loci in 
human, zebrafish, Rattus norvegicus, Xenopus tropicalis, and Gallus gallus genome databases 
(Ensembl). 
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Analysis of phylogeny 
To estimate phylogeny, additional β subunit and β subunit-like gene sequences were 
identified in Rattus norvegicus, Xenopus tropicalis, and Gallus gallus genome databases 
(Ensembl). Predicted amino acid sequences were aligned with cloned zebrafish sequences using 
CLUSTALX (v1.83). Phylogenetic trees were reconstructed using the neighbor-joining method of 
Saitou and Nei (Ref (232)) and viewed with NJplot software. Alignment gaps were excluded in the 
analysis, and the Kimura correction was made for multiple substitutions (379). The robustness of 
each node in the phylogenetic tree was analyzed with bootstrap analysis (n=1000). Trees were 
unrooted due to limited evidence for β subunit-like genes in non-vertebrate species. 
 
Genome databases 
All genome resources utilized for this study were accessed through the Ensembl gateway 
(380) with the exception of the sea urchin genome, which is available for BLAST searches by the 
National Human Genome Sequencing Center at Baylor College of Medicine (381). 
 
Expression vectors 
The full-length zebrafish β1D splice variant was amplified in one step from total D2 
embryonic RNA template using the Titan one-tube RT-PCR system (Roche) and the following 
primers: Fwd: Spe I - GACTCTGAAAACAAAGCCTG, Rev: Sac II – 
AGAGCTTCAAGCTTTTGGCT. The 733 base pair product was sublconed directly into the 
pGEM-TEasy vector. Multiple clones were purified, sequenced, and screened against the 
consensus sequence determined during the cloning of the zβ1 gene. Insert was digested out of a 
single zβ1D consensus clone and subcloned into the pGFP-IRES vector (Clontech) using Spe I 
and Sac II restriction sites. We have used similar methods to identify, clone and assemble a full-
length zscn5a expression construct (pBK-CMV-zscn5a) which encodes zebrafish Nav1.5. These 
methods are described elsewhere (manuscript in preparation). 
 
 154
Transient transfection and electrophysiology 
Cultured Chinese Hamster Ovary (CHO) cells were transiently transfected with pBK-
CMV-zscn5a and pGFP-IRES-zβ1D constructs using FuGENE6 (Roche). Cells were grown for 48 
hours after transfection before electrophysiologic study. Whole-cell voltage clamp was performed 
at room temperature with 2-M  patch microelectrodes and an Axopatch 200A amplifier. To 
minimize the capacitive transients, we compensated for approximately 70% to 80% of the cell 
capacitance and series resistance (233). Cells exhibiting very large currents (>6 nA) were also 
excluded from further analysis. Cells were also excluded if voltage control was compromised. The 
extracellular bath solution contained (in mmol/L) NaCl 145, KCl 4.0, MgCl2 1.0, CaCl2 1.8, glucose 
10, and HEPES 10; the pH was 7.4, adjusted with NaOH. The pipette (intracellular) solution 
contained (in mmol/L) NaF 10, CsF 110, CsCl 20, EGTA 10, and HEPES 10; the pH was 7.4, 
adjusted with CsOH. Cells were held at -120 mV, and activating currents were elicited with 
depolarizing pulses from -100 to +50 mV in 10 mV increments. Specific clamp protocols are 
indicated with the data. Data were acquired by pClamp8.0 (Axon Instruments Inc), sampled at 50 
kHz, and low-pass filtered at 5 kHz. All currents were normalized to the cell capacitance 
calculated by Membrane Test (OUT O) in pClamp8.0. 
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Results 
 
Identification and cloning of zebrafish sodium channel β subunit genes  
We identified 5 distinct zebrafish β subunit gene loci by mining the draft zebrafish 
genome sequence (ensembl Zv2-4) for genes homologous to the human and mouse β1- β4 
genes. In silico prediction of coding sequence on the relevant genomic DNA contigs enabled us 
to amplify partial β subunit gene sequences for each locus by RT-PCR and subsequently 
complete the full-length zebrafish β subunit clones by rapid amplification of cDNA ends (RACE)-
PCR. Analysis of putative open reading frames within each cDNA sequence predicted proteins 
ranging from 220-232 amino acids in length. Deduced translation and alignment of the five 
zebrafish amino acid sequences with each mammalian β subunit protein sequence suggested the 
identities of these genes (Figures 4.1A-4.4A). While single homologs were identified for the genes 
encoding β1-β3 (zβ1-zβ3), zebrafish express two distinct but closely-related β4 genes (zβ4.1, 
zβ4.2). Alignment of the amino acid sequences of zebrafish β1, β2, β3, β4.1, and β4.2 with their 
human homologs indicated that these proteins share 53.4%, 49.6%, 51.1%, 43.2%, and 40.8% 
identity, respectively.  
 
Conserved features of zebrafish sodium channel β subunits 
Mammalian sodium channel β subunits possess a single transmembrane domain, a short 
intracellular carboxyl C-terminal tail, a cleavable amine (N)-terminal signal peptide, and a 
conserved V-type extracellular IG domain that most closely resembles the type found in cell-
adhesion molecules (14;382). Hydropathy analysis of zebrafish β subunit amino acid sequences 
using TMpred software revealed that all 5 proteins are likely to possess cleavable N-terminal 
signal peptides and single transmembrane domains (Figure 4.10). To assess the presence of an 
extracellular V-type IG domain, we first analyzed each zebrafish beta subunit amino acid 
sequence with the NCBI conserved domain database. By this method, all 5 zebrafish β subunit 
genes are predicted to possess V-type extracellular IG domains (Figure 4.11). To more rigorously 
analyze these predictions, we manually examined the amino acid sequence of each zebrafish β 
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Figure 4.1: Analysis of the cloned zebrafish β1 subunit gene and novel splice variants.  (A) 
Alignment of cloned human, rat, and zebrafish β1 amino acid sequences. Black = identical in all 
three species; grey = identical in 2/3 species or conserved substitution. Shown for zebrafish is the 
most conserved β1 splice form (variant D). Hs = Homo sapiens, Rn = Rattus norvegicus, z = 
zebrafish; DS* = cysteine residue predicted to participate in a disulfide bridge, based on the 
myelin P0 protein crystal structure; DS = predicted second disulfide bridge; N = predicted N-
linked glycosylation site (N1 = human/rat, N2 = zebrafish); M1 = site of epilepsy-causing deletion 
(I70_E74del) in Hsβ1; M2 = site of second epilepsy-causing mutation (C121W) in Hsβ1; M3/4 = 
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site of third and fourth epilepsy-causing mutations (R85C, R85H); S1 = nonsynonymous Hsβ1 
single nucleotide polymorphism (SNP, G/A > R85H); S2 = nonsynonymous Hsβ1 SNP (C/T > 
T189M); P = phosphorylation site (tyrosine Y181) that regulates ankyrin recruitment (NOTE: Y200 
= Y181 following cleavage of 19 amino acid signal peptide); IN = putative internalization 
sequence. Consensus sequence for V-type IG domain is depicted beneath the alignment: G = 
glycine, x = any residue, ^ = hydrophobic residues, C = cysteine, - = gap in alignment with 
consensus sequence, W = tryptophan, * = basic residue, L = leucine, D = aspartic acid, & = 
glycine, alanine, or aspartate, and Y = tyrosine. Red indicates zebrafish residues that deviate 
from the consensus sequence. See Results for references supporting sequence annotation.  (B) 
5’ and 3’ RLM-RACE PCR and RT-PCR identified four distinct splice variants expressed from zβ1 
locus on zebrafish chromosome 16 (Ensembl).  (C) Splice donor and acceptor sites of zebrafish 
β1 splice variants, derived from comparing cloned cDNA against genomic DNA sequences 
(Ensembl). Consensus GT-AG splice sites are labeled in red. A splice-site deviating from the 
consensus appears in grey. (D) Schematic diagram of β1 splice variants A, B, and D, whose 
predicted proteins differ only in the length of their intracytoplasmic C-terminal tail. S-S = disulfide 
bridge. NH3 = 5’ amino terminus, CO2 = 3’ carboxyl terminus, β = putative N-linked glyosylation 
site. Alignment of C-terminal tail of variants zβ1A, zβ1B, and zβ1D (below). zβ1C is not shown as 
it is predicted to lack both extracellular IG and transmembrane domains. 
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subunit for the V-type IG domain consensus sequence (annotated beneath alignments, Figures 
4.1A-4.4A). With the exception of a conservative tyrosine to phenylalanine (Y>F) substitution in 
zβ1 and a non-polar methionine to basic lysine residue substitution (M>K) in zβ3 (illustrated in 
red text in Figures 4.1A and 4.3A), all 5 zebrafish β subunits exhibit 100% conservation of the 
consensus sequence for V-type IG domains (14;382). Typical of this domain is the linkage of 2 
cysteine residues in a disulfide bridge (DS*, Figures 4.1A-4.4A), the structural importance of 
which was revealed by a mutation that results in familial epilepsy (76). A second putative disulfide 
bridge that may further stabilize the extracellular IG domain in β1 and β3 is suggested of the 
crystal structure of myelin protein zero (MPZ), the primary structural protein of peripheral nerve 
myelin, whose IG domain closely resembles that found in sodium channel β subunits 
(12;382;383). The cysteine residues that contribute to proposed second bridge are conserved in 
zβ1 and zβ3 (DS, Figures 4.1A, 4.3A). Similar to mammalian β2 and β4, zβ2 and zβ4 proteins do 
not possess this second disulfide bridge but have an unpaired cysteine residue that may underlie 
covalent interactions with partnering sodium channel α subunits (S-, Figures 4.2A, 4.4A) (5;11;13). 
 In addition to V-type IG domains, our sequence analysis indicated that other functional 
and/or structural domains are conserved in zebrafish β subunits (Figures 4.1A-4.4A). These 
include a tyrosine in β1 that is phosphorylated and regulates interactions with ankyrin G (Y181 or 
Y200 with signal peptide intact) (348), the C-terminal tyrosine-leucine-alanine-isoleucine (Y-L-A-I) 
internalization motif in β1 and β3 which may be recognized by clathrin-coated pits (12), and a 
juxtatransmembrane gamma-secretase cleavage site in β2 that may play a role in cell adhesion 
or the movement of cells expressing this subunit (384). Zebrafish β subunits are also likely to 
exhibit post-translational modification by amide nitrogen (N)-linked glycosylation, a key feature of 
all 4 mammalian β subunits (10-13). The zβ1 protein possesses 2 of 4 predicted N-linked 
glycosylation sites found in human or rat β1 in addition to exhibiting two unique sites (Figure 
4.1A).  Similarly, zβ2 conserves 3 of 4 sites, zβ3 conserves 1 of 3 sites and displays 2 novel sites, 
zβ4.1 conserves 4 sites and displays 1 novel site, and zβ4.2 conserves 3 of four sites and 
displays 3 novel sites (Figures 4.2A-4.4A). 
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Figure 4.2: Analysis of the cloned zebrafish β2 subunit gene and novel splice variants.  
Presentation and labeling as in Figure 1. (A) Alignment of cloned human, rat, and zebrafish β2 
amino acid sequences. Shown for zebrafish is the most conserved β2 splice form (variant B). S- = 
conserved cysteine in β2 that is a putative site of covalent linkage with a partner α subunit; S1 = 
nonsynonymous Hsβ2 single nucleotide polymorphism (SNP, C/T > R28W) (NCBI dbSNP, 
PharmGKB); S2 = nonsynonymous Hsβ2 SNP (G/A > R47H) (NCBI dbSNP, PharmGKB); GSCS 
= γ-secretase cleavage site. (B) 5’ and 3’ RLM-RACE PCR and RT-PCR identified four distinct 
splice variants expressed from the zβ2 locus on zebrafish chromosome 15 (Ensembl). (C) Splice 
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donor and acceptor sites of zebrafish β2 splice variants. Zβ2 variants C and D both differ from the 
consensus sequences at the exon 4-intron 4 and intron 4-exon 5 splice junctions. (D) Schematic 
diagram of β2 splice variants A-D. With the exception of variant A, the predicted proteins of zβ2 
variants B-D differ only in the length of their intracytoplasmic C-terminal tail. Alignment of C-
terminal tail of variants zβ2B, zβ2C, and zβ2D (below).  
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Comparative genomics of β subunit gene variants 
The conservation of amino acid residues between homologous genes in distantly-related 
species may uncover previously unappreciated regions of functional importance and facilitate the 
evaluation of novel human mutations and polymorphisms. To determine whether previously 
identified mutations and polymorphisms are conserved in zebrafish β subunit genes, we mapped 
these variants onto the alignments of mammalian and zebrafish β subunit amino acid sequences. 
Four mutations in the human β1 gene have been linked to the heritable epilepsy syndrome 
GEFS+, the first resulting in a 5 amino acid deletion from isoleucine at position 70 to glutamic 
acid at position 74 (I70_E74del), the second in substitution of a cysteine residue that participates 
in a disulfide bridge (C121W), and the third and fourth resulting in substitution of an arginine at 
position 85 for either a cysteine or a histidine, respectively (R85C, R85H) (76;148;149). All of 
these mutations are expected to destabilize the extracellular IG domain of β1 and result in loss of 
function. In zβ1, 2 of 5 amino acids in the deleted segment (isoleucine, tyrosine), C121, and R85 
are all conserved (M1, M2, M3/4, Figure 4.1A). R85H was also previously reported as a non-
synonymous SNP in NCBI and PharmGKB SNP databases (S1, Figure 4.1A). A second reported 
SNP in human β1 results in a threonine to methionine substitution at position 189 (T189M), but 
T189 is not conserved in the amino acid sequence of zβ1 (S2, Figure 4.1A).  
Although disease-causing mutations are not currently associated with either SCN2B or 
SCN3B, nonsynonymous SNPs have been reported for SCN2B that result in an arginine to 
tryptophan substitution at position 28 (R28W) and an arginine to histidine substitution at position 
47 (R47H). R47 but not R28 is conserved in the amino acid sequence of zebrafish β2 (S1, S2, 
Figure 4.2A). A mutation in SCN4B resulting in a leucine to phenylalanine substitution at position 
179 (L179F) was recently implicated as a putative cause of the congenital long QT syndrome 
(385). Although this leucine is conserved in zebrafish β4.1, rat β4 and zebrafish β4.2 display a 
cysteine (C) and threonine (T) at this position, respectively (M1, Figure 4.4A). A nonsynonymous 
SCN4B polymorphism has also been reported, resulting in an asparagine to histidine substitution 
at position 210 (N210H). N210 is conserved in the sequences of both zβ4.1 and zβ4.2 (S1, Fig 
4A). 
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Figure 4.3:  Analysis of the cloned zebrafish β3 subunit gene.  Presentation and labeling as 
in Figure 1.  (A) Alignment of cloned human, mouse, rat, and zebrafish β3 amino acid sequences. 
INT = putative internalization sequence.  (B) 5’ and 3’ RLM-RACE PCR and RT-PCR identified a 
single transcript expressed from the zβ3 locus on zebrafish chromosome 15 (Ensembl). zβ3 has 
six exons.  (C) All zβ3 splice sites adhere to GT-AG consensus sequences.  (D) Schematic 
diagram of the β3 protein. 
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Alternative splicing of zebrafish β subunit genes 
The mammalian β1 subunit gene is alternatively-spliced in both rats (β1A) and humans 
(β1B), with retention of intron 3 being the primary event in both species that dramatically alters 
the transmembrane domain and intracellular C-terminus of the β1 subunit protein (386;387). An 
alternative splice-variant of β1 that retains intron 5 and adds 86 nucleotides to the 3’ untranslated 
region (UTR) of β1 mRNA transcripts has also been reported (388;389). In zebrafish, we detected 
4 alternatively-spliced variants of the β1 gene, designated here as A-D. Comparisons between 
complementary DNA and genomic DNA revealed that zβ1A transcripts have 5 exons whereas 
zβ1B and zβ1D each have 6 exons and zβ1C has only 2 (Figure 4.1B, Table 1). Transcripts of 
zβ1A, zβ1B, and zβ1D all share exons 1 through 4 but not exons 5 and 6; and all splice junctions 
except exon 5-intron 5 of zβ1B display canonical GT-AG splice donor-acceptor sites (Figures 
4.1B, 4.1C; Table 1). The zβ1 splice variant that shares the most identity with human β1 at the 
amino acid level (zβ1D) also shares nearly identical genomic organization (Table 1). With the 
exception of differences in exons 5 and 6, zβ1A and zβ1B variants also share this conserved 
genomic architecture (Table 1). 
Similar to splice variants of the mammalian β1 gene, splice variants of zβ1 are all 
predicted to encode proteins with variable C-termini. Unlike the mammalian variants, however, 
zβ1A, zβ1B, and zβ1D are predicted to possess identical transmembrane domains and differ only 
in their distal C-termini (Figure 4.1D). As a result of alternative-splicing, zβ1A lacks the conserved 
tyrosine residue (Y200, Figure 4.1A) that was found to regulate recruitment of ankyrin G by 
mammalian β1, as well as the putative internalization sequence (Y-L-A-I) discussed above 
(Figures 4.1A, 4.1D) (12;348;349). These alterations may affect interactions between zβ1A and 
zebrafish ankyrin, as well as influence the cycling of the mature zβ1A protein from its membrane 
compartment. The zβ1C splice variant, which results from retention of intron 2 and has an open 
reading frame of only 105 amino acids, is predicted to lack both an extracellular IG domain and a 
membrane-spanning segment. 
 Although alternative splicing of the β2 gene has not previously been identified in 
mammals, we identified 4 unique β2 transcripts in zebrafish. While zβ2A and zβ2B are spliced at 
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Figure 4.4: Analysis of cloned zebrafish β4.1 and β4.2 subunit genes.  Presentation and 
labeling as in Figure 1.  (A) Alignment of cloned human, rat, and zebrafish β4 amino acid 
sequences. S- = conserved cysteine in β4 that is a putative site of covalent linkage with a partner 
α subunit; N = predicted N-linked glycosylation site (N1 = human, N2 = rat, N3 = zebrafish β4.1, 
N4 = zebrafish β4.2); M = site of putative Long QT syndrome-causing mutation L179F; S1 = 
nonsynonymous Hsβ4 SNP (A/C > N210H).  (B) Genomic organization of zβ4.1 and zβ4.2 
derived from comparing cloned cDNA sequences with genomic sequences of zebrafish 
chromosomes 15 and 5, respectively. zβ4.1 has five exons and zβ4.2 has six exons.  (C) All 
zβ4.1 and zβ4.2 splice sites exhibit consensus GT-AG donor/acceptor sequences.  (D) 
Schematic diagram of zβ4.1 and zβ4.2 proteins. 
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canonical splice donor and acceptor sites, variants zβ2C and zβ2D are assembled by splicing at 
non-canonical exon 4-intron 4 and intron 4-exon 5 splice donor and acceptor sites. zβ2A is 
assembled from only 3 exons, zβ2B from 6 exons, and zβ2C and zβ2D from 5 exons each 
(Figure 4.2B). Mammalian and zebrafish β2 genes all share a second exon that is 167 
nucleotides in length and encodes the initial segment of the subunit’s extracellular IG domain. 
Otherwise, the genomic organization of zβ2 splice variants diverges from that of human, mouse, 
and rat β2 genes which all have 4 coding exons (Table 2). Nevertheless, exons 1 and 3 are 
similar in length in all species, as is the coding segment of exon 4 in the mammalian β2 genes 
and the zβ2B and zβ2D splice variants (Table 2). zβ2B, zβ2C, and zβ2D are unique in 
possessing a fifth exon that contributes to the gene’s open reading frame. Similar to mouse β2, 
the most conserved zebrafish β2 splice variant at the amino acid level (zβ2B) has a lengthy 
terminal exon that is entirely non-coding. 
As observed for zβ1, the conceptual translation of zβ2 splice variants predict zβ2 proteins 
that are of variable length and amino acid sequence at their intracellular C-terminal tail (Figure 
4.2D). The variant zβ2A results from retention of intron 3 and is predicted to result in a 160 amino 
acid protein that has an intact extracellular IG domain but no transmembrane domain (Figure 
4.2D). zβ2A is thus unlikely to display canonical beta subunit activities such as modulation of the 
trafficking and/or function of voltage-gated sodium channels α subunits, or mediation of cell-
adhesion between cells expressing this protein and other cells or the extracellular matrix, which 
all depend on integration in the cell membrane. Transcripts for variants zβ2B-D result from 
alternative splicing of exons 4-6 and are expected to produce proteins of 223, 201, and 231 
amino acids, respectively (Figure 4.2D, Table 2). Since the function of the intracellular C-terminal 
tail of zβ2 is not well-characterized, the predicted impact of these splice variants on zβ2 function 
cannot be readily predicted.  
 Unlike the zβ1 and zβ2 genes, alternatively-spliced transcripts of zβ3, zβ4.1, and zβ4.2 
genes were not detected. For each of these three genes, the genomic organization is well-
conserved compared to that of its respective mammalian homolog (Tables 3, 4). The open 
reading frame of SCN3B in humans, mice, rats, and zebrafish is derived from 5 exons (exons 2-6), 
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with a non-coding initial exon found in all 4 species and a non-coding terminal exon found only in 
the mammalian β3 gene (Table 3). Splicing of zebrafish β3 is determined by canonical GT-AG 
splice donor and acceptor sites, producing a putative protein whose secondary structure is similar 
to the β3 subunit found in mammals (Figures 4.3C, 4.3D). zβ4.1 and zβ4.2 transcripts are 
comprised of 5 and 6 exons, respectively, all of which are assembled from splicing at canonical 
GT-AG splice donor and acceptor sites (Figure 4.4B, C). zβ4.2 is unique among β4 genes in 
possessing a non-coding exon 1 (Table 4). The predicted secondary structures of zβ4.1 and 
zβ4.2 are both similar to the β4 subunit found in mammals (Figure 4.4D). 
 
Tissue-specific regulation of zebrafish β subunit gene expression and splicing 
Mammalian sodium channel β subunit genes are expressed primarily in excitable tissues 
such as the heart, brain, and skeletal muscle. By RT-PCR, we observed that zebrafish β subunit 
genes are also expressed in excitable tissues where they may act to regulate the expression or 
function of sodium channel α subunits (Figure 4.5, Table 5). Moreover, we detected distinct 
expression patterns for zβ1-4, suggesting that the functional importance of each β subunit likely 
varies by tissue type. Transcripts of zβ2 or zβ3 are absent from skeletal muscle whereas zβ1 and 
zβ4.2 are expressed only at low levels in the heart. As might be expected for non-excitable 
tissues, few β subunit transcripts were detected in the zebrafish liver and only zβ1 and zβ2 are 
expressed in the gill. 
 By designing splice variant-specific primers, we also found evidence for tissue-specific 
regulation of splicing of zebrafish β subunit genes (Figure 4.5). While zβ1 variants B and D are 
expressed primarily in the brain and eye (including the optic nerve), zβ1A is expressed in the 
atrium, ventricle, skeletal muscle and gill. Similarly, whereas zβ2 variant B is primarily expressed 
in the brain and eye, zβ2 variants A, C, and D are also expressed in the atrium, ventricle, brain, 
eye, and variant D is additionally expressed in the gill. Interestingly, zβ3 may be alternatively-
spliced in the brain and eye but not in the atrium or ventricle. We were unable to recover the 
shorter variant because of its apparent low level of expression. Although zβ1 variant C was 
identified by RACE-PCR using total embryonic RNA as template, we were unable to detect 
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Figure 4.5: Zebrafish sodium channel β1-4 subunit genes and novel splice variants are 
differentially expressed in excitable tissues.  Total RNA was isolated from wild-type adult 
zebrafish tissues. RT-PCR with gene and splice variant-specific primers was used to detect 
expression (see Table 5 for primer sequences and amplicon details). Atr = atrium, Ven = 
ventricle, Skm = skeletal muscle, Brn = Brain, Eye = eye/optic nerve, Liv = liver, Gil = gill. +  = 
enzyme added to reverse transcription step, - = no reverse transcriptase enzyme (negative 
control). Zebrafish β-actin was amplified from each template as a positive control. 
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expression of this short splice variant in the adult tissues analyzed for this study. This suggests 
that zβ1 variant C may be developmentally regulated, expressed in other tissues, unstable, or is 
the result of an infrequent alternative splicing event. 
 
Zebrafish β1 functionally modifies sodium channel expression, function in vitro 
As the first sodium channel auxiliary subunit to be identified, β1 is the most widely-
studied of the four known mammalian β subunit proteins. To evaluate whether functional α and β 
subunit interactions are likely to occur in zebrafish, we heterologously co-expressed the most 
conserved variant of zβ1 (variant D) with the gene encoding the zebrafish pore-forming sodium 
channel α subunit zNav1.5, whose expression we detected in the adult zebrafish brain and heart 
(unpublished observations). Prior studies suggest that the mammalian β1 subunit may influence 
the current amplitude and possibly the gating of mammalian Nav1.5 in vitro (154-157). Co-
expression of zβ1 with zscn5a in Chinese Hamster Ovary (CHO) cells increased peak sodium 
current by 68% at a -30 mV depolarizing pulse (n=5, p<0.001) compared to zscn5a alone (n=8) 
(Figure 4.6A-C, table 6). Co-expression of zβ1 with zscn5a also resulted in small but significant 
changes in the gating of the zNav1.5 channel protein. zβ1 induced hyperpolarizing shifts in both 
the voltage-dependence of activation and inactivation of zNav1.5, without altering recovery from 
inactivation (Figure 4.6D-F, table 6). These data suggest that the canonical modulatory effects of 
mammalian sodium channel β subunits on α subunit function and expression are likely to be 
conserved in teleosts and other non-mammalian vertebrates. 
 
Evolutionary relationships of vertebrate β subunit genes 
Although β subunit genes appear to be related both structurally and functionally to each 
other and to cell adhesion molecules with V-type IG domains such as myelin protein zero and 
contactin (11;12), the evolutionary relationships among these genes have not previously been 
formally studied. To investigate these relationships, we first identified an extended group of 
human genes that display sequence homology to β subunits. BLAST searches of the human 
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Figure 4.6. The zebrafish β1 subunit modulates the biophysical properties of the zebrafish 
sodium channel α subunit zNav1.5 in CHO cells.  (A) Typical whole-cell sodium current trace 
of zNav1.5 following expression of the pBK-CMV-zscn5a expression vector in CHO cells (n=8). 
(B) Typical whole-cell sodium current trace of zNav1.5 + zβ1 (variant D) following co-expression 
of pBK-CMV-zscn5a and pGFP-IRES-zβ1D. zβ1 significantly increased the peak amplitude of 
sodium current by 68% (p=0.005) at a -30 millivolt (mV) depolarizing pulse (n=5). (C) Current-
voltage relationship demonstrating an increase in sodium current at every test potential between -
50 and +50mV. Filled circles = zNav1.5 alone; open circles = zNav1.5 + zβ1. (D) Voltage 
dependence of activation (zNav1.5 alone, n=8; zNav1.5 + zβ1, n=5). (E) Voltage-dependence of 
inactivation. (zNav1.5 alone, n=5; zNav1.5 + zβ1, n=6). (F) Recovery from inactivation (zNav1.5 
alone, n=4; zNav1.5 + zβ1, n=6). Pulse protocol in inset. Summary data is reported in table 6. 
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genome with human β subunit nucleotide and amino acid sequences most frequently-identified 
the genes myelin protein zero, myelin protein zero-like 1, isoform A (MPZL1 iso A), epithelial V-
like antigen (EVA1), and hypothetical protein LOC196264 which we named “EVA1-like gene” 
(EVA1L) for its similarity to EVA1 and the proximity of these two genes in the human genome. 
Analysis of the amino acid sequence of each gene using the NCBI conserved domain database 
and TMpred software revealed that all 4 proteins likely possess single V-type IG domains and 
transmembrane segments, respectively, similar to sodium channel β subunits (Figure 4.7A). 
Moreover, comparison of the complementary DNA sequences of these genes against their 
respective genomic loci indicated that all 4 genes also possess genomic organization similar to 
sodium channel β subunits (Figure 4.7B). We therefore included these genes in our analysis of 
the synteny and phylogeny of the extended family of vertebrate β subunit genes.  To analyze 
synteny, we first identified all β subunit-like genes in human, rat, zebrafish, frog (Xenopus 
tropicalis) and bird (Gallus gallus) genomes (Table 7). Notably, whereas humans and rats each 
have 4 and zebrafish have 5 β subunit genes, only 3 β subunit genes were identified in frogs and 
birds (β1 was not found in either genome). Next, we used reciprocal BLAST searches and in 
silico chromosome walking to assess physical relationships among β-subunit like genes (Figure 
4.8). Strikingly, scn2b, scn4b, and EVA1/EVA1L genes map to common locations in every 
vertebrate genome analyzed (human chromosome 11, rat chromosome 8, zebrafish chromosome 
5/15, frog scaffold_39, and chicken chromosome 24), suggestive of a close evolutionary 
relationship that may have resulted from gene duplication. Although physically more distant, 
scn3b is also syntenic with this group of genes in 4/5 genomes analyzed. Of the 4 sodium 
channel β subunits, only scn1b falls outside this syntenic block. The common ancestry of human, 
rat, and zebrafish scn1b is supported, however, by the proximity of the genes encoding the 26S 
protease regulatory subunit 6B (PSMC4) and fibrillarin (FBL) to the scn1b locus in all three 
species (human chromosome 19, rat chromosome 1, zebrafish chromosome 16). The synteny of 
β subunit genes in mammalian, fish, amphibian, and avian lineages thus supports the hypothesis 
that extant vertebrate β subunits are orthologous. Moreover, these findings strongly suggest that 
the evolution of at least several members of this extended gene family (scn2b, scn4b, EVA1, 
 171
EVA1L) may have arisen from duplication events that predated the divergence of teleosts and 
tetrapods. 
To further analyze the evolution of vertebrate β subunit-like genes, we reconstructed the 
phylogeny of this gene family (Figure 4.9). Neighbor-joining phylogenetic analysis of amino acid 
sequences demonstrated that all-identified sodium channel β subunits fall on one of four 
branches corresponding to β1, β2, β3, or β4, supporting the preliminary identity assigned to each 
cloned zebrafish β subunit gene (including the duplicated zebrafish β4 genes) by alignment with 
each individual mammalian subunit (Figures 4.1A-4.4A). Despite synteny among scn2b, scn3b, 
and scn4b, phylogenetic analysis revealed that β3 is more closely related to β1 than to either β2 
or β4. Moreover, our phylogenetic model incorporating β subunit-like genes additionally indicated 
that β2 and β4 are more closely-related to each other and to β subunit-like genes than to either 
β1 or β3. Our analysis thus supports an evolutionary model where β2/β4/β subunit-like genes and 
β1/β3 arose following duplications of 2 distinct precursor genes. The timing of such duplications 
cannot be gleaned from this model. The presence of gene orthologs to all 4 β subunits in 
divergent vertebrates (mammals and teleosts) strongly suggests, however, that the early 
vertebrate common ancestor to these lineages already had four distinct β subunit genes. 
Duplication events that occurred in this gene family – aside from that which produced two 
zebrafish β4 genes – thus occurred earlier in vertebrate evolution or prior to the emergence of the 
vertebrates altogether. 
 
Absence of β subunit genes in invertebrates 
The sequenced genomes of the ascidians Ciona intestinalis and Ciona savignyi provide 
an opportunity to identify putative precursors to vertebrate β subunits genes in invertebrate 
chordates (390;391). Although both ascidian genomes contain several loci encoding Nav1 
voltage-gated sodium channel α subunits, BLAST searches using the nucleotide and protein 
sequences of zebrafish and mammalian sodium channel β subunits and related proteins (MPZ, 
EVA1) did not identify any homologous genes. The absence of β subunit-like genes in sequenced 
Ciona genomes does not preclude the presence of numerous other genes with V-type and other 
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Figure 4.7. Four additional human genes share homology with β subunits in sequence and 
genomic organization.  (A) BLASTP searches of the human genome using sodium channel β 
subunit amino acid sequences identified significant homology to myelin P0 protein (MPZ), myelin 
P0 protein-like protein isoform A (MPZL1 isoform A), epithelial V-like antigen 1 (EVA1), and 
epithelial V-like antigen 1-like gene (EVA1L), all of which are single transmembrane proteins with 
extracellular V-type immunoglobulin domains and intracellular C-terminal tails as predicted by 
NCBI conserved domain database v2.09 and TMPred (see Methods for further details).  (B) This 
group of genes additionally shares similar genomic organization. Numbers in grey boxes refer to 
exon size (nucleotides) with untranslated sequence excluded for clarity. 
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Figure 4.8: SCN2B, SCN3B, and SCN4B are syntenic with each other and with EVA1, EVA-
1L, and APOA-1 in multiple vertebrate genomes, whereas SCN1B is syntenic with FBL and 
PSMC4 in humans, rats, and zebrafish.  To analyze synteny, β subunits and subunit-like genes 
were identified in human, rat, zebrafish, frog and bird genomes (see Table 7 for gene IDs and 
physical locations). While humans and rats have four and zebrafish have five β subunit genes, 
only three β subunit genes were identified in frogs and birds (β1 was not found in either genome). 
Reciprocal blast searches and in silico chromosome walking were used to assess physical 
relationships among vertebrate β subunit-like genes. HUGO gene nomenclature symbol IDs: 
PSMC4 = 26S protease regulatory subunit 6B; FBL = fibrillarin; APOA1 = apolipoprotein A-1; 
MPZ = myelin protein zero; MPZL1 = myelin protein zero-like gene, isoform A; EVA1 = epithelial 
V-like antigen 1; EVA1L = unannotated gene similar to EVA1. Red = β subunit genes, Blue = β 
subunit-like genes, Black = unrelated genes that are syntenic with β subunits. 
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IG-like domains ((392;393) and unpublished observations). These findings strongly suggest that 
sodium channel β subunit genes are an innovation of vertebrates. As predicted, searches of the 
genome of the echinoderm Strongylocentrotus purpuratus (sea urchin) (394), a non-chordate 
deuterostome, also did not reveal any sodium channel β subunits genes. 
Despite the lack of evidence for β subunits genes outside of vertebrates, studies 
conducted in Drosophila melanogaster demonstrate that invertebrate sodium channels require 
additional subunits for normal function. Mutations in the Drosophila tip-E (temperature-induced 
paralysis) gene, which encodes a sodium channel auxiliary subunit, disrupt nerve conduction by 
perturbing the expression and function of the para voltage-gated sodium channel (395-399). 
Moreover, 4 recently-identified tip-E related genes (TEH1-4 or tip-E homologs 1-4) were found to 
modulate the density and kinetics of sodium currents of heterologously-expressed para sodium 
channels (400). Based on these findings, we sought to assess whether vertebrate and 
invertebrate sodium channel auxiliary subunits share common structural elements or functional 
domains. Use of TMPred software and the NCBI conserved domain database demonstrated, 
however, that Drosophila tip-E and tip-E homologous genes (TEH1-4) each possess two 
predicted membrane-spanning segments (not one) and lack the canonical V-type IG domain 
found in vertebrate β subunits. Additionally, alignment of the amino acid sequences of cloned 
zebrafish and human sodium channel β subunit genes with the sequences of Drosophila tip-E 
and tip-E homologous genes also revealed only minimal homology (<15% amino acid identity). 
BLAST searches of the Drosophila genome did not uncover any additional genes sharing 
homology with vertebrate β subunits, despite the presence of numerous genes encoding proteins 
with immunoglobulin domains ((401) and unpublished observations). These results indicate that 
vertebrate and invertebrate sodium channel auxiliary subunits are dissimilar in structure and 
unrelated. 
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Figure 4.9: Phylogenetic analysis demonstrates that vertebrate sodium channel β1-4 
subunit genes are orthologous, that β1/β3 and β2/β4 are closely related, and that zβ4.1 and 
zβ4.2 resulted from a recent gene duplication in fish.  Actual (human, zebrafish) and 
predicted (chicken, frog) amino acid sequences of β subunit and related genes were aligned 
using CLUSTALX (v1.83). Phylogenetic trees were reconstructed using the neighbor-joining 
method of Saitou and Nei and viewed with NJPlot software. Alignment gaps were excluded and 
the Kimura correction was made for multiple substitutions. Bootstrapping (n=1000) was applied to 
test the robustness of each node. Tree is unrooted due to the lack of evidence for β subunit-like 
genes in invertebrate species. HUGO gene nomenclature symbol IDs: MPZ = myelin protein zero; 
MPZL1 = myelin protein zero-like gene isoform A; EVA1 = epithelial V-like antigen 1; EVA1L = 
unannotated gene similar to EVA1. 
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Discussion 
Numerous studies of mammalian voltage-gated sodium channel β subunits have 
demonstrated that these small, single membrane-spanning proteins are integral components of 
sodium channel complexes in excitable tissues, modulators of the expression and function of 
pore-forming sodium channel α subunits, and candidate genes for clinical disorders linked to 
perturbed membrane excitability such as arrhythmia and epilepsy (19;402). Despite the early 
origins of the Nav1 family of sodium channel α subunits and their cloning from diverse metazoans 
including eels, jellyfish, flies, and humans, the evolutionary history of sodium channel β subunits 
has remained obscure. The primary objective of this study was thus to investigate β subunit 
genes in Danio rerio (zebrafish), a pivotal vertebrate species whose teleost ancestors diverged 
from mammals over 400 million years ago, in order to gain further insight into the origin and 
regulation of the voltage-gated sodium channel macromolecular complex. 
Using a combination of bioinformatics, molecular cloning, and phylogenetic analysis, we 
identified conserved orthologs of all 4 mammalian β subunit genes and 8 novel β1 and β2 splice 
variants in zebrafish. Using our cloned zebrafish sequences, we subsequently identified β subunit 
genes in other non-mammalian vertebrates including Xenopus tropicalis (Western clawed frog) 
and Gallus gallus (Red jungle fowl). The existence of conserved mammalian, teleost, amphibian, 
and avian sodium channel β subunit loci indicates that this gene family is likely to be found in 
most if not all vertebrate genomes. Moreover, our detection of zebrafish β subunit gene 
expression in tissues including the heart, muscle, and the brain suggests that the voltage-gated 
sodium channel α-β subunit macromolecular complex is likely to be a common structural feature 
of excitable membranes. 
 
Sodium channel complexes in non-mammalian vertebrates: An emerging concept 
Our data are the first to support the existence of voltage-gated sodium channel α-β 
subunit macromolecular complexes in non-mammalian vertebrates. Data from prior studies, 
however, suggest that sodium channels form α-β subunit complexes in mammals but not in other 
vertebrate lineages (5-7;142-145;403-407). While sodium channels biochemically purified from rat 
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neuronal membranes and rat and rabbit skeletal muscle membranes were found to be comprised 
of 1 α subunit and 1 or more auxiliary β subunits, for example, α subunits purified from the 
electroplax (electric organ) of the South American eel Electrophorus electricus and from chick 
cardiac muscle were unaccompanied by β subunits (5-7;142-145;403-407). Further investigation 
into the existence of sodium channel α-β macromolecular complexes in non-mammalian 
vertebrates is thus needed to reconcile our current findings with the results of previous studies. 
There are several possible reasons for the discord between biochemical and molecular 
genetic approaches. First, it is possible that some but not all voltage-gated sodium channel 
isoforms within a particular species form complexes by associating with auxiliary β subunits, or 
that pore-forming α subunits form complexes only in specific tissues. Evidence suggests that 
even in mammals, for example, the subunit composition of voltage-gated sodium channels 
significantly varies both by α subunit isoform and by tissue (9;143). Second, at least for the eel 
electroplax, the function of this organ may depend on sodium channel α subunits that have 
evolved unique properties which may preclude association with auxiliary subunits (408). Third, it 
is possible that sodium channel α subunit isoforms in certain tissues form complexes not with 
canonical β subunits but with yet unidentified proteins. In mammals, the interaction of sodium 
channel α subunits with a number of additional components and modulators in macromolecular 
complexes suggest that β subunits may not always serve as obligatory functional partners (for 
review, see refs (19;168)). Our detection of conserved β subunit mRNA expression in excitable 
organs such as heart, brain, and skeletal muscle, however, suggests the strong possibility of α-β 
subunit complexes in these zebrafish tissues. Moreover, co-expression of zebrafish α and β 
subunit genes in CHO cells demonstrated meaningful functional interactions between the two 
subunits, with significant differences observed in sodium current amplitude and channel gating 
when both subunit genes are expressed together versus when the α subunit gene is expressed 
alone. Despite these findings, however, we cannot completely rule out the possibility that sodium 
channel β subunit genes play different in vivo functional roles in mammals than in non-
mammalian vertebrates. 
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Evolution of sodium channel β subunits and related genes 
Our analysis of the synteny and phylogeny of vertebrate sodium channel β subunit genes 
suggests a different evolutionary history for α and β subunits. For sodium channel α subunits, 
prevailing evolutionary models posit that the 10 mammalian isoforms arose from the tandem 
duplication of at least 2 of 4 ancestral sodium channel genes, which in turn had duplicated from 1 
or 2 precursor chordate Nav1 sodium channel genes by polyploidization (97;98;175;180). As 
would be predicted by this model, the total number of Nav1 sodium channel genes varies between 
teleosts and mammals despite the phylogenetic clustering of all of these genes into 4 groups 
derived from ancestral vertebrate sodium channel genes (180;230). Sodium channel β subunits, 
which are fewer in number, do not appear to have undergone tandem duplication in either 
mammals or in non-mammalian vertebrates. This is supported by our finding that 4 distinct 
vertebrate lineages (mammals, ray-finned fishes, amphibians and birds) all appear to share 
distinct orthologs to 3 or 4 β subunit genes. Thus, it is likely that the common ancestor to teleosts 
and tetrapods over 400 million years ago also possessed 4 distinct ancestral β subunit genes 
(β1-4). The presence of 2 β4 orthologs on different zebrafish chromosomes is likely to be the 
remnant of an additional polyploidization event known to have occurred in teleost vertebrates but 
not in mammals (227). It is difficult to determine why duplicate genes for β1-3 have not been 
retained in zebrafish; it is possible that >5 β subunit genes did not offer teleosts any evolutionary 
advantage (176). 
The close phylogenetic relationship of SCN1B and SCN3B and the physical proximity of 
SCN2B and SCN4B to each other and to genes (e.g. EVA1) that are β subunit-like in sequence 
and genomic organization is strong evidence that duplication events gave rise to the β subunit 
gene family during the postulated large-scale expansion of the early vertebrate genome. Although 
we cannot accurately predict the early evolutionary history of sodium channel β subunit genes 
prior to the divergence of teleosts from other vertebrate lineages, the results of our phylogenetic 
analysis support the existence of 2 ancestral β subunit genes (β1/β3 and β2/β4) in early 
vertebrates. Somewhat surprisingly (but in agreement with a previous report (177)), BLASTN and 
BLASTP searches of available urochordate (Ciona intestinalis, Ciona savignyi) genomes did not 
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identify any sodium channel β subunit-like genes, despite the clear existence of genes encoding 
proteins with immunoglobulin domains similar to those found in β subunits (392;393). Moreover, 
we and others also found limited homology between vertebrate β subunit genes and the tip-
E/TEH subunits of the para sodium channel in Drosophila (178;397). These findings strongly 
suggest that sodium channel β subunits are a unique vertebrate innovation.  
The similarity of vertebrate sodium channel β subunits to members of a more ancient 
family of IG domain-containing proteins suggests that β subunit genes may have arisen de novo 
in early vertebrates from genes encoding cell-adhesion molecules, membrane receptors, or 
components of the innate immunity. The property of modulation of the expression and function of 
sodium channel β subunits may thus represent a more evolutionarily recent function for this gene 
family. These findings support the idea that molecular mechanisms enhancing functional diversity 
and specialization in electrical signaling – either through α subunit gene duplication, editing or 
alternative splicing of α subunit RNA transcripts, or the emergence of auxiliary proteins that 
associate with α subunits to modulate their expression and/or function – may have been adaptive 
and underwent selection in the evolving nervous system of early vertebrates and subsequently, in 
the increasingly complex excitable tissues of diverse vertebrate lineages including mammals. 
Despite the lack of common ancestry among invertebrate tip-E/TEH subunits and vertebrate IG-
like β subunits, the apparent independent evolution of Nav1 sodium channel-interacting proteins 
in distantly-related species demonstrates that the formation of sodium channel macromolecular 
complexes is an evolutionary advantageous and conserved mechanism for fine-tuning the 
properties of excitable membranes. 
 
Functional implications of alternative splicing of zebrafish β subunit genes 
The evidence we present for the extensive C-terminal alternative splicing of zebrafish β 
subunit genes is intriguing because it may represent another conserved molecular mechanism for 
modulating electrical signaling in vertebrates. Alternative splicing has been reported for both 
mammalian sodium channel α and β subunits and invertebrate α subunits, often with important 
functional consequences (386;387;409-415). The intronic retention events that produce both the 
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rat β1A and human β1B variants each result in a protein with a novel transmembrane domain and 
intracellular C-terminal tail. When stably expressed in Chinese Hamster Lung (CHL) fibroblasts, 
rat β1 and β1A differentially modulate the function of the rat sodium channel α subunit Nav1.2 
(scn2a) (386). Similarly, the human β1 and β1B subunits differentially modulate the function of 
human Nav1.2 in Xenopus oocytes (387). These studies suggest that the transmembrane domain 
and C-terminus of the human and rat β1 subunits contribute to the functional modulation of 
sodium channel α subunits. In a subsequent study, the β1 intracellular C-terminal tail in particular 
was found to be required for both efficient physical association with Nav1.2 and for the modulation 
of sodium channel function in both mammalian cells and Xenopus oocytes (416). This raises the 
possibility that the zebrafish β1 and  β2 subunit splice variants identified in this study may also 
differentially influence the function of sodium channel α subunits. Our identification of distinctive 
expression patterns for different splice variants of the same gene underscores the complexity of 
this putative sodium channel regulatory mechanism. 
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Figure 4.10: Hydropathy analysis of zebrafish β subunit amino acid sequences reveals 
conserved protein secondary structure.  TMPred hyropathy plot based on the method of Kyte 
and Doolittle. Dotted red line drawn at 0 (neutral). SP = signal peptide and TM = transmembrane 
domain. Dotted line plot (black) indicates outside>inside orientation relative to membrane, while 
solid line plot (black) indicates inside>outside orientation.  (A) Hydropathy plots for zβ1 variants 
A, B, and D are nearly identical (zβ1D shown).  (B) zβ2A and zβ2B-D.  (C) zβ3.  (D) zβ4.1 and 
zβ4.2. 
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Figure 4.11: Prediction of conserved extracellular V-type IG domains in the amino acid 
sequences of the most highly-conserved splice variants of zβ1-4, NCBI Conserved Domain 
Database (CDD v2.09).  Predicted V-type IG domain is shown in red, and the scale denotes the 
length of the full-length protein.  (A) zβ1D.  (B) zβ2B.  (C) zβ3.  (D) zβ4.1.  (E) zβ4.2. 
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Table 4.1: Comparative genomics of the sodium channel β1 gene in zebrafish and 
mammals. 
 
 
gene Genbank 
accession 
number 
gene 
location  
cDNA exon
1 
exon
2 
exon 
3 
exon 
4 
exon 
5 
exon
6 
protein %ID    
(%SIM) 
topology 
             
zβ1A DQ489722 Chr 16 1411 219  
(52) 
167 238 142 645 
(31) 
209 47.5%  
(57.0%) 
IG(V): 37-149 
TM: 164-185 
zβ1B DQ489723 Chr 16 1054 219    
(52) 
167 238 142 28 260      
(9) 
211 49.8%  
(59.6%)  
IG(V): 37-149 
TM: 164-185 
zβ1C DQ489724 Chr 16 574 219    
(52) 
355 
(266) 
   105 13.0%  
(17.5%)  
IG(V): none 
TM: none  
zβ1D DQ489725 Chr 16 1320 219    
(52) 
167 238 142 72     
(67) 
482      
(0) 
221 53.4%  
(63.7%)  
IG(V): 37-149 
TM: 164-185 
hβ1 NM_001037 Chr 19 1521 231    
(40) 
167 241 142 72     
(67) 
668      
(0) 
218 100%    
(100%) 
IG(V): 33-146 
TM: 161-182 
rβ1A AF182949 Chr 1 850 40 167 643 
(615) 
  273 55.1%  
(59.1%)  
IG(V): 33-146 
TM: 216-234  
hβ1B NM_199037 Chr 19 1170 231    
(40) 
167 772 
(600) 
  268 58.0%  
(60.2%) 
IG(V): 33-146 
TM: 244-263 
 
Gene: z = zebrafish, h = human, r = rat, and letters A-D refer to different splice variants. 
Accession numbers are identifiers for nucleotide sequences in NCBI GenBank. Values for cDNA 
and exons represent number of nucleotides. (Parentheses) indicate nucleotides within the open 
reading frame (difference = untranslated sequence or UTR). Protein values represent amino acid 
number with signal peptide intact. %ID (%SIM) refers to percentage identity and similarity with the 
human β1 protein sequence as determined by alignment. Zebrafish β subunit topology was 
determined as described in Methods. IG(V) = V-type immunoglobulin domain and TM = 
transmembrane domain. Numbering refers to β1 protein sequence with signal peptide intact. IG(V) 
domain and transmembrane regions for human β1 and human/rat splice variants were annotated 
based on previous reports (10;14;382;386;387).  
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Table 4.2: Comparative genomics of the sodium channel β2 gene in zebrafish and 
mammals. 
 
 
gene Genbank 
accession 
number 
gene 
location 
cDNA exon 
1 
exon 
2 
exon 
3 
exon 
4 
exon 
5 
exon 
6 
prot
ein 
%ID 
(%SIM) 
topology 
             
zβ2A DQ489726 Chr 15 821 243 
(82) 
167 411  
(234) 
  160 32.6% 
(42.5%) 
IG(V): 47-152 
TM: none  
zβ2B DQ489727 Chr 15 2449 243 
(82) 
167 217 196 68    
(10) 
1558    
(0) 
223 49.6% 
(64.7%) 
IG(V): 47-152 
TM: 162-186  
zβ2C DQ489728 Chr 15 851 243 
(82) 
167 217 124 100    
(13) 
201 45.2% 
(58.4%) 
IG(V): 47-152 
TM: 162-186  
zβ2D DQ489729 Chr 15 918 243 
(82) 
167 217 193 98     
(34) 
231 48.1% 
(62.8%) 
IG(V): 47-152 
TM: 162-186  
Hsβ2 NM_004588 Chr 11 4939 260 
(70) 
167 211 4301  
(200) 
 215 100% 
(100%) 
IG(V): 43-146 
TM: 156-180 
Mmβ2 NM_001014
761 
Chr 9 3980 213 
(70) 
167 211 618 
(200) 
2771    
(0) 
215 92.1% 
(94.4%) 
IG(V): 43-146 
TM: 156-180  
Rnβ2 NM_012877 Chr 8 873 236 
(70) 
167 211 259  
(200) 
 215 93.0% 
(94.9%) 
IG(V): 43-146 
TM: 156-180 
 
Presentation and labeling as in Table 1. %ID (%SIM) refers to percentage identity and similarity 
with the human β2 protein sequence as determined by alignment. Zebrafish β2 subunit topology 
was determined as described in Methods. Numbering refers to β2 protein sequence with signal 
peptide intact. IG(V) domain and transmembrane regions for human β2 and human/mouse/rat 
splice variants were annotated based on previous reports (11;14;382;417).  
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Table 4.3: Comparative genomics of the sodium channel β3 gene in zebrafish and 
mammals. 
 
gene Genbank 
accessio
n number 
gene 
loc. 
cDNA exon 
1 
exon 
2 
exon 
3 
exon 
4 
exon 
5 
exon 
6 
exon 
7 
prot
ein 
%ID 
(%SIM) 
topology 
              
zβ3 DQ48973
0 
Chr 
15 
1006 294  
(0) 
103 
(55) 
170 235 139 65 
(64) 
220 51.1% 
(65.2%) 
IG(V): 38-150   
TM: 165-186   
Hsβ3 NM_0184
00 
Chr 
11 
4052 778  
(0) 
80   
(55) 
164 226 139 86    
(64) 
2579  
(0) 
215 100% 
(100%) 
IG(V): 38-145  
TM: 160-181   
Mmβ3 NM_1782
27 
Chr 
9 
3549 206  
(0) 
80   
(55) 
164 226 139 80    
(64) 
2654  
(0) 
215 97.7% 
(97.7%) 
IG(V): 38-145 
TM: 160-181 
Rnβ3 NM_1390
97 
Chr 
8 
3910 350  
(0) 
82   
(55) 
164 226 139 80    
(64) 
2837  
(0) 
215 98.1% 
(98.1%) 
IG(V): 38-145  
TM: 160-181   
 
Presentation and labeling as in Table 1. %ID (%SIM) refers to percentage identity and similarity 
with the human β3 protein sequence as determined by alignment. Zebrafish β3 subunit topology 
was determined as described in Methods. Numbering refers to β3 protein sequence with signal 
peptide intact. IG(V) domain and transmembrane regions for human β3 and human/mouse/rat 
splice variants were annotated based on previous reports (12;14). 
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Table 4.4: Comparative genomics of the sodium channel β4 gene in zebrafish and 
mammals. 
 
 
gene Genbank 
accession 
number 
gene 
loc. 
cDNA exon 
-1 
exon 
1 
exon 
2 
exon 
3 
exon 
4 
exon 
5 
prot
ein 
%ID 
(%SIM) 
topology 
             
zβ4.1 DQ489731 Chr 22 2072  597 
(91) 
164 220 130 961 
(94) 
232 43.2% 
(59.3%) 
IG(V): 53-155 
TM: 165-187  
zβ4.2 DQ489732 Chr 5 1490 233     
(0) 
410 
(97) 
164 223 130 330 
(85) 
232 40.8% 
(56.7%) 
IG(V): 55-158 
TM: 168-190  
Hsβ4 NM_17493
4 
Chr 11 4489  214 
(61) 
173 229 130 3743 
(94) 
228 100% 
(100%) 
IG(V): 46-151 
TM: 162-183 
Mmβ4 NM_00101
3390 
Chr 9 4244  61 173 229 130 3651 
(94) 
228 79.4% 
(88.2%) 
IG(V): 46-151 
TM: 162-183  
Rnβ4 NM_00100
8880 
Chr 8 4272  61 173 229 130 3679 
(94) 
228 80.3% 
(88.6%) 
IG(V): 46-151 
TM: 162-183 
 
Presentation and labeling as in Table 1. %ID (%SIM) refers to percentage identity and similarity 
with the human β4 protein sequence as determined by alignment. Zebrafish β4 subunit topology 
was determined as described in Methods. Numbering refers to β4 protein sequence with signal 
peptide intact. IG(V) domain and transmembrane regions for human β4 and human/mouse/rat 
splice variants were annotated based on previous reports (13;14). 
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Table 4.5: Primers used to detect expression of zebrafish β subunit genes and splice 
variants in different tissues of the adult zebrafish. 
 
 
 
Forward Primer (5'-3') Reverse Primer (5'-3') Gene Variant Amplicon 
Size (bp)  
    
CTACACTTATGCAGAAATGACAGCCAGC GATGGACAGAGCTTCAAGCTTTTGGCT zβ1 A 422 
  zβ1 D 494 
GACAGAATCCTCATCTTCCCCAACTATG CTGCATTCTTCATTTAAACTCAGAGGT  zβ1 B 267 
  zβ1 D 534 
GTCCCTGCGCTGTTGTGTTTAACACAT GGGTGAACAATCCCTTTAAGCTGCACT zβ1 C 382 
CAGCTGACAGACGAGGGCATCTACAACT CAACACCTGCAGTGAGAAAACCCCATT zβ2 A 201 
CATCCTTGCTCTGCTCATTCTGTCCAT TCGCTACACGATAATACCAGGGAGTGT zβ2 B 304 
  zβ2 C 169 
  zβ2 D 236 
CTGGTGTGTGTGGATGTGCCATCA CTTGTTGGCGGAAAGCTTGAATGA zβ3  357 
AGGTGAGCACAGGGAAGGTCCATT GGAGGCCATTTTCTGTGTTGTCGT zβ4 loc1 543 
TGTGTTGTGTTCATGCTTTG GACCACCTTTAGTTCCTCTA zβ4  loc2 395 
 
Note: several primer pairs detected multiple splice variants, as indicated above and displayed in 
Figure 4.5. BP= base pairs or nucleotide number. 
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Table 4.6: Biophysical properties of zNav1.5 and zNav1.5 plus zβ1 (variant D) in CHO cells. 
 
 
 Peak amplitude (pA)*  Activation V1/2 (mV) Inactivation V1/2 (mV) Recovery from inactivation, 
Tau (ms) 
     
zNav1.5 alone -125.7 ± 16.9 pA/pF (n=8) -47.5 ± 1.6mV (n=8) -79.3 ± 1.0mV (n=5) 127.9 ± 8.1ms (n=4) 
zNav1.5 + zβ1 -211.1 ± 11.2 pA/pF† (n=5) -53.0 ± 2.5mV† (n=5) -82.6 ± 1.1mV† (n=6) 125.7 ± 4.1ms (n=6) 
 
All values are mean ± standard error of the mean (SEM). * at a -30 mV depolarizing pulse. † 
p<0.001 vs. zNav1.5 alone, Student's T-Test. pA = picoamperes; mV = millivolts; ms = 
milliseconds; pF = picofahrads; V1/2 = half maximal voltage.
 189
Table 4.7: List of cloned and predicted genes utilized for analysis of synteny and 
phylogeny of the extended β subunit gene family in vertebrates. 
 
 
  Analysis of Synteny  Analysis of Phylogeny 
Gene Species Accession No. (Gene) Physical Location Accession No. (Protein) 
     
SCN1B Homo sapiens ENSG00000105711 chr. 19 (FWD, 40.21-40.22Mb) ENSP00000262631 
 Rattus norvegicus ENSRNOG00000021102 chr. 1 (REV, 86.16-86.17Mb) n/a 
 Danio rerio ENSDARG00000060222 chr. 16 (REV, 47.82-47.83Mb) ABF47239 
     
SCN2B Homo sapiens ENSG00000149575 chr. 11 (REV, 117.54-117.55Mb) ENSP00000278947 
 Rattus norvegicus ENSRNOG00000016221 chr. 8 (FWD, 48.07-48.08Mb) n/a 
 Danio rerio ENSDARG00000041176 chr. 15 (REV, 27.32Mb) ABF47241. 
 Xenopus tropicalis ENSXETESTG00000009930 *scaffold_39 (FWD, 0.58-0.59Mb) ENSXETESTP00000016971 
 Gallus gallus ENSGALG00000021272 chr. 24 (REV, 5.10-5.11Mb) ENSGALP00000033652 
     
SCN3B Homo sapiens ENSG00000166257 chr. 11 (REV, 123.01-123.03Mb) ENSP00000299333 
 Rattus norvegicus ENSRNOG00000006937 chr. 8 (FWD, 43.23-43.25Mb) n/a 
 Danio rerio ENSDARESTG00000011553 chr. 15 (REV, 28.62-28.64Mb) ABF47244 
 Xenopus tropicalis ENSXETESTG00000002589 *scaffold_298 (FWD, 0.94-0.96Mb) ENSXETESTP00000004357 
 Gallus gallus ENSGALESTG00000012587 chr. 24 (FWD, 2.82-2.83Mb) ENSGALESTP00000019882 
     
SCN4B.1 Homo sapiens ENSG00000177098 chr. 11 (REV, 117.51-117.53Mb) ENSP00000322460 
 Rattus norvegicus ENSRNOG00000026679 chr. 8 (FWD, 48.09-48.11Mb) n/a 
 Danio rerio ENSDARESTG00000010162 chr. 15 (REV, 27.26-27.29Mb) ABF47245 
 Xenopus tropicalis ENSXETESTG00000009931 *scaffold_39 (FWD, 0.61-0.63Mb)  ENSXETESTP00000016972 
 Gallus gallus ENSGALG00000007409 chr. 24 (REV, 5.10Mb) ENSGALP00000011971 
     
SCN4B.2 Danio rerio ENSDARESTG00000000878 chr. 5 (FWD, 38.08-38.10Mb)  ABF47246 
     
MPZ Homo sapiens ENSG00000158887 chr. 1 (REV, 159.54-159.55Mb) ENSP00000289928 
 Rattus norvegicus ENSRNOESTG00000011377 chr. 13 (FWD, 87.04-87.05Mb) n/a 
 Danio rerio ENSDARG00000038609 chr. 2 (REV, 46.60-46.62Mb) ENSDARP00000056371 
 Gallus gallus ENSGALESTG00000015635 *chr. Un (REV, 60.79-60.80Mb) ENSGALP00000008810 
     
MPZL1 
isoA 
Homo sapiens ENSG00000197965 chr. 1 (FWD, 165.96-166.03Mb) ENSP00000352513 
 Rattus norvegicus ENSRNOG00000003248 chr. 13 (REV, 81.32-81.36Mb) n/a 
 Xenopus tropicalis ENSXETG00000023014 *scaffold_195 (REV, 1.78-1.79Mb) ENSXETP00000049765 
 Gallus gallus ENSGALG00000015438 chr. 1 (REV, 85.41-85.44Mb) ENSGALP00000024855 
     
EVA1 Homo sapiens ENSG00000149573 chr. 11 (REV, 117.63-117.64Mb) ENSP00000278937 
 Rattus norvegicus ENSRNOG00000016085 chr. 8 (FWD, 47.99-48.00Mb) n/a 
 Danio rerio ENSDARG00000027345 chr. 5 (FWD, 38.05-38.07Mb) ENSDARP00000032601 
 Xenopus tropicalis ENSXETESTG00000008504 *scaffold_39 (FWD, 0.51-0.54Mb) ENSXETESTP00000014524 
 Gallus gallus ENSGALG00000007412 chr. 24 (REV, 5.12-5.13Mb) ENSGALP00000011976 
     
"EVA1-
like" 
Homo sapiens ENSG00000160588 chr. 11 (REV, 117.60-117.63Mb) ENSP00000278949 
 Rattus norvegicus ENSRNOG00000026753 chr. 8 (FWD, 48.00-48.01Mb) n/a 
 Gallus gallus ENSGALG00000021271 chr. 24 (REV, 5.11-5.12Mb) ENSGALP00000033649 
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PSMC4 Homo sapiens ENSG00000013275 chr. 19 (FWD, 45.17-45.18Mb) n/a 
 Rattus norvegicus ENSRNOG00000018994 chr. 1 (REV, 83.15-83.16Mb) n/a 
 Danio rerio ENSDARG00000027099 chr. 16 (FWD, 47.99-5-48.00Mb) n/a 
 Xenopus tropicalis ENSXETG00000014266 *scaffold_1060 (REV, 0.17Mb) n/a 
     
FBL Homo sapiens ENSG00000105202 chr. 19 (REV, 45.02-45.03Mb) n/a 
 Rattus norvegicus ENSRNOG00000019229 chr. 1 (FWD, 83.27-83.28Mb) n/a 
 Danio rerio ENSDARG00000053912 chr. 16 (FWD, 47.49-47.50Mb) n/a 
 Xenopus tropicalis ENSXETG00000017830 *scaffold_1073 (REV, 0.14Mb) n/a 
     
APOA1 Homo sapiens ENSG00000118137 chr. 11 (REV, 116.21Mb) n/a 
 Danio rerio ENSDARG00000012076 chr. 5 (REV, 38.04Mb) n/a 
 Gallus gallus ENSGALG00000007114 chr. 24 (REV, 4.79-4.80Mb) n/a 
 
All genes and proteins are identified by Ensembl accession numbers, except for cloned zebrafish 
beta subunit protein sequences (which begin with ABF and represent accession numbers 
assigned by GenBank). * = unmapped scaffolds in Ensembl database. FWD = forward and REV 
= reverse and refers to gene orientation. n/a = not applicable (e.g. proteins for this species were 
not included in phylogenetic analysis). 
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CHAPTER V 
 
A DISCUSSION OF FUTURE STUDIES 
 
Introduction 
By initiating action potentials in excitable tissues, voltage-gated sodium channels underlie 
each human thought, movement, and heartbeat.  In vitro and in vivo models have recently begun 
to divulge how perturbations of the expression or function of sodium channels within single cells 
may underlie paroxysmal disorders of excitability including epilepsy, myotonia, and arrhythmia 
(257).  However, our nascent understanding of the functional importance of voltage-gated sodium 
channels is continually challenged by evidence that implicates these proteins in the genesis of 
multiple unexpected phenotypes.  In the adult heart, recent reports suggest that that mutations in 
the cardiac sodium channel gene SCN5A underlie a form of structural heart disease known as 
dilated cardiomyopathy (275;359;418;419).  In a deceased child who was heterozygous for 2 
distinct SCN5A mutations, post-mortem analysis of the myocardium revealed dilated 
cardiomyopathy accompanied by myocardial fibrosis and severe degenerative changes of the 
conduction system (420).  In a study of 18 patients with the Brugada syndrome, myocardial tissue 
of carriers of SCN5A mutations displayed cellular hypertrophy and degenerative changes 
including fibrofatty infiltration, vacuolization, and apoptosis, as revealed by biventricular 
endomyocardial biopsy (421).  Similarly, evaluation of the explanted heart of a patient with the 
Brugada syndrome demonstrated hypertrophy, fibrosis and fatty infiltration of the right ventricular 
myocardium (422).  In an emerging story, cardiac sodium channel mutations have been linked to 
a second form of cardiomyopathy known as left ventricular non-compaction, a disease of the 
myocardium that is thought to result from an arrest of myocardial development in utero (272;423).   
Mouse models of scn5a loss of function also display structural myocardial defects.  Mice 
heterozygous for scn5a (+/-), which are considered a model for Lenègre Disease (progressive 
cardiac conduction disorder), developed significant age-related myocardial fibrosis accompanied 
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by disorganized expression of gap junction proteins, elevated expression of the hypertrophic 
markers β-myosin heavy and skeletal α-actin, and upregulation of the transcription factors Atf3 
and Egr1 (424-426).  Mice overexpressing the transcriptional repressor Snail under the control of 
the MHC-α gene promoter (active shortly after birth) developed dilated cardiomyopathy that was 
strongly correlated with decreased sodium channel expression and function (427).  Finally, of 
particular interest to us, mice homozygous null for scn5a (-/-) were found to be embryo-lethal on 
E10 with severe defects in ventricular morphogenesis.   
The mechanisms underlying these structural myocardial phenotypes are not well 
understood and are likely to be complex.  Royer et al. hypothesized that the structural 
abnormalities observed in scn5a+/- mice resulted from the protracted effects of decreased sodium 
current and asynchronous ventricular excitation, which may have altered cardiac load and 
induced myocardial remodeling (424).  McNair et al. argued that sodium channel-associated 
dilated cardiomyopathy may have resulted from changes in ion homeostasis (359).  Both Olson et 
al. and Frustaci et al. elaborated on this concept, suggesting that SCN5A mutations may perturb 
intracellular sodium homeostasis, which in turn could trigger increased activity of membrane 
transporters such as the  Na+-Ca2+ exchanger and Na+-H+ exchanger, whose function depends 
on sodium gradients (421;428).  In the long-term, altered function of such transporters could lead 
to deleterious changes in intracellular calcium levels and pH.  Having observed an increased level 
of apoptosis in the hearts of 4 patients with SCN5A-associated Brugada syndrome, Frustaci et al. 
additionally hypothesized that cardiac structural abnormalities may have resulted from a 
previously-undefined role for sodium current in myocyte viability (421).  Although compelling, 
support for any of these models has been hampered by a lack of direct, empirical evidence from 
animal models or in vitro cellular assays.  Moreover, it remains to be explained in each model 
why patients with certain loss-of-function sodium channel mutations display only perturbations of 
heart rhythm, whereas patients with other mutations predicted to similarly compromise sodium 
channel function additionally develop structural abnormalities of the myocardium.   
Given the results of our recent studies and evidence from the literature, perturbations of 
electrical activation or ion homeostasis also do not readily explain the impressive role of scn5a in 
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murine cardiac morphogenesis.  Cultured myocytes isolated from E11-E13 mouse hearts 
displayed only small sodium currents, and in a pattern that was inconsistent with sodium 
channels being the primary mechanism of depolarization in the early mammalian heart (309).  
Similarly, studies conducted over two decades ago using chick embryos demonstrated that early 
action potentials were insensitive to high concentrations of tetrodotoxin and thus unlikely to be 
mediated by voltage-gated sodium channels (286;314).  In zebrafish, we found no role for 
voltage-gated sodium channels in cardiac rhythm until between days 4 and 5, well after the 
cardiac chambers had formed and looped (Chapter 3).  Moreover, our data suggested that 
cardiac-type sodium channels can function via a non-electrogenic mechanism to regulate the 
patterning of early cardiogenic mesoderm (Chapter 3).  Finally, a child who was compound 
heterozygous for mutations in SCN5A that were predicted to reduce sodium current by 90-95% 
died at 1 year of age but did not display congenital defects in cardiac chamber formation (420). 
In light of these findings, it is notable that a significant literature has emerged regarding 
the voltage-gated sodium channel “complex” that may guide future investigation into the proposed 
non-electrogenic roles of these proteins in development.  It is increasingly well-appreciated that 
sodium channel pore-forming α subunits do not exist alone at the membrane but recruit a number 
of functionally diverse proteins (429).  The canonical ancillary components of this complex are 
termed β subunits (SCN1B-4B) and are small, single membrane-spanning proteins with 
extracellular immunoglobulin domains and short intracellular C-terminal tails (5;8;143;430).  In 
addition to their well-known effects modulating the expression and function of pore-forming α 
subunits, β subunits have been shown to act as bidirectional signaling molecules at the 
membrane.  The β subunit IG domain, for example, can act as a cell-adhesion molecule by 
mediating interactions between the sodium channel complex and proteins in the extracellular 
matrix (345;346;348;349;431).  Intracellularly, the β subunit C-terminal tail has been shown to 
interact with the cytoskeletal protein ankyrin (348;349). In addition to β subunits, more recent 
studies indicate that cardiac-type sodium channels also interact with a functionally-diverse array 
of additional proteins including 14-3-3, Nedd-4 type ubiquitinases, calmodulin, ankyrin G, 
syntrophins, and fibroblast growth factor homologous factors, among others 
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(235;236;241;243;432-435).  Many of these interactions are mediated by discreet domains within 
the sodium channel protein.  With some minor exceptions, however, studies investigating the 
roles of sodium channel-interacting proteins have focused exclusively on the ability to modulate 
sodium current conveyed by the pore forming α subunits.  The idea that the pore-forming α 
subunit itself could act as a scaffold that facilitates the non-electrogenic functions of channel-
associated proteins has never been formally tested.  Given the demonstrated interaction of 
sodium channels with both ankyrin and components of the dystrophin complex, for example, it is 
notable that a phenotype recently associated with SCN5A mutations (heritable dilated 
cardiomyopathy) has most often been previously linked to mutations in the genes encoding 
components of the sarcomere or cytoskeleton (235;243;423).  It is unknown whether interactions 
with large membrane proteins such as voltage-gated sodium channels are important to the 
normal function and/or localization of structural components of myocytes, but such studies could 
be readily performed mice that lack one or more alleles of scn5a. 
It is also worth considering that particular regions of the voltage-gated sodium channel α 
subunit may act as signaling molecules independent of the channel protein.  The remarkable 
recent observation that the C-terminus of the L-type calcium channel is cleaved from the α 
subunit and subsequently travels to the nucleus to act as a transcriptional regulator lends further 
support to the concept that ion channel proteins may act via unanticipated, non-electrogenic 
mechanisms (337).  The close phylogenetic relationship between voltage-gated ion channels that 
convey sodium and calcium suggest an additional avenue for investigation into the mechanisms 
by which Nav1.5 regulates cardiac development. 
Future studies may test the hypothesis that voltage-gated sodium channels can 
influence both cardiac form and function by mechanisms that are independent of their role 
in generating action potentials.  Our studies in zebrafish were the first to explicitly uncouple 
sodium channel-mediated excitability from the expression of sodium channel protein and therein 
identified a putative non-electrogenic role for a Nav1 voltage-gated sodium channel in 
development.  Like mice, fish with reduced sodium channel expression developed significant 
defects in cardiac morphogenesis that are associated with a reduced number of embryonic 
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myocytes.  Our results indicated that these defects are likely to have arisen from changes in the 
expression of early cardiogenic transcription factors that are required for the production of 
appropriate numbers of cardiac progenitor cells.  The absence of early expression of nkx2.5 in 
sodium channel morphant zebrafish is not only of biological and developmental interest, but 
represents a discreet phenotype that can be now be exploited in vivo to test particular 
mechanistic hypotheses regarding the non-electrogenic functions of voltage-gated sodium 
channels.  Future studies may thus be performed to clarify the role of cardiac-type sodium 
channels in early development and to identify putative non-electrogenic mechanisms that govern 
this role.  These endeavors would be motivated by the following 2 key questions: 
1. Which signaling pathways underlying cardiac lineage specification are regulated 
by cardiac-type voltage-gated sodium channels? 
2. By what structural and/or functional mechanisms do sodium channels act to 
influence development? 
As described below in the following 4 proposed future studies, both animal models (zebrafish, 
mice) as well as in vitro approaches may be employed to investigate these questions. 
 
Future Study I 
To identify the pro-cardiogenic signaling pathways perturbed by reduced sodium 
channel expression in the gastrulating zebrafish embryo.  Recent fate mapping studies in 
zebrafish have revealed that presumptive cardiac progenitor cells are organized at the margin of 
the blastula between 60º and 140º bilaterally from the dorsal aspect (279).  During gastrulation, 
these cells involute and subsequently begin to express markers of the cardiac lineage including 
the homeobox transcription factors nkx2.7 (1 somite) and nkx2.5 (6 somites) in bilateral stripes of 
anterior lateral mesoderm (291;436).  The loss of expression of nkx2.5 at 6 somites following 
knockdown of zNav1.5a or zNav1.5b suggested the disruption of critical molecular mechanisms 
that normally act to specify the cardiac cell fate during gastrulation.  In zebrafish, a number of 
conserved molecules are required for cardiac fate specification including components of the bone 
morphogenetic protein (BMP), TGF-β/nodal, Wnt/β-catenin, retinoic acid, and fibroblast growth 
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factor (FGF) signaling pathways (290;300;437-441).  We hypothesize that one or more of these 
pathways are disrupted by reduced cardiac-type sodium channel expression in the gastrulating 
embryo. 
The proposed hypothesis may be tested using whole-mount in situ hybridization, 
transcriptional profiling, and analysis of epistasis in embryos with reduced expression of cardiac-
type sodium channels.  By conventional RT-PCR, we found that transcripts of both zscn5Laa and 
zscn5Lab are expressed during gastrulation.  As morpholino antisense oligonucleotides directed 
against zscn5Laa more consistently induced defects in the expression of nkx2.5, studies of this 
gene may be pursued in greater detail.  First, it is important to determine whether the loss of 
nkx2.5 can alone sufficiently account for the defects in cardiac morphogenesis and reduced 
myocyte number.  Although loss of expression of nkx2.5 in Drosophila leads to complete absence 
of a contractile dorsal vessel, nkx2.5 does not act alone to specify the cardiac cell fate in murine 
embryos (442;443).  These data indicate that unlike invertebrates, vertebrates are likely to have 
evolved additional genes that act in concert to specify the cardiac cell fate.  To determine whether 
the loss of nkx2.5 expression alone is sufficient to account for the cardiac development defects 
observed in zscn5Laa morphants, wild-type nkx2.5 may be overexpressed in the morphant 
background to look for rescue of heart tube morphogenesis and embryonic heart cell number in 
transgenic cmlc2:GFP and cmlc2:dsRed-nuclear embryos.  
Second, it is important to identify additional pro-cardiogenic signals that are adversely 
affected by the loss of cardiac-type voltage-gated sodium channel expression.  Initially, a 
candidate gene approach and whole mount in situ hybridization may be used to assay for 
changes in the expression of known genes that contribute to cardiac fate specification in 
zebrafish including BMP2b, Fgf8, and Oep (300;437;438;440;444).  A more unbiased, genome-
wide approach using microarray technology may also be employed to identify other signaling 
pathways that are disrupted by reduced sodium channel expression (445-447).  Zebrafish gene-
chips may be used to assay for significant changes in gene expression that occur in the late 
blastula (40% epiboly) and during gastrulation (90% epiboly) following injection of active or 
control morpholinos directed against transcripts encoding zNav1.5La.  Quantitative real-time PCR 
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and/or in situ hybridization may be used to confirm changes in the expression specific genes of 
interest that show the greatest changes in expression.  These studies are directed at identifying 
known or previously unappreciated factors that contribute to early cardiogenesis in zebrafish, and 
the signaling pathways by which zscn5Laa influences cardiogenesis. 
Finally, epistatic interactions between early cardiogenic-promoting pathways may be 
studied to clarify where the sodium channel acts within the hierarchy of signaling events that 
contribute to cardiac lineage specification in zebrafish.  Prior gain/loss of function studies in 
zebrafish demonstrated that gata5 is a potent positive regulator of nkx2.5 expression, potentially 
analogous to the role played by gata4 or gata6 in mammals (299;448-450).  Moreover, significant 
defects in the expression of gata5 were observed in embryos harboring mutations in components 
of the BMP and TGF-β/Nodal signaling pathways that result in a loss of early expression of 
nkx2.5 (299).  Despite the evidence supporting a gata5-nkx2.5 signaling axis for cardiogenesis, 
our results demonstrated that zscn5Laa regulates nkx2.5 expression without affecting levels of 
gata5, analogous to fgf8 signaling (300;440).  These findings suggest that zscn5Laa acts 
downstream of gata5 or fgf8, or in a parallel, previously-undefined pathway to regulate 
cardiogenesis.  To distinguish between these possibilities, zscn5Laa’s position relative to gata5 in 
cardiogenesis may be assessed by both overexpression and knockdown of gata5 and fgf8, 
followed by direct measurement of transcript levels of zscn5Laa by real-time, quantitative PCR.   
Although retinoic acid (RA, vitamin A) signaling plays multiple, time-dependent roles in 
heart development, it was recently demonstrated that RA signaling normally restricts the number 
of cells that adopt the cardiac cell fate during gastrulation (439;451).  Attenuation of RA signaling 
by mutation of an enzyme in the RA synthesis pathway (neckless) or by pharmacological 
treatment with RA receptor antagonists expanded the field of cells expressing nkx2.5 at 6 somites 
via mechanisms that independently required intact gata5 and fgf8 signals (439).  The neckless 
mutant and pharmacological tools may be employed to investigate the hypothesis that zscn5Laa 
regulates nkx2.5 by a previously undefined pathway.  If inhibition of RA signaling rescues the 
early expression of nkx2.5 in zscn5Laa morphants, for example, these data will provide further 
evidence that gata5 and fgf8 pathways are both intact despite the loss of zscn5Laa.  If inhibition 
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of RA signaling cannot rescue nkx2.5 expression in zscn5Laa morphants, however, this would 
suggest that RA acid either signals through zscn5aa or that zscn5aa is an integral component of 
gata5 or fgf8 signaling pathways.  Such findings would be interpreted within the context of in vivo 
data addressing the regulation of zscn5Laa expression by gata5 and fgf8, as described above.  
Finally, recent findings regarding the role of Wnt/β-catenin signals during cardiogenesis 
may be exploited to determine the potential interaction of zscn5Laa with this pathway.  A number 
of studies have suggested that similar to RA signaling, Wnt signals play both supportive and 
antagonistic roles in cardiogenesis depending on the timing of the signal (441;452-455).  In 
zebrafish, inhibition of Wnt signals at the onset of gastrulation (6hpf) by conditional 
overexpression of an inhibitor of canonical Wnt signaling (Dickkopf-1, Dkk-1) resulted in a 
dramatic expansion of the field of cells that express nkx2.5 at 6 somites (441).  We will use a 
transgenic line of zebrafish that expresses Dkk-1 under the control of heat shock promoter 
(hsDkk1:GFP) to determine whether inhibition of canonical Wnt signaling during gastrulation can 
rescue expression of nkx2.5 in zscn5Laa morphants (441;456).  This study will provide insight 
into whether zscn5Laa is downstream or parallel to Wnt signaling pathways during cardiac 
lineage specification. 
 
Future Study II 
To test the hypothesis that the zebrafish Nav1.5La channel regulates the 
expression of early cardiogenic signaling pathways via a non-electrogenic, structural 
mechanism.  Our preliminary data using multiple morpholino antisense oligonucleotides in 
zebrafish suggests that the channel Nav1.5La is required for normal expression of the early 
cardiogenic transcription factor nkx2.5 following gastrulation and thus for the production of normal 
numbers of cardiac progenitor cells.  Since prolonged exposure of early embryos to a number of 
mechanistically-distinct modulators of known sodium channel function failed to reproduce the 
profound developmental phenotype resulting from channel knockdown, we hypothesize that 
Nav1.5La acts via a previously undefined, non-electrogenic mechanism to regulate cardiac 
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development.  An important corollary of this hypothesis is that specific domains of the Nav1.5La 
protein are required for early heart development.  
In vivo mRNA rescue and detailed structure-function analysis are two effective methods 
for directly testing mechanisms of non-electrogenic sodium channel function.  These methods 
would first require the assembly of a full-length expression vector for the zebrafish Nav1.5La 
(zscn5Laa) channel and characterization of its biophysical properties in mammalian cells, as we 
have successfully performed for Nav1.5Lb (scn5Lab).  Given the provocative preliminary findings 
regarding the role of this channel in early development, the key question driving this effort will be 
whether Nav1.5La is capable of acting as a typical sodium channel or has evolved entirely novel 
functions (e.g. analogous to the gene product of SCN7A/scn6a, which encodes the atypical 
sodium channel Nax in humans and mice, respectively).  We have recently independently cloned 
and sequenced zebrafish scn5Laa and our detailed analysis of the deduced amino acid sequence 
of this channel suggests it will function as a typical Nav1 channel.  For example, zNav1.5La 
displays conservation of residues in many of the important structural determinants of voltage-
gated sodium channel function including the S4 voltage sensors, pore loop selectivity filters, the 
inactivation gate, and C-terminus.  In addition to assessing the function of the scn5Laa gene 
product, successful functional expression of an epitope-tagged channel in CHO or other 
mammalian cells may provide a convenient in vitro assay for testing the effects of various 
mutations on the function and expression of this channel, as discussed below. 
  Following the assembly and functional expression of zNav1.5La, zscn5Laa mRNA may 
be synthesized from our full-length construct for attempted rescue of the early expression of 
nkx2.5, which is significantly diminished in morphant embryos by both in situ hybridization and 
quantitative PCR.  As the sodium channel is encoded by a long mRNA (>6kb), this experiment 
will be performed with epitope-tagged channels to ensure that translation is successful in vivo.  If 
co-injection of wild-type zscn5Laa mRNA and splice-site directed morpholino antisense 
oligonucleotides results in normalization of the early expression of nkx2.5, a valuable in vivo 
experimental platform will have been established for structure-function analysis of zNav1.5La in 
the developing zebrafish embryo.   
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Initial experiments in this system may be directed towards further tests of the hypothesis 
that zNav1.5A acts in a non-electrogenic manner to regulate early cardiogenic pathways.  To 
accomplish this, mutations may be engineered based on the rich database of information 
previously assembled from studies of human patients with mutations in SCN5A and from 
structure-function studies of mammalian sodium channels by site-directed mutagenesis.  Based 
on the literature, we predict that single mutations in the zebrafish scn5Laa cDNA may result in a 
loss of sodium conductance without changes in the functional expression of the channel at the 
membrane (457).  Conversely, other mutations may be identified that perturb channel inactivation 
and result in persistent sodium current.  Mutations in the regions of SCN5A encoding the 
inactivation gate (DIII-IV linker) or an acidic region of the proximal C-terminus, for example, have 
already been shown to underlie the long QT syndrome, type 3, by encoding for channels that do 
not properly close during repolarization (458-460). The biophysical effects of both “loss of 
function” and “gain of function” mutations in the zebrafish Nav1.5a channel may first be studied in 
CHO cells, prior to overexpression of mutant scn5Laa mRNAs in vivo in zebrafish embryos for 
assessment of phenotype rescue. 
Using similar strategies of site-directed mutagenesis, in vitro analysis, and in vivo 
phenotype rescue, subsequent experiments may address additional questions regarding the 
putative structural requirements for the zNav1.5a in early cardiac development. For example, our 
system may enable one to test whether expression of zNav1.5a at the cell-surface is required for 
development, or whether the channel acts intracellularly as was recently reported in 
macrophages (353).  Guidance for engineering mutant channels with these properties may be 
found in the literature describing SCN5A mutations that underlie the Brugada syndrome, as the 
trafficking of Nav1.5 to the cell surface may be affected in this disease (461-464).  Moreover, as 
detailed in Chapter 2, a number of demonstrated sites of functional protein-protein interactions 
have been observed in mammalian cardiac sodium channels, including domains required for 
interaction with ankyrins, calmodulin, 14-3-3 proteins, protein ubiquitinases, syntrophins, and 
fibroblast growth factor homologous factors (141;236;243;360).  As prior studies have focused 
primarily on assaying sodium current through Nav1.5, it may now be of interest to test whether 
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sites of protein-protein interaction in the sodium channel protein are required for non-electrogenic 
functions (e.g. cardiac development). 
The C-terminus of the cardiac sodium channel is of interest because of two predicted 
Ca2+ binding EF hand structures (242;465).  Moreover, a close phylogenetic relative of Nav1 
channels, the L-type calcium channel, was recently demonstrated to have a C-terminus that is 
cleaved and acts as a transcription factor in a manner regulated by calcium (337).  Although it is 
unknown whether the C-terminus of Nav1 sodium channels is similarly cleaved or has function 
independent of the main channel protein, identification and mutation of conserved protease 
cleavage sites may also be readily tested in rescue experiments. 
 
Future Study III 
To test the hypothesis that the function of voltage-gated sodium channels in early 
cardiogenesis is mediated by one or more associated components in a channel complex.  
This study would more directly assess the role of known sodium channel-interacting proteins in 
early cardiac development, with an emphasis on those proteins that interact with sodium channel 
α subunits indirectly or by less discreet functional domains.  Previously unappreciated proteins 
that function in this context may also be identified.  At the outset of these studies, it would be 
important to determine whether sodium channel accessory β subunits, significant for extracellular 
immunoglobulin domains that mediate cell-adhesion, are requisite components of a sodium 
channel complex that functions in early zebrafish cardiogenesis.  Additional studies may employ 
mass spectrometry-based technique termed “direct analysis of large protein complexes” (DALPC) 
to characterize the complex of proteins associating with the sodium channel α subunit by 
immunoprecipitation of an epitope-tagged zNav1.5a channel expressed from sense RNA in the 
zebrafish embryo.  To identify sodium channel partners that may be required for early 
cardiogenesis, proteins associated with the channel in the gastrulating embryo may be directly 
compared to those associating with the channel in the embryonic heart. 
Unlike the accessory subunits of other ion channel complexes, sodium channel β 
subunits possess extracellular IG domains that enable them to interact with each other, 
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extracellular matrix proteins, and other proteins that mediate cell adhesion (162).  Although the 
role sodium channel of β subunits in cardiogenesis is unknown, a number of other cell adhesion 
molecules including N-cadherin, neural cell adhesion molecule (NCAM), fibronectin, tenascin, and 
fas (Drosophila) are all expressed in developing heart structures and/or have been shown to be 
required for normal cardiogenesis (350;466-470).  Among these proteins, the vast majority of 
available evidence supports a role for N-cadherin in heart development (468).  In the chick 
embryo, antibodies interfering with N-cadherin function disrupted early heart development in vivo 
and blocked the differentiation of presumptive cardiomyocytes in vitro (350;351;467).  In zebrafish, 
N-cadherin is expressed in the developing heart and its loss of function by morpholino antisense 
or mutation, respectively, resulted in defects in cardiac morphogenesis (471).  In mice, 
expression of N-cadherin was observed in early mesoderm, in precardiac mesoderm, and in the 
heart tube between E7.5 and E9.0 (352).  Mice lacking N-cadherin died on E10 with significant 
defects in cardiac morphogenesis, among other tissues (352).  We hypothesize that in early 
cardiac development, sodium channel complexes comprised of α and β subunits may play similar 
roles in cell-adhesion. 
To test this hypothesis, the expression and function of β subunits may be studied in early 
zebrafish embryos.  Prior studies have established that sodium channel β subunits interact 
homophilically via their extracellular IG domains, and subsequently recruit ankyrin to points of 
cell-cell contact via their short cytoplasmic domains (349).  Other studies have demonstrated that 
β subunits also interact heterophilically with proteins in the extracellular matrix including tenascin-
C and tenascin-R, as well as with other cell adhesion molecules including neurofascin, contactin, 
and NrCAM (346;349;431;472-474).  Moreover, the phosphorylated β1 subunit was shown to 
directly interact with N-cadherin, even in the absence of sodium channel α subunits (475).  Our 
previous studies indicate that zebrafish possess five distinct β subunit genes that represent single 
orthologs to mammalian β1- β3 and duplicate genes of β4 (476).  RT-PCR may be used to 
determine which, if any, of the zebrafish sodium channel beta subunits are expressed during 
gastrulation and in early somitogenesis, prior to the onset of expression of nkx2.5 at 6 somites.  
Those β subunit genes demonstrating early expression by RT-PCR may be further studied by in 
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situ hybridization, and the relevant genes subsequently knocked down using alone or in 
combination with morpholino antisense oligonucleotides directed against both translation initiation 
sites of mRNAs and intron-exon splice junctions of pre-mRNAs.  Effects on heart development 
may be assayed in cmlc2:GFP transgenic embryos on days 2 and 3.  Expression of nkx2.5 may 
be assayed by in situ hybridization at 6 somites and cmlc2 may be assayed at 16 somites to 
determine the effects of loss of beta subunit function on the specification and differentiation of 
cardiac progenitor cells, respectively.  For those β subunits whose loss of function results in a 
developmental phenotype, rescue experiments may be performed by co-injecting splice site-
directed morpholinos with sense RNA.  To determine whether the extracellular IG domain or the 
intracellular C-terminus is required for the observed phenotype, experiments may be repeated 
with sense RNA harboring mutations in either of those regions.  
 To identify novel channel partners in cardiogenesis, sense RNA encoding an epitope-
tagged zNav1.5a may be injected into zebrafish embryos followed by immunoprecipitation of the 
channel protein complex.  If this experiment is performed during gastrulation and again after the 
embryonic heart has formed, the DALPC application of mass spectrometry may be employed to 
characterize the identity of proteins associating zNav1.5a at different developmental stages (477-
480).  Proteins that are differentially associated with the sodium channel in the gastrulating 
embryo versus the embryonic heart may represent novel sodium channel partners required for 
early cardiogenesis. 
 
Future Study IV 
To investigate the expression and function of scn5a in the developing mouse heart.  
In this study, our findings in zebrafish may be pursued in greater detail within the context of a 
mammalian model system.  In five parts, a detailed investigation may be performed into the role 
of scn5a in murine heart development.  Although scn5a-/- mice displayed defects in cardiac 
morphogenesis and are embryo-lethal at E10, the expression pattern of scn5a during early 
development has not previously been investigated.  To address this question, our laboratory has 
knocked-in a bicistronic lacZ-GFP cassette into exon 2 of scn5a such that both markers will be 
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expressed by native regulatory elements within the murine sodium channel locus.  Second, the 
time course and etiology of cardiac defects resulting from the loss of scn5a expression may be 
characterized by performing anatomical and histological studies of the developing heart between 
E7.5 and E11 in homozygous scn5a lacZ-GFP (scn5a-/-) mice.  Third, flow cytometry and 
microarray technology may be used to compare the gene expression profiles of GFP+ cells 
isolated from both homozygous and heterozygous scn5a lacZ-GFP mice (scn5a-/- and scn5a+/-), 
in order to identify early cardiogenic signaling pathways that are autonomously disrupted in early 
murine cardiac progenitor cells that lack scn5a.  Fourth, in order to clarify whether the 
morphogenesis defects and early lethality of scn5a-/- mice are likely to have resulted from 
perturbed excitability or other, non-electrogenic mechanisms, action potentials may be recorded 
from the ventricular chamber of wild-type mice from E9-E12 to determine the precise timepoint at 
which sodium channels become required for cardiac excitability.  Finally, one may examine the 
morphogenesis of the developing heart in homozygous scn5a ∆KPQ transgenic mice, which were 
reported to be embryo-lethal at E10.5 by unexplained mechanisms.   
The propsed studies are made feasible by the successful application of Cre-
Recombinase-Mediated Cassette Exchange (RMCE) technology to engineer murine ES cells with 
a bicistronic lacZ-GFP cassette in place of exon 2 in the murine scn5a locus (481). Exon 2 was 
targeted because it contains the translation initiation site and because prior targeting of this exon 
abolished sodium channel expression (482).  Using these engineered ES cells, transgenic mice 
may be generated where the expression of both lacZ and GFP will be driven by endogenous 
regulatory elements in the murine scn5a locus.  Since heterozygous (scn5a+/-) mice develop 
normally (482), scn5a+/- lacZ-GFP transgenic mice may first be used to characterize the 
expression of scn5a in embryonic mice by conventional lacZ staining at various developmental 
timepoints.  The expression of scn5a may first be examined in gastrulating mouse embryos, 
followed by a detailed examination of expression of this gene in the developing heart.  As the 
embryonic heart is derived from two distinct heart fields, scn5a expression may be examined in 
either the 1º or 2º heart field of the cardiac crescent between E7.5 and E7.75, and subsequently, 
in the developing heart tube at E8.25 and in the embryonic heart during looping and chamber 
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morphogenesis between E9.5 and E10.5 (287;289;483).  Our preliminary results from 
conventional RT-PCR analysis suggested that scn5a is expressed at least as early as E8.5 in the 
mouse embryo (Chapter 3).  Moreover, we detected transcripts of scn5a specifically in the 
developing atrial and ventricular myocardium, the forebrain, and somites between E9.5 and E10.5 
by isotopic in situ hybridization, suggesting a cell-autonomous role for scn5a in the developing 
heart (Chapter 3). 
 In order to study the time course and etiology of cardiac defects resulting from the 
complete loss of scn5a expression, heterozygote transgenic mice may be interbred to obtain 
homozygous scn5a lacZ-GFP (scn5a-/-) mice.  We predict that these mice will recapitulate the 
reported cardiac developmental phenotype observed in scn5a-/- mice, which would permit the 
detailed anatomical and histological studies of the developing heart between E7.75 and E12.  
These studies may be guided by the timing and localization of scn5a expression as revealed by 
approaches taken in the first part of this specific aim.  Next, cells may be isolated from early 
mouse hearts (E7.75-9.5) by digestion and FACS used to isolate pure populations of GFP+ 
cardiac progenitors and/or embryonic myocytes from both homozygous and heterozygous scn5a 
lacZ-GFP mice (scn5a-/- and scn5a+/-).  Using total RNA isolated from these two cell populations, 
microarray technology may be used to compare the gene expression profiles in developing cells 
that harbor 0 or 1 wild-type alleles of scn5a, in order to identify early cardiogenic signaling 
pathways that are autonomously disrupted in progenitor cells lacking Nav1.5.  As before, the 
developmental timepoint at which these studies are performed would be dictated by the cardiac 
expression of murine scn5a.  The value of utilizing transgenic mice, flow cytometry, and 
transcriptome analysis to identify pathways driving early cardiogenesis has recently been 
demonstrated (484;485).  In these studies, mice expressing GFP under the direction of a cardiac-
specific enhancer of the transcription factor nkx2.5 were successfully generated and used to 
profile the molecular program driving cardiogenesis at different stages of heart development 
(484;485).  
   Finally, the role of sodium channels in generating action potentials in the early murine 
heart may be studied in order to determine whether the defects in ventricular morphogenesis 
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observed in scn5a-/- mice are likely to be caused by perturbations of nascent excitability or by 
other mechanisms.  Although our findings in the zebrafish model strongly suggest that excitability 
(whether mediated by sodium or calcium channels) is not required for heart development, 
transgenic mice expressing two alleles of the long QT syndrome mutation ∆KPQ that cause 
persistent sodium current and action potential prolongation were reported to die at E10.5 of 
unknown causes (256).  To determine the cause of death in these mice, and to assess whether 
significant perturbations of sodium channel-mediated excitability result in defects in cardiac 
morphogenesis, scn5a ∆KPQ transgenic mice may be obtained from the Carmeliet lab for further 
study.  In order to clarify the role of sodium channels in mediating excitation in the developing 
mouse heart, action potentials may be recorded from the ventricular chamber of wild-type mice 
from E9-E14 to determine the precise timepoint at which sodium channels become required for 
cardiac excitation. 
 207
Additional projects 
1. Novel molecular basis for tetrodotoxin resistance in a zebrafish cardiac sodium channel.  
Prior to understanding the developmental regulation of sodium channels in the zebrafish heart, 
we hypothesized that the resistance of the early embryonic heart to high concentrations of TTX 
was due to the intrinsic resistance of the molecular target of the toxin.  Mammalian cardiac 
sodium channels, for example, are prototypical TTX “resistant” channels because they have 
evolved a single mutation in the domain I pore loop that confers resistance to the nanomolar 
quantities of TTX that readily block neuronal and skeletal muscle-type sodium channels (246).  
Although we discovered that sodium channels become necessary for zebrafish heart function 
between days 4 and 5 of development, we noted that micromolar not nanomolar doses of TTX 
were required to perturb cardiac function at these and subsequent timepoints up to day 7.  These 
data conflicted with our prior findings that adult zebrafish ventricular action potentials were readily 
suppressed by nanomolar concentrations of toxin, and suggested the differential expression of 
TTX-sensitive and TTX-resistant sodium channel isoforms in the adult versus larval heart.  
Surprisingly, a survey of the domain I pore loop sequences of all 8 zebrafish Nav1 channels 
predicted that all of these proteins are sensitive to nanomolar TTX.  However, we identified novel 
pore loop mutations in both domains I and IV of the sodium channel encoded by the gene 
zscn5Laa that were not found in any other zebrafish sodium channel gene.  We hypothesized that 
these mutations conferred the property of TTX-resistance upon this channel, thus providing a 
rational explanation for the observed TTX resistance of the larval heart (days 5-7).  The results of 
our experiments are described in the abstract below. 
Background: Tetrodotoxin (TTX) is a naturally-occurring poison that occludes the sodium 
channel pore and has been instrumental in the cloning, characterization, and classification of 
Nav1 voltage-gated sodium channels.  Unlike most sodium channels, the cardiac isoform Nav1.5 
(SCN5A) has evolved a cysteine substitution of an aromatic residue (Y or F) in a highly 
conserved domain I pore loop sequence that confers TTX-resistance (C373).  Two other TTX-
resistant sodium channel isoforms, Nav1.8 (SCN10A) and Nav1.9 (SCN11A), have evolved serine 
substitutions at analogous positions (S357 and S360, respectively), further supporting the 
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prevailing concept that this aromatic residue in the domain I pore loop is critical for TTX-channel 
interactions. 
Methods and Results: We have identified a novel molecular mechanism underlying TTX-
resistance in a zebrafish cardiac sodium channel. While 1µM TTX solution microinjected into the 
systemic circulation rapidly impaired mobility and responsiveness in >95% of day 7 larvae, no 
effect was observed on cardiac function (n=22). The resistance of the zebrafish heart to TTX was 
confirmed by pericardial delivery of 1µM TTX, which elicited arrhythmia in only 28% of larvae 
(n=25). The zebrafish genome encodes two SCN5A orthologs (scn5Laa, scn5Lab), both of which 
are expressed in the early heart. Unexpectedly, the cloned sequences of scn5Laa and scn5Lab 
each predict the canonical, domain I aromatic residue required for high-affinity TTX binding. 
However, alignment of the pore loop sequences of all 8 zebrafish sodium channels revealed 
novel substitutions in domains I (N378S) and IV (D1634N) of scn5Laa. Heterologous expression 
of the full-length scn5Lab cDNA in CHO cells produced typical sodium current that was highly 
sensitive to TTX (IC50 9.6nM, n=5 cells). Introduction of N378S and D1634N in scn5Lab by site-
directed mutagenesis resulted in a nearly 100-fold reduction in TTX sensitivity (IC50 910nM, n=5 
cells), conferring the property of TTX-resistance on a TTX-sensitive channel. 
Conclusions: Mammals and zebrafish have independently evolved TTX-resistant cardiac sodium 
channels through unique mutations. Our findings support a structural model of the sodium 
channel pore where residues in the domain IV pore loop may be required for high-affinity TTX 
blockade. 
 
2.  The role of calcium in embryonic heart development.  Calcium is a ubiquitous second 
messenger that regulates numerous processes ranging from the contraction of muscle to the 
release of synaptic vesicles.  Calcium signals also regulate gene expression in by modulating the 
function of key transcription factors.  In the developing zebrafish heart, nonsense mutation of the 
cardiac L-type calcium channel (cacna1c) in the island beat mutant resulted in atrial fibrillation 
and a silent, non-contractile ventricle that displayed severe defects in morphogenesis and 
reduced myocyte number.  Although these findings suggested that calcium cycling in the early 
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embryonic heart is required for both for development of cardiac form and function, prolonged 
treatment of embryos with the L-type calcium channel blocker nisoldipine produced neither atrial 
fibrillation nor ventricular hypoplasia.  Rather, incubation in this pharmacological agent resulted in 
embryonic hearts that never beat but appear to form normally through day 2.  The primary defect 
observed in nisoldipine-treated embryos was a significant decrease in the intensity of GFP 
expression, suggesting reduced activity at the cmlc2 promoter.  Analogous to our observations 
with sodium channels, these results suggest that L-type calcium channels may regulate cardiac 
development independent of their role in facilitate calcium entry into myocytes.  The recent report 
that the C-terminus of an L-type calcium channel isoform is cleaved in neurons and acts as a 
transcription factor provides an avenue for further study of these provocative findings (337). 
 
3.  The role of voltage-gated sodium channels in other mesoderm-derived tissues such as 
skeletal muscle.  Evidence from zebrafish and mice suggest that two isoforms of the voltage-
gated sodium channel (scn5a) and (scn4a) are expressed in developing skeletal muscle at 
different timepoints (209;486).  As delivery of high doses of TTX to the zebrafish embryo resulted 
in paralysis but not in defects of muscle development, we propose to knockdown both isoforms 
alone and in combination to determine whether sodium channel proteins but not excitability are 
required for the development of muscle.  Interestingly, the results of our transplantation 
experiments indicated that morphant mesodermal cells lacking scn5a infrequently produced 
cardiomyocytes but frequently produced skeletal myocytes, suggesting distinct early sodium 
channel signaling mechanisms for the development of heart and muscle (Chapter 3). 
 210
REFERENCES 
 
 (1)  Hille B. Ion channels of excitable membranes. 3rd ed. Sunderland, MA: Sinauer 
Associates, 2001. 
 (2)  Yu FH, Catterall WA. Overview of the voltage-gated sodium channel family. Genome Biol 
2003; 4(3):207. 
 (3)  Goldin AL. Resurgence of sodium channel research. Annu Rev Physiol 2001; 63:871-894. 
 (4)  Anderson PA, Greenberg RM. Phylogeny of ion channels: clues to structure and function. 
Comp Biochem Physiol B Biochem Mol Biol 2001; 129(1):17-28. 
 (5)  Hartshorne RP, Messner DJ, Coppersmith JC, Catterall WA. The saxitoxin receptor of the 
sodium channel from rat brain. Evidence for two nonidentical beta subunits. J Biol Chem 
1982; 257(23):13888-13891. 
 (6)  Barchi RL. Protein components of the purified sodium channel from rat skeletal muscle 
sarcolemma. J Neurochem 1983; 40(5):1377-1385. 
 (7)  Roberts RH, Barchi RL. The voltage-sensitive sodium channel from rabbit skeletal 
muscle. Chemical characterization of subunits. J Biol Chem 1987; 262(5):2298-2303. 
 (8)  Isom LL, De Jongh KS, Catterall WA. Auxiliary subunits of voltage-gated ion channels. 
Neuron 1994; 12(6):1183-1194. 
 (9)  Maier SK, Westenbroek RE, McCormick KA, Curtis R, Scheuer T, Catterall WA. Distinct 
subcellular localization of different sodium channel alpha and beta subunits in single 
ventricular myocytes from mouse heart. Circulation 2004; 109(11):1421-1427. 
 (10)  Isom LL, De Jongh KS, Patton DE et al. Primary structure and functional expression of 
the beta 1 subunit of the rat brain sodium channel. Science 1992; 256(5058):839-842. 
 (11)  Isom LL, Ragsdale DS, De Jongh KS et al. Structure and function of the beta 2 subunit of 
brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell 1995; 
83(3):433-442. 
 (12)  Morgan K, Stevens EB, Shah B et al. Beta 3: an additional auxiliary subunit of the 
voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. 
Proc Natl Acad Sci (USA) 2000; 97(5):2308-2313. 
 (13)  Yu FH, Westenbroek RE, Silos-Santiago I et al. Sodium channel beta4, a new disulfide-
linked auxiliary subunit with similarity to beta2. J Neurosci 2003; 23(20):7577-7585. 
 (14)  Isom LL, Catterall WA. Na+ channel subunits and Ig domains. Nature 1996; 
383(6598):307-308. 
 (15)  Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. 
Nomenclature and structure-function relationships of voltage-gated sodium channels. 
Pharmacol Rev 2005; 57(4):397-409. 
 211
 (16)  Goldin AL, Snutch T, Lubbert H et al. Messenger RNA coding for only the alpha subunit 
of the rat brain Na channel is sufficient for expression of functional channels in Xenopus 
oocytes. Proc Natl Acad Sci (USA) 1986; 83(19):7503-7507. 
 (17)  Chen C, Westenbroek RE, Xu X et al. Mice lacking sodium channel beta1 subunits 
display defects in neuronal excitability, sodium channel expression, and nodal 
architecture. J Neurosci 2004; 24(16):4030-4042. 
 (18)  Chen C, Bharucha V, Chen Y et al. Reduced sodium channel density, altered voltage 
dependence of inactivation, and increased susceptibility to seizures in mice lacking 
sodium channel beta 2-subunits. Proc Natl Acad Sci (USA) 2002; 99(26):17072-17077. 
 (19)  Meadows LS, Isom LL. Sodium channels as macromolecular complexes: implications for 
inherited arrhythmia syndromes. Cardiovasc Res 2005; 67(3):448-458. 
 (20)  Isom LL. Sodium channel beta subunits: anything but auxiliary. Neuroscientist 2001; 
7(1):42-54. 
 (21)  Seyfarth EA. Julius Bernstein (1839-1917): pioneer neurobiologist and biophysicist. Biol 
Cybern 2006; 94(1):2-8. 
 (22)  Schuetze S. The discovery of the action potential. Trends Neurosci 1983; 6:164-168. 
 (23)  Nilius B. Pflugers Archiv and the advent of modern electrophysiology. From the first 
action potential to patch clamp. Pflugers Arch 2003; 447(3):267-271. 
 (24)  Ringer S, Murrell W. The Action of Chloride of Potassium on the Nervous System of 
Frogs. J Anat Physiol 1877; Oct 12(Pt 1):54-57. 
 (25)  Ringer S, Morshead EA. The Influence on the Afferent Nerves of the Frog's Leg from the 
Local Application of the Chlorides, Bromides, and Iodides of Potassium, Ammonium, and 
Sodium. J Anat Physiol 1877; Oct 12(Pt 1):58-72. 
 (26)  Ringer S, Morshead EA. The Effect of the Chlorides, Bromides, and Iodides of Potassium 
and Sodium on Frogs. J Anat Physiol 1877; Oct 12(Pt 1):73-84. 
 (27)  Ringer S. Regarding the Action of Hydrate of Soda, Hydrate of Ammonia, and Hydrate of 
Potash on the Ventricle of the Frog's Heart. J Physiol 1882; Jan 3(3-4):195-202. 
 (28)  Ringer S. A further Contribution regarding the influence of the different Constituents of 
the Blood on the Contraction of the Heart. J Physiol 1883; Jan 4(1):29-42. 
 (29)  Ringer S. Concerning the Influence exerted by each of the Constituents of the Blood on 
the Contraction of the Ventricle. J Physiol 1882; Aug 3(5-6):380-393. 
 (30)  Ringer S. A third contribution regarding the Influence of the Inorganic Constituents of the 
Blood on the Ventricular Contraction. J Physiol 1883; Aug 4(2-3):222-225. 
 (31)  Bernstein J. Untersuchungen zur Thermodynamik der bioelektrischen Ströme. Pflugers 
Arch 1902; 92:521-562.  
 (32)  Seyfarth EAPL. A hundred years ago: Julius Bernstein (1839-1917) formulates his 
"membrane theory". Neuroforum 2002; 274-276.  
 212
 (33)  Hodgkin AL. Nobel Lectures, Physiology or Medicine 1963-1970. Amsterdam: Elsevier 
Publishing Company, 1972. 
 (34)  Huxley AF. Nobel Lectures, Physiology or Medicine 1963-1970. Amsterdam: Elsevier 
Publishing Company, 1972. 
 (35)  De WP. A century of thinking about cell membranes. Annu Rev Physiol 2000; 62:919-
26:919-926. 
 (36)  Neuroscience. second ed. Sunderland, MA: Sinauer Associates, Inc., 2001. 
 (37)  Keynes R. John Zachary Young (18 March 1907-4 July 1997). Proc Amer Philosoph Soc. 
1999;143[4]:728-732.  
 (38)  Hodgkin AL, Huxley AF. Action potentials recorded from inside a nerve fiber. Nature 1939; 
144:710-711.  
 (39)  Hodgkin AL, Huxley AF. Potassium leakage from an active nerve fibre. J Physiol 1947; 
106(3):341-367. 
 (40)  Hodgkin AL, KATZ B. The effect of sodium ions on the electrical activity of the giant axon 
of the squid. J Physiol 1949; 108(1):37-77. 
 (41)  Cole KS. Dynamic electrical characteristics of the squid axon membrane. Arch Sci 
Physiol. 1949; 3:253-258.  
 (42)  Marmont G. Studies on the axon membrane; a new method. J Cell Physiol 1949; 
34(3):351-382. 
 (43)  Hodgkin AL, Huxley AF. A quantitative description of membrane current and its 
application to conduction and excitation in nerve. J Physiol 1952; 117(4):500-544. 
 (44)  Neher E, Sakmann B. Single-channel currents recorded from membrane of denervated 
frog muscle fibres. Nature 1976; 260(5554):799-802. 
 (45)  Sigworth FJ, Neher E. Single Na+ channel currents observed in cultured rat muscle cells. 
Nature 1980; 287(5781):447-449. 
 (46)  Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp 
techniques for high-resolution current recording from cells and cell-free membrane 
patches. Pflugers Arch 1981; 391(2):85-100. 
 (47)  Ackerman MJ, Clapham DE. Ion channels--basic science and clinical disease. N Engl J 
Med 1997; 336(22):1575-1586. 
 (48)  Hodgkin AL, Huxley AF. The components of membrane conductance in the giant axon of 
Loligo. J Physiol 1952; 116(4):473-496. 
 (49)  Marban E, Yamagishi T, Tomaselli GF. Structure and function of voltage-gated sodium 
channels. J Physiol 1998; 508(Pt 3):647-657. 
 (50)  George AL, Jr. Inherited disorders of voltage-gated sodium channels. J Clin Invest 2005; 
115(8):1990-1999. 
 213
 (51)  Roden DM, Balser JR, George AL, Jr., Anderson ME. Cardiac ion channels. Annu Rev 
Physiol 2002; 64:431-75.:431-475. 
 (52)  Koopmann TT, Bezzina CR, Wilde AA. Voltage-gated sodium channels: action players 
with many faces. Ann Med 2006; 38(7):472-482. 
 (53)  Escayg A, MacDonald BT, Meisler MH et al. Mutations of SCN1A, encoding a neuronal 
sodium channel, in two families with GEFS+2. Nat Genet 2000; 24(4):343-345. 
 (54)  Sugawara T, Tsurubuchi Y, Agarwala KL et al. A missense mutation of the Na+ channel 
alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes 
channel dysfunction. Proc Natl Acad Sci (USA) 2001; 98(11):6384-6389. 
 (55)  Weiss LA, Escayg A, Kearney JA et al. Sodium channels SCN1A, SCN2A and SCN3A in 
familial autism. Mol Psychiatry 2003; 8(2):186-194. 
 (56)  Ptacek LJ, George AL, Jr., Griggs RC et al. Identification of a mutation in the gene 
causing hyperkalemic periodic paralysis. Cell 1991; 67(5):1021-1027. 
 (57)  Wang Q, Shen J, Splawski I et al. SCN5A mutations associated with an inherited cardiac 
arrhythmia, long QT syndrome. Cell 1995; 80(5):805-811. 
 (58)  Trudeau MM, Dalton JC, Day JW, Ranum LP, Meisler MH. Heterozygosity for a protein 
truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, 
and mental retardation. J Med Genet 2006; 43(6):527-530. 
 (59)  Yang Y, Wang Y, Li S et al. Mutations in SCN9A, encoding a sodium channel alpha 
subunit, in patients with primary erythermalgia. J Med Genet 2004; 41(3):171-174. 
 (60)  Lossin C, Wang DW, Rhodes TH, Vanoye CG, George AL, Jr. Molecular basis of an 
inherited epilepsy. Neuron 2002; 34(6):877-884. 
 (61)  Dichgans M, Freilinger T, Eckstein G et al. Mutation in the neuronal voltage-gated sodium 
channel SCN1A in familial hemiplegic migraine. Lancet 2005; 366(9483):371-377. 
 (62)  Claes L, Del-Favero J, Ceulemans B, Lagae L, Van BC, De JP. De novo mutations in the 
sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum 
Genet 2001; 68(6):1327-1332. 
 (63)  Sugawara T, Mazaki-Miyazaki E, Fukushima K et al. Frequent mutations of SCN1A in 
severe myoclonic epilepsy in infancy. Neurology 2002; 58(7):1122-1124. 
 (64)  Fujiwara T, Sugawara T, Mazaki-Miyazaki E et al. Mutations of sodium channel alpha 
subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized 
tonic-clonic seizures. Brain 2003; 126(Pt 3):531-546. 
 (65)  Mantegazza M, Gambardella A, Rusconi R et al. Identification of an Nav1.1 sodium 
channel (SCN1A) loss-of-function mutation associated with familial simple febrile 
seizures. Proc Natl Acad Sci (USA) 2005; 102(50):18177-18182. 
 (66)  Heron SE, Crossland KM, Andermann E et al. Sodium-channel defects in benign familial 
neonatal-infantile seizures. Lancet 2002; 360(9336):851-852. 
 (67)  Berkovic SF, Heron SE, Giordano L et al. Benign familial neonatal-infantile seizures: 
characterization of a new sodium channelopathy. Ann Neurol 2004; 55(4):550-557. 
 214
 (68)  Feero WG, Wang J, Barany F et al. Hyperkalemic periodic paralysis: rapid molecular 
diagnosis and relationship of genotype to phenotype in 12 families. Neurology 1993; 
43(4):668-673. 
 (69)  McClatchey AI, Van den BP, Pericak-Vance MA et al. Temperature-sensitive mutations in 
the III-IV cytoplasmic loop region of the skeletal muscle sodium channel gene in 
paramyotonia congenita. Cell 1992; 68(4):769-774. 
 (70)  McClatchey AI, Kenna-Yasek D, Cros D et al. Novel mutations in families with unusual 
and variable disorders of the skeletal muscle sodium channel. Nat Genet 1992; 2(2):148-
152. 
 (71)  Orrell RW, Jurkat-Rott K, Lehmann-Horn F, Lane RJ. Familial cramp due to potassium-
aggravated myotonia. J Neurol Neurosurg Psychiatry 1998; 65(4):569-572. 
 (72)  Bulman DE, Scoggan KA, van O et al. A novel sodium channel mutation in a family with 
hypokalemic periodic paralysis. Neurology 1999; 53(9):1932-1936. 
 (73)  Sokolov S, Scheuer T, Catterall WA. Gating pore current in an inherited ion 
channelopathy. Nature 2007; 446(7131):76-78. 
 (74)  Cox JJ, Reimann F, Nicholas AK et al. An SCN9A channelopathy causes congenital 
inability to experience pain. Nature 2006; 444(7121):894-898. 
 (75)  Fertleman CR, Baker MD, Parker KA et al. SCN9A mutations in paroxysmal extreme pain 
disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006; 
52(5):767-774. 
 (76)  Wallace RH, Wang DW, Singh R et al. Febrile seizures and generalized epilepsy 
associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet 
1998; 19(4):366-370. 
 (77)  Spampanato J, Kearney JA, de HG et al. A novel epilepsy mutation in the sodium 
channel SCN1A identifies a cytoplasmic domain for beta subunit interaction. J Neurosci 
2004; 24(44):10022-10034. 
 (78)  An RH, Wang XL, Kerem B et al. Novel LQT-3 mutation affects Na+ channel activity 
through interactions between alpha- and beta1-subunits. Circ Res 1998; 83(2):141-146. 
 (79)  Wan X, Wang Q, Kirsch GE. Functional suppression of sodium channels by beta(1)-
subunits as a molecular mechanism of idiopathic ventricular fibrillation. J Mol Cell Cardiol 
2000; 32(10):1873-1884. 
 (80)  Makita N, Shirai N, Wang DW et al. Cardiac Na(+) channel dysfunction in Brugada 
syndrome is aggravated by beta(1)-subunit. Circulation 2000; 101(1):54-60. 
 (81)  Medeiros-Domingo A, Kaku T, Tester DJ et al. SCN4B-Encoded Sodium Channel {beta}4 
Subunit in Congenital Long-QT Syndrome. Circulation 2007; 116:134-142. 
 (82)  Planells-Cases R, Caprini M, Zhang J et al. Neuronal death and perinatal lethality in 
voltage-gated sodium channel alpha(II)-deficient mice. Biophys J 2000; 78(6):2878-2891. 
 (83)  Watanabe E, Fujikawa A, Matsunaga H et al. Nav2/NaG channel is involved in control of 
salt-intake behavior in the CNS. J Neurosci 2000; 20(20):7743-7751. 
 215
 (84)  Burgess DL, Kohrman DC, Galt J et al. Mutation of a new sodium channel gene, Scn8a, 
in the mouse mutant 'motor endplate disease'. Nat Genet 1995; 10(4):461-465. 
 (85)  Buchner DA, Seburn KL, Frankel WN, Meisler MH. Three ENU-induced neurological 
mutations in the pore loop of sodium channel Scn8a (Na(v)1.6) and a genetically linked 
retinal mutation, rd13. Mamm Genome 2004; 15(5):344-351. 
 (86)  Nassar MA, Stirling LC, Forlani G et al. Nociceptor-specific gene deletion reveals a major 
role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci (USA) 2004; 
101(34):12706-12711. 
 (87)  Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel 
expressed by sensory neurons. Nature 1996; 379(6562):257-262. 
 (88)  Zimmermann K, Leffler A, Babes A et al. Sensory neuron sodium channel Nav1.8 is 
essential for pain at low temperatures. Nature 2007; 447(7146):855-858. 
 (89)  Roden DM, Balser JR, George AL, Jr., Anderson ME. Cardiac ion channels. Annu Rev 
Physiol 2002; 64:431-75.:431-475. 
 (90)  Marban E. Cardiac channelopathies. Nature 2002; 415(6868):213-218. 
 (91)  Wehrens XH, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. 
Annu Rev Physiol 2005; 67:69-98.:69-98. 
 (92)  Wehrens XH, Marks AR. Novel therapeutic approaches for heart failure by normalizing 
calcium cycling. Nat Rev Drug Discov 2004; 3(7):565-573. 
 (93)  Ter Keurs HE, Boyden PA. Calcium and arrhythmogenesis. Physiol Rev 2007; 87(2):457-
506. 
 (94)  Dulhunty AF. Excitation-contraction coupling from the 1950s into the new millennium. Clin 
Exp Pharmacol Physiol 2006; 33(9):763-772. 
 (95)  Wang Q, Li Z, Shen J, Keating MT. Genomic organization of the human SCN5A gene 
encoding the cardiac sodium channel. Genomics 1996; 34(1):9-16. 
 (96)  George AL, Jr., Varkony TA, Drabkin HA et al. Assignment of the human heart 
tetrodotoxin-resistant voltage-gated Na+ channel alpha-subunit gene (SCN5A) to band 
3p21. Cytogenet Cell Genet 1995; 68(1-2):67-70. 
 (97)  Plummer NW, Meisler MH. Evolution and diversity of mammalian sodium channel genes. 
Genomics 1999; 57(2):323-331. 
 (98)  Goldin AL. Evolution of voltage-gated Na(+) channels. J Exp Biol 2002; 205(Pt 5):575-
584. 
 (99)  Maier SK, Westenbroek RE, Schenkman KA, Feigl EO, Scheuer T, Catterall WA. An 
unexpected role for brain-type sodium channels in coupling of cell surface depolarization 
to contraction in the heart. Proc Natl Acad Sci (USA) 2002; 99(6):4073-4078. 
 (100)  Maier SK, Westenbroek RE, McCormick KA, Curtis R, Scheuer T, Catterall WA. Distinct 
subcellular localization of different sodium channel alpha and beta subunits in single 
ventricular myocytes from mouse heart. Circulation 2004; 109(11):1421-1427. 
 216
 (101)  Lei M, Jones SA, Liu J et al. Requirement of neuronal- and cardiac-type sodium channels 
for murine sinoatrial node pacemaking. J Physiol 2004; 559(Pt 3):835-848. 
 (102)  Maier SK, Westenbroek RE, Yamanushi TT et al. An unexpected requirement for brain-
type sodium channels for control of heart rate in the mouse sinoatrial node. Proc Natl 
Acad Sci (USA) 2003; 100(6):3507-3512. 
 (103)  Zimmer T, Bollensdorff C, Haufe V, Birch-Hirschfeld E, Benndorf K. Mouse heart Na+ 
channels: primary structure and function of two isoforms and alternatively spliced variants. 
Am J Physiol Heart Circ Physiol 2002; 282(3):H1007-H1017. 
 (104)  Pereon Y, Lande G, Demolombe S et al. Paramyotonia congenita with an SCN4A 
mutation affecting cardiac repolarization. Neurology 2003; 60(2):340-342. 
 (105)  George AL, Jr., Knittle TJ, Tamkun MM. Molecular cloning of an atypical voltage-gated 
sodium channel expressed in human heart and uterus: evidence for a distinct gene family. 
Proc Natl Acad Sci (USA) 1992; 89(11):4893-4897. 
 (106)  Felipe A, Knittle TJ, Doyle KL, Tamkun MM. Primary structure and differential expression 
during development and pregnancy of a novel voltage-gated sodium channel in the 
mouse. J Biol Chem 1994; 269(48):30125-30131. 
 (107)  Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98(21):2334-2351. 
 (108)  Vincent GM. The molecular genetics of the long QT syndrome: genes causing fainting 
and sudden death. Annu Rev Med 1998; 49:263-74.:263-274. 
 (109)  Roden DM, Anderson ME. Proarrhythmia. Handb Exp Pharmacol 2006;(171):73-97. 
 (110)  Priori SG, Barhanin J, Hauer RN et al. Genetic and molecular basis of cardiac 
arrhythmias; impact on clinical management. Study group on molecular basis of 
arrhythmias of the working group on arrhythmias of the european society of cardiology. 
Eur Heart J 1999; 20(3):174-195. 
 (111)  Kusmirek SL, Gold MR. Sudden cardiac death: the role of risk stratification. Am Heart J 
2007; 153(4 Suppl):25-33. 
 (112)  Anderson ME, Al-Khatib SM, Roden DM, Califf RM. Cardiac repolarization: current 
knowledge, critical gaps, and new approaches to drug development and patient 
management. Am Heart J 2002; 144(5):769-781. 
 (113)  Somberg JC. Arrhythmia therapy. Am J Ther 2002; 9(6):537-542. 
 (114)  Elming H, Brendorp B, Pehrson S, Pedersen OD, Kober L, Torp-Petersen C. A benefit-
risk assessment of class III antiarrhythmic agents. Expert Opin Drug Saf 2004; 3(6):559-
577. 
 (115)  Prystowsky EN. Primary and secondary prevention of sudden cardiac death: the role of 
the implantable cardioverter defibrillator. Rev Cardiovasc Med 2001; 2(4):197-205. 
 (116)  Grant AO. Molecular biology of sodium channels and their role in cardiac arrhythmias. 
Am J Med 2001; 110(4):296-305. 
 (117)  Viswanathan PC, Balser JR. Inherited sodium channelopathies: a continuum of channel 
dysfunction. Trends Cardiovasc Med 2004; 14(1):28-35. 
 217
 (118)  Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and 
sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A 
multicenter report. J Am Coll Cardiol 1992; 20(6):1391-1396. 
 (119)  Wang DW, Makita N, Kitabatake A, Balser JR, George AL, Jr. Enhanced Na(+) channel 
intermediate inactivation in Brugada syndrome. Circ Res 2000; 87(8):E37-E43. 
 (120)  Balser JR. Sodium "channelopathies" and sudden death: must you be so sensitive? Circ 
Res 1999; 85(9):872-874. 
 (121)  Valdivia CR, Tester DJ, Rok BA et al. A trafficking defective, Brugada syndrome-causing 
SCN5A mutation rescued by drugs. Cardiovasc Res 2004; 62(1):53-62. 
 (122)  Herfst LJ, Rook MB, Jongsma HJ. Trafficking and functional expression of cardiac Na+ 
channels. J Mol Cell Cardiol 2004; 36(2):185-193. 
 (123)  Moss AJ. Long QT Syndrome. JAMA 2003; 289(16):2041-2044. 
 (124)  Splawski I, Shen J, Timothy KW et al. Spectrum of mutations in long-QT syndrome genes. 
KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000; 102(10):1178-1185. 
 (125)  Roden DM. The problem, challenge and opportunity of genetic heterogeneity in 
monogenic diseases predisposing to sudden death. J Am Coll Cardiol 2002; 40(2):357-
359. 
 (126)  Mohler PJ, Schott JJ, Gramolini AO et al. Ankyrin-B mutation causes type 4 long-QT 
cardiac arrhythmia and sudden cardiac death. Nature 2003; 421(6923):634-639. 
 (127)  Vatta M, Ackerman MJ, Ye B et al. Mutant caveolin-3 induces persistent late sodium 
current and is associated with long-QT syndrome. Circulation 2006; 114(20):2104-2112. 
 (128)  Wang DW, Yazawa K, George AL, Jr., Bennett PB. Characterization of human cardiac 
Na+ channel mutations in the congenital long QT syndrome. Proc Natl Acad Sci (USA) 
1996; 93(23):13200-13205. 
 (129)  Keating MT. The long QT syndrome. A review of recent molecular genetic and 
physiologic discoveries. Medicine (Baltimore) 1996; 75(1):1-5. 
 (130)  Dumaine R, Wang Q, Keating MT et al. Multiple mechanisms of Na+ channel--linked 
long-QT syndrome. Circ Res 1996; 78(5):916-924. 
 (131)  Antzelevitch C, Brugada P, Brugada J et al. Brugada syndrome: a decade of progress. 
Circ Res 2002; 91(12):1114-1118. 
 (132)  Nuyens D, Stengl M, Dugarmaa S et al. Abrupt rate accelerations or premature beats 
cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 2001; 
7(9):1021-1027. 
 (133)  Papadatos GA, Wallerstein PM, Head CE et al. Slowed conduction and ventricular 
tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc 
Natl Acad Sci (USA) 2002; 99(9):6210-6215. 
 (134)  Lei M, Goddard C, Liu J et al. Sinus node dysfunction following targeted disruption of the 
murine cardiac sodium channel gene Scn5a. J Physiol 2005; 567(Pt 2):387-400. 
 218
 (135)  Echt DS, Liebson PR, Mitchell LB et al. Mortality and morbidity in patients receiving 
encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J 
Med 1991; 324(12):781-788. 
 (136)  Pu J, Balser JR, Boyden PA. Lidocaine action on Na+ currents in ventricular myocytes 
from the epicardial border zone of the infarcted heart. Circ Res 1998; 83(4):431-440. 
 (137)  Liu H, Tateyama M, Clancy CE, Abriel H, Kass RS. Channel openings are necessary but 
not sufficient for use-dependent block of cardiac Na(+) channels by flecainide: evidence 
from the analysis of disease-linked mutations. J Gen Physiol 2002; 120(1):39-51. 
 (138)  Balser JR. Inherited sodium channelopathies: novel therapeutic and proarrhythmic 
molecular mechanisms. Trends Cardiovasc Med 2001; 11(6):229-237. 
 (139)  Viswanathan PC, Bezzina CR, George AL, Jr., Roden DM, Wilde AA, Balser JR. Gating-
dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes. 
Circulation 2001; 104(10):1200-1205. 
 (140)  Shimizu W, Antzelevitch C, Suyama K et al. Effect of sodium channel blockers on ST 
segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J 
Cardiovasc Electrophysiol 2000; 11(12):1320-1329. 
 (141)  Abriel H, Kass RS. Regulation of the voltage-gated cardiac sodium channel Nav1.5 by 
interacting proteins. Trends Cardiovasc Med 2005; 15(1):35-40. 
 (142)  Hartshorne RP, Catterall WA. Purification of the saxitoxin receptor of the sodium channel 
from rat brain. Proc Natl Acad Sci (USA) 1981; 78(7):4620-4624. 
 (143)  Hartshorne RP, Catterall WA. The sodium channel from rat brain. Purification and subunit 
composition. J Biol Chem 1984; 259(3):1667-1675. 
 (144)  Hartshorne RP, Keller BU, Talvenheimo JA, Catterall WA, Montal M. Functional 
reconstitution of the purified brain sodium channel in planar lipid bilayers. Proc Natl Acad 
Sci (USA) 1985; 82(1):240-244. 
 (145)  Casadei JM, Gordon RD, Barchi RL. Immunoaffinity isolation of Na+ channels from rat 
skeletal muscle. Analysis of subunits. J Biol Chem 1986; 261(9):4318-4323. 
 (146)  Isom LL. Sodium channel beta subunits: anything but auxiliary. Neuroscientist 2001; 
7(1):42-54. 
 (147)  Medeiros-Domingo A, Kaku T, Tester DJ et al. SCN4B-Encoded Sodium Channel {beta}4 
Subunit in Congenital Long-QT Syndrome. Circulation 2007; 116:134-142. 
 (148)  Scheffer IE, Harkin LA, Grinton BE et al. Temporal lobe epilepsy and GEFS+ phenotypes 
associated with SCN1B mutations. Brain 2007; 130(Pt.1):100-109. 
 (149)  Audenaert D, Claes L, Ceulemans B, Lofgren A, Van BC, De JP. A deletion in SCN1B is 
associated with febrile seizures and early-onset absence epilepsy. Neurology 2003; 
61(6):854-856. 
 (150)  Wallace RH, Scheffer IE, Parasivam G et al. Generalized epilepsy with febrile seizures 
plus: mutation of the sodium channel subunit SCN1B. Neurology 2002; 58(9):1426-1429. 
 219
 (151)  Hanlon MR, Wallace BA. Structure and function of voltage-dependent ion channel 
regulatory beta subunits. Biochemistry 2002; 41(9):2886-2894. 
 (152)  McClatchey AI, Cannon SC, Slaugenhaupt SA, Gusella JF. The cloning and expression 
of a sodium channel beta 1-subunit cDNA from human brain. Hum Mol Genet 1993; 
2(6):745-749. 
 (153)  Wallner M, Weigl L, Meera P, Lotan I. Modulation of the skeletal muscle sodium channel 
alpha-subunit by the beta 1-subunit. FEBS Lett 1993; 336(3):535-539. 
 (154)  Makita N, Bennett PB, Jr., George AL, Jr. Voltage-gated Na+ channel beta 1 subunit 
mRNA expressed in adult human skeletal muscle, heart, and brain is encoded by a single 
gene. J Biol Chem 1994; 269(10):7571-7578. 
 (155)  Qu Y, Isom LL, Westenbroek RE et al. Modulation of cardiac Na+ channel expression in 
Xenopus oocytes by beta 1 subunits. J Biol Chem 1995; 270(43):25696-25701. 
 (156)  Nuss HB, Chiamvimonvat N, Perez-Garcia MT, Tomaselli GF, Marban E. Functional 
association of the beta 1 subunit with human cardiac (hH1) and rat skeletal muscle (mu 1) 
sodium channel alpha subunits expressed in Xenopus oocytes. J Gen Physiol 1995; 
106(6):1171-1191. 
 (157)  Xiao YF, Wright SN, Wang GK, Morgan JP, Leaf A. Coexpression with beta(1)-subunit 
modifies the kinetics and fatty acid block of hH1(alpha) Na(+) channels. Am J Physiol 
Heart Circ Physiol 2000; 279(1):H35-H46. 
 (158)  Makita N, Shirai N, Wang DW et al. Cardiac Na(+) channel dysfunction in Brugada 
syndrome is aggravated by beta(1)-subunit. Circulation 2000; 101(1):54-60. 
 (159)  Makielski JC. The heart sodium channel phenotype for inactivation and lidocaine block. 
Jpn Heart J 1996; 37(5):733-739. 
 (160)  Makielski JC, Limberis J, Fan Z, Kyle JW. Intrinsic lidocaine affinity for Na channels 
expressed in Xenopus oocytes depends on alpha (hH1 vs. rSkM1) and beta 1 subunits. 
Cardiovasc Res 1999; 42(2):503-509. 
 (161)  Malhotra JD, Chen C, Rivolta I et al. Characterization of sodium channel alpha- and beta-
subunits in rat and mouse cardiac myocytes. Circulation 2001; 103(9):1303-1310. 
 (162)  Isom LL. The role of sodium channels in cell adhesion. Front Biosci 2002; 7:12-23. 
 (163)  Stevens EB, Cox PJ, Shah BS et al. Tissue distribution and functional expression of the 
human voltage-gated sodium channel beta3 subunit. Pflugers Arch 2001; 441(4):481-488. 
 (164)  Fahmi AI, Patel M, Stevens EB et al. The sodium channel beta-subunit SCN3b 
modulates the kinetics of SCN5a and is expressed heterogeneously in sheep heart. J 
Physiol 2001; 537(Pt 3):693-700. 
 (165)  Medeiros-Domingo A, Kaku T, Tester DJ et al. SCN4B-Encoded Sodium Channel {beta}4 
Subunit in Congenital Long-QT Syndrome. Circulation 2007; 116:134-142. 
 (166)  Medeiros-Domingo A, Kaku T, Tester DJ et al. SCN4B-Encoded Sodium Channel {beta}4 
Subunit in Congenital Long-QT Syndrome. Circulation 2007; 116:134-142. 
 220
 (167)  Ko SH, Lenkowski PW, Lee HC, Mounsey JP, Patel MK. Modulation of Na(v)1.5 by 
beta1-- and beta3-subunit co-expression in mammalian cells. Pflugers Arch 2005; 
449(4):403-412. 
 (168)  Abriel H, Kass RS. Regulation of the voltage-gated cardiac sodium channel Nav1.5 by 
interacting proteins. Trends Cardiovasc Med 2005; 15(1):35-40. 
 (169)  Messner DJ, Catterall WA. The sodium channel from rat brain. Separation and 
characterization of subunits. J Biol Chem 1985; 260(19):10597-10604. 
 (170)  Stainier DY, Fouquet B, Chen JN et al. Mutations affecting the formation and function of 
the cardiovascular system in the zebrafish embryo. Development 1996; 123:285-92.:285-
292. 
 (171)  Chen JN, Haffter P, Odenthal J et al. Mutations affecting the cardiovascular system and 
other internal organs in zebrafish. Development 1996; 123:293-302.:293-302. 
 (172)  Stainier DY, Fouquet B, Chen JN et al. Mutations affecting the formation and function of 
the cardiovascular system in the zebrafish embryo. Development 1996; 123:285-92.:285-
292. 
 (173)  Chen JN, Haffter P, Odenthal J et al. Mutations affecting the cardiovascular system and 
other internal organs in zebrafish. Development 1996; 123:293-302.:293-302. 
 (174)  Baker K, Warren KS, Yellen G, Fishman MC. Defective "pacemaker" current (Ih) in a 
zebrafish mutant with a slow heart rate. Proc Natl Acad Sci (USA) 1997; 94(9):4554-4559. 
 (175)  Piontkivska H, Hughes AL. Evolution of vertebrate voltage-gated ion channel alpha 
chains by sequential gene duplication. J Mol Evol 2003; 56(3):277-285. 
 (176)  Hughes AL. The evolution of functionally novel proteins after gene duplication. Proc Biol 
Sci 1994; 256(1346):119-124. 
 (177)  Okamura Y, Nishino A, Murata Y et al. Comprehensive analysis of the ascidian genome 
reveals novel insights into the molecular evolution of ion channel genes. Physiol 
Genomics 2005; 22(3):269-282. 
 (178)  Littleton JT, Ganetzky B. Ion channels and synaptic organization: analysis of the 
Drosophila genome. Neuron 2000; 26(1):35-43. 
 (179)  Blackshaw SE, Henderson LP, Malek J et al. Single-cell analysis reveals cell-specific 
patterns of expression of a family of putative voltage-gated sodium channel genes in the 
leech. J Neurobiol 2003; 55(3):355-371. 
 (180)  Lopreato GF, Lu Y, Southwell A et al. Evolution and divergence of sodium channel genes 
in vertebrates. Proc Natl Acad Sci (USA) 2001; 98(13):7588-7592. 
 (181)  Long M, Betran E, Thornton K, Wang W. The origin of new genes: glimpses from the 
young and old. Nat Rev Genet 2003; 4(11):865-875. 
 (182)  Hughes AL. Gene duplication and the origin of novel proteins. Proc Natl Acad Sci (USA) 
2005; 102(25):8791-8792. 
 (183)  Taylor JS, Raes J. Duplication and divergence: the evolution of new genes and old ideas. 
Annu Rev Genet 2004; 38:615-43.:615-643. 
 221
 (184)  Ohta T. Evolution by gene duplication revisited: differentiation of regulatory elements 
versus proteins. Genetica 2003; 118(2-3):209-216. 
 (185)  Li WH, Yang J, Gu X. Expression divergence between duplicate genes. Trends Genet 
2005; 21(11):602-607. 
 (186)  Gibert JM. The evolution of engrailed genes after duplication and speciation events. Dev 
Genes Evol 2002; 212(7):307-318. 
 (187)  Ono S. Ancient linkage groups and frozen accidents. Nature 1973; 244(5414):259-262. 
 (188)  Byun-McKay SA, Geeta R. Protein subcellular relocalization: a new perspective on the 
origin of novel genes. Trends Ecol Evol 2007; 22(7):338-344. 
 (189)  Force A, Lynch M, Pickett FB, Amores A, Yan YL, Postlethwait J. Preservation of 
duplicate genes by complementary, degenerative mutations. Genetics 1999; 
151(4):1531-1545. 
 (190)  Lynch M, Force A. The probability of duplicate gene preservation by subfunctionalization. 
Genetics 2000; 154(1):459-473. 
 (191)  Chiu CH, Amemiya C, Dewar K, Kim CB, Ruddle FH, Wagner GP. Molecular evolution of 
the HoxA cluster in the three major gnathostome lineages. Proc Natl Acad Sci (USA) 
2002; 99(8):5492-5497. 
 (192)  Lynch VJ, Roth JJ, Wagner GP. Adaptive evolution of Hox-gene homeodomains after 
cluster duplications. BMC Evol Biol 2006; 6:86.:86. 
 (193)  Rodin SN, Parkhomchuk DV, Rodin AS, Holmquist GP, Riggs AD. Repositioning-
dependent fate of duplicate genes. DNA Cell Biol 2005; 24(9):529-542. 
 (194)  Katju V, Lynch M. On the formation of novel genes by duplication in the Caenorhabditis 
elegans genome. Mol Biol Evol 2006; 23(5):1056-1067. 
 (195)  Sangameswaran L, Fish LM, Koch BD et al. A novel tetrodotoxin-sensitive, voltage-gated 
sodium channel expressed in rat and human dorsal root ganglia. J Biol Chem 1997; 
272(23):14805-14809. 
 (196)  Lu CM, Han J, Rado TA, Brown GB. Differential expression of two sodium channel 
subtypes in human brain. FEBS Lett 1992; 303(1):53-58. 
 (197)  Noda M, Ikeda T, Kayano T et al. Existence of distinct sodium channel messenger RNAs 
in rat brain. Nature 1986; 320(6058):188-192. 
 (198)  Klugbauer N, Lacinova L, Flockerzi V, Hofmann F. Structure and functional expression of 
a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from 
human neuroendocrine cells. EMBO J 1995; 14(6):1084-1090. 
 (199)  Ahmed CM, Ware DH, Lee SC et al. Primary structure, chromosomal localization, and 
functional expression of a voltage-gated sodium channel from human brain. Proc Natl 
Acad Sci (USA) 1992; 89(17):8220-8224. 
 (200)  Chen YH, Dale TJ, Romanos MA, Whitaker WR, Xie XM, Clare JJ. Cloning, distribution 
and functional analysis of the type III sodium channel from human brain. Eur J Neurosci 
2000; 12(12):4281-4289. 
 222
 (201)  Whitaker WR, Clare JJ, Powell AJ, Chen YH, Faull RL, Emson PC. Distribution of 
voltage-gated sodium channel alpha-subunit and beta-subunit mRNAs in human 
hippocampal formation, cortex, and cerebellum. J Comp Neurol 2000;422(1):123-139. 
 (202)  Whitaker WR, Faull RL, Waldvogel HJ, Plumpton CJ, Emson PC, Clare JJ. Comparative 
distribution of voltage-gated sodium channel proteins in human brain. Brain Res Mol 
Brain Res 2001; 88(1-2):37-53. 
 (203)  Suzuki H, Beckh S, Kubo H et al. Functional expression of cloned cDNA encoding 
sodium channel III. FEBS Lett 1988; 228(1):195-200. 
 (204)  Gordon D, Merrick D, Auld V et al. Tissue-specific expression of the RI and RII sodium 
channel subtypes. Proc Natl Acad Sci (USA) 1987; 84(23):8682-8686. 
 (205)  Felipe A, Knittle TJ, Doyle KL, Tamkun MM. Primary structure and differential expression 
during development and pregnancy of a novel voltage-gated sodium channel in the 
mouse. J Biol Chem 1994; 269(48):30125-30131. 
 (206)  George AL, Jr., Knittle TJ, Tamkun MM. Molecular cloning of an atypical voltage-gated 
sodium channel expressed in human heart and uterus: evidence for a distinct gene family. 
Proc Natl Acad Sci (USA) 1992; 89(11):4893-4897. 
 (207)  Rogart RB, Cribbs LL, Muglia LK, Kephart DD, Kaiser MW. Molecular cloning of a 
putative tetrodotoxin-resistant rat heart Na+ channel isoform. Proc Natl Acad Sci (USA) 
1989; 86(20):8170-8174. 
 (208)  Gellens ME, George AL, Jr., Chen LQ et al. Primary structure and functional expression 
of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc 
Natl Acad Sci (USA) 1992; 89(2):554-558. 
 (209)  Kallen RG, Sheng ZH, Yang J, Chen LQ, Rogart RB, Barchi RL. Primary structure and 
expression of a sodium channel characteristic of denervated and immature rat skeletal 
muscle. Neuron 1990; 4(2):233-242. 
 (210)  White MM, Chen LQ, Kleinfield R, Kallen RG, Barchi RL. SkM2, a Na+ channel cDNA 
clone from denervated skeletal muscle, encodes a tetrodotoxin-insensitive Na+ channel. 
Mol Pharmacol 1991; 39(5):604-608. 
 (211)  Sangameswaran L, Delgado SG, Fish LM et al. Structure and function of a novel voltage-
gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J Biol Chem 
1996; 271(11):5953-5956. 
 (212)  Rabert DK, Koch BD, Ilnicka M et al. A tetrodotoxin-resistant voltage-gated sodium 
channel from human dorsal root ganglia, hPN3/SCN10A. Pain 1998; 78(2):107-114. 
 (213)  Dib-Hajj SD, Tyrrell L, Black JA, Waxman SG. NaN, a novel voltage-gated Na channel, is 
expressed preferentially in peripheral sensory neurons and down-regulated after axotomy. 
Proc Natl Acad Sci (USA) 1998; 95(15):8963-8968. 
 (214)  Jeong SY, Goto J, Hashida H et al. Identification of a novel human voltage-gated sodium 
channel alpha subunit gene, SCN12A. Biochem Biophys Res Commun 2000; 267(1):262-
270. 
 (215)  Whitaker W, Faull R, Waldvogel H et al. Localization of the type VI voltage-gated sodium 
channel protein in human CNS. Neuroreport 1999; 10(17):3703-3709. 
 223
 (216)  Krzemien DM, Schaller KL, Levinson SR, Caldwell JH. Immunolocalization of sodium 
channel isoform NaCh6 in the nervous system. J Comp Neurol 2000; 420(1):70-83. 
 (217)  Caldwell JH, Schaller KL, Lasher RS, Peles E, Levinson SR. Sodium channel Na(v)1.6 is 
localized at nodes of ranvier, dendrites, and synapses. Proc Natl Acad Sci (USA) 2000; 
97(10):5616-5620. 
 (218)  George AL, Jr., Komisarof J, Kallen RG, Barchi RL. Primary structure of the adult human 
skeletal muscle voltage-dependent sodium channel. Ann Neurol 1992; 31(2):131-137. 
 (219)  Wang JZ, Rojas CV, Zhou JH, Schwartz LS, Nicholas H, Hoffman EP. Sequence and 
genomic structure of the human adult skeletal muscle sodium channel alpha subunit 
gene on 17q. Biochem Biophys Res Commun 1992; 182(2):794-801. 
 (220)  Trimmer JS, Cooperman SS, Tomiko SA et al. Primary structure and functional 
expression of a mammalian skeletal muscle sodium channel. Neuron 1989; 3(1):33-49. 
 (221)  Dhar MJ, Chen C, Rivolta I et al. Characterization of sodium channel alpha- and beta-
subunits in rat and mouse cardiac myocytes. Circulation 2001; 103(9):1303-1310. 
 (222)  Ahmad S, Dahllund L, Eriksson AB et al. A stop codon mutation in SCN9A causes lack of 
pain sensation. Hum Mol Genet 2007; 16(17):2114-21. 
 (223)  Goldberg YP, MacFarlane J, MacDonald ML et al. Loss-of-function mutations in the 
Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin 
Genet 2007; 71(4):311-319. 
 (224)  Ribera AB, Nusslein-Volhard C. Zebrafish touch-insensitive mutants reveal an essential 
role for the developmental regulation of sodium current. J Neurosci 1998; 18(22):9181-
9191. 
 (225)  Tsai CW, Tseng JJ, Lin SC et al. Primary structure and developmental expression of 
zebrafish sodium channel Na(v)1.6 during neurogenesis. DNA Cell Biol 2001; 20(5):249-
255. 
 (226)  Warren KS, Baker K, Fishman MC. The slow mo mutation reduces pacemaker current 
and heart rate in adult zebrafish. Am J Physiol Heart Circ Physiol 2001; 281(4):H1711-
H1719. 
 (227)  Amores A, Force A, Yan YL et al. Zebrafish hox clusters and vertebrate genome 
evolution. Science 1998; 282(5394):1711-1714. 
 (228)  Postlethwait JH, Yan YL, Gates MA et al. Vertebrate genome evolution and the zebrafish 
gene map. Nat Genet 1998; 18(4):345-349. 
 (229)  Novak AE, Taylor AD, Pineda RH, Lasda EL, Wright MA, Ribera AB. Embryonic and 
larval expression of zebrafish voltage-gated sodium channel alpha-subunit genes. Dev 
Dyn 2006; 235(7):1962-1973. 
 (230)  Novak AE, Jost MC, Lu Y, Taylor AD, Zakon HH, Ribera AB. Gene duplications and 
evolution of vertebrate voltage-gated sodium channels. J Mol Evol 2006; 63(2):208-221. 
 (231)  Venkatesh B, Lu SQ, Dandona N, See SL, Brenner S, Soong TW. Genetic basis of 
tetrodotoxin resistance in pufferfishes. Curr Biol 2005; 15(22):2069-2072. 
 224
 (232)  Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing 
phylogenetic trees. Mol Biol Evol 1987; 4(4):406-425. 
 (233)  Darbar D, Yang T, Churchwell K, Wilde AA, Roden DM. Unmasking of brugada syndrome 
by lithium. Circulation 2005; 112(11):1527-1531. 
 (234)  LeMaillet G, Walker B, Lambert S. Identification of a conserved ankyrin-binding motif in 
the family of sodium channel alpha subunits. J Biol Chem 2003; 278(30):27333-27339. 
 (235)  Mohler PJ, Rivolta I, Napolitano C et al. Nav1.5 E1053K mutation causing Brugada 
syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of 
cardiomyocytes. Proc Natl Acad Sci (USA) 2004; 101(50):17533-17538. 
 (236)  Liu CJ, Dib-Hajj SD, Renganathan M, Cummins TR, Waxman SG. Modulation of the 
cardiac sodium channel Nav1.5 by fibroblast growth factor homologous factor 1B. J Biol 
Chem 2003; 278(2):1029-1036. 
 (237)  Deschenes I, Neyroud N, DiSilvestre D, Marban E, Yue DT, Tomaselli GF. Isoform-
specific modulation of voltage-gated Na(+) channels by calmodulin. Circ Res 2002; 
90(4):E49-E57. 
 (238)  Tan HL, Kupershmidt S, Zhang R et al. A calcium sensor in the sodium channel 
modulates cardiac excitability. Nature 2002; 415(6870):442-447. 
 (239)  Young KA, Caldwell JH. Modulation of skeletal and cardiac voltage-gated sodium 
channels by calmodulin. J Physiol 2005; 565(Pt 2):349-370. 
 (240)  Shah VN, Wingo TL, Weiss KL, Williams CK, Balser JR, Chazin WJ. Calcium-dependent 
regulation of the voltage-gated sodium channel hH1: intrinsic and extrinsic sensors use a 
common molecular switch. Proc Natl Acad Sci (USA) 2006; 103(10):3592-3597. 
 (241)  van Bemmelen MX, Rougier JS, Gavillet B et al. Cardiac voltage-gated sodium channel 
Nav1.5 is regulated by Nedd4-2 mediated ubiquitination. Circ Res 2004; 95(3):284-291. 
 (242)  Wingo TL, Shah VN, Anderson ME, Lybrand TP, Chazin WJ, Balser JR. An EF-hand in 
the sodium channel couples intracellular calcium to cardiac excitability. Nat Struct Mol 
Biol 2004; 11(3):219-225. 
 (243)  Ou Y, Strege P, Miller SM et al. Syntrophin gamma 2 regulates SCN5A gating by a PDZ 
domain-mediated interaction. J Biol Chem 2003; 278(3):1915-1923. 
 (244)  Zhou J, Yi J, Hu N, George AL, Jr., Murray KT. Activation of protein kinase A modulates 
trafficking of the human cardiac sodium channel in Xenopus oocytes. Circ Res 2000; 
87(1):33-38. 
 (245)  Zhou J, Shin HG, Yi J, Shen W, Williams CP, Murray KT. Phosphorylation and putative 
ER retention signals are required for protein kinase A-mediated potentiation of cardiac 
sodium current. Circ Res 2002;91(6):540-546. 
 (246)  Satin J, Kyle JW, Chen M et al. A mutant of TTX-resistant cardiac sodium channels with 
TTX-sensitive properties. Science 1992; 256(5060):1202-1205. 
 (247)  Pineda RH, Heiser RA, Ribera AB. Developmental, molecular, and genetic dissection of 
INa in vivo in embryonic zebrafish sensory neurons. J Neurophysiol 2005; 93(6):3582-
3593. 
 225
 (248)  Black JA, Dib-Hajj S, Cohen S, Hinson AW, Waxman SG. Glial cells have heart: rH1 Na+ 
channel mRNA and protein in spinal cord astrocytes. Glia 1998; 23(3):200-208. 
 (249)  Hartmann HA, Colom LV, Sutherland ML, Noebels JL. Selective localization of cardiac 
SCN5A sodium channels in limbic regions of rat brain. Nat Neurosci 1999; 2(7):593-595. 
 (250)  Donahue LM, Coates PW, Lee VH, Ippensen DC, Arze SE, Poduslo SE. The cardiac 
sodium channel mRNA is expressed in the developing and adult rat and human brain. 
Brain Res 2000; 887(2):335-343. 
 (251)  Renganathan M, Dib-Hajj S, Waxman SG. Na(v)1.5 underlies the 'third TTX-R sodium 
current' in rat small DRG neurons. Brain Res Mol Brain Res 2002; 106(1-2):70-82. 
 (252)  Wu L, Nishiyama K, Hollyfield JG, Wang Q. Localization of Nav1.5 sodium channel 
protein in the mouse brain. Neuroreport 2002; 13(18):2547-2551. 
 (253)  Ou Y, Gibbons SJ, Miller SM et al. SCN5A is expressed in human jejunal circular smooth 
muscle cells. Neurogastroenterol Motil 2002; 14(5):477-486. 
 (254)  Tate S, Benn S, Hick C et al. Two sodium channels contribute to the TTX-R sodium 
current in primary sensory neurons. Nat Neurosci 1998; 1(8):653-655. 
 (255)  Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. 
Cell 2001; 104(4):569-580. 
 (256)  Nuyens D, Stengl M, Dugarmaa S et al. Abrupt rate accelerations or premature beats 
cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 2001; 
7(9):1021-1027. 
 (257)  George AL, Jr. Inherited disorders of voltage-gated sodium channels. J Clin Invest 2005; 
115(8):1990-1999. 
 (258)  Echt DS, Liebson PR, Mitchell LB et al. Mortality and morbidity in patients receiving 
encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J 
Med 1991; 324(12):781-788. 
 (259)  Burns CG, Milan DJ, Grande EJ, Rottbauer W, Macrae CA, Fishman MC. High-
throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat 
Chem Biol 2005; 1(5):263-264. 
 (260)  Mably JD, Mohideen MA, Burns CG, Chen JN, Fishman MC. heart of glass regulates the 
concentric growth of the heart in zebrafish. Curr Biol 2003; 13(24):2138-2147. 
 (261)  Milan DJ, Giokas AC, Serluca FC, Peterson RT, Macrae CA. Notch1b and neuregulin are 
required for specification of central cardiac conduction tissue. Development 2006; 
133(6):1125-1132. 
 (262)  Milan DJ, Peterson TA, Ruskin JN, Peterson RT, Macrae CA. Drugs that induce 
repolarization abnormalities cause bradycardia in zebrafish. Circulation 2003; 
107(10):1355-1358. 
 (263)  Desai SP, Marsh JD, Allen PD. Contractility effects of local anesthetics in the presence of 
sodium channel blockade. Reg Anesth 1989; 14(2):58-62. 
 226
 (264)  Sakura S, Bollen AW, Ciriales R, Drasner K. Local anesthetic neurotoxicity does not 
result from blockade of voltage-gated sodium channels. Anesth Analg 1995; 81(2):338-
346. 
 (265)  Josephson I, Sperelakis N. Local anesthetic blockade of Ca2+ -mediated action 
potentials in cardiac muscle. Eur J Pharmacol 1976; 40(2):201-208. 
 (266)  Josephson IR. Lidocaine blocks Na, Ca and K currents of chick ventricular myocytes. J 
Mol Cell Cardiol 1988; 20(7):593-604. 
 (267)  Campbell TJ, Wyse KR, Pallandi R. Differential effects on action potential duration of 
class IA, B and C antiarrhythmic drugs: modulation by stimulation rate and extracellular 
K+ concentration. Clin Exp Pharmacol Physiol 1991; 18(8):533-541. 
 (268)  Follmer CH, Cullinan CA, Colatsky TJ. Differential block of cardiac delayed rectifier 
current by class Ic antiarrhythmic drugs: evidence for open channel block and unblock. 
Cardiovasc Res 1992; 26(11):1121-1130. 
 (269)  Nasevicius A, Ekker SC. Effective targeted gene 'knockdown' in zebrafish. Nat Genet 
2000; 26(2):216-220. 
 (270)  Rottbauer W, Baker K, Wo ZG, Mohideen MA, Cantiello HF, Fishman MC. Growth and 
function of the embryonic heart depend upon the cardiac-specific L-type calcium channel 
alpha1 subunit. Dev Cell 2001; 1(2):265-275. 
 (271)  Royer A, van Veen TA, Le BS et al. Mouse model of SCN5A-linked hereditary Lenegre's 
disease: age-related conduction slowing and myocardial fibrosis. Circulation 2005; 
111(14):1738-1746. 
 (272)  Makita N, Sasaki K, Yokoshiki H, Yamada S, Tsutsui H. Left ventricular noncompaction 
assocated with mutations in cardiac sodium channel gene SCN5A. American Heart 
Association Scientific Sessions, Abstract, 2006.  
 (273)  McNair WP, Ku L, Taylor MR et al. SCN5A mutation associated with dilated 
cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004; 110(15):2163-
2167. 
 (274)  Adler E, Fuster V. SCN5A--a mechanistic link between inherited cardiomyopathies and a 
predisposition to arrhythmias? JAMA 2005; 293(4):491-493. 
 (275)  Olson TM, Michels VV, Ballew JD et al. Sodium channel mutations and susceptibility to 
heart failure and atrial fibrillation. JAMA 2005; 293(4):447-454. 
 (276)  van Veen TA, Stein M, Royer A et al. Impaired impulse propagation in Scn5a-knockout 
mice: combined contribution of excitability, connexin expression, and tissue architecture 
in relation to aging. Circulation 2005; 112(13):1927-1935. 
 (277)  Garrity DM, Childs S, Fishman MC. The heartstrings mutation in zebrafish causes 
heart/fin Tbx5 deficiency syndrome. Development 2002; 129(19):4635-4645. 
 (278)  Yelon D, Horne SA, Stainier DY. Restricted expression of cardiac myosin genes reveals 
regulated aspects of heart tube assembly in zebrafish. Dev Biol 1999; 214(1):23-37. 
 (279)  Keegan BR, Meyer D, Yelon D. Organization of cardiac chamber progenitors in the 
zebrafish blastula. Development 2004; 131(13):3081-3091. 
 227
 (280)  Rottbauer W, Saurin AJ, Lickert H et al. Reptin and pontin antagonistically regulate heart 
growth in zebrafish embryos. Cell 2002; 111(5):661-672. 
 (281)  Jia H, King IN, Chopra SS et al. Vertebrate heart growth is regulated by functional 
antagonism between Gridlock and Gata5. Proc Natl Acad Sci (USA). in press. 2007.  
 (282)  Kupperman E, An S, Osborne N, Waldron S, Stainier DY. A sphingosine-1-phosphate 
receptor regulates cell migration during vertebrate heart development. Nature 2000; 
406(6792):192-195. 
 (283)  Mably JD, Mohideen MA, Burns CG, Chen JN, Fishman MC. heart of glass regulates the 
concentric growth of the heart in zebrafish. Curr Biol 2003; 13(24):2138-2147. 
 (284)  Cestele S, Catterall WA. Molecular mechanisms of neurotoxin action on voltage-gated 
sodium channels. Biochimie 2000; 82(9-10):883-892. 
 (285)  Catterall WA, Cestele S, Yarov-Yarovoy V, Yu FH, Konoki K, Scheuer T. Voltage-gated 
ion channels and gating modifier toxins. Toxicon 2007; 49(2):124-141. 
 (286)  Renaud JF, Romey G, Lombet A, Lazdunski M. Differentiation of the fast Na+ channel in 
embryonic heart cells: interaction of the channel with neurotoxins. Proc Natl Acad Sci 
(USA) 1981; 78(9):5348-5352. 
 (287)  Garry DJ, Olson EN. A common progenitor at the heart of development. Cell 2006; 
127(6):1101-1104. 
 (288)  Olson EN. Gene regulatory networks in the evolution and development of the heart. 
Science 2006; 313(5795):1922-1927. 
 (289)  Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. 
Cell 2006; 126(6):1037-1048. 
 (290)  Olson EN, Schneider MD. Sizing up the heart: development redux in disease. Genes Dev 
2003; 17(16):1937-1956. 
 (291)  Chen JN, Fishman MC. Zebrafish tinman homolog demarcates the heart field and 
initiates myocardial differentiation. Development 1996; 122(12):3809-3816. 
 (292)  Holtzinger A, Evans T. Gata4 regulates the formation of multiple organs. Development 
2005; 132(17):4005-4014. 
 (293)  Heicklen-Klein A, McReynolds LJ, Evans T. Using the zebrafish model to study GATA 
transcription factors. Semin Cell Dev Biol 2005; 16(1):95-106. 
 (294)  Yelon D, Ticho B, Halpern ME et al. The bHLH transcription factor hand2 plays parallel 
roles in zebrafish heart and pectoral fin development. Development 2000; 127(12):2573-
2582. 
 (295)  Angelo S, Lohr J, Lee KH et al. Conservation of sequence and expression of Xenopus 
and zebrafish dHAND during cardiac, branchial arch and lateral mesoderm development. 
Mech Dev 2000; 95(1-2):231-237. 
 (296)  Langheinrich U, Vacun G, Wagner T. Zebrafish embryos express an orthologue of HERG 
and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. 
Toxicol Appl Pharmacol 2003; 193(3):370-382. 
 228
 (297)  Keegan BR, Meyer D, Yelon D. Organization of cardiac chamber progenitors in the 
zebrafish blastula. Development 2004; 131(13):3081-3091. 
 (298)  Yelon D, Horne SA, Stainier DY. Restricted expression of cardiac myosin genes reveals 
regulated aspects of heart tube assembly in zebrafish. Dev Biol 1999; 214(1):23-37. 
 (299)  Reiter JF, Alexander J, Rodaway A et al. Gata5 is required for the development of the 
heart and endoderm in zebrafish. Genes Dev 1999; 13(22):2983-2995. 
 (300)  Reiter JF, Verkade H, Stainier DY. Bmp2b and Oep promote early myocardial 
differentiation through their regulation of gata5. Dev Biol 2001; 234(2):330-338. 
 (301)  Yu FH, Yarov-Yarovoy V, Gutman GA, Catterall WA. Overview of molecular relationships 
in the voltage-gated ion channel superfamily. Pharmacol Rev 2005; 57(4):387-395. 
 (302)  Robu ME, Larson JD, Nasevicius A et al. p53 activation by knockdown technologies. 
PLoS Genet 2007; 3(5):e78. 
 (303)  Poelzing S, Forleo C, Samodell M et al. SCN5A polymorphism restores trafficking of a 
Brugada syndrome mutation on a separate gene. Circulation 2006; 114(5):368-376. 
 (304)  Ebert AM, Hume GL, Warren KS et al. Calcium extrusion is critical for cardiac 
morphogenesis and rhythm in embryonic zebrafish hearts. Proc Natl Acad Sci (USA) 
2005; 102(49):17705-17710. 
 (305)  Langenbacher AD, Dong Y, Shu X et al. Mutation in sodium-calcium exchanger 1 (NCX1) 
causes cardiac fibrillation in zebrafish. Proc Natl Acad Sci (USA) 2005; 102(49):17699-
17704. 
 (306)  Shu X, Cheng K, Patel N et al. Na,K-ATPase is essential for embryonic heart 
development in the zebrafish. Development 2003; 130(25):6165-6173. 
 (307)  Arnaout R, Ferrer T, Huisken J et al. Zebrafish model for human long QT syndrome. Proc 
Natl Acad Sci (USA) 2007; 104(27):11316-11321. 
 (308)  Yuan S, Joseph EM. The small heart mutation reveals novel roles of Na+/K+-ATPase in 
maintaining ventricular cardiomyocyte morphology and viability in zebrafish. Circ Res 
2004; 95(6):595-603. 
 (309)  Davies MP, An RH, Doevendans P, Kubalak S, Chien KR, Kass RS. Developmental 
changes in ionic channel activity in the embryonic murine heart. Circ Res 1996; 78(1):15-
25. 
 (310)  Maltsev VA, Wobus AM, Rohwedel J, Bader M, Hescheler J. Cardiomyocytes 
differentiated in vitro from embryonic stem cells developmentally express cardiac-specific 
genes and ionic currents. Circ Res 1994; 75(2):233-244. 
 (311)  van der Heyden MA, Defize LH. Twenty one years of P19 cells: what an embryonal 
carcinoma cell line taught us about cardiomyocyte differentiation. Cardiovasc Res 2003; 
58(2):292-302. 
 (312)  van der Heyden MA, van Kempen MJ, Tsuji Y, Rook MB, Jongsma HJ, Opthof T. P19 
embryonal carcinoma cells: a suitable model system for cardiac electrophysiological 
differentiation at the molecular and functional level. Cardiovasc Res 2003; 58(2):410-422. 
 229
 (313)  Wobus AM, Kleppisch T, Maltsev V, Hescheler J. Cardiomyocyte-like cells differentiated 
in vitro from embryonic carcinoma cells P19 are characterized by functional expression of 
adrenoceptors and Ca2+ channels. In Vitro Cell Dev Biol Anim 1994; 30A(7):425-434. 
 (314)  Sperelakis N, Pappano AJ. Physiology and pharmacology of developing heart cells. 
Pharmacol Ther 1983; 22(1):1-39. 
 (315)  Shigenobu K, Sperelakis N. Development of sensitivity to tetrodotoxin of chick embryonic 
hearts with age. J Mol Cell Cardiol 1971; 3(3):271-286. 
 (316)  McDonald TF, Sachs HG. Electrical activity in embryonic heart cell aggregates. 
Developmental aspects. Pflugers Arch 1975; 354(2):151-164. 
 (317)  Pappano AJ. Action potentials in chick atria. Increased susceptibility to blockade by 
tetrodotoxin during embryonic development. Circ Res 1972; 31(3):379-388. 
 (318)  Sperelakis N, Shigenobu K. Changes in membrane properties of chick embryonic hearts 
during development. J Gen Physiol 1972; 60(4):430-453. 
 (319)  McDonald TF, Sachs HG, DeHaan RL. Development of sensitivity to tetrodotoxin in 
beating chick embryo hearts, single cells, and aggregates. Science 1972; 176(40):1248-
1250. 
 (320)  Nathan RD, DeHaan RL. In vitro differentiation of a fast Na+ conductance in embryonic 
heart cell aggregates. Proc Natl Acad Sci (USA) 1978; 75(6):2776-2780. 
 (321)  Galper JB, Catterall WA. Developmental changes in the sensitivity of embryonic heart 
cells to tetrodotoxin and D600. Dev Biol 1978; 65(1):216-227. 
 (322)  Iijima T, Pappano AJ. Ontogenetic increase of the maximal rate of rise of the chick 
embryonic heart action potential. Relationship to voltage, time, and tetrodotoxin. Circ Res 
1979; 44(3):358-367. 
 (323)  Fujii S, Hirota A, Kamino K. Optical signals from early embryonic chick heart stained with 
potential sensitive dyes: evidence for electrical activity. J Physiol 1980; 304:503-18.:503-
518. 
 (324)  Marcus NC, Fozzard H. Tetrodotoxin sensitivity in the developing and adult chick heart. J 
Mol Cell Cardiol 1981; 13(3):335-340. 
 (325)  Fishman MC, Chien KR. Fashioning the vertebrate heart: earliest embryonic decisions. 
Development 1997; 124(11):2099-2117. 
 (326)  Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, Stainier DY. Cardiac troponin T 
is essential in sarcomere assembly and cardiac contractility. Nat Genet 2002; 31(1):106-
110. 
 (327)  Anderson ME. Connections count: excitation-contraction meets excitation-transcription 
coupling. Circ Res 2000; 86(7):717-719. 
 (328)  Barlow CA, Rose P, Pulver-Kaste RA, Lounsbury KM. Excitation-transcription coupling in 
smooth muscle. J Physiol 2006; 570(Pt 1):59-64. 
 (329)  Bers DM, Guo T. Calcium signaling in cardiac ventricular myocytes. Ann N Y Acad Sci 
2005; 1047:86-98.:86-98. 
 230
 (330)  Dolmetsch R. Excitation-transcription coupling: signaling by ion channels to the nucleus. 
Sci STKE 2003; 2003(166):E4. 
 (331)  Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell 
2002; 109 Suppl:S67-79.:S67-S79. 
 (332)  Kalil RE. The influence of action potentials on the development of the central visual 
pathway in mammals. J Exp Biol 1990; 153:261-76.:261-276. 
 (333)  Shatz CJ. Emergence of order in visual system development. Proc Natl Acad Sci (USA) 
1996; 93(2):602-608. 
 (334)  Katz LC, Shatz CJ. Synaptic activity and the construction of cortical circuits. Science 
1996; 274(5290):1133-1138. 
 (335)  Bergey GK, Fitzgerald SC, Schrier BK, Nelson PG. Neuronal maturation in mammalian 
cell culture is dependent on spontaneous electrical activity. Brain Res 1981; 207(1):49-58. 
 (336)  Jackson MB, Lecar H, Brenneman DE, Fitzgerald S, Nelson PG. Electrical development 
in spinal cord cell culture. J Neurosci 1982; 2(8):1052-1061. 
 (337)  Gomez-Ospina N, Tsuruta F, Barreto-Chang O, Hu L, Dolmetsch R. The C terminus of 
the L-type voltage-gated calcium channel Ca(V)1.2 encodes a transcription factor. Cell 
2006; 127(3):591-606. 
 (338)  Srivastava D, Gottlieb PD, Olson EN. Molecular mechanisms of ventricular hypoplasia. 
Cold Spring Harb Symp Quant Biol 2002; 67:121-5. 
 (339)  Olson EN. A genetic blueprint for growth and development of the heart. Harvey Lect 2002; 
98:41-64. 
 (340)  Bruneau BG. Transcriptional regulation of vertebrate cardiac morphogenesis. Circ Res 
2002; 90(5):509-519. 
 (341)  Bruneau BG, Nemer G, Schmitt JP et al. A murine model of Holt-Oram syndrome defines 
roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 2001; 
106(6):709-721. 
 (342)  Bruneau BG, Logan M, Davis N et al. Chamber-specific cardiac expression of Tbx5 and 
heart defects in Holt-Oram syndrome. Dev Biol 1999; 211(1):100-108. 
 (343)  van KM, van GA, de G, I et al. Expression of the electrophysiological system during 
murine embryonic stem cell cardiac differentiation. Cell Physiol Biochem 2003; 13(5):263-
270. 
 (344)  McEwen DP, Meadows LS, Chen C, Thyagarajan V, Isom LL. Sodium channel beta1 
subunit-mediated modulation of Nav1.2 currents and cell surface density is dependent on 
interactions with contactin and ankyrin. J Biol Chem 2004; 279(16):16044-16049. 
 (345)  Isom LL. Sodium channel beta subunits: anything but auxiliary. Neuroscientist 2001; 
7(1):42-54. 
 (346)  Xiao ZC, Ragsdale DS, Malhotra JD et al. Tenascin-R is a functional modulator of sodium 
channel beta subunits. J Biol Chem 1999; 274(37):26511-26517. 
 231
 (347)  Malhotra JD, Thyagarajan V, Chen C, Isom LL. Tyrosine-phosphorylated and 
nonphosphorylated sodium channel beta1 subunits are differentially localized in cardiac 
myocytes. J Biol Chem 2004; 279(39):40748-40754. 
 (348)  Malhotra JD, Koopmann MC, Kazen-Gillespie KA, Fettman N, Hortsch M, Isom LL. 
Structural requirements for interaction of sodium channel beta 1 subunits with ankyrin. J 
Biol Chem 2002; 277(29):26681-26688. 
 (349)  Malhotra JD, Kazen-Gillespie K, Hortsch M, Isom LL. Sodium channel beta subunits 
mediate homophilic cell adhesion and recruit ankyrin to points of cell-cell contact. J Biol 
Chem 2000; 275(15):11383-11388. 
 (350)  Linask KK, Knudsen KA, Gui YH. N-cadherin-catenin interaction: necessary component 
of cardiac cell compartmentalization during early vertebrate heart development. Dev Biol 
1997; 185(2):148-164. 
 (351)  Nakagawa S, Takeichi M. N-cadherin is crucial for heart formation in the chick embryo. 
Dev Growth Differ 1997; 39(4):451-455. 
 (352)  Radice GL, Rayburn H, Matsunami H, Knudsen KA, Takeichi M, Hynes RO. 
Developmental defects in mouse embryos lacking N-cadherin. Dev Biol 1997; 181(1):64-
78. 
 (353)  Carrithers MD, Dib-Hajj S, Carrithers LM et al. Expression of the voltage-gated sodium 
channel NaV1.5 in the macrophage late endosome regulates endosomal acidification. J 
Immunol 2007; 178(12):7822-7832. 
 (354)  Ritchie JM. Voltage-gated ion channels in Schwann cells and glia. Trends Neurosci 1992; 
15(9):345-351. 
 (355)  Sontheimer H, Waxman SG. Expression of voltage-activated ion channels by astrocytes 
and oligodendrocytes in the hippocampal slice. J Neurophysiol 1993; 70(5):1863-1873. 
 (356)  Sontheimer H. Voltage-dependent ion channels in glial cells. Glia 1994; 11(2):156-172. 
 (357)  Sontheimer H, Black JA, Waxman SG. Voltage-gated Na+ channels in glia: properties 
and possible functions. Trends Neurosci 1996; 19(8):325-331. 
 (358)  Royer A, van Veen TA, Le BS et al. Mouse model of SCN5A-linked hereditary Lenegre's 
disease: age-related conduction slowing and myocardial fibrosis. Circulation 2005; 
111(14):1738-1746. 
 (359)  McNair WP, Ku L, Taylor MR et al. SCN5A mutation associated with dilated 
cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004; 110(15):2163-
2167. 
 (360)  Mohler PJ, Rivolta I, Napolitano C et al. Nav1.5 E1053K mutation causing Brugada 
syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of 
cardiomyocytes. Proc Natl Acad Sci (USA) 2004; 101(50):17533-17538. 
 (361)  Ou Y, Strege P, Miller SM et al. Syntrophin gamma 2 regulates SCN5A gating by a PDZ 
domain-mediated interaction. J Biol Chem 2003; 278(3):1915-1923. 
 (362)  Morita H, Seidman J, Seidman CE. Genetic causes of human heart failure. J Clin Invest 
2005; 115(3):518-526. 
 232
 (363)  Shatz CJ, Stryker MP. Prenatal tetrodotoxin infusion blocks segregation of 
retinogeniculate afferents. Science 1988; 242(4875):87-89. 
 (364)  Gyllensten L, Malmfors T, Norrlin ML. Effect of visual deprivation on the optic centers of 
growing and adult mice. J Comp Neurol 1965; 124:149-60. 
 (365)  Wiesel TN, Hubel DH. Single-cell responses in striate cortex of kittens deprived of vision 
in one eye. J Neurophysiol 1963; 26:1003-17. 
 (366)  Wiesel TN, Hubel DH. Effects of visual deprivation on morphology and physiology of cells 
in the cats lateral geniculate body. J Neurophysiol 1963; 26:978-93. 
 (367)  Cragg BG. The effects of vision and dark-rearing on the size and density of synapses in 
the lateral geniculate nucleus measured by electron microscopy. Brain Res 1969; 
13(1):53-67. 
 (368)  Godfrey EW, Nelson PG, Schrier BK, Breuer AC, Ransom BR. Neurons from fetal rat 
brain in a new cell culture system: a multidisciplinary analysis. Brain Res 1975; 90(1):1-
21. 
 (369)  Kalil RE, Dubin MW, Scott G, Stark LA. Elimination of action potentials blocks the 
structural development of retinogeniculate synapses. Nature 1986; 323(6084):156-158. 
 (370)  Pineda RH, Svoboda KR, Wright MA et al. Knockdown of Nav1.6a Na+ channels affects 
zebrafish motoneuron development. Development 2006; 133(19):3827-3836. 
 (371)  Isom LL. Sodium channel beta subunits: anything but auxiliary. Neuroscientist 2001; 
7(1):42-54. 
 (372)  Medeiros-Domingo A, Kaku T, Tester DJ et al. SCN4B-Encoded Sodium Channel {beta}4 
Subunit in Congenital Long-QT Syndrome. Circulation 2007; 116:134-142. 
 (373)  Simple Modular Architecture Research Tool (SMART) [http://smart.embl-heidelberg.de/]. 
2007. 
 (374)  Conserved Domain Database, NCBI 
[http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi]. 2007. 
 (375)  TM Pred [http://www.ch.embnet.org/]. 2007. 
 (376)  Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. 
J Mol Biol 1982; 157(1):105-132. 
 (377)  Prosite [http://ca.expasy.org/]. 2007. 
 (378)  NetNGlyc [http://www.cbs.dtu.dk/services/]. 2007. 
 (379)  Kimura M. The Neutral Theory of Molecular Evolution. Cambridge: Cambridge University 
Press, 1983. 
 (380)  Ensembl genome browser [www.ensembl.org]. 2007. 
 (381)  National Human Genome Sequencing Center, Baylor College of Medicine 
[http://www.hgsc.bcm.tmc.edu/projects/seaurchin/]. 2007. 
 233
 (382)  McCormick KA, Isom LL, Ragsdale D, Smith D, Scheuer T, Catterall WA. Molecular 
determinants of Na+ channel function in the extracellular domain of the beta1 subunit. J 
Biol Chem 1998; 273(7):3954-3962. 
 (383)  Shapiro L, Doyle JP, Hensley P, Colman DR, Hendrickson WA. Crystal structure of the 
extracellular domain from P0, the major structural protein of peripheral nerve myelin. 
Neuron 1996; 17(3):435-449. 
 (384)  Kim DY, Ingano LA, Carey BW, Pettingell WH, Kovacs DM. Presenilin/gamma-secretase-
mediated cleavage of the voltage-gated sodium channel beta2-subunit regulates cell 
adhesion and migration. J Biol Chem 2005; 280(24):23251-23261. 
 (385)  Medeiros-Domingo A, Kaku T, Tester DJ et al. SCN4B-Encoded Sodium Channel {beta}4 
Subunit in Congenital Long-QT Syndrome. Circulation 2007; 116:134-142. 
 (386)  Kazen-Gillespie KA, Ragsdale DS, D'Andrea MR, Mattei LN, Rogers KE, Isom LL. 
Cloning, localization, and functional expression of sodium channel beta1A subunits. J 
Biol Chem 2000; 275(2):1079-1088. 
 (387)  Qin N, D'Andrea MR, Lubin ML, Shafaee N, Codd EE, Correa AM. Molecular cloning and 
functional expression of the human sodium channel beta1B subunit, a novel splicing 
variant of the beta1 subunit. Eur J Biochem 2003; 270(23):4762-4770. 
 (388)  Oh Y, Waxman SG. The beta 1 subunit mRNA of the rat brain Na+ channel is expressed 
in glial cells. Proc Natl Acad Sci (USA) 1994; 91(21):9985-9989. 
 (389)  Dib-Hajj SD, Waxman SG. Genes encoding the beta 1 subunit of voltage-dependent Na+ 
channel in rat, mouse and human contain conserved introns. FEBS Lett 1995; 
377(3):485-488. 
 (390)  Dehal P, Satou Y, Campbell RK et al. The draft genome of Ciona intestinalis: insights into 
chordate and vertebrate origins. Science 2002; 298(5601):2157-2167. 
 (391)  Canestro C, Bassham S, Postlethwait JH. Seeing chordate evolution through the Ciona 
genome sequence. Genome Biol 2003; 4(3):208. 
 (392)  Azumi K, De SR, De TA et al. Genomic analysis of immunity in a Urochordate and the 
emergence of the vertebrate immune system: "waiting for Godot". Immunogenetics 2003; 
55(8):570-581. 
 (393)  Du PL, Zucchetti I, De SR. Immunoglobulin superfamily receptors in protochordates: 
before RAG time. Immunol Rev 2004; 198:233-248. 
 (394)  Sodergren E, Weinstock GM, Davidson EH et al. The genome of the sea urchin 
Strongylocentrotus purpuratus. Science 2006; 314(5801):941-952. 
 (395)  Jackson FR, Wilson SD, Hall LM. The tip-E mutation of Drosophila decreases saxitoxin 
binding and interacts with other mutations affecting nerve membrane excitability. J 
Neurogenet 1986; 3(1):1-17. 
 (396)  O'Dowd DK, Aldrich RW. Voltage-clamp analysis of sodium channels in wild-type and 
mutant Drosophila neurons. J Neurosci 1988; 8(10):3633-3643. 
 234
 (397)  Feng G, Deak P, Chopra M, Hall LM. Cloning and functional analysis of TipE, a novel 
membrane protein that enhances Drosophila para sodium channel function. Cell 1995; 
82(6):1001-1011. 
 (398)  Warmke JW, Reenan RA, Wang P et al. Functional expression of Drosophila para 
sodium channels. Modulation by the membrane protein TipE and toxin pharmacology. J 
Gen Physiol 1997; 110(2):119-133. 
 (399)  Hodges DD, Lee D, Preston CF, Boswell K, Hall LM, O'Dowd DK. tipE regulates Na+-
dependent repetitive firing in Drosophila neurons. Mol Cell Neurosci 2002; 19(3):402-416. 
 (400)  Derst C, Walther C, Veh RW, Wicher D, Heinemann SH. Four novel sequences in 
Drosophila melanogaster homologous to the auxiliary Para sodium channel subunit TipE. 
Biochem Biophys Res Commun 2006; 339(3):939-948. 
 (401)  Hobert O, Hutter H, Hynes RO. The immunoglobulin superfamily in Caenorhabditis 
elegans and Drosophila melanogaster. Development 2004; 131(10):2237-2238. 
 (402)  Isom LL. Sodium channel beta subunits: anything but auxiliary. Neuroscientist 2001; 
7(1):42-54. 
 (403)  Agnew WS, Levinson SR, Brabson JS, Raftery MA. Purification of the tetrodotoxin-
binding component associated with the voltage-sensitive sodium channel from 
Electrophorus electricus electroplax membranes. Proc Natl Acad Sci (USA) 1978; 
75(6):2606-2610. 
 (404)  Miller JA, Agnew WS, Levinson SR. Principal glycopeptide of the tetrodotoxin/saxitoxin 
binding protein from Electrophorus electricus: isolation and partial chemical and physical 
characterization. Biochemistry 1983; 22(2):462-470. 
 (405)  Rosenberg RL, Tomiko SA, Agnew WS. Single-channel properties of the reconstituted 
voltage-regulated Na channel isolated from the electroplax of Electrophorus electricus. 
Proc Natl Acad Sci (USA) 1984; 81(17):5594-5598. 
 (406)  Recio-Pinto E, Duch DS, Levinson SR, Urban BW. Purified and unpurified sodium 
channels from eel electroplax in planar lipid bilayers. J Gen Physiol 1987; 90(3):375-395. 
 (407)  Lombet A, Lazdunski M. Characterization, solubilization, affinity labeling and purification 
of the cardiac Na+ channel using Tityus toxin gamma. Eur J Biochem 1984; 141(3):651-
660. 
 (408)  Zakon HH, Lu Y, Zwickl DJ, Hillis DM. Sodium channel genes and the evolution of 
diversity in communication signals of electric fishes: Convergent molecular evolution. 
Proc Natl Acad Sci (USA) 2006; 103(10):3675-3680. 
 (409)  Camacho JA, Hensellek S, Rougier JS et al. Modulation of Nav1.5 channel function by an 
alternatively spliced sequence in the DII/DIII linker region. J Biol Chem 2006; 
281(14):9498-9506. 
 (410)  Thimmapaya R, Neelands T, Niforatos W et al. Distribution and functional 
characterization of human Nav1.3 splice variants. Eur J Neurosci 2005; 22(1):1-9. 
 (411)  Tan BH, Valdivia CR, Rok BA et al. Common human SCN5A polymorphisms have 
altered electrophysiology when expressed in Q1077 splice variants. Heart Rhythm 2005; 
2(7):741-747. 
 235
 (412)  Makielski JC, Ye B, Valdivia CR et al. A ubiquitous splice variant and a common 
polymorphism affect heterologous expression of recombinant human SCN5A heart 
sodium channels. Circ Res 2003; 93(9):821-828. 
 (413)  Zimmer T, Bollensdorff C, Haufe V, Birch-Hirschfeld E, Benndorf K. Mouse heart Na+ 
channels: primary structure and function of two isoforms and alternatively spliced variants. 
Am J Physiol Heart Circ Physiol 2002; 282(3):H1007-H1017. 
 (414)  Dietrich PS, McGivern JG, Delgado SG et al. Functional analysis of a voltage-gated 
sodium channel and its splice variant from rat dorsal root ganglia. J Neurochem 1998; 
70(6):2262-2272. 
 (415)  O'Dowd DK, Gee JR, Smith MA. Sodium current density correlates with expression of 
specific alternatively spliced sodium channel mRNAs in single neurons. J Neurosci 1995; 
15(5 Pt 2):4005-4012. 
 (416)  Meadows L, Malhotra JD, Stetzer A, Isom LL, Ragsdale DS. The intracellular segment of 
the sodium channel beta 1 subunit is required for its efficient association with the channel 
alpha subunit. J Neurochem 2001; 76(6):1871-1878. 
 (417)  Eubanks J, Srinivasan J, Dinulos MB, Disteche CM, Catterall WA. Structure and 
chromosomal localization of the beta2 subunit of the human brain sodium channel. 
Neuroreport 1997; 8(12):2775-2779. 
 (418)  Adler E, Fuster V. SCN5A--a mechanistic link between inherited cardiomyopathies and a 
predisposition to arrhythmias? JAMA 2005; 293(4):491-493. 
 (419)  Chen S, Chung MK, Martin D, Rozich R, Tchou PJ, Wang Q. SNP S1103Y in the cardiac 
sodium channel gene SCN5A is associated with cardiac arrhythmias and sudden death in 
a white family. J Med Genet 2002; 39(12):913-915. 
 (420)  Bezzina CR, Rook MB, Groenewegen WA et al. Compound heterozygosity for mutations 
(W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances 
and degenerative changes in the conduction system. Circ Res 2003; 92(2):159-168. 
 (421)  Frustaci A, Priori SG, Pieroni M et al. Cardiac histological substrate in patients with 
clinical phenotype of Brugada syndrome. Circulation 2005; 112(24):3680-3687. 
 (422)  Coronel R, Casini S, Koopmann TT et al. Right ventricular fibrosis and conduction delay 
in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, 
genetic, histopathologic, and computational study. Circulation 2005; 112(18):2769-2777. 
 (423)  Towbin JA, Bowles NE. The failing heart. Nature 2002; 415(6868):227-233. 
 (424)  Royer A, van Veen TA, Le BS et al. Mouse model of SCN5A-linked hereditary Lenegre's 
disease: age-related conduction slowing and myocardial fibrosis. Circulation 2005; 
111(14):1738-1746. 
 (425)  van Veen TA, Stein M, Royer A et al. Impaired impulse propagation in Scn5a-knockout 
mice: combined contribution of excitability, connexin expression, and tissue architecture 
in relation to aging. Circulation 2005; 112(13):1927-1935. 
 (426)  Probst V, Kyndt F, Potet F et al. Haploinsufficiency in combination with aging causes 
SCN5A-linked hereditary Lenegre disease. J Am Coll Cardiol 2003;41(4):643-652. 
 236
 (427)  Hesse M, Kondo CS, Clark RB et al. Dilated cardiomyopathy is associated with reduced 
expression of the cardiac sodium channel Scn5a. Cardiovasc Res 2007; 75(3):498-509. 
 (428)  Olson TM, Michels VV, Ballew JD et al. Sodium channel mutations and susceptibility to 
heart failure and atrial fibrillation. JAMA 2005; 293(4):447-454. 
 (429)  Abriel H, Kass RS. Regulation of the voltage-gated cardiac sodium channel Nav1.5 by 
interacting proteins. Trends Cardiovasc Med 2005; 15(1):35-40. 
 (430)  Isom LL, De Jongh KS, Patton DE et al. Primary structure and functional expression of 
the beta 1 subunit of the rat brain sodium channel. Science 1992; 256(5058):839-842. 
 (431)  Kazarinova-Noyes K, Malhotra JD, McEwen DP et al. Contactin associates with Na+ 
channels and increases their functional expression. J Neurosci 2001; 21(19):7517-7525. 
 (432)  Allouis M, Le BF, Wilders R et al. 14-3-3 is a regulator of the cardiac voltage-gated 
sodium channel Nav1.5. Circ Res 2006; 98(12):1538-1546. 
 (433)  Shah VN, Wingo TL, Weiss KL, Williams CK, Balser JR, Chazin WJ. Calcium-dependent 
regulation of the voltage-gated sodium channel hH1: intrinsic and extrinsic sensors use a 
common molecular switch. Proc Natl Acad Sci (USA) 2006; 103(10):3592-3597. 
 (434)  Young KA, Caldwell JH. Modulation of skeletal and cardiac voltage-gated sodium 
channels by calmodulin. J Physiol 2005; 565(Pt 2):349-370. 
 (435)  Kim J, Ghosh S, Liu H, Tateyama M, Kass RS, Pitt GS. Calmodulin mediates Ca2+ 
sensitivity of sodium channels. J Biol Chem 2004; 279(43):45004-45012. 
 (436)  Lee KH, Xu Q, Breitbart RE. A new tinman-related gene, nkx2.7, anticipates the 
expression of nkx2.5 and nkx2.3 in zebrafish heart and pharyngeal endoderm. Dev Biol 
1996; 180(2):722-731. 
 (437)  Kishimoto Y, Lee KH, Zon L, Hammerschmidt M, Schulte-Merker S. The molecular nature 
of zebrafish swirl: BMP2 function is essential during early dorsoventral patterning. 
Development 1997; 124(22):4457-4466. 
 (438)  Griffin KJ, Kimelman D. One-Eyed Pinhead and Spadetail are essential for heart and 
somite formation. Nat Cell Biol 2002; 4(10):821-825. 
 (439)  Keegan BR, Feldman JL, Begemann G, Ingham PW, Yelon D. Retinoic acid signaling 
restricts the cardiac progenitor pool. Science 2005; 307(5707):247-249. 
 (440)  Reifers F, Walsh EC, Leger S, Stainier DY, Brand M. Induction and differentiation of the 
zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar). Development 2000; 
127(2):225-235. 
 (441)  Ueno S, Weidinger G, Osugi T et al. Biphasic role for Wnt/beta-catenin signaling in 
cardiac specification in zebrafish and embryonic stem cells. Proc Natl Acad Sci (USA) 
2007; 104(23):9685-9690. 
 (442)  Bodmer R. The gene tinman is required for specification of the heart and visceral 
muscles in Drosophila. Development 1993; 118(3):719-729. 
 (443)  Harvey RP. NK-2 homeobox genes and heart development. Dev Biol 1996; 178(2):203-
216. 
 237
 (444)  Gritsman K, Zhang J, Cheng S, Heckscher E, Talbot WS, Schier AF. The EGF-CFC 
protein one-eyed pinhead is essential for nodal signaling. Cell 1999; 97(1):121-132. 
 (445)  Xu J, Srinivas BP, Tay SY et al. Genomewide expression profiling in the zebrafish 
embryo identifies target genes regulated by Hedgehog signaling during vertebrate 
development. Genetics 2006; 174(2):735-752. 
 (446)  Rohrschneider MR, Elsen GE, Prince VE. Zebrafish Hoxb1a regulates multiple 
downstream genes including prickle1b. Dev Biol 2007;309(2):358-72. 
 (447)  Douglas SE. Microarray studies of gene expression in fish. OMICS 2006; 10(4):474-489. 
 (448)  Brewer AC, Alexandrovich A, Mjaatvedt CH, Shah AM, Patient RK, Pizzey JA. GATA 
factors lie upstream of Nkx 2.5 in the transcriptional regulatory cascade that effects 
cardiogenesis. Stem Cells Dev 2005; 14(4):425-439. 
 (449)  Brown CO, III, Chi X, Garcia-Gras E, Shirai M, Feng XH, Schwartz RJ. The cardiac 
determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a 
novel upstream enhancer. J Biol Chem 2004; 279(11):10659-10669. 
 (450)  Peterkin T, Gibson A, Loose M, Patient R. The roles of GATA-4, -5 and -6 in vertebrate 
heart development. Semin Cell Dev Biol 2005; 16(1):83-94. 
 (451)  Pan J, Baker KM. Retinoic Acid and the heart. Vitam Horm 2007; 75:257-83.:257-283. 
 (452)  Kwon C, Arnold J, Hsiao EC, Taketo MM, Conklin BR, Srivastava D. Canonical Wnt 
signaling is a positive regulator of mammalian cardiac progenitors. Proc Natl Acad Sci 
(USA) 2007; 104(26):10894-10899. 
 (453)  Naito AT, Shiojima I, Akazawa H et al. Developmental stage-specific biphasic roles of 
Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proc Natl Acad Sci 
(USA) 2006; 103(52):19812-19817. 
 (454)  Tzahor E. Wnt/beta-catenin signaling and cardiogenesis: timing does matter. Dev Cell 
2007; 13(1):10-13. 
 (455)  Eisenberg LM, Eisenberg CA. Wnt signal transduction and the formation of the 
myocardium. Dev Biol 2006; 293(2):305-315. 
 (456)  Stoick-Cooper CL, Weidinger G, Riehle KJ et al. Distinct Wnt signaling pathways have 
opposing roles in appendage regeneration. Development 2007; 134(3):479-489. 
 (457)  McNulty MM, Edgerton GB, Shah RD, Hanck DA, Fozzard HA, Lipkind GM. Charge at 
the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-
gated sodium channels. J Physiol 2007; 581(Pt 2):741-755. 
 (458)  Bennett PB, Yazawa K, Makita N, George AL, Jr. Molecular mechanism for an inherited 
cardiac arrhythmia. Nature 1995; 376(6542):683-685. 
 (459)  Wei J, Wang DW, Alings M et al. Congenital long-QT syndrome caused by a novel 
mutation in a conserved acidic domain of the cardiac Na+ channel. Circulation 1999; 
99(24):3165-3171. 
 (460)  Viswanathan PC, Balser JR. Inherited sodium channelopathies: a continuum of channel 
dysfunction. Trends Cardiovasc Med 2004; 14(1):28-35. 
 238
 (461)  Liu K, Yang T, Viswanathan PC, Roden DM. New mechanism contributing to drug-
induced arrhythmia: rescue of a misprocessed LQT3 mutant. Circulation 2005; 
112(21):3239-3246. 
 (462)  Pfahnl AE, Viswanathan PC, Weiss R et al. A sodium channel pore mutation causing 
Brugada syndrome. Heart Rhythm 2007; 4(1):46-53. 
 (463)  Valdivia CR, Tester DJ, Rok BA et al. A trafficking defective, Brugada syndrome-causing 
SCN5A mutation rescued by drugs. Cardiovasc Res 2004; 62(1):53-62. 
 (464)  Herfst LJ, Rook MB, Jongsma HJ. Trafficking and functional expression of cardiac Na+ 
channels. J Mol Cell Cardiol 2004; 36(2):185-193. 
 (465)  Shah VN, Wingo TL, Weiss KL, Williams CK, Balser JR, Chazin WJ. Calcium-dependent 
regulation of the voltage-gated sodium channel hH1: intrinsic and extrinsic sensors use a 
common molecular switch. Proc Natl Acad Sci (USA) 2006; 103(10):3592-3597. 
 (466)  Crossin KL, Hoffman S. Expression of adhesion molecules during the formation and 
differentiation of the avian endocardial cushion tissue. Dev Biol 1991; 145(2):277-286. 
 (467)  Imanaka-Yoshida K, Knudsen KA, Linask KK. N-cadherin is required for the 
differentiation and initial myofibrillogenesis of chick cardiomyocytes. Cell Motil 
Cytoskeleton 1998; 39(1):52-62. 
 (468)  Linask KK, Manisastry S, Han M. Cross talk between cell-cell and cell-matrix adhesion 
signaling pathways during heart organogenesis: implications for cardiac birth defects. 
Microsc Microanal 2005; 11(3):200-208. 
 (469)  Imanaka-Yoshida K, Matsumoto K, Hara M, Sakakura T, Yoshida T. The dynamic 
expression of tenascin-C and tenascin-X during early heart development in the mouse. 
Differentiation 2003; 71(4-5):291-298. 
 (470)  Burroughs CL, Watanabe M, Morse DE. Distribution of the neural cell adhesion molecule 
(NCAM) during heart development. J Mol Cell Cardiol 1991; 23(12):1411-1422. 
 (471)  Bagatto B, Francl J, Liu B, Liu Q. Cadherin2 (N-cadherin) plays an essential role in 
zebrafish cardiovascular development. BMC Dev Biol 2006; 6:23.:23. 
 (472)  Srinivasan J, Schachner M, Catterall WA. Interaction of voltage-gated sodium channels 
with the extracellular matrix molecules tenascin-C and tenascin-R. Proc Natl Acad Sci 
(USA) 1998; 95(26):15753-15757. 
 (473)  Ratcliffe CF, Westenbroek RE, Curtis R, Catterall WA. Sodium channel beta1 and beta3 
subunits associate with neurofascin through their extracellular immunoglobulin-like 
domain. J Cell Biol 2001; 154(2):427-434. 
 (474)  McEwen DP, Isom LL. Heterophilic interactions of sodium channel beta1 subunits with 
axonal and glial cell adhesion molecules. J Biol Chem 2004; 279(50):52744-52752. 
 (475)  Malhotra JD, Thyagarajan V, Chen C, Isom LL. Tyrosine-phosphorylated and 
nonphosphorylated sodium channel beta1 subunits are differentially localized in cardiac 
myocytes. J Biol Chem 2004; 279(39):40748-40754. 
 239
 (476)  Chopra SS, Watanabe H, Zhong TP, Roden DM. Molecular cloning and analysis of 
zebrafish voltage-gated sodium channel beta subunit genes: Implications for the 
evolution of electrical signaling in vertebrates. BMC Evol Biol 2007; 7(1):113. 
 (477)  Link AJ, Eng J, Schieltz DM et al. Direct analysis of protein complexes using mass 
spectrometry. Nat Biotechnol 1999; 17(7):676-682. 
 (478)  Gould KL, Ren L, Feoktistova AS, Jennings JL, Link AJ. Tandem affinity purification and 
identification of protein complex components. Methods 2004; 33(3):239-244. 
 (479)  Link AJ, Fleischer TC, Weaver CM, Gerbasi VR, Jennings JL. Purifying protein 
complexes for mass spectrometry: applications to protein translation. Methods 2005; 
35(3):274-290. 
 (480)  Fleischer TC, Weaver CM, McAfee KJ, Jennings JL, Link AJ. Systematic identification 
and functional screens of uncharacterized proteins associated with eukaryotic ribosomal 
complexes. Genes Dev 2006; 20(10):1294-1307. 
 (481)  Liu K, Hipkens S, Yang T et al. Recombinase-mediated cassette exchange to rapidly and 
efficiently generate mice with human cardiac sodium channels. Genesis 2006; 
44(11):556-564. 
 (482)  Papadatos GA, Wallerstein PM, Head CE et al. Slowed conduction and ventricular 
tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc 
Natl Acad Sci (USA) 2002; 99(9):6210-6215. 
 (483)  Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of 
myocardial cells. Nat Rev Genet 2005; 6(11):826-835. 
 (484)  Latif S, Masino A, Garry DJ. Transcriptional pathways direct cardiac development and 
regeneration. Trends Cardiovasc Med 2006; 16(7):234-240. 
 (485)  Masino AM, Gallardo TD, Wilcox CA, Olson EN, Williams RS, Garry DJ. Transcriptional 
regulation of cardiac progenitor cell populations. Circ Res 2004; 95(4):389-397. 
 (486)  Novak AE, Taylor AD, Pineda RH, Lasda EL, Wright MA, Ribera AB. Embryonic and 
larval expression of zebrafish voltage-gated sodium channel alpha-subunit genes. Dev 
Dyn 2006; 235(7):1962-1973. 
 
 
